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ABSTRACT 
Poor inhaler technique maintenance amongst patients with asthma is a persistent 
problem.  Importantly, it contributes to suboptimal disease control.  Why inhaler 
technique deteriorates, even in the absence of identifiable barriers (e.g. lack of 
technique education), is unknown.  This thesis aimed to address this gap in knowledge 
via research exploring the phenomenon of inhaler technique maintenance.  This 
research was empirically and theoretically underpinned and conducted in two phases.    
 
The first phase of research was designed to identify the determinants of inhaler 
technique maintenance via quantitative methods.  It involved trained community 
pharmacists delivering inhaler technique education to patients with asthma at baseline 
and re-assessing patients’ technique after one month.  Data were collected on 
patients’ inhaler technique scores, demographics, medical history, clinical factors, past 
inhaler technique education and a range of psychosocial aspects of disease 
management.  Three significant predictors of inhaler technique maintenance were 
identified: 1) device type, 2) asthma control, and 3) motivation to practice correct 
technique [X2 (N=125,3)=16.22, p=.001].  This study revealed, for the first time, the 
important role that patient psychosocial factors, motivation in particular, may play in 
inhaler technique maintenance.    
 
The second phase of research aimed to gain a better understanding of the novel 
relationship identified between patient motivation and inhaler technique maintenance, 
via qualitative methods.  In-depth semi-structured interviews were conducted with 
patients with asthma.  Several themes were found to illuminate why some patients 
possessed higher, whereas others possessed lower, motivation to maintain correct 
inhaler technique.  These themes were: 1) motivation to engage in asthma 
management, 2) motivation to self-manage via a preventative-medication based 
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approach, and 3) self-management self-efficacy.  Health care professionals were also 
found to have an influence on patient motivation to maintain correct inhaler technique, 
particularly amongst those patients who were more receptive to their health care 
providers’ input.  This study deepened understanding of the interrelationships between 
patient psychosocial and behavioural factors in the context of inhaler technique 
maintenance.   
 
The body of work presented in this thesis has generated new insights in the field of 
inhaler technique research.  This work highlights that the key to ensuring optimal 
inhaler technique maintenance may lie in more holistic approaches to inhaler 
technique interventions that address, not only physical skill related barriers, but also 
patient psychosocial barriers in technique maintenance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vii 
 
CONTENTS 
DECLARATION ........................................................................................................... ii 
ACKNOWLEDGEMENTS ............................................................................................ iii 
ABSTRACT ................................................................................................................. v 
COMMUNICATIONS ...................................................................................................xi 
LIST OF TABLES ...................................................................................................... xiii 
LIST OF FIGURES .....................................................................................................xv 
LIST OF ABBREVIATIONS ..................................................................................... xviii 
 
CHAPTER 1: INTRODUCTION TO THESIS ................................................................ 1 
A. Motivation for research ............................................................................................ 2 
B. Approach and scope of research ............................................................................. 5 
C. Structure of thesis ................................................................................................... 7 
 
CHAPTER 2: INHALER DEVICE USE IN PATIENTS WITH ASTHMA, THE 
CURRENT UNDERSTANDING: A LITERATURE REVIEW ........................................ 8 
A. Introduction to asthma ............................................................................................. 9 
i. Asthma burden in Australia ................................................................................... 9 
ii. Asthma pathophysiology, severity and control .................................................... 11 
iii. Medication therapy in asthma ............................................................................ 13 
B. Inhaled medication therapies in asthma ................................................................. 16 
i. The inhaled route and inhaler technique as a determinant of drug deposition ..... 16 
ii. Inhaler technique and its clinical implications ...................................................... 19 
iii. Current inhaler devices and their features.......................................................... 23 
iv. Steps for correct inhaler technique .................................................................... 32 
 viii 
 
C. Inhaler technique in patients with asthma .............................................................. 41 
i. Prevalence of suboptimal inhaler technique ........................................................ 41 
ii. Known barriers to optimal inhaler technique ....................................................... 43 
iii. Suboptimal inhaler technique persists in the absence of known barriers ............ 50 
D. Overarching aim of thesis ...................................................................................... 55 
 
CHAPTER 3: DETERMINANTS OF INHALER TECHNIQUE MAINTENANCE IN 
COMMUNITY BASED ASTHMA PATIENTS IN SYDNEY, A QUANTITATIVE STUDY
 .................................................................................................................................. 56 
A. Background ........................................................................................................... 57 
i. Framework for conceptualising inhaler technique maintenance ........................... 57 
ii. Inhaler technique maintenance from the perspective of patient skill learning ...... 61 
iii. Technique maintenance from the perspective of patient asthma self-management
............................................................................................................................... 71 
B. Aim and hypotheses .............................................................................................. 77 
C. Methods ................................................................................................................ 78 
i. Overview ............................................................................................................. 78 
ii. Phase 1: Study Pharmacists ............................................................................... 78 
iii. Phase 2: Study Patients ..................................................................................... 91 
iv. Study Data ......................................................................................................... 95 
D. Results ................................................................................................................ 107 
i. Pharmacists ...................................................................................................... 107 
ii. Patients ............................................................................................................ 114 
E. Discussion ........................................................................................................... 126 
F. Summary ............................................................................................................. 139 
 ix 
 
CHAPTER 4: INHALER TECHNIQUE MAINTENANCE FROM THE PERSPECTIVE 
OF PATIENT MOTIVATION, A QUALITATIVE STUDY .......................................... 140 
A. Background ......................................................................................................... 141 
i. Defining motivation ............................................................................................ 141 
ii. Empirical evidence to guide an in-depth exploration of patient motivation in inhaler 
technique maintenance. ....................................................................................... 142 
iii. Theoretical underpinning to guide an exploration of patient motivation in inhaler 
technique maintenance. ....................................................................................... 145 
iv. A qualitative, theoretically underpinned study. ................................................. 157 
B. Aim and hypotheses ............................................................................................ 159 
C. Methods .............................................................................................................. 160 
i. Overview ........................................................................................................... 160 
ii. Recruitment and patient sample ....................................................................... 160 
iii. Patient Interviews ............................................................................................ 161 
iv. Data analysis ................................................................................................... 165 
D. Results ................................................................................................................ 170 
i. Recruitment and patient sample ........................................................................ 170 
ii. Patient interviews and emergent themes .......................................................... 174 
E. Discussion ........................................................................................................... 209 
F. Summary ............................................................................................................. 233 
 
CHAPTER 5: SUMMARY AND CONCLUSIONS .................................................... 234 
A. Summary of work ................................................................................................. 235 
B. Recommendations for facilitating optimal inhaler technique maintenance ............ 241 
C. Future research directions ................................................................................... 244 
D. Concluding remarks............................................................................................. 246 
 x 
 
CHAPTER 6: REFERENCES .................................................................................. 247 
 
APPENDICES .............................................................. Error! Bookmark not defined. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xi 
 
COMMUNICATIONS 
Peer-reviewed journal article: 
Ovchinikova, L., Smith, L. & Bosnic-Anticevich, S. 2011. Inhaler Technique  
Maintenance: Gaining an Understanding from the Patient's Perspective. Journal of  
Asthma, 48, 616-24. 
 
Conference presentations: 
Ovchinikova, L., Smith, L. & Bosnic-Anticevich, S.  Determinants of Inhaler Technique 
Maintenance: Patient, Device or Education?  Oral and poster presentation at the 
Thoracic Society of Australia and New Zealand (TSANZ) conference, 2012 (Canberra). 
 
Ovchinikova, L., Smith, L. & Bosnic-Anticevich, S.  Inhaler Technique Maintenance in 
People with Asthma – “Knowing how” is Not Enough.  Oral and poster presentation at 
the Australasian Pharmaceutical Science Association (APSA) conference, 2011 
(Adelaide). 
 
Ovchinikova, L., Smith, L. & Bosnic-Anticevich, S.  The Inhaler Technique 
Maintenance Study in Patients with Asthma.  Oral presentation at the Australasian 
Pharmaceutical Science Association (APSA) conference, 2010 (Brisbane). 
 
Ovchinikova, L., Smith, L. & Bosnic-Anticevich, S.  Inhaler Device Use in Asthma – a 
Literature Review.  Poster presentation at the University of Syndey Faculties of Health 
Research Conference, From Cell to Society, 2008 (Leura). 
 
 
 
 
 
 xii 
 
Faculty presentations: 
Ovchinikova, L., Smith, L. & Bosnic-Anticevich, S.  “Knowing how” is not enough:  
an empirical and theory based investigation into why people with asthma do not 
maintain correct inhaler technique.  Oral presentation at the Faculty of Pharmacy 
Seminar Series (2012) 
 
Ovchinikova, L., Smith, L. & Bosnic-Anticevich, S.  The Inhaler Technique 
Maintenance Study in People with Asthma.  Oral presentation at the Faculty of Post-
graduate Forum (2009) 
 
Ovchinikova, L., Smith, L. & Bosnic-Anticevich, S.  Inhaler Device Use – A Review of 
the Literature to Date.  Oral presentation at the Faculty of Post-graduate Forum (2008) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xiii 
 
LIST OF TABLES 
Table 2.01 Correct inhaler technique for the pressurised Metered Dose 
Inhaler, Turbuhaler™ and Accuhaler™……………………………. 
 
 
 
34 
Table 2.02 Prospective repeated measures studies, showing decline in 
inhaler technique post education, across various settings……… 
 
 
 
51 
Table 3.01 Delivery of the QUIP workshop – strategies to enhance 
pharmacists’ motivation to engage in active learning and their 
implementation……………………………………………………….. 
 
 
 
 
84 
Table 3.02 The QUIP workshop – alignment of aims and content, and 
theoretical basis for content development………………………… 
 
 
 
85 
Table 3.03 Pharmacist data collected during the QUIP workshops and 
method of collection………........................................................... 
 
 
 
95 
Table 3.04 Patient data collected during study – what, how and when……... 
 
 
96 
Table 3.05 Pharmacist recruitment………...................................................... 
 
 
107 
Table 3.06 Pharmacists completing the QUIP workshop in its small group 
and individual format………………………………………………… 
 
 
 
107 
Table 3.07 Pharmacist demographics and past inhaler technique 
education……………………………………………………………… 
  
 
 
108 
Table 3.08 Characteristics of study pharmacies............................................. 
 
 
110 
Table 3.09 Pharmacists’ evaluation of the QUIP workshop – number of 
pharmacists rating “entirely met”, “partially met” or “not met” for 
each item, and any comments written……………………………...  
 
 
 
 
113 
Table 3.10 Demographics and asthma history of study patients…………….. 
 
115 
 xiv 
 
Table 3.11 Inhaler devices used and previous technique education in study 
patients…………………................................................................ 
 
 
 
116 
Table 3.12 The backward logistic regression model, and its 3 significant 
variables, predicting the likelihood of maintaining correct inhaler 
techniquea at one month.…………………..................................... 
 
 
 
 
123 
Table 4.01 Existing studies on motivation and asthma, and their limitations 
for guiding this research…………………………………………….. 
 
 
 
143 
Table 4.02 “Autonomy”, “Competence” and “Relatedness” in the context of 
patient self-management, and how they can be facilitated by 
health care professionals……………………………………………. 
 
 
 
 
156 
Table 4.03 Factors, explored during interviews, hypothesised to influence 
patient motivation in inhaler technique maintenance, with the 
typical questions asked……………………………………………… 
 
 
 
 
162 
Table 4.04 The data analysis conducted in this study as guided by the five 
stages of the Framework approach (Ritchie and Spencer, 
1994)…………………………………………………………………...  
 
 
 
 
168 
Table 4.05 Patient demographic and clinical characteristics…………………. 172 
 
 
 
 
 
 
 xv 
 
LIST OF FIGURES 
Figure 2.01 Influence of patients’ inhaler technique on drug deposition in the 
airways, oropharyngeal area and inhaler device mouthpiece…... 
 
 
 
19 
Figure 2.02 Association between poor inhaler technique, with proposed 
mechanisms of action (a, b, c), and reduced asthma control (d) 
over time………………………………………………………………. 
 
 
 
 
22 
Figure 2.03 The pMDI (A), Turbuhaler™ (B) and Accuhaler™ (C)……….......
  
 
39 
Figure 3.01 The Inhaler Technique Maintenance Framework (ITMF) – a 
conceptual framework for exploring inhaler technique 
maintenance………………………………………………………….. 
 
 
 
 
59 
Figure 3.02 Cornford’s nine defining attributes of skill and skilled 
performance (Cornford,1996)………………………………………. 
 
 
 
62 
Figure 3.03 The three phases of Fitts’ Skill Learning Theory (FSLT) and the 
predominant type of activity that occurs at each phase…………. 
 
 
 
63 
Figure 3.04 The Common Sense Model of Illness Regulation (CSM) (Horne 
and Weinman, 2002, Leventhal et al., 2003)……………………...  
 
 
 
73 
Figure 3.05 Potential predictors of inhaler technique maintenance after 
exploring the Inhaler Technique Maintenance Framework 
(ITMF)………………………………………………………………….   
 
 
 
 
76 
Figure 3.06 The QUIP workshop training room arrangement………………….       
 
 
82 
Figure 3.07 Implementing Fitts’ Skill Learning Theory (FSLT) in the QUIP 
workshop……………………………………………………………… 
 
 
89 
Figure 3.08 The inhaler technique checklists used in this study to assess 
pMDI, Turbuhaler™ and Accuhaler™ techniques………………... 
 
 
 
97 
Figure 3.09 Geographic distribution of study pharmacies……………………... 109 
 xvi 
 
Figure 3.10 A. Pharmacists’ assessment of pMDI technique after viewing 
the pre-recorded video demonstration.  B. Allocation of scores 
using the pMDI checklist to give a correct assessment of the 
video demonstration (i.e. score of 6 out of 11)……………………. 
 
 
 
 
 
111 
Figure 3.11 A. Pharmacist assessment of Turbuhaler™ (TH) technique after 
viewing the pre-reorded video demonstration. B. Allocation of 
scores using the Turbuhaler™ checklist to give a correct 
assessment of the video demonstration (i.e. score of 6 out of 
11)……………………………………………………………………... 
 
 
 
 
 
 
111 
Figure 3.12 A. Pharmacist assessment of Accuhaler™ (ACC) technique 
after viewing the pre-recorded video demonstration. B. 
Allocation of scores using Accuhaler™ checklist to give a 
correct assessment of the video demonstration (i.e. score of 8 
out of 11)……………………………………………………………… 
 
 
 
 
 
 
112 
Figure 3.13 Patient recruitment and retention throughout study……………… 
 
 
114 
Figure 3.14 Proportion of patients maintaining correct inhaler technique one 
month post education………………………………………………... 
 
 
 
117 
Figure 3.15 A. Proportion of patients correctly performing inhaler technique 
steps 1 to 11 required for pMDI administration at visit 1 (pre-
education) and visit 2.  B. Steps for pMDI administration……….. 
 
 
 
 
118 
Figure 3.16 A. Proportion of patients correctly performing inhaler technique 
steps 1 to 11 required for Turbuhaler™ administration at visit 1 
(pre-education) and visit 2. B. Steps for Turbuhaler™ 
administration………………………………………………………… 
 
 
 
 
 
119 
Figure 3.17 A. Proportion of patients correctly performing inhaler technique 
steps 1 to 11 required for Accuhaler™ administration at visit 1 
(pre-education) and visit 2. B. Steps for Accuhaler™ 
administration………………………………………………………… 
 
 
 
 
 
120 
Figure 4.01 “Controlled” versus “Autonomous” motivation and the process of 
“Internalising” Extrinsic motivation in Self-Determination Theory 
(SDT)………………………………………………………………….. 
 
 
152 
 xvii 
 
Figure 4.02 Patient recruitment into this study between March and 
November 2011………………………………………………………. 
 
 
 
171 
Figure 4.03 The Inhaler Technique Maintenance and Motivation (ITMAM) 
model characterising Maintainers and Non-maintainers………… 
 
 
 
197 
Figure 4.04 The influence of therapeutic relationships on inhaler technique 
maintenance………………………………………………………….. 
 
 
 
206 
Figure 4.05 The ITMAM model, highlighting the points when patients 
become most receptive to health care professionals’ (HCP) 
influence, and may most benefit from health care intervention…. 
 
 
 
 
208 
Figure 5.01 Summary of the work presented in this thesis……………………. 
 
240 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xviii 
 
LIST OF ABBREVIATIONS 
ACAM: Australian Centre for Asthma Monitoring 
ACC: Accuhaler™ 
AMH: Australian Medicines Handbook 
BA-MDI: Breath Activated Metered Dose Inhalers 
BMQ-S: Beliefs about Medicines Questionnaire Specific 
CFC: Chlorofluorocarbon 
COPD: Chronic Obstructive Pulmonary Disease 
CPE: Continuing Professional Education 
CSM: Common Sense Model of Illness Regulation 
DPI: Dry Powder Inhaler  
FSLT: Fitts’ Skill Learning Theory 
GINA: Global Initiative for Asthma 
HCP: Health Care Professional 
HFA: Hydrofluoroalkane 
ITBQ: Inhaler Technique Beliefs Questionnaire  
ITMAM: Inhaler Technique Maintenance and Motivation  
ITMF: Inhaler Technique Maintenance Framework 
M: Maintainer 
MARS-5: Medication Adherence Report Scale (5 items) 
NAC: National Asthma Council Australia 
NM: Non-maintainer 
pMDI: pressurised Metered Dose Inhaler  
PSA: Pharmaceutical Society of Australia 
QUIP: Quality Use of Inhalers in Pharmacy workshop 
S-ACQ: Shortened Asthma Control Questionnaire  
SCT: Social Cognitive Theory  
 xix 
 
SDT: Self Determination Theory 
TH: Turbuhaler™  
WIMR: Woolcock Institute of Medical Research 
 
Chapter 1 – Introduction To Thesis 
 1 
 
 CHAPTER 1  
INTRODUCTION TO THESIS 
_____________________________________________________________________ 
“There are not too many things worse than not being able to breathe… It’s terrible, it’s 
frightening, it’s scary.  So it’s very important to be in control” – F.E. 
 
THE STATEMENT ABOVE is from a patient who has been living with asthma, a 
chronic respiratory disease, for the past 20 years.  It was sourced from an interview 
conducted as part of this thesis and offers a window through which the personal 
impact of asthma can be glimpsed.  Asthma, however, is not only a costly disease 
because of its negative impact on the quality of life and productivity of individual 
sufferers, but also because of its burden on the community at large.  Australia has one 
of the highest rates of asthma globally (Australian Centre for Asthma Monitoring and 
Woolcock Institute of Medical Research [ACAM and WIMR], 2011), and the resultant 
costs, to both the patient and community, are not only associated with that of health 
care utilisation, but notably, also due to the consequences of poorly controlled disease 
(Barnes, Jonsson and Klim, 1996).  As such, asthma has been deemed by the 
Australian Government as a National Health Priority Area (Australian Institute of Health 
and Welfare, 2013).     
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A. Motivation for research 
Poor asthma control is a widespread, yet often preventable phenomenon, since 
effective and long standing treatment options are available to mitigate both the acute 
symptoms and underlying inflammation of the disease (Australian Medicines 
Handbook [AMH], 2013).  The efficacy of these treatment options, however, is largely 
dependent on the degree to which patients actively and optimally engage in their use.  
How patients self-manage their asthma, on a day-to-day basis and over time,  is 
therefore a key determinant of asthma outcomes (Smith et al., 2007).  Patients’ 
asthma self-management and how it  may be improved, thus forms the broad 
foundations of this thesis. 
 
Patients with asthma need to effectively engage in a range of self-management 
activities, on a persistent basis, as an important part of maintaining well controlled 
asthma.  Successfully using inhaled therapy is an indispensable part of the asthma 
self-management process.  Fundamental to efficacious inhaled therapy, is whether 
patients are using their asthma inhalers with the correct technique.  That is, patients 
need to use their devices with the correct inhaler technique in order to gain the 
benefits, and reduce the chances of experiencing adverse effects, with their prescribed 
asthma therapy (Haughney et al., 2010, Lindgren, Bake and Larsson, 1987, Mirza et 
al., 2004, Newman 1991).       
 
Suboptimal inhaler technique, however, is demonstrated by large proportions of 
patients (Lavorini et al., 2008, Melani et al., 2004, 2011), and has been since the 
introduction of the first hand-held inhaler device in 1955 (Freedman, 1956).  Incorrect 
inhaler technique, and its cumulative effects over time, is detrimental to patients’ 
asthma.  This is especially so in the context of preventer therapy, aimed at improving 
asthma control by reducing the underlying inflammation of the disease.  Significant 
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associations between poor  asthma control and poor preventer inhaler technique, have 
been shown in large cross sectional studies (Giraud and Roche, 2002) as well as 
randomised controlled trials (Basheti, Reddel, Armour and Bosnic-Anticevich, 2007).           
 
Given the important therapeutic implications of poor inhaler technique, improving how 
patients use their inhalers has attracted much research attention for over fifty years.  
The fruits of this research include: innovations in inhaler device design and the 
availability of a variety of device types to suit a spectrum of patients’ physical needs 
(Dolovich and Dhand, 2011), improvements in drug formulations that, for example, 
result in more comfortable inhalations (Crompton, 1990), and innovations in patient 
education for teaching and learning inhaler technique (Basheti, Armour, Bosnic-
Anticevich, and Reddel, 2008).   
 
Nevertheless, suboptimal asthma outcomes are still being attributed to patients using 
their inhalers with poor technique (Haughney et al., 2008).  Various studies have also 
shown that inhaler technique tends to deteriorate over time.  This can occurin patients 
who demonstrate no physical difficulties using their inhaler device,  and who have 
been educated on inhaler technique  (Bosnic-Anticevich, Sinha, So, Armour, & Reddel, 
2003, 2010, Hardwell et al., 2011).  Despite advancements in treatment technology 
and inhaler technique education over the decades, the improvements patients initially 
achieve in inhaler use do not appear to be maintained over time.  Further, the current 
clinical recommendation to rectify this situation – repeating inhaler technique 
instructions – does not appear to result in lasting improvements either (Basheti et al., 
2007).  The reason/s why patients do not maintain correct inhaler technique over time, 
despite being capable of demonstrating the manoeuvre, remains unknown. 
 
It is at this juncture in the literature, that inhaler technique maintenance in patients with 
asthma was identified as a phenomenon worthy of further research.  Despite the 
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plethora of studies on inhaler device use and technique, no published research had 
focused on investigating the long term maintenance of inhaler technique.  In particular, 
it was not possible to identify any evidence based reasons in response to the question 
of why patients did not maintain correct inhaler technique despite “knowing how” to 
perform correct technique.  Discovering the answers to this important question was 
thus the overarching driver behind the research presented in this thesis.     
 
Overarching research question: 
Why do patients with asthma not maintain correct inhaler technique despite 
“Knowing how”? 
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B. Approach and scope of research 
Quantitative and qualitative studies are presented in this thesis, and both adopt an 
exploratory approach.    An exploratory approach was deemed necessary and 
appropriate, given that the phenomenon of inhaler technique maintenance was being 
examined for the first time, and also because there was a lack of clear evidence to 
inform investigations in this area.  Taking an exploratory approach to this research 
meant that several fields of literature, not only the traditional asthma and inhaler 
technique literature, were consulted.  This resulted in well-established theories and 
empirical evidence being drawn upon in this thesis to underpin both the quantitative 
and qualitative studies presented.   
 
Further, a patient-centred approach, delving into patients’ behaviours, views and 
experiences around asthma, was considered highly relevant to this research.  This 
type of patient-centred stance was found to be clearly lacking in the existing literature 
around inhaler technique and device use.  Published evidence often focuses on the 
inhaler device itself, or inhaler device education centred on the transfer of physical 
skill.  Inhaler technique research, which encompasses behavioural and psychosocial 
considerations, is rare.  This is rather surprising given the clearly recognised need to 
improve patients’ inhaler technique (Haughney et al., 2008, Price et al., 2013) and the 
fact that practicing inhaler technique is an activity embedded in patients’ day-to-day 
asthma self-management.  Factors that influence patients’ self-management behaviour 
would thus seem relevant to consider in the context of inhaler technique maintenance.   
 
The research presented in this thesis is clinically oriented and  set in the context of 
primary health care, specifically,  community pharmacy.  The primary health care 
setting is where the bulk of asthma care occurs in Australia (ACAM and WIMR, 2011).  
Further, the community pharmacy is an ideal environment for  service delivery aimed 
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at optimising asthma medication use  because it is readily accessible to patients.  In 
addition, pharmacists have a fundamental role in ensuring the safe and efficacious use 
of medicines, which   in asthma includes the correct administration of inhaled therapy.   
 
Most patients are likely to access their local pharmacy more frequently than any other 
health care setting for their asthma. .   On every occasion during which a patient 
obtains asthma related medication, a pharmacist will be involved in the interaction.  
This is the case for  preventer, reliever,  and oral asthma medication.  For some 
patients,  the pharmacist may be the only health care professional with whom they are 
in contact for their asthma.  For example, those patients who only use reliever 
medication purchased over the counter at their local pharmacy.  Pharmacists are also 
involved when patients obtain medication for allergic rhinitis, a comorbidity in 80% of 
asthma patients  (Bousquet, Van Cauwenberge, Khaltaev and the WHO, 2001).  The 
important role that community pharmacists have in the context of asthma management 
is further illustrated by  randomised controlled trials showing improved patient and cost 
related outcomes after the delivery of asthma self-management services by 
pharmacists  (Armour et al., 2013). 
 
Pharmacists, based in community pharmacies, are thus in a prime position to improve 
and monitor asthma patients’ medication therapy, including how they maintain inhaler 
technique over time.  In addition, since pharmacists are the community’s medication 
experts, they are the ideal health care professional to be involved in any innovative 
strategies around the quality use of asthma medications that may evolve from the body 
of research in this thesis. Thus the community pharmacy was chosen as the ideal 
setting for the studies of this thesis.      
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C. Structure of thesis 
The ensuing chapters present the first body of research investigating the phenomenon 
of inhaler technique maintenance in patients with asthma.  In particular, the chapters 
address the gap identified in the current literature by: 
 Reviewing the current literature around inhaler device use and technique 
(Chapter 2). 
 Explaining the empirical and theoretical underpinnings guiding both the 
quantitative and qualitative studies conducted (Chapters 3 and 4, section A). 
 Discussing how the study findings deepen our understanding of inhaler 
technique maintenance (Chapters 3 and 4, section E).   
Practical recommendations for how health care professionals can facilitate better 
inhaler technique maintenance in patients with asthma, as well as future directions for 
research, are also advanced (Chapter 5)Ultimately this thesis hopes to contribute in 
some way to reducing the burden of asthma on the community and the individual 
patient by shedding more light on a very fundamental, yet problematic, aspect of 
asthma therapy – maintaining correct inhaler technique.   
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 CHAPTER 2  
INHALER DEVICE USE IN PATIENTS WITH ASTHMA, 
THE CURRENT UNDERSTANDING: A LITERATURE 
REVIEW 
_____________________________________________________________________ 
THIS LITERATURE REVIEW is divided into three sections, A, B and C.  Section A 
highlights the fact that asthma remains a high burden disease in Australia despite the 
availability of effective treatment options in the form of inhaled therapy.  Section B 
provides a more in depth view of inhaled asthma therapy, with a focus on patients’ 
inhaler technique as a significant determinant of the efficacy of inhaled therapy and 
therefore, patients’ asthma control status.  Finally, section C reviews the prevalence of 
poor inhaler technique amongst asthma patients, explores the barriers to good 
technique, and concludes by highlighting the problem of the poor inhaler technique 
maintenance in  the absence of known barriers.  
 
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A. Introduction to asthma 
Asthma is a high burden disease in Australia for individual sufferers, their families and 
the community at large.  This section examines the burden  of asthma at multiple 
levels, outlines asthma pathophysiology, examines the difference between asthma 
severity and control, and outlines the main classes of medication used in current 
asthma therapy.    
    
i. Asthma burden in Australia  
The prevalence of asthma in Australia is one of the highest by international 
comparison, with the latest figure on the incidence of asthma at approximately 10% in 
both adults and children in the year 2007-8 (ACAM and WIMR, 2011).  Death caused 
by asthma is the gravest result of the disease, and here Australian mortality rates also 
remain one of the highest internationally with the latest statistics attributing four 
hundred and eleven deaths due to asthma in 2009, representing 0.29% of all deaths 
that year (ACAM and WIMR, 2011).  Fortunately, deaths due to asthma have been on 
the decrease since its last peak in the late 1980s and are a relatively uncommon 
occurrence today (ACAM and WIMR, 2011, Garrett, Kolbe, Richards, Whitlock, and 
Rea, 1995).  However, it should be noted that the burden of asthma is not evenly 
distributed within Australian society, with both prevalence and death due to asthma 
overrepresented in some populations, namely amongst those from areas of lower 
socio-economic status and indigenous Australians (ACAM and WIMR, 2011).  
 
Simply having an asthma diagnosis is associated with reduced quality of life in both 
the physical and psychosocial domains for individual patients. People diagnosed with 
asthma experience reduced physical functioning (Marks et al., 2007), reduced 
participation in social roles (Collins et al., 2008, King, Kenny and Marks, 2009), 
increased depression and anxiety (Scott et al., 2007, Vuillermin et al., 2010, Wilson et 
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al., 2010) and poor perceived health status (ACAM and WIMR, 2011).  The physical 
and psychosocial burden of asthma is exacerbated by poorly controlled disease 
(Vollmer et al., 1999).  Poor levels of disease control are a common feature amongst 
asthma patients (Haughney et al., 2008), characterised by frequent symptoms and 
symptom exacerbations (National Asthma Council Australia [NAC], 2006).   
 
Fortunately effective pharmacological treatments to bring asthma under control are 
available.  Typically over half the government’s total expenditure ($606 million in 2004-
05) on asthma health care is attributed to subsidising such medicines via the 
Pharmaceutical Benefits Scheme (ACAM and WIMR, 2011), reflecting the priority 
given to pharmacological management in asthma.  Poorly controlled asthma, however, 
persists despite these support mechanisms (availability of effective medication at 
subsidised cost), suggesting that these health care resources are not being utilised to 
their full benefit and that most patients with poor disease control are shouldering an 
unnecessary burden.   
 
On a societal level, poor disease control is an economic burden.  Greater demand for 
emergency or acute health care services due to uncontrolled asthma is more costly 
than planned treatment (Barnes et al., 1996, Boyd et al., 2009, Castro et al., 2003).  
Indirect economic costs related to poorly controlled asthma can result from lost 
productivity arising from days away from work, study and performance of other 
necessary duties (ACAM and WIMR, 2011, NAC, 2006).  Asthma, and in particular, 
poorly controlled asthma, is thus a significant burden, associated with increased costs, 
to both the patient and community. 
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ii. Asthma pathophysiology, severity and control 
Patients with asthma suffer from a complex, heterogeneous respiratory disease 
characterised by chronically inflamed airways that are hypersensitive to a range of 
stimuli, resulting in widespread variable airflow obstruction.  Airways inflammation is 
chronic and is mediated by many different cells and cellular components, whereas 
airways narrowing is episodic and triggered by allergens or non-allergens such as 
acute respiratory infections, gastor-oesophageal reflux, tobacco smoke, air pollutants, 
occupational chemicals, certain drugs, cold air and exercise.  Symptoms of asthma 
include wheezing, shortness of breath, chest tightness and coughing, particularly at 
night or in the early morning, and are typically reversible with or without acute 
treatment (i.e. reliever medication) (Global Initiative for Asthma [GINA], 2012, NAC, 
2006).   There is no firm evidence regarding the cause/s of asthma, although it has 
been associated with environmental (e.g. viral infections), lifestyle (e.g. tobacco 
smoking) and genetic factors (e.g. atopy) (ACAM and WIMR, 2011).   
 
The severity of asthma varies among individuals and relates to the extent of underlying 
disease as well as its responsiveness to treatment (Greening, Stempel, Bateman and 
Virchow, 2008, Fuhlbrigge, 2004).  Symptoms can present as mild and episodic in 
some individuals, compared to severe and persistent in others.  In a few individuals, 
asthma can be very severe, life threatening and resistant to pharmacological 
treatment, even at maximal doses (GINA, 2012).  Severe asthma can be attributed to 
both environmental and genetic factors, however the actual occurrence of severe 
disease is very rare and in general, the majority of patients are treatment responsive 
(Barnes, 2013).  Despite the variation in asthma severity amongst individuals, the goal 
of treatment remains unchanged, and that is to achieve and maintain optimal asthma 
control (GINA, 2012).   
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Asthma control refers to the prevention or management of the negative impact of the 
disease on individuals (Juniper, 2007, Taylor et al., 2008).  To have well-controlled 
asthma means that the patient experiences minimal symptoms, symptom flare-ups, 
and interference with usual activities and has normal lung function (Clatworthy et al., 
2009).  Well-controlled asthma indicates that a patient’s asthma is mild in severity (i.e. 
well controlled with minimal need for regular medication), or that their asthma is well 
managed (i.e. well controlled with regular medication treatment).  On the contrary, poor 
asthma control indicates that a patient’s asthma is either more severe or is poorly 
managed (Fuhlbrigge, 2004).  In this way, the concepts of asthma control and asthma 
severity are related.  
 
Classification of asthma according to asthma control rather than asthma severity has 
taken precedence in the clinical management of asthma in recent years (Humbert, 
Holgate, Boulet and Bousquet, 2007).  Earlier, classifying asthma according to its 
severity was the recommendation for clinical practice, to aid in the selection of 
appropriate medication therapy, although its practical application proved to be limited.  
This is the case because asthma severity measures disease status in the absence of 
medication treatment (Taylor et al., 2008).  This limits its clinical use in adjusting 
treatment appropriately (stepping up or down) in line with changing symptom 
presentation.  Severity classifications also do not account for the potential change in 
disease severity over time – the degree of asthma severity, although a relatively stable 
disease feature, is not fixed and can vary over months or years.  Asthma severity 
measures thus have a static quality in the face of a dynamic disease.  Further, asthma 
severity measurements are not validated, nor well adopted in the primary care setting 
(Humbert et al., 2007). 
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Clinical assessment of asthma control taps into factors such as the frequency of 
symptom experience, exacerbations, night time asthma, reliever/rescue medication 
use, degree of physical limitations in daily activities, current lung function and degree 
of airway hyperresponsiveness (Juniper, 2007, Ko et al., 2009, Revicki and Weiss, 
2006).  Thus, unlike asthma severity, asthma control measurements account for 
individuals’ asthma status both in the presence and absence of medication 
(Fuhlbrigge, 2004).    Asthma control measurements can be taken at any point in time 
and various validated instruments for measurement are available for use (Boulet, 
Boulet and Milot, 2002, Juniper, O'Byrne, Guyatt, Ferrie and King, 1999, Juniper, 
Svensson, Mork and Stahl, 2005, Nathan et al., 2004, Schatz et al., 2007).  This 
renders asthma control a useful tool to aid ongoing monitoring of the responsiveness 
of disease to different treatment regimens and adjustment of medication in accordance 
with fluctuating asthma symptoms, as recommended in national and international 
guidelines (GINA, 2012, NAC, 2006).     
 
iii. Medication therapy in asthma  
Medication treatment is key in asthma management and with the current therapies 
available, the goal for well controlled asthma is attainable even in patients who have 
severe asthma (Therapeutic Guidelines, 2012a).  There are currently three main 
classes of pharmacological agents available: “relievers”, “preventers” and “symptom 
controllers”.  While relievers target asthma symptom relief, preventers and symptom 
controllers mainly target symptom prevention (AMH, 2013).    
 
Reliever medications, also known as bronchodilators, are inhaled and provide rapid 
symptomatic relief within a matter of 5 to 15 minutes (AMH, 2013). They are used on 
an as-needed basis during symptom exacerbations (bouts of shortness of breath, 
chest tightness and wheezing), or for the immediate prevention of exercise induced 
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asthma.   Beta2agonists (salbutamol and terbutaline) are the most commonly used 
reliever medications, although occasionally, short-acting anticholinergic drugs 
(ipratropium) are also used (AMH, 2013).   
 
Preventer medications ease the airways inflammation and control asthma by reducing 
the incidence of symptom onset and exacerbation.  Currently, inhaled corticosteroids 
(beclomethasone, budesonide, fluticasone and ciclesonide) used in low doses, are 
highly effective for attaining well controlled asthma in most adult patients (Therapeutic 
Guidelines, 2012b, Adams, Bestall and Jones, 2000, Powell and Gibson, 2003).  
Regular (daily or twice daily) inhaled corticosteroid preventer therapy is recommended 
for people experiencing persistent symptoms of asthma.   
 
Oral medications (montelukast and zafirlukast) can also be used as preventive 
therapy, however they are less effective compared to inhaled corticosteroids (Chauhan 
and Ducharme, 2012), and in Australia treatment can be costly for people over 12 
years of age in whom these medications (montelukast and zafirlukast) are not 
subsidised by the government (Australian Government Department of Health and 
Ageing, 2014).  Inhaled corticosteroids remain the pillar of asthma control therapy.  
Preventer medication regimens need to be reviewed regularly and be adjusted with the 
aim of using the lowest possible dose of inhaled corticosteroids (to reduce the 
likelihood of drug side effects) while maintaining the best possible level of asthma 
control (AMH, 2013, Therapeutic Guidelines, 2012b).   
  
Symptom controller medications, in the form of long-acting beta2agonists (salmeterol 
and formoterol), are used in combination with inhaled preventer therapy to achieve 
equivalent or better levels of asthma control whilst reducing the amount of inhaled 
corticosteroids required.  This “corticosteroid sparing” effect of symptom controllers 
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reduces the likelihood of side effects resulting from high doses of inhaled 
corticosteroids (Kuna et al., 2007).  
 
Recently, the combination of rapid onset long-acting beta2agonists  with inhaled 
corticosteroids has been approved to be used in people with asthma (12 years and 
over) for the dual purposes of symptom relief as well as prevention.  The Symbicort™ 
maintenance and reliever program (SMART) makes use of formoterol (long-acting 
beta2agonist) and budesonide (inhaled corticosteroid) in one combined formulation and 
is prescribed on a daily (for asthma control) and an as-needed (for symptom relief) 
basis (Bateman et al., 2010, Welsh and Cates, 2010).  
 
Over the past decade there has also been an injectable drug available to people with 
moderate to severe allergic asthma.  Omalizumab is an immunoregulatory medication 
(anti-IgE monoclonal antibody), given every two to four weeks, and can be used 
effectively in conjunction with inhaled corticosteroids to achieve asthma control 
(Walker, Monteil, Phelan, Lasserson and Walters, 2006).  The cost of this medication 
($425 per 150mg vial in June 2012) can be prohibitive for widespread use in Australia; 
subsidies to patients are only granted in exceptional cases under the S100 Highly 
Specialised Drugs scheme (Australian Government Department of Health and Ageing, 
2014).  The three main classes of inhaled therapies described earlier (relievers, 
preventers and symptom controllers), however, are subsidised and/or much less costly 
to produce, and are therefore much more accessible to patients.  Importantly, these 
inhaled therapies are also highly effective in keeping asthma well controlled in the 
majority of patients, provided they are used to appropriately.  The next section will 
focus on inhaled medication therapies in asthma.   
 
 
 
Chapter 2 – Literature Review  
 16 
 
B. Inhaled medication therapies in asthma 
Asthma therapies are predominantly administered via the inhaled route using small 
hand-held inhaler devices (AMH, 2013, Rees, 2005).  In this section, the literature 
regarding the importance of correct inhaler technique for the efficacy of inhaled 
therapy is discussed, and  the steps required for correct inhaler technique for three of 
the most commonly used inhaler devices in asthma therapy are outlined and 
explained.    
 
i. The inhaled route and inhaler technique as a determinant of 
drug deposition 
Medications delivered via the inhaled route directly target the site of action in asthma – 
bronchial smooth muscles and tissues of the respiratory tract – and are immediately 
absorbed via the vast epithelial surface areas of the lung.  Direct delivery to the 
airways reduces the amount of medication required to produce therapeutic results 
(Newman and Clarke, 1983) by up to ten fold (McFadden, 1995).  This therefore 
reduces the potential for systemic side effects (Newhouse and Dolovich, 1986), and 
also results in faster onset of action, which is critical for obtaining rapid relief during 
asthma exacerbations (Everard, 2001).  
 
The deposition of inhaled drug in the lung, and therefore its clinical efficacy, is 
dependent on various factors, including the formulation and design of the inhaler 
device, patient airway anatomy, the properties of the aerosol cloud generated and 
patient inhaler technique (Haughney et al., 2010).  Of these, patient inhaler technique 
is the only immediately modifiable factor.  Importantly patient inhaler technique also 
has a direct influence on the physical properties of the aerosol generated, as explained 
below.   
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Each time a dose of drug is discharged from an inhaler device it takes the form of an 
aerosol cloud, a rapidly moving suspension of particulate matter in the air.  Ideally the 
particles of drug in the aerosol should be from 1 to 5 microns (Frijlink and De Boer, 
2004) to enable drug deposition both in the large and conducting airways (target for 
bronchodilator therapy) and in the inflamed tissues in the smaller peripheral airways of 
the lungs (target for inhaled corticosteroid therapy) (Haughney et al., 2010). Larger 
particles  tend to deposit in the upper airways and the mouth/oropharyngeal area, 
where they have no clinical effect but can cause local and systemic (when swallowed) 
side effects (Haughney et al., 2010).  Smaller particles, on the other hand, can be 
exhaled and lost with the next breath, although this drug loss can be considered to be 
off-set by the greater extent that smaller particles deposit in the lungs compared to 
larger particles (Martin, 2008, Newman and Clarke, 1983, Orehek, Gayrard, Grimaud 
and Charpin, 1976).   
 
In relation to patient inhaler technique – the positioning of the mouthpiece, the force 
and speed of inhalation from an inhaler device, whether breath was exhaled before 
inhalation and held after inhalation, and how inhalation and dose actuation is 
coordinated – are examples of specific steps which influence the physical properties of 
the aerosol such as the size of drug particles and the speed and direction of the 
aerosol cloud, and therefore the location and degree of deposition of the inhaled drug 
(Newman and Clarke, 1983).    
 
Various clinical studies demonstrate the direct relationship between patient inhaler 
technique and inhaled drug deposition, showing diminished drug deposition in the lung 
as a result of sub-optimal inhaler technique.  For example, Leach, Davidson, 
Hasselquist and Bodureau (2005) showed (using HFA-134a-beclomethasone 
dipropionate radiolabeled with technetium-99m) that patients who used their 
pressurised Metered Dose Inhaler with better technique had 22% more drug 
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depositing in their lungs compared to those patients with poor technique.  These 
findings, i.e. significant reductions in lung drug deposition as a result of poor inhaler 
technique, are echoed in other studies employing similar methods (Newman, 1991).  
Further it is possible that in some cases of poor inhaler technique, no drug actually 
deposits in the lungs (Newman 1991).   
 
Since patients’ inhaler technique influences the physical properties of the drug aerosol 
and its deposition, this means that it can impact on the degree to which drug deposits 
both in the patient’s airways, where it is desired for clinical efficacy; as well as in the 
patient’s oropharynx and the inhaler device mouthpiece, where deposition is not 
desired as it increases the risk of local side effects and reduces the available dose 
respectively (Mirza, Kasper Schwartz and Antin-Ozerkis, 2004, Newman, 1991).  This 
is illustrated in Figure 2.01.  Thus the benefits of administering asthma medication via 
the inhaled route can only be gained if patients use their inhaler devices with optimal 
technique (Cochrane, Bala, Downs, Mauskopf and Ben-Joseph, 2000, Dolovich and 
Dhand, 2011). 
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Figure 2.01: Influence of patients’ inhaler technique on drug deposition in the airways, 
oropharyngeal area and inhaler device mouthpiece. 
 
 
 
 
 
 
 
 
 
 
 
 
ii. Inhaler technique and its clinical implications  
Patients’ inhaler technique, in using both asthma reliever and preventer therapy, is a 
vital determinant of the therapeutic efficacy, as well as the propensity for adverse 
effects of these treatments.  In regard to reliever therapy, inhaler technique can 
influence the rapidity and degree of symptom relief obtained.  Poor inhaler technique 
with reliever medication is associated with reduction in bronchodilatory relief obtained 
(Shim and Williams Jr, 1980) to the magnitude of 30% (Lindgren et al., 1987).  In the 
face of inadequate symptom relief, additional doses of reliever medication are likely to 
be used by patients, which  can result in unnecessarily excessive amounts of 
medication being used,  increasing the likelihood of adverse drug effects such as 
tremor, palpitations and headache (AMH, 2013).  However, it should be noted that 
even with poor inhaler technique, patients often still obtain adequate symptom relief 
with their short-acting medication.  Further, with reliever therapy, there is immediate 
feedback in the event of inadequate relief (i.e. patients will notice if their symptoms 
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have not improved), which prompts further action such as taking another dose or 
seeking urgent medical care.      
 
The consequences of poor inhaler technique with preventer therapy, however, are not 
immediately detectable by the patient.  What is of clinical concern is that asthma 
control can be compromised as a result of undetected and persistently poor inhaler 
technique over time with preventer therapy (Haughney et al., 2008).  Achieving and 
maintaining good asthma control often remains problematic despite the availability of 
effective preventative treatment (outlined in section A, iii) (Giraud, Allaert, and Roche, 
2011).  Although the factors contributing to poor asthma control are multi-factorial (e.g. 
smoking, co-morbid rhinitis, resistance to therapy and patient perceptual barriers) 
(Haughney et al., 2008), poor inhaler technique has been consistently shown to be an 
independent and significant contributor (Basheti et al., 2007, Giraud et al., 2011, 
Giraud and Roche, 2002).       
 
The association between poor inhaler technique (with preventer therapy) and reduced 
asthma control has been demonstrated in many studies, several of which are large 
scale clinical studies (Basheti et al., 2007, Giraud et al., 2011, Giraud and Roche, 
2002, Lindgren et al., 1987, Melani et al., 2011, Molimard and Le Gros, 2008).  For 
instance, data from 4362 patients with persistent asthma in an European hospital 
outpatient setting reveal that those demonstrating optimal inhaler technique were more 
likely to have good asthma control (63% good control)  compared to those 
demonstrating poor inhaler technique (47% good control) (Molimard and Le Gros, 
2008).  Further, amongst 3955 adult patients with asthma in a general practice setting, 
not only was inhaler technique significantly associated with asthma control but, 
interestingly, it was shown that asthma control worsened as the number of inhaler 
technique mistakes increased (Giraud and Roche, 2002).  In Australia, randomised 
control trials solely focused on inhaler technique have also shown a significant 
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association between patients’ inhaler technique and asthma control status, and have 
highlighted a trend toward worse asthma control with poorer inhaler technique (Basheti 
et al., 2007).  
 
Inhaler technique can affect the level of asthma control in various ways (Basheti et al., 
2007, Price, Thomas, Mitchell, Niziol, and Featherstone, 2003).  As shown earlier, 
poor inhaler technique reduces the degree of medication depositing in the target sites 
in the airways (Leach et al., 2005, Newman, 1991), which results in less than the 
intended treatment dose available and therefore diminishes the efficacy of preventer 
therapy to control the underlying inflammation in asthma, leading to poor asthma 
control.   Further it may be speculated that, from the patient’s perspective, amongst 
those with suboptimal inhaler technique, the chances of experiencing and perceiving 
the benefits of preventer therapy (i.e. better asthma control and therefore less 
symptom experience) is reduced; yet simultaneously, the chances of experiencing and 
perceiving the adverse effects of preventer therapy (e.g. local side effects such as oral 
candidiasis) is increased, and that with these two sets of beliefs, patients may be less  
motivated to use their preventer therapy.   
 
To elaborate on the situation from the patient’s perspective, the lack of perceived 
benefit of preventer therapy may be attributed to the reduced therapeutic efficacy of 
medication inhaled with poor technique, as described earlier.  On the other hand, 
perceived harm of preventer therapy can be attributed to the fact that poor inhaler 
technique increases the likelihood of drug deposition in the oropharyngeal area, which 
with the use of inhaled corticosteroids leads to higher incidence of oral mucosal 
irritation, candidiasis and dysphonia (McFadden, 1995, Mirza et. al., 2004, Roland, 
Bhalla and Earis, 2004).  Although these local side effects do not generally pose a 
serious health threat in-and-of themselves, they may reduce patient motivation to use 
preventer therapy regularly.  The proportion of patients who discontinue preventer 
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therapy after experiencing inhaled corticosteroid induced oropharyngeal side effects 
has been shown to be as high as 31%, and further, patients who report these side 
effects were more likely to have poor asthma control (Fitzgerald, Chan, Holroyde and 
Boulet, 2008).  Thus, preventer therapy, administered with poor inhaler technique can 
compromise asthma control in various ways, directly (reduced dose of drug reaching 
airways) and indirectly (reduced patient motivation to use preventer therapy).  These 
mechanisms are illustrated in Figure 2.02 below.  
 
Figure 2.02: Association between poor inhaler technique, with proposed mechanisms 
of action (a, b, c), and reduced asthma control (d) over time. 
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iii. Current inhaler devices and their features   
In this section, the range of inhaler devices currently available for asthma treatment 
and their features is examined.  An awareness of the features of various inhaler 
devices, how they compare and contrast, and how their design and technology have 
evolved over time can perhaps lead to a greater appreciation of the steps which need 
to be taken to ensure optimal administration (explained in the next section: B, iv).  In 
current clinical practice, inhaled therapy is delivered either via nebulisers or hand-held 
inhaler devices consisting of either pressurised Metered Dose Inhalers (pMDIs) or Dry 
Powder Inhalers (DPIs) (Dolovich and Dhand, 2011).  These three classes of inhaler 
devices/systems are discussed in detail below.     
 
1. Nebulisers 
Nebulisers are devices that generate aerosols from solution or suspension (Dolovich 
and Dhand, 2011) and have been used for centuries to treat lung conditions (Muers, 
1997).  Early nebulisers (1930s) used in asthma were cruder in design and technology 
and would generate aerosol outputs consisting of a wide range of particle sizes, much 
of which was non-respirable, they  were also more costly and fragile, being made of 
glass (Muers, 1997).  Current nebulisers have been improved so that the aerosols 
generated will more likely be in the respirable size range, i.e. 1-5 microns.  They are 
available as either jet nebulisers (where liquid is converted to mist driven by 
compressed gas) or ultrasonic nebulisers (where liquid is converted to mist driven by 
an ultrasonically vibrating crystal) (Dolovich and Dhand, 2011).  Nebulisers, once set 
up for use, do not require any special technique on the patient’s part to consume the 
dose.  The inhalation procedure is relatively passive, and this makes nebulised therapy 
suitable for some patient populations who do not have the functional capacity to self-
administer treatment using hand-held inhaler devices, such as young children below 
the age of five or six (Dolovich and Dhand, 2011, Haughney et al., 2008).       
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Nebulisers, in comparison to hand-held inhaler devices, however, remain more costly, 
bulky and inconvenient to administer.  That is, they are not portable, require electricity, 
are noisy, and a single dose requires 5-10 minutes to fully inhale (Therapeutic 
Guidelines, 2012c).  Nebulisers also have  low dose consistency and poor delivery 
efficiency (Chrystyn and Price, 2009, Dolovich and Dhand, 2011).  Local side effects 
such as skin and eye irritation often result when nebulisers are used with a face mask.  
Nebulisers also require thorough cleaning in order to decontaminate all of the 
connecting tubing and mouthpiece or mask.  Generally, nebulised therapy in asthma 
can be readily replaced with hand-held inhaler devices that are more convenient (e.g. 
small and portable, quicker dosing), less costly, and when used properly, are just as 
therapeutically effective as nebulised therapy (Amirav and Newhouse, 1997, Cates, 
2003, Turner, Patel, Ginsburg and FitzGerald, 1997).   
 
2. Hand-held inhaler devices 
The first hand-inhaler device was a pressurised Metered Dose Inhaler (pMDI) 
introduced in 1955 and formulated with adrenaline and isoprenaline for asthma reliever 
therapy (Freedman, 1956).I  It was considered a breakthrough as it superseded the 
need for inconvenient and costly nebulised therapy.  The successful uptake of the 
pMDI fuelled further innovations in inhaler device therapy, and the first DPI, the 
Spinhaler™, was introduced in 1971 (Bell, Hartley and Cox, 1971).  Currently there is 
a large range of hand-held inhaler devices that have been developed from these 
original prototypes.  The advantage of this large range is that it allows inhaler device 
therapy to be tailored to individual patient preferences and needs.  For this to be of 
practical significance however, care and attention by health care professionals and 
patients must be given to appropriate inhaler device selection and use, especially 
considering that each device will have different requirements for optimal use due to 
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their unique features.  The features of the most commonly available pMDIs and DPIs 
for asthma treatment are examined below.       
 
a. Pressurised Metered Dose Inhalers   
The physical design of current pMDIs remains very much unchanged from its original 
form.  Current pMDIs are small and portable and consist of a cylinder shaped canister, 
containing approximately 200 doses of drug in solution or suspension (AMH, 2013, 
Dolovich et al., 2005). This canister is inserted into an outer plastic casing which at the 
other end has a nozzle projecting into a rectangular mouth piece. Doses of drug are 
emitted automatically and driven by propellant when the patient pushes down on the 
top of the canister.  As the emitted dose is consistent each time, the device is called a 
“metered-dose” inhaler.   
 
There has, however, been a major change in the formulation of drugs made for use 
with pMDIs as a result of the phasing out of Chlorofluorocarbon (CFC) propellants 
between 1994 and 2005 (under The Montreal Protocol on Substances that Deplete the 
Ozone Layer) (Hendeles, Colice, and Meyer, 2007).  Hydrofluroalkane (HFA) 
propellants have since been used in place of CFC propellants and this has altered 
some of the physical characteristics of the aerosol cloud generated from pMDIs, which  
in turn may have therapeutic implications both directly (via changes in degree of drug 
deposition) and indirectly (by affecting patient handling) (Dolovich, 1999).  
Hydrofluoroalkane containing formulations produce finer drug particles and warmer 
and softer aerosol clouds compared to CFC containing formulations (Gabrio, Stein, 
and Velasquez, 1999).  The finer drug particles produced has been shown to result in 
enhanced drug deposition to the distal airways of the lungs, with one study indicating a 
48% increase in airways deposition from 7% with CFCs to 55% with HFAs (Haughney 
et al., 2010).   Further, the warmer and softer (i.e. lower impact force) aerosol cloud 
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produced by HFAs reduces the “cold-freon effect” typical of CFC containing aerosols.  
The cold-freon effect is a sudden, cold sensation felt at the back of the throat from the 
impact of a fast-moving CFC containing aerosol cloud, which would often stop patients 
from completing their inhalation properly and thus hinder optimal pMDI use (Crompton, 
1990).  Although the introduction of HFA propellants may have reduced the cold-freon 
effect and therefore potentially improved pMDI use,  other aspects of pMDI use can 
still pose a challenge for many patients. 
 
The ability to coordinate dose actuation and inhalation is a critical requirement for 
optimal pMDI use.  Patients must be able to actuate a dose (by pressing down on top 
of the canister) and then inhale the dose simultaneously, with 0-0.2 seconds being the 
optimum time frame to start inhaling after releasing a dose (Broeders, Molema, Hop 
and Folgering, 2003). This narrow time window perhaps illustrates why so many 
patients find the coordination steps with pMDI use to be challenging (Hampson and 
Mueller, 1994). There is evidence to show that a 90% reduction in drug deposition 
occurs if a patient starts to inhale a mere one second after dose actuation (Fink and 
Rubin, 2005).    
 
Recently it has been argued that perfect coordination perhaps should not be the goal, 
and that rather, it is just as therapeutically effective for patients to start with a slow 
inhalation of a few seconds first, which is then followed by actuation of the dose with 
continued inhalation  for approximately 5 seconds (Haughney et al., 2010).  Although 
this sequence of manoeuvres may be less difficult to master, patients must still ensure 
they are correctly performing other critical elements of pMDI technique, namely that 
their inhalation is slow, steady and continuous.  This type of breathing pattern is 
important because the cloud of aerosol that is emitted from a pMDI is travelling rapidly 
(10 - 100m/sec) and requires sufficient time to slow down in order for the drug particles 
to reduce to sizes small enough to settle in the distal airways of the lungs (Hiller, 
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Mazumder, Wilson, Renninger, and Bone, 1981).  Many patients however find difficulty 
with performing these critical steps, which unfortunately reduces the potential for drug 
efficacy while increasing the potential for adverse drug effects with pMDI therapy.  
 
〉 Breath Activated Metered Dose Inhalers (BA-MDI) 
Breath Activated Metered Dose Inhalers (BA-MDI) were designed with the intention to 
reduce the coordination difficulties patients found with pMDI use.  Breath Activated 
Metered Dose Inhalers are almost identical in appearance to pMDIs, similar in shape 
and size.  They use the same pressurised canister, with the addition of a lever at the 
top of the device.  The lever is pulled up in order to prime the BA-MDI for use, after 
which the patient begins to inhale through the mouth piece.  Only when the patient 
reaches an inspiratory rate of approximately 30 L/min ( the rate required to trigger the 
rotation of a vane in the device responsible for dose release) is the dose actuated 
(Ruggins Milner, and Swarbrick, 1993).   
 
Breath Activated Metered Dose Inhalers therefore do not require patients to have the 
level of coordination that pMDIs do, and are thus considered to be an easier to use 
device (Hampson and Mueller, 1994), and an option that can result in better asthma 
control (Price et. al., 2003).  However, Newman (1991) showed that while BA-MDIs are 
beneficial in patients who find difficulty with pMDI coordination steps, they do not 
confer any benefit to those patients who can use their pMDI correctly.   
 
Further, although some patients may find BA-MDIs easier to use than pMDIs, care 
must still be taken to ensure correct BA-MDI use, that is, patients are still required to 
perform an optimal inhalation that is slow, steady and continuous, just as for the pMDI 
(since the properties of the aerosol cloud, once actuated from a BA-MDI, are similar to 
those of a pMDI, the same principles regarding optimal inhalation apply).   
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Finally, a practical implication with the BA-MDI is that, unlike the pMDI, there are only 
a limited number of drugs formulated for this device (AMH, 2013) and so it often does 
not present as an option to patients for asthma therapy.      
 
〉 Spacers 
Spacers are an add-on device and used in conjunction with a pMDI, connected to its 
mouthpiece.  Spacers are available in a variety of shapes and sizes, however as its 
name implies, the spacer’s essential function is to create a space between the moving 
aerosol cloud and the patient’s mouth.  Using spacers can improve the therapeutic 
efficacy obtained from treatment with pMDIs.   
 
Spacers can increase the likelihood of optimal pMDI use in those patients who have 
difficulty with pMDI coordination steps.  That is, spacers allow patients to actuate and 
then inhale the drug dose in two separate steps, rather than simultaneously.  The use 
of spacers also enables the aerosol cloud to develop more favourable characteristics 
before it is inhaled by the patient.  The size and speed of the drug particles in the 
aerosol cloud are reduced (due to evaporation of the aerosol cloud and the impaction 
of larger particles on the spacer’s inside surfaces) as they travel through the spacer 
(Lavorini and Fontana, 2009).  These physical drug properties enhance therapeutic 
efficacy and reduce the potential for adverse drug effects, as discussed earlier (section 
B, ii).   
 
Despite the benefits that the use of spacers offer to patients on pMDI therapy, uptake 
of  these add-on devices is poor, and may be related to the perceived inconvenience 
of using such a bulky device (Brennan, Osman, Graham, Critchlow, and Everard, 
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2005, Rees, 2005, Virchow 2004).  A recent review indicated that spacers are patients’ 
least preferred device (Capstick and Clifton, 2012).  
 
b. Dry Powder Inhalers  
Dry Powder Inhalers were introduced approximately two decades after the first pMDI.  
In their physical design features they are markedly different compared to pMDIs with 
the only commonalities being that DPIs are also small, portable and hand-held.  Dry 
Powder Inhalers, as the name indicates, contains drug formulated as inert dry powder. 
DPIs are available in a much wider variety of shapes and forms than pMDIs and can 
be classified as either single-dose or multiple-dose devices.  Single dose DPIs require 
patients to load the medication (formulated in individual capsules) into the device 
during each use, examples include the Aerolizer™, Spinhaler™, Handihaler™ and 
Rotahaler™.   Multiple-dose DPIs can either contain many individually blister-packed 
doses that sit within the device, e.g. the Accuhaler™; or an enclosed drug reservoir, 
e.g. the Turbuhaler™.  Dry Powder Inhalers are often embedded with dose counters to 
aid in the tracking of medication use (Aerosol Drug Management Improvement Team 
[ADMIT], 2013, AMH, 2013). 
 
A common feature across DPIs is that they are breath-activated devices.  DPIs, unlike 
pMDIs, are propellant free and thus doses of drug are not automatically emitted.  
Instead, the inert drug powder contained within a DPI relies on the patient’s inspiratory 
effort to actuate and draw-out of the device (Haughney et al., 2010).  This feature has 
meant that DPIs have often been perceived to be easier to use than pMDIs because 
patients do not need to coordinate dose actuation with inhalation when using a DPI 
(Blaiss, 2007, Rees, 2005, Virchow, 2004).   
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The notion that DPIs are more user friendly that pMDIs however is not necessarily the 
case.  Evidence shows that poor inhaler technique with DPIs is just as prevalent 
amongst asthma patients as that with pMDIs (Brocklebank et al., 2001, Lavorini et al., 
2008, Melani et al., 2011).  This may not be surprising given that the unique features of 
various DPIs require patients to be accurate and careful during its use, just as for the 
pMDI.  Two critical elements relating to DPI technique that are common sources of 
patient error relate to dose loading and inspiratory flow rates (Dolovich and Dhand, 
2011, Sanchis, Corrigan, Levy, and Viejo, 2012). 
 
Correct dose loading procedure for DPIs (whether it is a single or multiple-dose 
device) is essential for ensuring that the full amount of drug is made available in the 
dose path, ready for the patient to inhale (Sanchis et al., 2012).  The dose loading 
procedure varies for each differently designed DPI and therefore calls for special 
attention.  For example, single dose capsule DPIs (e.g. the Handihaler™, Spinhaler™ 
and Aerolizer™) require the patient, with each use, to open the device, place a single 
capsule to fit into a receptor in the device, and pierce the capsule (by pressing a set of 
buttons on the side of device attached to internal needles) to release the dose.  In 
contrast, a multi-dose DPI such as the Accuhaler™ requires the patient to pull down 
on a lever until a click is heard.  The Turbuhaler™, although also a multi-dose device, 
has yet another loading procedure – it requires patients to hold the device upright 
whilst twisting the base back and forth until a click sounds (Wieshammer and 
Dreyhaupt, 2008).  Immediately after dose loading, patients should also take care not 
to blow or exhale into the device for risk of displacing the drug from the dose path 
(Dolovich and Dhand, 2011). These examples indicate the precision that is required to 
correctly load a DPI, and the marked differences in the procedure for various devices, 
highlighting the attention required to correctly perform the procedure.    
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Once the dose in a DPI has been loaded, it needs to be de-aggregated into a fine-
powder before it can deposit in the lungs, and the degree to which this is achieved 
depends on the patient’s inspiratory flow rate (Newman, 2004).  The optimal 
inspiratory flow rate varies between 30 and 90 L/min (Fink and Rubin, 2005) for 
different types of DPIs and is related to the level of internal resistance of the device.  
Dry Powder Inhalers are often described as having low (e.g. Spinhaler™), medium 
(e.g. Accuhaler™) or high (e.g. Turbuhaler™) internal resistance (Frijlink and De Boer, 
2004).  DPIs   with a low internal resistance require a greater inspiratory flow rate to 
reach a turbulent force strong enough to de-aggregate the powder in the dose path 
and vice versa (Frijlink and De Boer, 2004).  For DPIs with medium internal resistance, 
60 L/min is the optimal flow rate (Dolovich and Dhand, 2011).  Further, for some DPIs 
like the Turbuhaler™, it is not only important to reach the maximum inspiratory flow 
rate, but  also to do so as quickly as possible at the beginning of the inhalation (Frijlink 
and De Boer, 2004).   
 
Inhalation flow rates that are not within the recommended range can compromise 
therapy by making it less likely to produce drug particles optimal for inhalation (i.e. 
particles that are de-aggregated to an extent that enhances lung deposition whilst 
reducing oropharyngeal deposition).  De-aggregation of the dose powder can also be 
compromised if there is additional moisture introduced into the device, as moisture 
increases adhesive forces in the powder.  Thus it is important that patients do not blow 
or exhale into their device or store their device where it is likely to be contaminated 
with moisture (Frijlink and De Boer, 2004). 
 
 
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This section, on current inhaler devices and their features, has thus discussed, with 
reference to a wide range of inhaler devices, the broad elements necessary for correct 
device use.  Given the different types of inhaler devices available to patients, each with 
its unique technological features, achieving correct inhaler technique is not as simple 
and intuitive as  some may perceive (Crompton, 2006). Both patients and health care 
professionals can underestimate the precision and attention to detail required for 
correct inhaler technique (Molimard et al., 2003, Pinto Pereira, Clement, and Simeon, 
2001), resulting in a critical “blind-spot” in asthma management (Crompton, 2006).  
The details of inhaler technique are important and warrant attention due to its 
implications for asthma outcomes (Basheti et al., 2007).  In the next section the 
precise steps required for correct inhaler technique will be elaborated upon, with 
reference to three specific devices – the pMDI, Turbuhaler™ and Accuhaler™. 
 
iv. Steps for correct inhaler technique 
The three most commonly used inhaler devices in Australia for asthma therapy are: 
the pMDI, Turbuhaler™ and Accuhaler™ (Turbuhaler™ and Accuhaler™ being DPIs) 
(AMH, 2013).  In order to use these devices with the correct technique, patients must 
follow a specific sequence of steps. Instructions for correct inhaler technique can be 
sourced from manufacturers’ drug information pamphlets, clinical guidelines (Asthma 
Australia, 2013, AMH, 2013, National Asthma Council Australia, 2008) and the 
published literature (Basheti et al., 2008, Melani et al., 2011, Melani et al., 2004, van 
der Palen, Klein, Kerkhoff, and van Herwaarden, 1995).  There are slight variations in 
the way in which instructions are presented between various sources (e.g. some are 
more detailed as instructions are broken down into smaller steps), however, all up-to-
date instructions encapsulate what is required for optimal inhaler use. 
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Using an inhaler device with the correct technique may demand more than what is 
initially expected with checklists usually comprising of at least 7 steps.  Performing all 
of the stipulated steps, rather than a select few, is important because there is a 
rationale behind each instruction for enhancing the efficacy and safety of inhaled 
therapy.  The steps for correct inhaler technique for the pMDI, Turbuhaler™ and 
Accuhaler™ are detailed in Table 2.01, with an explanation of how each contributes to 
the safe and effective use of inhaled medication.  These instructions have been 
derived from the clinical guidelines and published checklists (as cited above), however 
they are conceptualised here as three distinct stages, namely: 1. preparing for 
inhalation, 2. performing the inhalation, and 3. completing the inhalation.  Inhaler 
technique instructions are conceptualised as such here in order to make it clearer to 
compare the steps and to view the similarities and differences among the three 
devices. 
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Phases 
Pressurised Metered Dose Inhaler  Turbuhaler™ Accuhaler™ 
Step (Purpose) Step (Purpose) Step (Purpose) 
1. 
Preparing 
For 
Inhalation 
 
1. Remove cap (makes dose available 
to inhale)  
2. Shake inhaler well (mixes drug and 
propellant)   
3. Exhale air out of lungs (allows 
greater lung capacity to perform 
continual steady inhalation) 
4. Hold inhaler upright (positions 
device optimally for aerosol to travel to 
the lungs)   
5. Put mouthpiece between teeth and 
seal with lips (positions device 
optimally for aerosol to travel to the 
lungs  and prevents drug escaping) 
 
 
1. Unscrew and lift off cap (makes 
dose available to inhale) 
2. Hold inhaler upright (ensures dose 
will be loaded into dose path) 
3. Rotate grip one way, then back until 
click is heard (to load dose and make 
available for inhalation)      
4. Exhale air out of lungs (allows for 
greater lung capacity to perform 
inhalation manoeuvre) 
5. Exhale away from mouthpiece 
(prevents drug from being blown out of 
dosing chamber; reduces moisture 
contamination of device which causes 
powder to aggregate) 
6. Put mouthpiece between teeth and 
seal with lips (positions device 
optimally for aerosol to travel to the 
lungs)   
 
1.   Open inhaler (makes dose 
available to inhale) 
2.   Push lever back completely to load 
dose (ensures dose will be fully 
loaded) 
3.   Exhale air out of lungs (allows for 
greater lung capacity to perform 
inhalation manoeuvre) 
4.   Exhale away from mouthpiece 
(prevents drug from being blown out of 
dosing chamber; reduces moisture 
contamination of device which causes 
powder to aggregate) 
5.   Hold inhaler horizontally (positions 
device optimally for aerosol to travel to 
the lungs)    
6.  Put mouthpiece between teeth and 
seal with lips (positions device 
optimally for aerosol to travel to the 
lungs)   
 
Table 2.01: Correct inhaler technique for the pressurised Metered Dose Inhaler, Turbuhaler™ and Accuhaler™  
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2. 
Performing 
Inhalation 
 
6. Inhale slowly and press canister 
firmly 
7. Continue slow and deep inhalation  
(allows time for smaller particles to 
develop, enhances drug lung 
deposition and reduces oropharyngeal 
deposition) 
 
7. Inhale forcefully and deeply 
(generates the required force to de-
agglomerate drug into small particles 
that can reach lungs) 
 
 
7.   Inhale steadily and deeply 
(generates the required force to de-
agglomerate drug into small particles 
that can reach lungs) 
 
3. 
Completing 
Inhalation 
 
8. Hold breath, aim for ten seconds 
(permits more time for particles to 
deposit in lungs via sedimentation) 
9. While still holding breath remove 
inhaler from mouth (minimises chance 
of moisture clogging nozzle) 
10. Exhale away from mouthpiece 
(minimises chance of moisture 
clogging nozzle) 
11. Replace cap (for hygienic storing, 
protects from dust) 
 
 
8. Hold breath, aim for ten seconds 
(permits more time for particles to 
deposit in lungs via sedimentation) 
9. While still holding breath remove 
inhaler from mouth (reduces moisture 
contamination of device) 
10. Exhale away from mouthpiece 
(reduces moisture contamination of 
device) 
11. Replace cap (for hygienic storing, 
protects from dust) 
 
8. Hold breath, aiming for ten seconds 
(permits more time for particles to 
deposit in lungs via sedimentation) 
9. While still holding breath remove 
inhaler from mouth (reduces moisture 
contamination of device) 
10.  Exhale away from mouthpiece 
(reduces moisture contamination of 
device) 
11.  Close cover (for hygienic storing, 
protects from dust) 
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1. Preparing for inhalation 
During this first phase a common instruction across all three devices is for patients to 
empty out their lungs as much as possible, this allows for a greater lung capacity to 
perform the inhalation manoeuvre.  The remaining steps during this preparation phase 
relate to dose loading and differ for each device.   
 
For the Turbuhaler™ and Accuhaler™ (both DPIs), the correct dose loading procedure 
is critical for making the drug available for inhalation (as explained in section B, iii, 2, 
b).  Inside the Turbuhaler™, a measured dose of drug from a powder reservoir is 
loaded into the dose path by firstly keeping the device upright and then twisting its 
base one way and then another until a click sound is heard (Frijlink and De Boer, 
2004).  Inside the Accuhaler™, a unit dose of drug contained within a foil pack is 
loaded into the dose path when patients pull down a lever (Sanchis et al., 2012).   
 
By contrast, pMDIs do not require patients to manually load the drug into a dose path 
since a metered dose, driven by propellant, is automatically released when the patient 
pushes down on the canister.  Shaking of the canister before use, however, is required 
for some pMDIs, specifically those containing drug in suspension rather than in 
solution, in order to uniformly mix the drug and propellant phases.   
 
Patients who have completed all of the steps in this first phase correctly are now 
adequately prepared to inhale the drug dose from their inhaler.  However, for those 
who have not correctly performed the technique steps, even during this early stage, 
the beneficial effects of treatment will be compromised. 
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2.  Performing the inhalation 
During this second phase it is important that patients inhale at the optimal rate 
determined for the device that they are using, in order to generate the most favourable 
physical conditions in the aerosol cloud that they are inhaling for lung deposition.  Key 
differences exist among all three devices regarding optimal inhalation rates.   
 
As mentioned earlier, the inhalation rate for pMDIs must be slow and steady 
(approximately 25 L/min) in order to allow adequate time and space for the fast moving 
propellant-driven aerosol to slow down and reduce in particle size to be small enough 
for lung deposition (Newman, Pavia and Clarke, 1981).   
 
In contrast, the inhalation rate for breath-activated DPIs must be markedly higher to 
produce enough energy to de-agglomerate the larger drug particles sitting inertly in 
powder form into finer particles for lung deposition.  The Turbuhaler™ requires 
patients to inhale deeply and forcefully, and further it is important that patients reach a 
peak inspiratory flow rate at the beginning of the inhalation to enhance the amount of 
fine particles present in the aerosol that is generated (Everard, Devadason, and Le 
Soue, 1997).  The Accuhaler™ also requires a similar inhalation manoeuver as that for 
the Turbuhaler™, i.e. one that is strong, deep and continuous, although, reaching a 
peak inspiratory flow rate at the beginning of the inhalation is not critical for the 
Accuhaler™.   
 
3. Completing the inhalation 
During this final phase, across all three inhaler devices, a breath hold for 
approximately ten seconds after inhalation is stipulated as this enhances the amount 
of drug depositing in the lungs through sedimentation (Newman et al., 1981).   When 
patients complete their breath hold and begin to exhale, they should direct this 
Chapter 2 – Literature Review  
 38 
 
exhalation away from the inhaler device mouthpiece to reduce moisture contamination, 
a more critical instruction for DPIs than pMDIs.   
 
Patients must be careful to protect their DPI from any additional moisture because this 
makes the powder more adhesive and less likely to de-agglomerate into a fine powder 
(Price, Young, Edge, and Staniforth, 2002).  The Turbuhaler™ is especially sensitive 
to moisture contamination since its entire drug doses are contained in one reservoir 
rather than separately packed as in an Accuhaler™.   
 
Finally, to maintain the hygiene of the inhaler device for the next use the last steps 
remind the patient to replace the mouth piece cover.  The steps discussed for correct 
use of the pMDI, Turbuhaler™ and Accuhaler™, in the three phases above, are 
summarised in Table 2.01 and accompanied by photographs of the three devices in 
Figure 2.03.     
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Figure 2.03: The pMDI (A), Turbuhaler™ (B) and Accuhaler™ (C).  
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Section B of this literature review has  highlighted the importance of correct inhaler 
technique for the effective and safe use of inhaled therapy in asthma.  It has also 
discussed the wide range of inhaler devices currently available for asthma treatment, 
with a focus on the three most common – the pMDI, Turbuhaler™ and Accuhaler™.  
Further, step-by-step instructions exists for the correct use of all inhaler devices, and 
these instructions should be accessible to both patients (e.g. via manufactures’ 
pamphlets that accompany each device dispensed, Asthma Australia website, and 
National Asthma Council Australia website) and health care professionals (e.g. via 
clinical guidelines and the patient sources mentioned above).  However, as will be 
shown in the final section of this literature review, despite the availability of clearly 
articulated technique instructions, having patients achieve and maintain correct inhaler 
technique has not proven to be a straightforward process. 
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C. Inhaler technique in patients with asthma 
This section outlines the evidence showing suboptimal inhaler technique as a common 
occurrence amongst patients with asthma, the reasons that contribute to suboptimal 
technique, and current recommendations on how technique can be improved.  The 
final part of this section highlights the gaps in the literature, where it remains uncertain 
why poor inhaler technique persists despite the absence of known barriers.         
 
i. Prevalence of suboptimal inhaler technique 
The use of inhaler devices with incorrect or suboptimal inhaler technique can be found 
in a large proportion of patients with asthma, which is of course of concern given the 
clinical implications of poor inhaler technique discussed previously (section B, ii).  
Incorrect inhaler technique during device use has been observed from the outset of 
inhaled therapy, with the introduction of the first pMDI.   
 
Amongst pMDI users, the proportion of patients demonstrating incorrect inhaler 
technique can be between 17 and 90% based on a range of both relatively older and 
newer studies (Broeders et al., 2003; Broeders, Sanchis, Levy, Crompton, and 
Dekhuijzen, 2009; Epstein, Manning, Ashley, and Corey, 1979; Melani et al., 2011; 
Orehek et al., 1976; Saunders, 1965).  As can be seen, there is somewhat of a 
variation in the rates of suboptimal inhaler technique reported, which makes it difficult 
to quote a definitive proportion of patients who demonstrate incorrect  pMDI technique.  
An explanation for the variation in figures reported may lie in the differences in the 
methods employed between studies (e.g. various versions of inhaler technique 
checklists are used and different criteria for determining what constitutes 
correct/incorrect inhaler technique exist).  Nevertheless, regardless of  these study 
inconsistencies, a key point to note is that a sizeable proportion of patients still cannot 
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use their pMDI with the correct inhaler technique, despite the device having been in 
use for over half a century.   
 
Patient problems with inhaler technique were anticipated to be a thing of the past   with 
the introduction of the DPI after the pMDI.  Dry Powder Inhalers were initially perceived 
to be more “user friendly” than pMDIs, mainly based on the fact that DPIs did not 
require patients to coordinate dose actuation and inhalation, a manoeuvre observed to 
be problematic for many from the outset (Crompton, 1990, Epstein, Maidenberg, 
Hallett, Khan and Chapman, 2001, Paterson and Crompton, 1976).  It is now clear 
however, that patients may find DPIs just a problematic to use as pMDIs.   
 
In a large European study comparing the inhaler technique of patients using  a pMDI 
compared to three types of DPIs (Diskus™, Turbuhaler™ and Aeroliser™), almost 
identical rates of suboptimal inhaler technique were found to exit between the four 
devices (24%, 24%, 23% and 17% respectively) (Melani et al., 2004).  Similar rates of 
incorrect inhaler technique between pMDIs and DPIs have been shown in various 
other studies (Brocklebank et al., 2001, Cochrane et al., 2000, Fink and Rubin 2005).  
Further, the proportion of patients demonstrating poor inhaler technique with DPIs can 
be quite high, with international data reporting up to 94% (Lavorini et al., 2008) and 
local data identifying 87 to 93% of patients to have poor inhaler technique with DPIs 
(Basheti et al., 2007).     
 
The evidence thus shows that both pMDIs and DPIs (in their various designs) are used 
with suboptimal inhaler technique by a substantial proportion of patients.     Further, 
suboptimal inhaler technique has persisted over time despite predictions that 
advances in inhaler device design and technology would reduce or eliminate this 
problem.  This suggests that the problem of poor inhaler technique cannot be 
adequately addressed only from the stance of improving drug design and technology, 
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especially since optimal inhaler technique ultimately depends on how the inhaler 
device is handled by the patient (or carer).   
 
This human element means that the reasons behind poor inhaler technique are multi-
dimensional and can be complex. Gaining an understanding about these patient 
related factors, however, may be an important part of achieving effective and safe use 
of inhaled therapy in asthma.   Patient related factors behind poor inhaler technique 
have been explored in various studies, although from a predominantly practical 
standpoint.  That is, patient related factors previously examined, in the context of  
inhaler technique, mainly pertained  to functional barriers during device use.  Other 
barriers in optimal device use that have been investigated in the literature relate to 
inhaler technique education (or rather its lack thereof).  These main factors, 
established in the literature as barriers to good inhaler technique, have been brought 
together and are now further examined. 
 
ii. Known barriers to optimal inhaler technique 
Poor inhaler technique can be associated with patient functional limitations (physical 
and cognitive) and lack of effective inhaler technique education.  Both factors are 
discussed below along with the evidence indicating how they can be overcome.  
       
1. Patient functional limitations  
Patient functional limitations are a well-established reason for poor inhaler technique.  
Not surprisingly, patients with physical and cognitive limitations will find it more 
challenging to perform the manoeuvres required for correct inhaler technique 
(Broeders et al., 2003, Rees, 2005) compared to patients who do not experience these 
limitations.  Medication administered using inhaler devices demands greater skill and 
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manipulation than other commonly self-administered dosage forms (e.g. oral 
medication) and functional limitations, such as reduced hand strength, dexterity, 
eyesight, lung capacity and hand-lung coordination, increase the difficulty in achieving 
correct inhaler technique and sometimes make it impossible with certain devices 
(Blaiss, 2007, Broeders et al., 2003, Gray et al., 1996, Haughney et al., 2008, 
McFadden, 1995, Ruggins et al., 1993, Sestini et al., 2006, Shim and Williams Jr, 
1980, Tsang et al., 1997, Wieshammer and Dreyhaupt, 2008).   
 
The very young and elderly constitute specific patient groups who are more likely to 
have difficulty with inhaler technique due to physical and cognitive barriers (Lavorini et 
al., 2008).  Children below the age of four have been shown not to have the physical or 
cognitive skills (e.g. coordination and inspiratory capacity) to self-administer inhaler 
device therapy, and therefore depend on their parents or carers to do so for them 
(Goren et al., 1994).  Parents and carers, however, often do not possess the skills 
themselves to correctly administer inhalation therapy to their child (Aziz, Norzila, 
Hamid, and Noorlaili, 2006).  Even amongst parents and carers who can administer 
correctly, challenges still exist because some manoeuvres are largely dependent on 
the child’s own ability, for example children still need to know how to inhale at the 
correct rate whether a pMDI or DPI is used.  
 
Elderly patients, on the opposite end of the age spectrum, often possess or develop 
over time, a decline in physical function that make them prone to suboptimal inhaler 
technique.  Many elderly patients show a reduction in hand strength and dexterity 
(Gray et al., 1996) which can be further compromised by co-morbidities such as 
arthritis (Wolstenholme, Shettar, Taher and Hatton, 1986).  These factors can pose as 
barriers, particularly in pMDI use, since reduced hand strength and dexterity makes 
well timed dose actuation and inhalation difficult (Cochrane et al., 2000, Hampson and 
Mueller, 1994, Sestini et al., 2006, Shim and Williams Jr, 1980).  Many elderly patients 
Chapter 2 – Literature Review  
45 
 
also experience reduced vision, which  can make it difficult particularly when using 
DPIs that require individual capsules to be loaded before each use (Press et al., 2011).  
Further, elderly patients with reduced lung capacity (such as those with more 
prolonged asthma or respiratory co-morbidities, such as COPD) will likely find it difficult 
when using those DPIs that require deep and forceful inhalations to activate the dose 
(Broeders et al., 2003, Ruggins et al., 1993, Wieshammer and Dreyhaupt, 2008).   
 
Although patient functional limitations clearly pose as a barrier to optimal inhaler 
technique, given the variety of inhaler devices, add-on devices and delivery systems 
currently available for asthma therapy (section B, iii), a suitable inhaler device/delivery 
system to meet different functional abilities should exist for the majority of patients and 
parents/carers.  For example, children can be  prescribed nebulised therapy as it 
provides a more passive delivery system that does not require as much skill during 
dose inhalation or coordinated effort between child and parent/carer compared to 
hand-held devices (Rees, 2005).  Another suitable option for children is the use of a 
pMDI with a spacer and facemask, which if well adopted is just as effective as 
nebulised therapy with the added advantage of being less expensive, quicker to 
administer and easier to keep clean (Brand, 2005).   
 
In elderly patients, before selecting a DPI for asthma therapy, it should be ascertained 
whether the patient has the sufficient inspiratory force to use the device.  Since this 
can be challenging to detect via observation alone, there are various tools available 
(both sophisticated and simple) to assess the adequacy of patients’ inspiratory force 
such as   the InCheck Dial™, Turbuhaler Trainer™, 2-Tone Trainer™ and the 
Vitalograph™  (Capstick and Clifton, 2012).  For patients with insufficient inspiratory 
force, a better alternative to a DPI is the pMDI.  While of course challenges may still 
exist in the use of the pMDI, they too can be overcome.  For example, add-on devices 
can assist those patients who find it difficult to actuate a dose from a pMDI due to 
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reduced hand strength and dexterity.  The HaleraidTM (Pierce and Rubinfeld, 1990, 
Wolstenholme et al., 1986) is one such device which clips over the pMDI and is quite 
easily squeezed to then release a dose.  A spacer used in conjunction with a pMDI is 
another alternative that can reduce difficulties with pMDI use.    
 
The examples given above illustrate some of the important issues to be taken into 
consideration when selecting an appropriate inhaler device/delivery system for a 
patient.  Further and more importantly, these examples highlight the range of inhaler 
devices/delivery systems available to patients which should (if due consideration is 
given during the selection process by health care professionals) minimise the 
limitations posed by any patient functional issues, so that they are no longer significant 
barriers to optimal inhaler device use.   
 
2. Inadequate inhaler technique education  
Inadequate inhaler technique education has been shown to be another barrier to 
correct inhaler technique, and it is considered here as either the lack of inhaler 
technique instruction, or the provision of ineffective inhaler technique instruction. 
Inadequate inhaler technique education perhaps explains why, in patients where there 
are no functional barriers to device use, poor inhaler technique can still exit.   
 
A large proportion of patients, 16 to 40%, have never received any inhaler technique 
education from their health care providers (Basheti et al., 2007, Giraud and Roche, 
2002, Lavorini et al., 2008, Melani et al., 2004, King, Earnshaw and Delaney, 1991) 
and this can be associated with both misconceptions and lack of skill on health care 
professionals’ part.  Firstly, regarding misconceptions, many health care professionals 
may not be aware of the problem of suboptimal inhaler technique and its magnitude 
amongst their own patients, especially if they rely on patients’ self-appraisals of inhaler 
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technique, which tend to be large overestimations (Erickson, Horton, and Kirking, 
1998, Pinto Pereira et al., 2001, Souza, Meneghini, Ferraz, Vianna, and Borges, 
2009).  Some health care professionals also believe that using an inhaler device 
correctly is a self-explanatory and straightforward process which therefore does not 
warrant time to be spent on instructing patients during the limited consultation period 
(Fink and Rubin, 2005).  However, all the existing evidence regarding patient inhaler 
device use and clinical guidelines emphasising the need to train patients on technique, 
indicate achieving correct inhaler technique is not as intuitive as it may first appear 
(Crompton, 2006, Molimard et al., 2003, Pinto Pereira et al., 2001). 
 
Secondly, some health care professionals’ own lack of ability to perform correct inhaler 
technique is another contributing factor as to why many patients do not receive 
technique education.    Although some variation in technique skill may exist amongst 
different types of health care professionals, (Guidry, Brown, Stogner and George, 
1992, Hanania, Wittman, Kesten and Chapman, 1994), overall, suboptimal inhaler 
technique has been identified amongst many types of health care professionals 
(including physicians, nurses, pharmacists and respiratory therapists), from diverse 
clinical settings, and across a range of inhaler devices (Cain, Cable and Oppenheimer, 
2001, Guidry et al., 1992, Hanania et al., 1994, Kesten, Zive and Chapman, 1993, 
Scarpaci, Tsoukleris and McPherson, 2007).  This suggests that, for both patients and 
health care professionals alike, correct inhaler technique is not a skill that is intuitive.   
 
On a more promising note however, health care professionals’ inhaler technique is 
highly amenable to improvement after technique education, even with training as brief 
as 10 minutes (Basheti, Armour, Reddel and Bosnic-Anticevich, 2009, Cain et al., 
2001, Guidry et al., 1992).  Further, health care professionals who have successfully 
learned correct inhaler technique have been shown to maintain these skills for the 
entire duration in a longitudinal study of up to 2 years (Basheti et al., 2009).  
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Referring back to inadequate inhaler technique education in asthma patients, it is 
important to note that this can be the case even amongst those patients who do 
receive education from their health care professional.  This can be due to health care 
professionals using ineffective methods to teach inhaler technique.  Inhaler technique 
education can be delivered in various ways, for example, via written instructions, 
verbal explanations, physical demonstration, one-on-one between patient and health 
care provider or via video recording (van der Palen et al., 1995, van der Palen et al., 
1997).  Some methods have been shown to be more effective than others and thus, 
whilst many patients may have received inhaler technique instructions, it may not have 
resulted in improved technique due to the method of education adopted.   
 
Physical demonstration of inhaler technique supplemented with verbal counselling and 
written information has been shown to be the most effective means of inhaler 
technique education over time.  Various comparative studies shows that the addition of  
physical demonstration to verbal and written information, as opposed to verbal and/or 
written information alone, markedly improves patients’ ability to learn the correct 
inhaler technique (McElnay, Scott, Armstrong and Stanford, 1989, Roberts, Robinson, 
Doering, Dallman and Steeves, 1982, Self, Brooks, Lieberman and Ryan, 1983, van 
der Palen, Klein, Kerkhoff, van Herwaarden and Seydel, 1997). Further, 
demonstrations occuring face-to-face or via video recordings have been shown to be 
equally effective methods (van der Palen et al., 1995, van der Palen et al., 1997).  
Face-to-face sessions, though, allow for interactive teaching and learning between 
patients and health care providers, which may have benefits such as patients receiving 
real-time tailored feedback on their learning. 
 
Drawing together the two components discussed in this section, it can be observed 
that inadequate inhaler technique education can be due to the absence of education or 
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ineffective delivery of education.  Both instances contribute to the suboptimal inhaler 
technique observed amongst patients.  Nevertheless, there are successful strategies 
for overcoming these barriers.  Evidence show that health care professionals can be 
educated to learn and retain correct inhaler technique, and that subsequently patients 
can be educated on correct technique, featuring physical demonstrations of proper 
inhaler device use as part of the instruction (Basheti et al., 2008, 2009, 2007).  
Patients who have received gold-standard inhaler technique education (i.e. those that 
include physical demonstration) successfully learn and show marked improvements in 
their inhaler technique (Basheti et al., 2007). 
 
 
 
The known barriers to optimal inhaler technique presented in this section (C, ii) can all 
be associated with evidence based strategies in how to overcome them.  In practice, 
assuming that these strategies are adopted, problems with suboptimal inhaler 
technique should recede.  Of course it must be acknowledged that, in practice, there 
are often environmental impediments to implementing the strategies discussed, such 
as time pressures.  However, in the study-setting, this is not usually the case, 
especially in those studies focused solely on inhaler technique (e.g. Basheti et al., 
2007).  Interestingly and perhaps unexpectedly, it is in such study settings that patient 
inhaler technique has been shown to be suboptimal.  This is despite the absence of 
known barriers (i.e. no issues with patient functional limitations, patient lack of 
education, health care provider lack of education, ineffective education, busy 
practice/lack of time).  Further, the evidence to guide recommendations to overcome 
this particular problem is lacking.  The problem of poor inhaler technique in the 
absence of known barriers will be elaborated upon in the following and final section of 
this literature review.       
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iii. Suboptimal inhaler technique persists in the absence of 
known barriers 
Although patients can successfully learn to use their inhalers with the correct 
technique – provided a suitable device/delivery system is chosen and effective 
instruction is given – optimal inhaler technique is not maintained and there is no clear 
evidence as to why this deterioration in technique occurs in the absence of known 
barriers.  Correct inhaler technique amongst patients with asthma (and parents/carers) 
has been shown to decline in many studies regardless of the clinical setting, time 
frame involved or the type of education provided.  The evidence for this is presented in 
Table 2.02, which provides a summary of the existing prospective, repeated measures 
studies that have measured patients’ inhaler technique status over time.  Table 2.02 
includes studies involving both asthma and non-asthma patients.  This is simply to 
point out the fact that inhaler technique decline is not  a problem exclusive to asthma 
patients.  Although there are differences in the reported figures concerning technique 
decline , which may be explained by the different study methods used (e.g. setting of 
study, subjects involved, type of education provided and how inhaler technique was 
assessed and classified), it is worth noting that, even in those studies where gold-
standard technique education was provided, large proportions of patients/subjects still 
did not maintain optimal inhaler technique (Aziz et al., 2006, Basheti et al., 2007, 
Bosnic-Anticevich et al., 2010).  Further, inhaler technique has been found to 
deteriorate in as little as a few days after education (Shim and Williams Jr, 1980).          
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Table 2.02: Prospective repeated measures studies, showing decline in inhaler 
technique post education, across various settings. 
Study  
(author, year, 
setting) 
Type of inhaler technique 
education 
Time period 
between 
baseline/ 
previous 
visit and 
final visit 
Proportion of 
patients with 
incorrect technique 
at final visit. 
Studies with asthma patient as subjects 
Bosnic-Anticevich 
et al., 2010.   
 
N=52 asthma or 
COPD patients ≥18 
years; pMDI used; 
set in community 
pharmacy.  
 
Two education groups were 
compared: 
1. Intervention: written, verbal 
and physical demonstration 
(n=26)  
2. Control: written and verbal 
(n=26) 
 
Technique reinforcement 
occurred up to 3 times for both 
groups. 
 
2 months 
 
 
40% intervention 
group patients, 
80% control group 
patients. 
 
Basheti et al., 
2007. 
 
N=97 asthma 
patients ≥14 years; 
DPIs used 
(Turbuhaler™ and 
Accuhaler™); set in 
community 
pharmacy. 
Two education groups were 
compared: 
1. Intervention: written, verbal 
and physical demonstration 
(n=53) 
2. Control: standard care 
(n=44) 
 
Technique reinforcement 
occurred up to 3 times for both 
groups. 
 
3 months 17% (Accuhaler™ 
users) and 35% 
(Turbuhaler™ 
users); both 
intervention group 
patients. 
 
Aziz et al., 2006.  
 
N=85 parents of 
children 1-12 years;  
pMDI with spacer 
used; set in hospital 
primary care clinic. 
 
One technique education 
session with physical 
demonstration and written 
information (on asthma in 
general) lasting 25-30 minute. 
2 months 35% parents 
Broeders et al., 
2003. 
 
N=58 asthma and 
COPD patients >37 
years; 
Turbuhaler™, 
Accuhaler™ or 
pMDI used. 
 
Written and verbal instructions 5 weeks Inhaler technique 
values not reported; 
inhalation profile 
values reported; 
deterioration shown in 
some values for 
Turbuhaler™ and 
Accuhaler™ users; 
and in all values for 
pMDI users.  
 
Shim et al., 1980. 
 
N=30 hospitalised 
asthma patients;  
pMDI used. 
 
Physical demonstration with a 
‘horn’ audio signalling teaching 
device 
1 day-1 
month 
50% patients 
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De Blaquiere et 
al., 1989. 
 
N=100 asthma and 
COPD patients ≥24 
years; pMDI used; 
set in hospital 
outpatient clinic. 
 
Two education groups were 
compared: 
1. Verbal instruction 
2. Verbal instruction + visual 
signal during inspiration 
 
6-10 weeks Technique declined 
for all users – 45% for 
initial ‘incorrect users’ 
and 20% decline in 
initial ‘correct users’. 
Studies with non-asthma patient as subjects 
Chafin et al., 2000. 
 
N=83 pharmacy 
students; pMDI with 
spacer used. 
 
20min in-lecture physical 
demonstration followed by one-
on-one assessment and 
feedback 
1 week 11% students 
Van der Palen et 
al., 1997. 
 
N= 152 COPD 
patients ≥18 years; 
pMDI, 
Turbuhaler™, 
Diskhaler™, or 
Rotahaler™, used;  
set in pulmonary 
outpatient clinic. 
 
Four education groups were 
compared: 
1. One-on-one physical 
demonstration  
2. Video recorded 
demonstration viewed at 
home 
3. Small group physical 
demonstration (5-7 patients 
per group, 45minutes per 
session) 
4. Control group: technique 
assessment only 
19-26 weeks - 25%  first group 
- 24%  second group 
- 3% third group  
- 51% fourth group 
 
Gray et al., 1996. 
 
N=29 COPD 
patients and n = 42 
healthy volunteers, 
≥50 years; pMDI 
used; set in hospital 
clinic. 
 
Verbal, written, physical 
demonstration with practise 
time and feedback; training 
lasted for up to 30min.  
1 week 20% patients and 
volunteers (pooled 
data) 
McElnay et al., 
1989. 
 
N=150 device naïve 
non-medical 
hospital staff 
volunteers;  
pMDI used.  
 
Three education groups were 
compared: 
1. Written instruction and 
placebo practise for the 
patient. 
2. Physical demonstration by 
pharmacist and written 
information, and placebo 
practise for the patient. 
3. Video presentation  
2 weeks Technique declined 
regardless of method 
of education (values 
not reported). 
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Although the reasons for inhaler technique deterioration are unclear, the current 
consensus recommendation to overcome this problem is to repeat inhaler technique 
instructions to patients on a regular basis (Aziz et al., 2006, Basheti et al., 2007, 
Blaiss, 2007, Cochrane et al., 2000, Crompton et al., 2006, Cross, 2001, Haughney et 
al., 2008, McFadden, 1995, Mehuys et al., 2006, Sestini et al., 2006, van Beerendonk, 
Mesters, Mudde, and Tan, 1998, Virchow 2004), this seems to  suggest that the 
problem is simply related to patients forgetting how to use their inhaler.  However 
evidence supporting this notion is sparse, and on the contrary, studies have shown 
that inhaler technique declines even with repeated instructions (Basheti et al., 2007). 
   
The inhaler technique education provided to patients involved in a study conducted by 
Basheti et al. (2007) is summarised here in some detail in order to suggest how 
unlikely it would seem for patients to simply forget how to use their inhaler after 
receiving such robust training.  In this study, community based patients with asthma 
using either a Turbuhaler™ or Accuhaler™ for regular preventer therapy were 
recruited.   Although baseline technique was poor for most patients, after the provision 
of gold-standard education by a trained pharmacist – i.e. that which involved repeated 
physical demonstrations of inhaler technique by both the pharmacist and the patient 
(for assessment purposes) – the vast majority of patients could successfully 
demonstrate correct technique.  A written technique checklist printed on a sticker (on 
which the steps that the patient needed to pay extra attention to was highlighted) was 
affixed to the patient’s inhaler device as a constant and accessible reminder of correct 
technique each time the patient used their device.  Further, as reinforcement, patients’ 
inhaler technique was re-assessed and inhaler technique instructions were repeated if 
necessary (i.e. if patient’s technique had deteriorated) during four follow up visits 
spaced at monthly intervals.   
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Despite the intensity of this educational intervention that focused purely on inhaler 
technique, it is interesting to note that amongst patients in this study, at the final visit 
(which occurred three months after the last follow up visit), correct inhaler technique 
had deteriorated in 35% of  Turbuhaler™ users and 17% of Accuhaler™ users.  
Further evidence to substantiate these findings is provided by a study conducted by 
Bosnic-Anticevich et al. (2010) which showed a decline in correct inhaler technique 
amongst 40% of the study patients, who had, of note, previously achieved and 
demonstrated, correct technique.  This was despite repetition, on three separate 
occasions, of gold-standard inhaler technique education.  Clearly, it seems that simply 
repeating inhaler technique instructions is not enough as a recommendation to ensure 
patients not only achieve, but maintain optimal inhaler technique over time.    
 
Poor inhaler technique that persists over time, i.e. poor inhaler technique maintenance, 
if unaddressed, is likely to continue to contribute to the high rates of suboptimal 
disease control and the overall burden of asthma in Australia.  Currently, there is no 
clear evidence as to why, amongst those patients who can successfully learn to use 
their inhalers with the correct technique, that this skill and practice is not maintained for 
the duration of their treatment. Therefore it is imperative for future studies to not only 
consider the notion of optimal inhaler technique, but more importantly optimal inhaler 
technique maintenance.  This thus forms the underpinning motivation for the work 
subsequently presented in this thesis.  That is, to explore the phenomenon of inhaler 
technique maintenance, with the aim of understanding why patients with asthma do 
not maintain correct inhaler technique despite “knowing how” to perform correct 
technique and in the absence of known barriers.          
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D. Overarching aim of thesis 
 
 
 
 
 
 
 
 
 
 
 
To explore the phenomenon of inhaler technique 
maintenance, and to investigate why patients with 
asthma do not maintain correct inhaler technique 
despite “knowing how”. 
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 CHAPTER 3  
DETERMINANTS OF INHALER TECHNIQUE 
MAINTENANCE IN COMMUNITY BASED ASTHMA 
PATIENTS IN SYDNEY, A QUANTITATIVE STUDY 
_____________________________________________________________________ 
THE IMPORTANT ROLE of inhaler technique in asthma management was established 
in the previous chapter.  Specifically it was shown that how patients maintain inhaler 
technique over time has significant implications for their asthma outcomes, including 
asthma control.  (Chapter 2, section B, ii).  Suboptimal inhaler technique that persists 
over time is especially problematic with respect to the preventative inhaled 
corticosteroid class of inhalers.  Poor handling of these inhalers contributes to reduced 
asthma control and increased chances of medication side effects (Chapter 2, section 
B, ii).   Despite its important clinical implications, currently there are no-known studies 
directly investigating the phenomenon of inhaler technique maintenance, and what is 
poorly understood in particular is why many patients fail to maintain correct inhaler 
technique in the absence of known barriers (Chapter 2, section C, iii).  This chapter 
thus commences exploration of inhaler technique maintenance at this juncture.  A 
quantitative study aiming to identify the underlying determinants of inhaler technique 
maintenance in patients with asthma, with a focus on preventative inhaled 
corticosteroid therapy, in the community pharmacy setting will be presented.        
 
 
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A. Background 
i. Framework for conceptualising inhaler technique 
maintenance  
Establishing a conceptual framework to better understand the phenomenon of inhaler 
technique maintenance is an important first step for commencing investigations in the 
area.  Literature in the inhaler device use domain however, offers a rather narrow 
perspective for this purpose, as poor inhaler technique is typically presented as either 
a problem relating to adherence, or one that is predominantly practical in nature.  
These existing conceptualisations of inhaler technique will be explored further below.   
 
Inhaler technique is often considered to be a part of adherence, with poor technique 
classified as “unintentional non-adherence/compliance”, describing the scenario where 
a patient is adhering to the use of their preventer therapy, only with the incorrect 
inhaler technique (Cochrane, Horne, and Chanez, 1999, Haughney et al., 2008, Price 
et al., 2013).  At first glance, the concepts of adherence to, and inhaler technique 
maintenance with, preventer therapy may appear to be closely linked.  This is because 
both concepts refer to persisting with an inhaler device related activity over time.  
However, maintaining regular use of one’s preventer inhaler (adherence), compared to 
using one’s preventer inhaler with the correct technique at every instance of device 
use (correct inhaler technique maintenance) are separate concepts.  Further, a clear 
relationship between adherence and inhaler technique maintenance has never been 
unequivocally demonstrated.   
 
Although some studies indicate an association between adherence and inhaler 
technique (showing better inhaler technique amongst those patients using their 
preventer inhalers on a more regular basis) (Epstein et al., 1979, Sestini et al., 2006), 
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1979), others show no relationship (Chan et al., 2006, Dompeling et al., 1992). 
Further, while a recent cross-sectional study showed that repeated inhaler technique 
instruction correlated with better adherence to preventer therapy, no results were 
reported on the relationship between adherence and inhaler technique itself 
(Takemura et al., 2010).  Based on these findings, and for the purposes of this study, it 
thus seems best to draw a clear distinction between the processes of adherence and 
inhaler technique maintenance.  Without doing so, and by closely relating the two 
processes as has been done in the past, the perspective required for gaining 
understanding into inhaler technique maintenance may be clouded.      
 
Poor inhaler technique is also often classified as a “practical barrier” in asthma 
management (Haughney et al., 2008), with much attention currently placed on the 
physical aspects of patient inhaler device use.  Numerous studies detail patient 
physical considerations in inhaler device use (e.g. hand-lung coordination, dexterity, 
lung capacity, hand strength, eye sight etc.) (Chapter 2, section C, ii, 1).  Further, the 
research into technique education, likewise, focuses on practical teaching and learning 
strategies (e.g. examining the role of repeat instruction in technique maintenance) 
(Chapter 2, section C, ii, 2).  Although the physical and practical are undeniably 
important elements of inhaler technique maintenance, it is worth reiterating that, in 
many patients, technique is poor even when the physical and practical issues have 
been addressed (Chapter 2, section C, iii).  Thus focussing only on literature in the 
inhaler technique domain is insufficient for the purposes of creating a conceptual 
framework to understand inhaler technique maintenance in more depth.          
 
Maintaining inhaler technique clearly involves an element of physical skill and 
coordination, however the enactment of this skill does not occur in isolation, but exists 
in the context of a patient’s overall asthma self-management repertoire.  Thus an 
alternative framework is proposed in this thesis that conceptualises inhaler technique 
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maintenance as consisting of two interrelated processes, namely that of: 1) skill 
maintenance and 2) self-management behaviour maintenance (Figure 3.01).  This 
conceptual framework will be referred to as the “Inhaler Technique Maintenance 
Framework” (ITMF) and will be used to guide this first in-depth exploration of inhaler 
technique maintenance.   
 
In an area with a paucity of research, the ITMF allows for a richer, multi-dimensional 
exploration of inhaler technique maintenance, whereby two well established bodies of 
literature (i.e. skill learning and asthma self-management literatures) can be drawn 
upon in order to identify relevant factors to explore and test in the context of technique 
maintenance.  That is, this framework suggests that potential determinants of inhaler 
technique maintenance may be related to those factors instrumental in the processes 
of skill and asthma self-management behaviour maintenance.  
 
Figure 3.01: The Inhaler Technique Maintenance Framework (ITMF) – a conceptual 
framework for exploring inhaler technique maintenance.  
 
           
 
 
 
  
SKILL
Maintenance
SELF-
MANAGEMENT 
BEHAVIOUR
Maintenance
Inhaler Technique Maintenance 
Interrelated, patient-centred processes, both 
underpinned by self-regulation  
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The two processes proposed to form the basis of inhaler technique maintenance, as 
shown in Figure 3.01, are interrelated by their patient-centred orientation and by virtue 
that both are underpinned by the process of self-regulation.  The important role of self-
regulation is described in both the skill learning and self-management literatures.  In 
the health-care context, self-regulation has been defined as a patient’s ability to 
exercise control over their thoughts, emotions and behaviours (e.g. inhaler technique), 
and to monitor their present condition and make behavioural adjustments, for the 
attainment of health-related goals (or desired outcomes/states) (Maes and Karoly, 
2005, Rothman, Baldwin and Hertel 2004).  Further, an implicitly important 
consideration in the process of self-regulation is that of patient motivation (Bandura, 
2005b).  That is, a certain level and/or quality of motivation are required in order for 
patients to self-regulate effectively.  By applying these principles in the context of 
inhaler technique maintenance it appears  that the level and/or quality of a patient’s 
motivation may influence how successfully they maintain inhaler technique over time.  
Specifically, it is hypothesised that the greater a patient’s motivation to maintain 
correct inhaler technique, the more likely they are to achieve this(Hypothesis 1). 
 
The patient-centred nature of skill and self-management behaviour maintenance  
stems from the notion that both processes are embedded in patients’ daily routines, 
and it is patients themselves who largely determine their successful implementation.  
Although there may be initial and subsequent intermittent external input, for example, 
from health care professionals and other social support networks, the bulk of the 
responsibility for inhaler technique maintenance during the course of preventer therapy 
lies with the patient.  With this in consideration, the next two sections will examine 
inhaler technique maintenance from the perspectives of patient skill learning and self-
management behaviour.   
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ii. Inhaler technique maintenance from the perspective of 
patient skill learning 
There is a large body of literature in the area of skill learning and development with 
important implications for various fields where skill learning and teaching are relevant. 
However, despite this, the understanding and application of the principles behind this 
science in those contexts where it may be relevant, including the health care setting, 
have been very limited (Cornford, 2008).  It is somewhat surprising that inhaler 
technique has not lent itself to investigations in the past through the perspective of skill 
learning, given that it is recognised that a relatively high degree of skill is involved in 
self-administrating inhaled therapy (Chapter 2, section B, iv).   
 
Skill can be briefly defined as “the ability to do something well, expertise” (The Oxford 
English Dictonary, 2000). Cornford (1996), however, has articulated “skill” and the 
performance of a skill, in a more substantial way, with nine defining attributes, listed in 
Figure 3.02.  From this list, what is most noteworthy in the context of inhaler technique 
maintenance is the defining attribute recognising the important role of motivation and 
self-regulation in the maintenance of optimal skill performance (in bold).  This adds 
further support for the hypothesis made earlier that patient motivation may play a role 
in technique maintenance (Hypothesis 1).            
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Figure 3.02: Cornford’s nine defining attributes of skill and skilled performance 
(Cornford, 1996). 
 
• Skill is learned. 
• Skill involves motivation, purpose and goals; motivation is especially 
important for maintenance of optimal skill performance. 
• Mental models are required in memory detailing the steps, processes, 
sequencing, and timing of a skill. 
• Skills are context specific, with performance of the skill triggered by specific 
cues. 
• Skills involve context-relevant problem solving. 
• Skills involve relative judgements with individual differences in skill 
performance evident. 
• Standards of excellence exist to judge skill performance against. 
• Skill performance can be comparably replicated to similar standards by the 
performer. 
• Considerable periods of time are required to achieve high levels of skill.    
 
 
The list of defining attributes of skill and skill performance above may provide valuable 
insight into the nature of skills.  Although, further understanding of skill development in 
the context of inhaler technique maintenance may be gained through taking a more 
structured approach in examining the phases involved in the skill learning and 
maintenance process.  In order to understand the process of skill development and the 
implications for inhaler technique maintenance, a theoretical basis was adopted 
through the use of Fitts’ Skill Learning Theory (Cornford, 2008, Fitts and Posner, 
1967).   
 
Fitts’ Skill Learning Theory (FSLT) 
Fitts’ Skill Learning Theory (FSLT) was selected as the guiding theoretical framework 
here as it is well established and endorsed (Annett, 1991, VanLehn, 1996), and it can 
effectively account for the learning stages across all types of skills, including single-
task skills, such as inhaler technique (as opposed to more complex and multi-task 
skills, e.g. professional development) (Cornford, 2008).  Thus by drawing on a theory 
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with the features of FSLT to explore inhaler technique maintenance, potentially new 
insights may be gained about the phenomenon.  
 
Fitts’ Skill Learning Theory describes the process of skill development as occurring in 
three distinct phases: 1) the cognitive, 2) the practice-fixation, and 3) the autonomous 
phase (Cornford, 2008, Fitts and Posner, 1967). During each phase a predominant 
type of skill learning activity occurs.  The phases, however, are not mutually exclusive 
and the process of skill development is not linear.  The three main phases of FSLT are 
depicted in Figure 3.03.  In line with these principles it is proposed that patients may 
transition backwards and forwards between the three phases during the process of 
learning and maintaining inhaler technique.  In the following sections these phases will 
be analysed in the context of inhaler technique maintenance.  Further it will be argued 
that autonomy failure may occur due to inadequate development of skills at the 
cognitive and practice-fixation phases.    
 
Figure 3.03: The three phases of Fitts’ Skill Learning Theory (FSLT) and the 
predominant type of activity that occurs at each phase (Cornford, 2008, Fitts and 
Posner, 1967).   
 
 
 
 
 
 
 
 
 
1. Cognitive 
Phase
Mental depiction 
of skill formed 
and refined 
through practise. 
2. Practice-
Fixation 
Phase
Consolidation of 
skill in long term 
memory via 
repeated 
practise. 
3. 
Autonomous 
Phase
Skill is performed 
automatically 
with accuracy 
and speed.
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The first phase of FSLT, the cognitive phase, represents the learner’s initial attempts 
to grasp a skill through the formation of a mental depiction (Cornford, 2008, Fitts and 
Posner, 1967).  In the context of inhaler technique, during this phase patients would be 
learning to use an inhaler device for the first time and attempting to build an overall 
representation in their minds of the correct technique manoeuvre, patients may notice 
the individual steps, their timing and how they fit into a sequence.  Mental depictions of 
inhaler technique that are higher in accuracy and detail (as opposed to less accurate 
and detailed depictions), serve as a better reference point and guide for monitoring 
and enacting future performances of inhaler technique.  Self-regulation of skill 
performance may therefore be more effective with more detailed and accurate mental 
depictions (Schmidt, 1975).   
 
This principle offers further insight into why better inhaler technique learning occurs 
after patients have viewed a physical demonstration, rather than having received 
written and/or verbal instruction only (as discussed in Chapter 2, section C, ii).  That is, 
through observing an expert physically demonstrating correct inhaler technique, a 
richer and more accurate mental depiction of inhaler technique may be formed by 
patients to guide and monitor their future technique demonstrations, as compared to 
reading and/or listening to technique instructions alone.  These mental representations 
of a skill are enriched and refined through practise of the skill, and this interfaces with 
the second phase of FSLT. 
 
The practice-fixation phase is the second phase in FSLT, and as the name implies, the 
predominant activity in this phase entails the repeated practise of a skill until it 
becomes “fixed” or consolidated in long term memory (Cornford, 2008, Fitts and 
Posner, 1967).  More complex skills tend to require a greater degree of practise before 
consolidation occurs, however this is not to say that less complex skills require minimal 
practise.  Skills at all levels of complexity can benefit from increased practise. 
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Continued practise of a skill, even after competence has developed, such as after a 
patient has initially grasped and demonstrated correct inhaler technique, may enhance 
skill consolidation and maintenance (Healy and Sinclair, 1996).   
 
The principles behind skill practise and consolidation may offer some insight into the 
positive correlation found between inhaler technique and adherence in some studies, 
as discussed earlier (Epstein et al., 1979, Sestini et al., 2006). That is, a patient’s level 
of adherence with preventer therapy, after having competently learned the correct 
technique, can be an indicator for the degree of inhaler technique practise that they 
engage in, with greater or more consistent practise enhancing the likelihood of better 
consolidation of inhaler technique.  Thus, it is hypothesised that the regularity of 
inhaler technique practise, as indicated by subsequent adherence (and after the 
patient demonstrates ability to perform the skill correctly), may predict how well a 
patient maintains inhaler technique over time (Hypothesis 2).   
 
A critical consideration beyond the degree of practise, is the accuracy of the practise, 
during the practise-fixation phase of FSLT.  Accurate practise is essential to prevent 
an incorrect version of the skill being consolidated in long term memory.  The repeated 
incorrect enactment of a skill may result in its consolidation, and once this occurs it 
may be difficult and time consuming to undo and to re-learn the correct version.  This 
is especially the case in skills involving a significant physical component such as 
inhaler technique (Cornford, 2008).  Interestingly this possibility was commented upon 
decades ago in the inhaler technique literature – “many years of inhaling incorrectly, 
often thousands of times, must have established a habit difficult to break” (Shim and 
Williams Jr, 1980), however little has been done to further investigate this mechanism.   
 
How well a skill has been initially learned/mastered has also been shown to predict its 
long term maintenance in other domains (e.g. cardiopulmonary resuscitation) 
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(Glendon, McKenna, Hunt and Blaylock, 1988).  These observations, supported by 
skill learning theory, imply that patients’ accuracy during practise may mediate the 
relationship between the degree of inhaler technique practise that they engage in and 
whether they maintain correct inhaler technique.  This also suggests that how well a 
patient learns the correct inhaler technique for their device from the out-set (i.e. at the 
commencement of their inhaler therapy) may impact on their inhaler technique over 
time.   
 
Thus if the initial teaching and learning conditions were not supportive of accurate 
practise, patients may not master correct inhaler technique to begin with, and 
subsequent poor technique demonstrations can reinforce and entrench poor technique 
over time.  Patients’ baseline inhaler technique may be a useful indicator of how 
accurately (after past technique education) they have consolidated the skill.  Further, 
patients demonstrating correct (as opposed to incorrect) baseline technique are 
proposed to have more successfully consolidated the skill.  Thus, it is hypothesised 
that patients demonstrating correct inhaler technique at baseline, compared to those 
with incorrect baseline technique, are be more likely to maintain optimal inhaler 
technique over time (Hypothesis 3).   
       
During the practise-fixation phase, the act of showing others how to use their inhaler 
device may also constitute technique practise.  There is some evidence to suggest that 
this form of practise can foster optimal inhaler technique maintenance.  In the study by 
Basheti et al. (2009), both pharmacists and patients were taught inhaler technique via 
similar methods of repeat physical demonstration.  The results revealed that 
pharmacists were more successful at maintaining correct inhaler technique for up to 
two years after training, than patients were during the six month study period.   
Interestingly, while both the pharmacists and patients received almost identical training 
on inhaler technique, one of the key differences between the two groups is that the 
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pharmacists, who although would not personally use the inhaler on a day-to-day basis 
for asthma as the patients would, did regularly engage in teaching and showing others 
correct inhaler technique.  This implies that the act of showing others correct inhaler 
technique may be a further means of consolidating this skill beyond the initial training 
received.   
 
Similar implications can be found in an unpublished study (conducted at the Faculty of 
Pharmacy in 2010), involving 200 pharmacy students who had received inhaler 
technique training (in a similar fashion as in the study by Basheti et al., 2009, 
described above), and who were followed up 12 months later.  The study showed that 
the students who were most likely to maintain correct inhaler technique were those 
who were working in the clinical practice setting and had engaged in teaching patients, 
via physical demonstration, inhaler technique (Hendricks, Bosnic-Anticevich and 
Smith, 2010).  Based on the importance placed on skill practise in FSLT and these 
empirical observations, it can thus be hypothesised that patients who have engaged in 
showing others how to use an inhaler device (similar to their own device) are more 
likely to maintain correct inhaler technique over time (Hypothesis 4).   
 
Feedback is another important factor to consider during the practise-fixation phase of 
FSLT and is critical in enabling the learner of any skill to appropriately monitor and 
adjust their skill enactments, that is, to self-regulate their skill enactments (Cornford, 
2008).  Without appropriate feedback during the initial learning period, achieving 
competence with a skill may be compromised and this may lead to a poorly or 
inaccurately consolidated skill, which over time can be difficult to unlearn and then 
relearn in the correct manner (as discussed above).   
 
Timely and accurate provision of feedback by experts during inhaler technique 
education can help shape the mental depiction of the skill that patients hold in 
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memory, and can impact on patients’ ability to correctly master inhaler technique.  
Feedback derived from the learning environment, also known as external feedback (as 
opposed to intrinsic feedback generated from the task itself), can be classified as 
either quantitative or qualitative in nature (Kilduski and Rice, 2003).  Quantitative 
feedback (e.g. “you scored 8 out of 11 for your puffer technique”) tends to provide 
concrete information on performance outcomes and details specific areas for 
improvement.  Whereas qualitative feedback (e.g. “your technique is getting better”) 
can serve as verbal guidance and encouragement and has been shown to improve 
skill performance, possibly through enhancing motivation to persist with learning a skill 
(Chitwood, Moffatt,  Burke, Luchino and Jordan, 1997).  Encouragement and 
motivation derived from the learning environment during inhaler technique learning 
would seem especially important given that there may be minimal feedback from the 
activity itself (or intrinsic feedback) to guide patients to improve their technique.   
 
There is, however, some evidence to suggest that intrinsic feedback during inhaler use 
may have an impact on patients’ inhaler technique.  That is, patient perceived 
feedback after inhaler use has been implicated to play a role in inhaler technique.  In 
one study involving short-acting reliever inhalers, patients who obtained a greater 
degree of relief immediately after consuming a dose (measured by the degree of 
bronchodilation), were more likely to demonstrate correct inhaler technique compared 
to those who were less sensitive to the effects of the reliever medication (i.e. received 
less somatic feedback after dosing) (De Blaquiere, Christensen, Carter and Martin, 
1989).  Further, in a large cross-sectional study investigating a range of inhaler 
devices (the pMDI and three types of DPIs: Aerolizer™, Turbuhaler™, and Diskus™), 
more patients who used the Aerolizer™ demonstrated better technique compared to 
patients using any other device (Melani et al., 2004).  The Aerolizer™ is a single dose 
DPI that provides immediate visual feedback of the amount of drug powder consumed.  
That is, after inhaling patients can open the device’s dosing chamber to see if any 
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medication remains and if further inhalations are required (Aerosol Drug Management 
Improvement Team).   
 
In a less direct fashion, patient-perceived asthma control (or asthma symptoms) may 
also act as feedback on inhaler technique performance and potentially impact on 
technique maintenance.  As discussed in the Literature Review (Chapter 2, section B, 
ii) there may be a relationship between inhaler technique maintenance and asthma 
control mediated by patient perceptions of the benefits and risks of inhaled therapy 
over time. This, albeit limited, empirical evidence, supported by the principles of skill 
learning theory, suggests that patient-perceived feedback during inhaler device use 
(e.g. symptom and visual feedback), may have an influence on how they maintain 
inhaler technique.  Further, it is hypothesised that patient-perceived feedback in the 
form of asthma control may have an influence on inhaler technique maintenance over 
time.  That is, more accurate perceptions of feedback may result is better inhaler 
technique maintenance (Hypothesis 5).         
 
The third and final phase of FSLT, the autonomous phase, was so named to indicate 
that the individual is primarily in control of their own skill performances with much less 
reliance on external support and feedback compared to the earlier stages.  
Successfully reaching this stage means that individuals are effectively self-regulating 
their skill performances (i.e. the performance is being monitored and adjusted 
according to an accurate mental model) so that skill is enacted with competence, 
accuracy and speed (if necessary) (Cornford, 2008).  In the context of inhaler 
technique, reaching the autonomous phase would mean that patients are correctly 
maintaining inhaler technique in their day-to-day inhaler use.   
 
In reality however, a large proportion of patients never successfully reach the 
autonomous stage.  That is, many patients do not maintain optimal inhaler technique 
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despite having seemingly mastered correct technique after receiving education 
(Chapter 2, section C, iii). With the application of FSLT, potential reasons for poor 
inhaler technique maintenance in the autonomous phase may be understood by 
examining what occurred (or did not occur) during the previous two phases, that is, the 
cognitive and practice-fixation phases.   
 
For example, poor technique maintenance may result if patients are not presented with 
learning opportunities that facilitate the formation of an accurate and vivid mental 
depiction of the correct inhaler technique manoeuver (important feature in the cognitive 
phase); or if patients did not engage in accurate and sufficient practise guided by 
timely and accurate feedback from an expert (important aspects during the practice-
fixation phase).  Under these circumstances patients are less enabled to engage in the 
optimal self-regulation of inhaler technique when they are using their inhaler device on 
a day-to-day basis.  In other words, patients are less likely to appropriately monitor and 
adjust their inhaler technique according to an accurate and well consolidated mental 
reference point.   
 
Thus it can be seen that by exploring inhaler technique maintenance from the 
perspective of skill learning, and specifically through the application of FSLT, much 
insight can be gained into the phenomenon.  In particular, new light can be shed on 
interpreting existing findings, and directions provided for generating hypotheses 
regarding the skill learning related factors influencing inhaler technique maintenance.  
Further exploration of inhaler technique maintenance from the second domain of the 
ITMF, i.e. from the perspective of self-management, will now follow.       
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iii. Technique maintenance from the perspective of patient 
asthma self-management  
Inhaler technique maintenance can also be explored from the perspective of asthma 
self-management as it can be considered a specific type of self-management 
behaviour.  Self-management plays a critical role in asthma treatment and can be 
considered to encompass the strategies that patients adopt to cope with both the 
physical and emotional challenges presented by their illness (Smith et al., 2007).  In 
asthma, good self-management requires the patient to carry out a range of activities 
including monitoring symptoms, identifying and avoiding triggers, knowing when to 
seek health care professionals’ assistance and using their medications optimally (NAC, 
2006).  Maintaining correct inhaler technique is clearly a vital part of optimal 
medication use and therefore an indispensable part of a patient’s self-management 
repertoire.   
 
Placing inhaler technique maintenance in the context of patient self-management 
further highlights the need to adopt a patient-centred perspective as discussed earlier 
(section A, i).   Notably, from this perspective it can be seen that potential reasons for 
poor inhaler technique maintenance, despite the lack of currently known barriers 
(Chapter 2, section C, iii), may lie beyond those factors pertaining to the 
physical/practical and skill development process, and be related to various less 
tangible patient-centred factors.  However, since the relationship between self-
management behaviours (such as inhaler technique maintenance) and patient-centred 
factors can be complex and multidimensional, the use of well-established theories in 
the area can be instrumental.   
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The Common Sense Model of Illness Regulation (CSM) 
One such theory, used extensively to study self-management behaviour in chronic 
illnesses, including asthma, is Leventhal’s Common Sense Model of Illness Regulation 
(CSM) (Leventhal, Brissette and Leventhal, 2003).  At the core of the CSM is the 
notion that how patients cope with their chronic illness, or patient self-management 
behaviour, is influenced by their “common sense” interpretations relating to their illness 
and its treatment (Diefenbach and Leventhal, 1996, Horne and Weinman, 2002).  In 
particular, patient cognitions (i.e. beliefs, knowledge, interpretations) and affect (i.e. 
feelings) regarding their illness and treatment can influence self-management 
behaviours, and have in fact been shown to play a role in asthma (Horne and 
Weinman, 1999, Osman, 1997).  By extension, this suggests that such patient-centred 
factors may also be relevant to explore in relation to inhaler technique maintenance.   
 
To examine the CSM more closely, three principal components can be identified in the 
model depicting how patients self-manage and self-regulate around their illness.  They 
are: 1. interpretation, 2. coping (or self-management) and 3. appraisal (Leventhal et 
al., 2003).  The first component of the CSM refers to how patients interpret their 
illness, specifically in terms of their beliefs and feelings regarding the identity (label 
and symptoms connected with the illness), cause, time course, amenability to 
cure/control and consequences of the illness (Leventhal et al., 2003).  In addition, 
patients’ beliefs and feelings regarding the treatment prescribed for their illness (with 
inhaled corticosteroids being the mainstay of preventative treatment in asthma), in 
terms of perceived necessity and concerns, are also important considerations (Horne 
and Weinman, 2002).   
 
The second component of the CSM, coping, refers to the actual self-management 
strategies and behaviours that patients enact.  This would include how patients 
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maintain their inhaler technique.  The third component of the CSM, appraisal, refers to 
patient evaluations regarding the effectiveness of their coping (or self-management) 
strategies for reducing the perceived negative impact (physical and emotional) of their 
illness (Leventhal et al., 2003).   For example, to what extent does the patient believe 
that maintaining correct inhaler technique makes a difference to their experience of 
asthma?  The relationship between the various components of the CSM is dynamic 
and interconnected (Diefenbach and Leventhal, 1996, Orbell, 2007) as represented in 
Figure 3.04.   
 
Figure 3.04.  The Common Sense Model of Illness Regulation (CSM) (Horne and 
Weinman, 2002, Leventhal et al., 2003).  
 
 
 
 
 
 
 
 
 
 
 
The CSM can be a useful tool for highlighting the challenges that patients may 
experience in self-managing and self-regulating around their asthma, including with 
activities such as inhaler technique maintenance.  Considering the interrelatedness of 
the various components represented in the CSM, it is perhaps not surprising to 
suggest that lack of consistent and immediate feedback from both the condition of 
asthma and its treatment could be a potential barrier in asthma self-management and 
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self-regulation.  That is, asthma can often be a “silent illness”, where symptoms are not 
always present to remind patients to actively self-manage, and feedback in terms of 
perceived benefits after using preventer therapy is delayed (AMH, 2013).  This may do 
little to motivate patients to persist with optimal inhaler use – the importance of 
feedback in motivating persistence with skilled performance was discussed earlier 
(section B, ii).  It may not make sense to the patient, as a “common sense problem 
solver” (according to the CSM), to enact what are considered appropriate/effective 
coping strategies (e.g. maintaining correct inhaler technique), in the absence of cues 
from their condition (e.g. change in symptoms) and its treatment (e.g. lack of 
immediate feedback after using preventer therapy).   
 
Further, due to the fact that various other factors, separate to a patient’s medication 
related coping/self-management, may impact on their symptom experience (e.g. 
exposure to triggers, respiratory tract infections, strong emotions), the value of 
practicing optimal self-management behaviours (such as persisting with correct inhaler 
technique) may become less, or not, apparent.  The CSM highlights the intricacies and 
challenges involved in asthma self-management, and from this perspective it is not 
surprising to note, again, the important role that patient motivation may play in 
facilitating optimal self-regulation and self-management around key areas such as 
inhaler technique maintenance (Hypothesis 1).            
 
As illustrated in Figure 3.04, self-management behaviours (coping) are embedded in 
various interrelationships with patient cognitive and affective factors.  This suggests 
that in order to improve self-management behaviours, such as patient inhaler 
technique maintenance, better understanding of the potential patient psychological 
determinants of the behaviour is required.  There are numerous studies in asthma that 
have shown various patient psychological factors to be determinants of self-
management behaviour.  For example, patient beliefs about the consequences and 
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time course of asthma, and beliefs regarding the necessity of, and concerns relating 
to, preventer asthma therapy, have been linked to self-management behaviours.  In 
particular these patient beliefs have been linked with medication adherence (Clifford, 
Barber and Horne, 2008, Horne and Weinman, 2002, Mardby, Akerlind and 
Jorgensen, 2007, Menckeberg et al., 2008, Ponieman, Wisnivesky, Leventhal, 
Musumeci-Szabo and Halm, 2009, Rand, 2005). 
 
In relation to inhaler technique maintenance as the self-management behaviour of 
focus, however, there is a dearth of studies.  Yet there does exist limited empirical 
evidence to suggest that the role of patient psychological factors in the context of 
inhaler technique maintenance is an avenue worthy of further exploration.  In one 
study involving patients who were using  inhaler device therapy (reliever therapy via 
pMDIs), those who believed more strongly that using inhaler therapy was an important 
and necessary part of their treatment, were more likely to demonstrate and maintain 
correct inhaler technique (De Blaquiere et al., 1989).  Although this finding was noted 
over thirty years ago it has never been followed up on.  Thus, supported by the 
principles of the CSM and to pursue the available empirical evidence, it is 
hypothesised that patient beliefs regarding the necessity of preventer therapy, and the 
importance of correct inhaler technique, may have an influence on their inhaler 
technique maintenance behaviour over time (Hypotheses 6 and 7). 
 
In summary, despite the paucity of existing studies, the phenomenon of inhaler 
technique maintenance has been explored from multiple perspectives in this 
Background (Chapter 3, section A).  The ITFM, a framework conceptualising inhaler 
technique maintenance (Figure 3.01), was set up in this thesis, grounded in well-
established theories in the fields of skill learning and self-management behaviour.  The 
ITMF allowed for a multi-faceted exploration of inhaler technique maintenance.  
Through this exploration, a pool of potential predictors of inhaler technique 
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maintenance warranting further investigation has been identified.  This is illustrated in 
Figure 3.05.   
 
Figure 3.05: Potential predictors of inhaler technique maintenance after exploring the 
Inhaler Technique Maintenance Framework (ITMF).    
 
 
 
 
 
 
 
In order to address the aim of this study – to uncover the determinants of inhaler 
technique maintenance in patients with asthma – various hypotheses have now been 
generated that lend themselves to further testing. 
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B. Aim and hypotheses 
The aim of this study is to investigate, from a patient-centred perspective, the 
determinants of inhaler technique maintenance in patients with asthma. 
 
Based on the literature presented in the Background to this chapter (section A), it is 
hypothesised that how patients maintain inhaler technique over time may be 
influenced by the following factors: 
1. Motivation to maintain correct inhaler technique 
2. Preventer adherence  (indicating regularity of inhaler device use and therefore 
degree of inhaler technique practise) 
3. Baseline inhaler technique (indicating whether or not there was accurate 
consolidation of inhaler technique)  
4. Showing and teaching others inhaler technique (indicating nature of inhaler 
technique practise) 
5. Level of asthma control (indicating patient-perceived feedback on inhaler 
technique performance) 
6. Beliefs about the necessity of regular preventer therapy  
7. Beliefs about the importance of correct inhaler technique  
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C. Methods 
i. Overview 
The study conducted was exploratory in nature and involved repeated measures over 
two time points.  The initial phase of the study consisted of the recruitment and training 
of community pharmacists, who then in the subsequent phase, enrolled and delivered 
an inhaler technique assessment and intervention to study participants.  Study 
participants were community dwelling patients with asthma who were required to visit 
their local pharmacy on two occasions, approximately one month apart in order to 
complete the study. 
 
This study was approved by the University of Sydney Human Research Ethics 
Committee (Appendix 3.01: Quantitative study ethics approval). 
 
ii. Phase 1: Study Pharmacists 
1. Sampling and recruitment 
A purposive sample of community pharmacists was recruited from the Sydney 
metropolitan region.  That is, community pharmacies located from a wide range of 
Sydney suburbs were approached in order to maximise the socio-demographic 
variation in the patients recruited into the study.  Pharmacists were invited to 
participate in the study by the researcher (LO) either in person (at their pharmacies), 
over the telephone or via email.  A letter of invitation to participate in the study was 
also given (Appendix 3.02: Pharmacist letter of invitation).   
 
Incentives for pharmacists to take part included the opportunity to attend a free training 
workshop to update skills and knowledge on inhaler device therapy in asthma 
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management, and Continuing Professional Education (CPE) points (3.5 points) 
available upon completion of the workshop (Appendix 3.03: PSA CPE accreditation).  
Pharmacists who expressed an interest were further provided with written information 
about the study (Appendix 3.04: Pharmacist study information statement).   
 
All pharmacists who agreed to participate were visited by the researcher (LO) at their 
pharmacies.  During this visit, pharmacists’ written consent to participate in the study 
were obtained (Appendix 3.05: Pharmacist study consent form).  Subsequently, an 
appointment to attend a training session on inhaler device therapy and the study 
protocol, the Quality Use of Inhalers in Pharmacy workshop, was made.  
 
2. The Quality Use of Inhalers in Pharmacy workshop 
The Quality Use of Inhalers in Pharmacy (QUIP) workshop was a 2 hour training 
session that all study pharmacists completed before enrolling patients into the study.   
 
The aims of the QUIP workshop were to: 
1. Update pharmacists’ skills and knowledge on inhaler device therapy in asthma. 
2. Teach pharmacists to demonstrate correct inhaler technique for the 
pressurised Metered Dose Inhaler, Turbuhaler™ and Accuhaler™ (the three 
most commonly prescribed devices for asthma treatment).   
3. Teach pharmacists how to accurately assess and teach inhaler technique to 
asthma patients.  
4. Inform pharmacists about the study protocol and how to effectively implement 
it.  
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a. Development and delivery of the QUIP workshop 
The QUIP workshop was developed with reference to previous studies that delivered 
inhaler technique education to community pharmacists (Basheti et al., 2009).  In 
addition, theories relevant in adult education, including skill learning and small group 
education theories were also referred to during the development of the QUIP workshop 
(Bandura, 2005a, Cornford, 2008, Olmstead, 1974).  The purpose of using such 
theories was to create a learning environment that would enhance pharmacists’ 
motivation to be engaged in the learning activities and achieve the QUIP workshop 
aims as detailed above.  How specific tenets of skill development and small group 
learning theories were applied to the QUIP workshop will be elaborated upon in the 
upcoming sections.    
 
The QUIP small group workshop was presented and facilitated by three researchers 
(LO, LS, SBA) on 2 scheduled sessions, pharmacists could choose to attend either a 
Saturday morning (9-11am) or a Monday evening (7-9pm) training session.  Both 
sessions were held at the Faculty of Pharmacy, the University of Sydney.  Pharmacists 
who could not attend either session were trained individually at their pharmacies by 
one researcher (LO).  The same content was delivered in both the individual and group 
training sessions.  Continuing Professional Education points were available after the 
completion of all training sessions and demonstrated competency with inhaler 
techniques (Appendix 3.03: PSA CPE accreditation). 
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b. QUIP workshop room arrangement  
The QUIP workshop was interactive in nature and therefore its physical set-up aimed 
to enhance communication between pharmacists and facilitators and amongst 
pharmacists themselves.  Figure 3.06 shows the set-up of the workshop room during 
the small group training sessions.  Pharmacists’ tables and chairs were arranged in a 
U-shaped configuration, unlike previously, when they have been placed in straight 
rows configuration (Basheti et al., 2009).  The purpose of this modification was to 
better use the physical space to facilitate interaction, that is, in this arrangement 
pharmacists can better see, hear and speak with the rest of the group.  Large, visible 
name tags identifying workshop participants were placed at the front of each table also 
to facilitate communication.       
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Figure 3.06: The QUIP workshop training room arrangement.        
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c. Facilitating pharmacists’ motivation to learn during the QUIP 
workshop  
Enhancing pharmacists’ motivation to learn was an important process goal that guided 
how the QUIP workshops were facilitated and delivered.  Motivation to learn has been 
shown to be a key determinant of the extent to which adults actively participate and 
persist with learning activities during training workshops.  Further, how the training is 
delivered can influence participants’ motivation to learn (Klein, Noe and Wang, 2006).   
 
In order to sustain pharmacists’ interest and motivation, during the delivery of the 
QUIP workshop, various modalities of teaching and learning were used.  For example, 
a brief interactive lecture supported by power point slides, inhaler technique 
demonstrations with commentary, hands on learning with placebo devices and 
interactive peer learning (explained in detail in Table 3.02).  Further, the duration of the 
QUIP workshop was kept as brief as possible (2 hours) without compromising the 
ability to achieve the learning outcomes, and refreshments and lunch were provided.     
 
In a small group learning environment, individual participants’ motivation to learn can 
also be influenced by the group dynamics.  Although group dynamics cannot be 
completely pre-determined, as it is unique to each specific group on each separate 
occasion, it can be steered, to some extent, by the facilitators (Olmstead, 1974).  The 
QUIP workshop was facilitated to promote group dynamics that were conducive to 
learning, specifically via the strategies of: establishing rapport, clearly stating group 
goals, and conveying the group norms (Olmstead, 1974), and using various modalities 
of teaching and learning to maintain interest and engagement.  The various methods 
used to enhanced pharmacists’ motivation to actively learn during the QUIP workshops 
is summarised in Table 3.01.   
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Table 3.01: Delivery of the QUIP workshop – strategies to enhance pharmacists’ 
motivation to engage in active learning and their implementation.  
STRATEGY IMPLEMENTATION 
Establish 
rapport 
1. Pharmacists were greeted and welcomed by facilitators. 
 
2. A round of self-introductions was made. 
 
3. A brief comic video about inhaler technique was shown as an ice-
breaker. 
 
Clearly state 
group goals 
1. The workshop aims were re-framed to focus on the pharmacists and 
were presented at the start.  They were stated as the following group 
goals: 
i. To become inhaler technique experts. 
ii. To master correct inhaler technique with the pMDI, 
Turbuhaler™ and Accuhaler™. 
iii. To accurately assess and teach inhaler technique to asthma 
patients.  
iv. To understand the study protocol.     
 
Convey group 
norms 
1. Pharmacists’ existing knowledge regarding asthma and inhaler device 
use was acknowledged.  Simultaneously, the high rates of incorrect 
inhaler technique amongst health care professionals were also 
communicated.  This was normalised to facilitate pharmacists to feel 
open to recognising and learning from any mistakes identified in their 
own inhaler techniques.     
 
2. Pharmacists were encouraged to work at their own pace and focus on 
accurate practise of inhaler technique. 
 
3. Pharmacists were informed of the interactive nature of the workshop, 
encouraged to ask questions at any time, and encouraged to support 
each other in learning.  
 
Use multiple 
modalities of 
teaching and 
learning 
1. The teaching and learning was interactive between pharmacists and 
facilitators and amongst pharmacists themselves. 
 
2. Various materials were used for teaching and learning correct inhaler 
techniques (these are explained in detail in Table 3.02).  
 
 
 
d. QUIP workshop content and activities 
The content and activities of the QUIP workshop were developed to be aligned with 
the workshop aims.  Table 3.02 shows each of the four workshop aims, and the related 
content/activities developed around each aim.  Figure 3.07 is also incorporated at the 
end of the table to illustrate how workshop content/activities were developed based on 
the theoretical principles of Fitts’ Skill Learning Theory (as discussed in the 
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Background, section A, ii).  For a timetable of the QUIP workshop activities, see 
Appendix 3.06.  
 
Table 3.02: The QUIP workshop – alignment of aims and content, and theoretical 
basis for content development. 
WORKSHOP AIMS 
 
RELATED CONTENT/ACTIVITIES 
 
1. To update 
pharmacists’ skills 
and knowledge on 
inhaler device 
therapy in 
asthma. 
A ten-minute interactive lecture accompanied by power point slides was 
presented.  The prevalence of poor technique and its consequences, 
and the importance of correct technique and need for improvement in 
the context of asthma management were highlighted (Appendix 3.07: 
QUIP lecture slides). 
 
 
2. To teach 
pharmacists to 
demonstrate 
correct inhaler 
technique for the 
pMDI, 
Turbuhaler™ and 
Accuhaler™. 
a. Physical demonstrations of correct inhaler techniques for the pMDI, 
Turbuhaler™ and Accuhaler™ were given by facilitators.  Techniques 
were demonstrated by one facilitator whilst another explained the 
purpose behind each step.  Power point slides listing the technique 
steps accompanied the demonstrations (Appendix 3.08: QUIP workshop 
slides). 
 
b. Individual hands-on practise of inhaler techniques by pharmacists 
(using a personal set of placebo inhaler devices supplied) occurred after 
facilitators’ demonstrations.   Pharmacists were asked to practise until 
they felt confident. 
 
c. Peer feedback on inhaler technique was obtained after individual 
practise.  Pharmacists worked in pairs, demonstrating inhaler technique 
to one another.  During this process pharmacists assessed each other’s 
demonstrations of inhaler techniques using print outs of the 11-step 
technique checklists (Appendix 3.09: Technique checklists for peer 
assessment) and gave each other feedback and guidance.   
 
d. Facilitators provided feedback during individual and peer practise with 
techniques if requested. 
 
e. Assessment of pharmacists’ inhaler techniques were conducted by 
facilitators towards the end of the workshop.  This was based on the 
“train the trainer” strategy developed by Basheti et al. (2009) previously, 
depicted in the diagram below: 
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                 “Train the trainer” strategy developed by Basheti et al. (2009) 
 
 
3. To teach 
pharmacists how 
to accurately 
assess and teach 
inhaler technique 
to asthma 
patients. 
a. A five-minute presentation accompanied by power point slides was 
given to explain the iterative “train the trainer” approach (Basheti et al., 
2009), also shown to be effective for teaching patients inhaler technique 
(Appendix 3.08: QUIP workshop slides). 
 
b. Pre-recorded video footage of an individual of incorrectly using the 
pMDI, Turbuhaler™ and Accuhaler™ were shown to pharmacists.   
 
i. For the pMDI video demonstration, inhaler technique was 
incorrect at steps 3 (exhale air out of lungs), 6 (inhale slowly and 
press canister firmly), 7 (continue slow and deep inhalation), 8 
(hold breath, aim for ten seconds) and 9 (while still holding 
breath remove inhaler from mouth).  Therefore an accurate 
assessment of this video demonstration by pharmacists would 
result in a score of 6 out of 11.   
 
ii. Similarly, for the Turbuhaler™ video demonstration, inhaler 
technique was incorrect at steps 2 (hold inhaler upright), 4 
(exhale air out of lungs), 5 (exhale away from mouthpiece), 8 
(hold breath, aim for ten seconds) and 9 (while still holding 
breath remove inhaler from mouth).  Therefore an accurate 
assessment of this video demonstration by pharmacists would 
result in a score of 6 out of 11.   
 
iii. Finally, for the Accuhaler™ video demonstration, inhaler 
technique was incorrect at steps 3 (exhale air out of lungs), 4 
(exhale away from the mouthpiece) and 10 (exhale away from 
the mouthpiece). Therefore an accurate assessment of this 
video demonstration by pharmacists would result in a score of 8 
out of 11. 
Educate: 
“Demonstration with 
return demonstration” 
 
Assess Technique 
Pharmacists 
demonstrate technique 
to facilitators 
Facilitators assess and 
re-demonstrate 
technique to make 
corrections if needed 
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Pharmacists used checklists to assess the 3 pre-recorded video 
demonstrations shown and thus gained practise with technique 
assessment.  The 3 checklists that pharmacists used to assess the 
video demonstrations were the same as those used during the peer 
assessment activity (Appendix 3.09).   
 
The 3 checklists that pharmacists marked their assessment and scores 
on were collected.  The data on how pharmacists scored each pre-
recorded video demonstration were collected. This gave an indication of 
how accurate the pharmacists would be in assessing patients’ inhaler 
techniques (note: the pre-recorded videos ensured that pharmacists 
across all training sessions viewed identical demonstrations, thus 
rending their assessments comparable).   
 
c. A role play between a pharmacist and a pseudo-patient was 
conducted as a final activity to consolidate the learning around this aim.  
The role play required the pharmacist to approach the pseudo-patient in 
order to assess their inhaler technique, whilst contending with barriers 
that are likely to occur in practice (in this case the pseudo-patient was in 
a rush and did not perceive their technique to be problematic).  
Facilitators provided feedback on pharmacists’ performance.  Learning 
points and questions arising from the role play were discussed with the 
entire group. 
 
4. To inform 
pharmacists of the 
study protocol and 
how to effectively 
implement it. 
a. Pharmacists were asked to recruit 5 patients each and then to assess 
patients’ inhaler technique in their pharmacies on two occasions one 
month apart and to facilitate the completion of questionnaires collecting 
patient data.  
 
b. Recruitment challenges and strategies were discussed. The group 
brainstormed recruitment strategies.  Pharmacists who were involved in 
past studies involving patient recruitment shared their experiences and 
insights.    
 
c. An “Inhaler Technique Maintenance”/“ITeM” study manual was 
allocated to each pharmacist to refer to whilst facilitators explained the 
study protocol (Appendix 3.10: ITeM study manual).   
 
The ITeM manual consisted of:  
 a one page study protocol summary 
 5 sets of data collection forms  
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 tips for recruiting 
 laminated bench top technique checklists 
 inhaler technique stickers for affixing onto patients’ inhaler 
devices 
 patient gift vouchers 
 patient appointment reminder cards  
 workshop power point slides 
 inhaler technique literature 
 
d. At the end of the workshop, each pharmacist was equipped with 
various resources for conducting the study.  They were: 
 the ITeM study manual. 
 A3 and A4 posters to aid in recruitment (Appendix 3.11: 
Recruitment posters). 
 placebo inhaler devices (pMDI, Turbuhaler™ and Accuhaler™).  
 the National Asthma Council of Australia’s Asthma Handbook 
2006.  
 
 
THEORETICAL UNDERPINNINGS OF WORKSHOP CONTENT 
 
 
The principles outlined in Fitts’ Skill Learning Theory (FSLT) were implemented to facilitate 
pharmacists developing and maintaining the correct inhaler techniques.  This is illustrated in 
Figure 3.07. 
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Figure 3.07: Implementing Fitts’ Skill Learning Theory (FSLT) in the QUIP workshop 
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e. QUIP workshop evaluation 
In order for pharmacists to be credited CPE points for participating in the QUIP 
workshop, the professional body, the Pharmaceutical Society of Australia (PSA), 
required pharmacists to complete a brief evaluation of the workshop.  The PSA asked 
pharmacists to respond in writing and anonymously to the following three questions: 
1. To what extent were the workshop aims met? 
2. To what degree were your own learning needs met though participating in this 
activity? 
3. To what degree was this activity relevant to your practise? 
 
Responses were tick box, with the options – “Entirely met”, “Partially met” or “Not met” 
and with space for written comments after each question. 
 
Finally, at the end of the QUIP workshop, pharmacists received a certificate 
recognising their participation in the training and 3.5 CPE points (Appendix 3.12: QUIP 
workshop certificate of completion). 
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iii. Phase 2: Study Patients  
Community based patients with asthma were recruited into this study by their local 
pharmacist (i.e. those pharmacists who had completed the QUIP workshop described 
in the previous section).  Patients eligible to participate in this study had to meet the 
following inclusion criteria: 
 Over 18 years of age 
 Able to speak English 
 Have a previous diagnosis of asthma 
 Using preventative asthma treatment in the form of a pMDI, Turbuhaler™ or 
Accuhaler™ .  
 Able to attend the follow up visit in one month 
A further two criteria excluded patients who were: 
 Not self-administering their inhaler therapy  
 Involved in another clinical asthma study 
 
To identify potential patients for the study, pharmacists were instructed to approach 
consecutive customers who had entered their pharmacy with a prescription for a pMDI, 
Turbuhaler™ or Accuhaler™ device, used for preventative asthma therapy.  Pharmacy 
dispensary records could also be used to identify potential patients.   
 
Pharmacists were asked to explain the study to the patient with the provision of written 
information (Appendix 3.13: Patient study information statement).  Benefits and 
incentives for patients to participate in the study included the opportunity to learn more 
about using their inhaler device and a twenty dollar gift voucher to spend in the 
pharmacy when they completed the final study visit.  Written informed consent was 
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obtained from those patients who agreed to participate in the study (Appendix 3.14: 
Patient study consent form). 
 
1. Study Visits 
Patients enrolled in the study were required to complete two visits approximately one 
month apart.  At each visit patients were required to fill out a brief questionnaire 
(approximately 10 minutes in duration).  Patients were then required to demonstrate 
their inhaler technique to the pharmacist using their own device.  The pharmacist 
would assess and, if necessary, educate patients on correct inhaler technique (via 
repeat demonstration using placebo devices).  The patient data collected at each visit 
are summarised in Table 3.04.   
   
a. Visit 1 
At visit 1 (baseline) patients completed a questionnaire seeking information regarding 
their demographics, asthma history, medical history, past inhaler device use history, 
past inhaler technique education received, asthma control, preventer adherence and 
beliefs and motivations around inhaler use (Appendix 3.15: Patient visit 1 
questionnaire_F4).  In addition, a record of patients’ current medications (asthma and 
non-asthma) was completed by the pharmacist (Appendix 3.16: Patient medication 
record_F5). 
 
After patients completed the questionnaire, their inhaler technique was assessed by 
the pharmacist.  Using their own device, patients were asked to demonstrate how they 
would usually use their inhaler. The pharmacist assessed patients’ inhaler technique 
using the appropriate 11-step checklist (for pMDI, Turbuhaler™ or Accuhaler™) 
(Appendix 3.17: Visit 1 patient technique checklist_F6).    
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Patients with suboptimal technique were educated by pharmacists via an iterative 
process of repeat demonstrations (Basheti et al., 2007).  That is, pharmacists 
demonstrated correct inhaler technique (using a placebo device) to the patient and 
then assessed the patient’s technique demonstration.  This was repeated until the 
patient could demonstrate correct inhaler technique.   
 
Finally, a sticker was affixed to the patient’s inhaler device, printed with all 11 
technique steps for the use of their device.  Any step/s that proved problematic for the 
patient during visit 1 were highlighted on the sticker by the pharmacist to draw 
awareness to in daily use (Basheti et al., 2008) (Appendix 3.18: Stickers affixed on 
patients’ inhaler device). 
 
b. Visit 2 
At visit 2, approximately one month after visit 1, patients returned to their pharmacy 
and completed a questionnaire that collected follow up data on asthma control, 
preventer adherence and beliefs and motivations around inhaler use (Appendix 3.19: 
Patient visit 2 questionnaire_F7).  Patients’ inhaler technique was re-assessed by the 
pharmacist and, if necessary, patients were re-educated on correct inhaler technique 
via the same process as described for visit 1 (Appendix 3.20: Visit 2 patient technique 
checklist_F8).    
 
2. Quality control and support measures 
The patient recruitment phase lasted approximately 3 months and to sustain 
pharmacists’ motivation to complete both visits with patients and reach the target 
sample size, the researcher (LO) kept in regular communication in person, via phone 
calls and newsletters (5 in total).  Feedback regarding the number of patients recruited 
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and the numbers required to reach the target sample size (quantitative feedback) as 
well as tips from fellow pharmacists who had successfully recruited (qualitative 
feedback) were features of the newsletters (Appendix 3.21: Newsletters to 
pharmacists). 
 
Approximately halfway through the patient recruitment phase (14th - 23rd May 2010), 
audits were conducted to review the data collection process and documentation.  This 
was undertaken via the researcher visiting all pharmacies and consulting with the 
study pharmacists.  The audit served two purposes.  Firstly, to ensure data were being 
collected and recorded accurately.  Secondly, to identify pharmacists experiencing 
difficulty with recruitment and to offer them support.  This included assistance with 
recruitment in person, at the pharmacy, by the researcher.  
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iv. Study Data 
1. Pharmacist data 
Table 3.03 below summarises the data relating to pharmacists collected during the 
QUIP workshops, as well as the method of data collection. 
Table 3.03: Pharmacist data collected during the QUIP workshops and method of 
collection. 
Data Method of Collection 
Pharmacist Demographics: 
i. age group 
ii. gender 
iii. job description 
 
Self-report questionnaire  
Past inhaler technique education 
 
Self-report questionnaire 
Pharmacy demographics: 
i. location of pharmacy 
ii. average number of scripts dispensed per 
week 
iii. whether any specialised services were 
provided  
 
Self-report questionnaire 
Pharmacists’ assessment of the pre-recorded video 
demonstrations of inhaler technique for the pMDI, 
Turbuhaler™ and Accuhaler™ (described in the 
Methods, Table 3.02). 
 
Self-complete inhaler technique 
checklists 
Pharmacists’ workshop evaluation (described in the 
Methods, section ii, 2, e). 
 
Self-complete evaluation survey 
 
2. Patient data 
Patient data on inhaler technique, asthma control, demographics, medical history, 
inhaler device history, inhaler technique education history and beliefs and motivations 
around inhaler use were collected.  Table 3.04 outlines the patient data collected, the 
method of data collection and the time point/s at which the data were collected.  In 
regards to the method of data collection, “patient self-report” refers to the data 
collected from questionnaires completed by patients during visits 1 and 2 (Appendices 
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3.15 and 3.19).  “Pharmacist-report” and “pharmacist assessment” refers to any patient 
data that pharmacists collected (Appendices 3.16, 3.17 and 3.20). 
Table 3.04: Patient data collected during study – what, how and when. 
Data type Data collected Method of 
collection 
Visit 
1 
Visit 
2 
 
Outcome 
variable 
 
Inhaler technique (11 point checklist)  
 
Pharmacist 
assessment 
 
 
 
 
Demographics 
and 
clinical/medical 
history 
Age Patient self-report   
Gender Patient self-report   
Education level Patient self-report   
Asthma duration Patient self-report   
Asthma control 
(Shortened Asthma Control 
Questionnaire) (Juniper et al., 2005) 
Patient self-report   
Number of asthma related emergency 
care and hospitalisations in past year Patient self-report   
Number of asthma related health care 
provider consultations in past year Patient self-report   
Respiratory co-morbidities Patient self-report   
Other co-morbidities Patient self-report   
Oral asthma medication used Pharmacist report   
Other regular medications used Pharmacist report   
Dose of preventer medication  Pharmacist report   
Inhaler device 
factors 
Type of preventer device used Pharmacist report   
Duration of preventer device use Pharmacist report   
Number of different types of inhaler 
devices used (for any chronic 
respiratory conditions) 
Pharmacist report   
Technique 
education and 
learning 
factors 
Health care provider/s who gave past 
technique education Patient self-report   
Method of past technique education Patient self-report   
Time since last inhaler technique 
education Patient self-report   
Number of times technique was re-
check (by a health care professional) 
since starting preventer therapy 
 
Patient self-report   
If and number of times patient has 
shown others inhaler technique Patient self-report   
Preventer adherence (Medication 
Adherence Report Scale-5) (van de 
Steeg et al., 2009) 
Patient self-report   
Psychological 
factors  
 
Necessity of preventer medication  
(Beliefs about Medicines 
Questionnaire) (Horne et al., 1999) 
Patient self-report   
Importance of correct inhaler 
technique 
(Inhaler Technique Beliefs 
Questionnaire; devised for this study) 
Patient self-report   
Motivation for correct technique 
(motivation for correct inhaler 
technique question; devised for this 
study). 
Patient self-report   
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1. Unscrew and lift off 
cap 
2. Hold inhaler upright 
3. Rotate grip one way, 
then back until click is 
heard        
4. Exhale air out of lungs 
5. Exhale away from 
mouthpiece 
6. Put mouthpiece 
between teeth and seal 
with lips 
7. Inhale forcefully and 
deeply  
8. Hold breath, aim for 10 
seconds 
9. While still holding 
breath remove inhaler 
from mouth 
10. Exhale away from 
mouthpiece 
11. Replace cap 
 
1. Open inhaler  
2. Push lever back 
completely to load dose 
3. Exhale air out of lungs 
4. Exhale away from 
mouthpiece 
5. Hold inhaler 
horizontally 
6. Put mouthpiece 
between teeth and seal 
with lips 
7. Inhale steadily and 
deeply 
8. Hold breath, aiming for 
10 seconds 
9. While still holding 
breath remove inhaler 
from mouth 
10. Exhale away from 
mouthpiece 
11. Close cover  
 
3. Development of data collection tools 
a. Inhaler technique and technique maintenance assessment  
The inhaler technique checklists (for the pMDI, Turbuhaler™ and Accuhaler™) used 
throughout this study were based on published studies, clinical guidelines and 
manufactures’ instructions (as reviewed in Chapter 2, section B, iv).  The checklists 
were also based on discussion and consensus between three researchers, one of 
whom is an expert in the area (SBA).  The 11 steps for correct inhaler technique in 
each of the three checklists are shown in Figure 3.08.  Copies of the actual checklists 
that pharmacists used in the study were only different in appearance and format 
(shown in Appendices 3.17 and 3.20). 
 
Figure 3.08: The inhaler technique checklists used in this study to assess pMDI, 
Turbuhaler™ and Accuhaler™ techniques.  
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Remove cap   
2. Shake inhaler well 
3. Exhale air out of lung  
4. Hold inhaler upright 
5. Put mouthpiece 
between teeth and seal 
with lips 
6. Inhale slowly and 
press canister firmly 
7. Continue slow and 
deep inhalation 
8. Hold breath, aim for 10 
seconds 
9. While still holding 
breath remove inhaler 
from mouth 
10. Exhale away from 
mouthpiece 
11. Replace cap 
 
pMDI Checklist Turbuhaler™ Checklist Accuhaler™ Checklist 
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“Correct” inhaler technique was used to describe patients who (prior to education by 
the pharmacist) performed all steps on the checklist correctly, these patients scored 11 
(out of 11) on technique.   
 
“Incorrect” inhaler technique was used to describe patients who (prior to education 
by the pharmacist) did not perform all steps on the checklist correctly, these patients 
scored < 11 on technique.   
 
Further, “correct inhaler technique maintenance”, was used to describe those 
patients who scored 11 on technique at visit 2.  “Incorrect inhaler technique 
maintenance” was used to describe those patients who scored <11 on technique at 
visit 2. 
 
b. Questionnaire design:  format and style 
The questionnaires used in this study were designed to be as clear and simple as 
possible in order to maximise accurate completion.  Patient questionnaires were 
written in plain English (as conferred by 3 researchers) and printed in black, size 14, 
Arial Rounded MT Bold font.  The questionnaires that pharmacists were to complete   
(on patient medication history and inhaler technique score) were also written in plain 
English and printed in black, size 12, Arial Rounded MT Bold font.  Different coloured 
paper was used to print the patient (gold) and pharmacist (green) questionnaires so 
that they could be readily differentiated.  The questionnaires were kept as brief as 
possible to encourage completion in the often busy community pharmacy setting.  In 
addition, to ensure the set of data collection forms for each patient were matched 
accurately (for the purposes of data entry and analysis) all documents used in data 
collection were coded prior to dissemination (e.g. 001605 identified patient number 5, 
recruited by pharmacist number 16). 
Chapter 3 – Quantitative Study  
99 
 
c. Questionnaire design:  Instruments used   
The two patient questionnaires used in this study (Appendices 3.15 and 3.19) were 
each composed of various instruments, selected individually to be used in this study to 
measure the areas of relevance.  As a priority, previously validated instruments were 
sought out and used, however if this did not exist, instruments that were frequently 
reported in the literature were incorporated.  Where neither of these two options 
existed, questions were generated by the researchers and used as instruments; these 
questions were underpinned by literature and tested for face-validity.  The 5 individual 
instruments used in the patient questionnaires are listed and explained below under 
individual headings.        
 
〉 Asthma control (S-ACQ) 
The validated Shortened Asthma Control Questionnaire (S-ACQ) was used to assess 
patients’ asthma control at visits 1 and 2 (Juniper et al., 2005).  This instrument 
consisted of 6 items measuring asthma symptom experience, asthma-related 
limitations in daily activities and short-acting bronchodilator use on a seven point scale 
that ranged from 0 to 6, with the numerical increase indicating increase in frequency or 
intensity.  The mean asthma control score was calculated by adding the scores from 
each item (ranging from 0 – 6) and dividing by the total number of items (6).  Well 
controlled asthma was indicated by mean scores < 1.5, and poorly controlled asthma 
was indicated by mean scores ≥ 1.5 (Clatworthy et al., 2009). 
 
〉  Adherence/Regularity of inhaler technique practise (MARS-5) 
The validated Medication Adherence Report Scale (MARS-5) was used at visits 1 and 
2 to assess patients’ adherence to preventer therapy, as an indicator of how regularly 
patients practised inhaler technique (Horne and Weinman, 2002, van de Steeg, Sielk, 
Pentzek, Bakx and Altiner, 2009).  The MARS-5 consists of 5 items and measures the 
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extent to which patients believe they enact the following behaviours relating to 
preventer inhaler use: “I alter the dose”, “I forget to use it”, “I stop taking it for a while”, 
“I decide to miss out on a dose”, and “I take less than instructed” (van de Steeg et al., 
2009).  Each of the items are rated on a five point Likert scale (where 1 = always; 2 = 
often; 3 = sometimes; 4 = rarely; 5 = never), and scores from all five of items are 
summed.  Scores can range from 5 to 25, with higher scores indicating a greater 
adherence (Menckeberg et al., 2008).     
 
〉 Beliefs about preventer medication – necessity and concerns (BMQ-S) 
The validated Beliefs about Medicines Questionnaire Specific (BMQ-S) was used at 
visits 1 and 2 to assess patient beliefs about inhaled preventer medication (Horne, 
Weinman and Hankins, 1999).  The BMQ-S consists of 10 items in total with 5 items 
relating to each of two subscales, the necessity and concerns subscales.  The 
necessity subscale measures the strength of patient beliefs regarding the necessity of 
taking inhaled preventer medication (e.g. “my health at present depends on this 
medicine”, “this medicine protects me from becoming worse”), and the concerns 
subscale measures the strength of patient beliefs regarding concerns about taking 
inhaled preventer medication (e.g. “having to take this medicine worries me”, “this 
medicine disrupts my life”). 
 
Patients rated each item in the BMQ-S using a five point Likert scale (where 1 = 
strongly agree; 2 = agree; 3 = uncertain; 4 = disagree; 5 = strongly disagree).  Scores 
from the necessity and concerns subscales were summed separately, and ranged 
from 5 to 25, with higher scores indicating stronger beliefs in either the necessity or 
concerns domain.  Subsequently, the “necessity-concerns differential” was calculated 
by subtracting the concerns subscale scores from the necessity subscale scores.  The 
necessity-concerns differential scores ranged from –20 to +20.  Negative scores 
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indicated that patient concerns over preventer medication were stronger than their 
beliefs in the necessity of preventer medication; whereas positive scores indicated the 
opposite (necessity beliefs were stronger than concerns). 
 
〉 Beliefs about the importance of correct inhaler technique (ITBQ) 
The 3-item Inhaler Technique Beliefs Questionnaire (ITBQ) was used at visits 1 and 2 
to measure patient beliefs about the importance, or value, of practising correct inhaler 
technique.  This instrument was devised by the current researchers as there are no 
previously published instruments for use in this area.  The ITBQ was assessed for face 
validity (i.e. three researchers, LO, SBA, LS, discussed  the items and reached 
consensus that they  reflected patients’ beliefs concerning the importance of correct 
inhaler technique).  The 3 items in the ITBQ were: 
 “It is important to follow the correct steps every time I use my inhaler” 
 “My inhaler will work just as well if I follow most of the correct steps”  
 “The way I use my inhaler will not affect my asthma” 
 
Patients rated each item listed above on a ten point Likert scale ranging from 1 
(strongly agree) to 10 (strongly disagree).  The scores from all three items were 
summed with higher scores indicating stronger beliefs regarding the importance of 
practising correct inhaler technique and lower scores indicating weaker beliefs in the 
importance of practising correct inhaler technique.  
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〉 Motivation for practising correct inhaler technique 
The level of patient motivation to practise correct inhaler technique was measured at 
visits 1 and 2 using the following item:   
 “I am motivated to follow the correct steps when I use my inhaler”.   
 
This item was devised by the current researchers as there are no previously published 
instruments measuring patient motivation in relation to inhaler technique.  The item 
was assessed for face-validity (i.e. three researchers, LO, SBA, LS, conferred that the 
item reflected inhaler technique specific motivation).  Patients rated the item using a 
ten point Likert scale ranging from 1 (strongly agree) to 10 (strongly disagree).  Higher 
scores indicated greater patient motivation to practise correct inhaler technique and 
lower scores indicated less patient motivation to practise correct inhaler technique. 
 
4. Statistical analyses 
a. Descriptive statistics  
Descriptive statistical analyses were conducted on the pharmacist data and patient 
data relating to demographics, medical and asthma history, history of inhaler device 
use, and past inhaler technique education.   
 
b. Changes in repeat measure variables 
Variables that were measured at both visits 1 and 2 (S-ACQ, MARS-5, BMQ-S, ITBQ 
and motivation) were tested for changes over time.  To do so, firstly the normality of 
distribution for each variable (using the difference in scores between visits 1 and 2 for 
each specific variable) was assessed both visually (using distribution histograms and 
P-P plots) and statistically (using measures of skewness and kurtosis and the 
Kromologov-Smirnov and Shapiro-Wilks tests).  For variables which were normally 
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distributed, the parametric dependent-t-test (or paired-samples t-test) was used to test 
for changes over time.  For variables which were not normally distributed, the non-
parametric Wilcoxon signed-rank Test was used (Field, 2009). 
 
c. Logistic regression analysis 
In order to determine the predictors of patient inhaler technique maintenance over 
time, logistic regression analysis was conducted.  The dependent (outcome) variable 
was inhaler technique maintenance.  That is, whether patients maintained (technique 
scored = 11) or did not maintain (technique score < 11) correct inhaler technique at 
study visit 2.  The independent (predictor) variables consisted of the remaining study 
variables collected, listed previously in Table 3.04.      
 
〉 Fitting procedure  
The backward stepwise (likelihood ratio) fitting procedure was selected to perform the 
logistic regression.  The backward stepwise method is favoured over the forward 
stepwise method as it accounts for suppressor effects, that is, when a variable exerts a 
significant influence only when another variable is held constant (Field, 2009).  The 
likelihood ratio was used as the removal criterion as it is more reliable than methods 
such as the Conditional or Wald removal criteria (Field, 2009).      
 
Stepwise fitting procedures for logistic regression have been criticised for being more 
likely to be affected by random variations in data – it relies on mathematical criteria for 
variable selection, as opposed to prior researcher assumptions (in the hierarchical 
entry procedure), or the simultaneous entry of all variables (in the forced entry 
procedure).  However, the stepwise fitting procedure was deemed the most suitable for 
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the purposes of this study (Field, 2009) (Appendix 3.23: Rationale for statistical 
selection of independent variables).   
 
The stepwise fitting procedure was chosen because no previous research exists to 
clearly identify those factors likely to be predictors of inhaler technique maintenance.  It 
was therefore deemed inappropriate to make assumptions in variable selection (as 
would be required using the hierarchical entry method) without firm evidence.  Further, 
it was not within the scope of this study to reliably use the forced entry procedure as it 
required a sample size that would not have been feasibly achieved (i.e. n ≥ 560 patient 
cases in order to test for all of the 28 unique study variables collected).   
 
Stepwise fitting procedures may run the risk of “over-fitting”, having too many variables 
in the model with minimal contribution to outcome prediction (Field, 2009).  This may 
also increase the risk of the model being unduly influenced by random variations in the 
sample data (Bagley, White and Golomb, 2001).  In order to mitigate this, initial 
statistical screening of variables, via univariate regression and bivariate correlations, 
was conducted as described below. 
 
〉 Statistical screening of predictor variables 
Selection of independent variables for inclusion in the logistic regression was 
performed statistically.  This was based on the results of univariate logistic regressions 
and bivariate correlations between the dependent (inhaler technique maintenance) and 
the independent variables (remaining study variables).  The independent variables 
tested were deemed suitable for inclusion in the logistic regression if p<0.25, a level 
large enough to reduce the potential for overlooking any significant interactions 
between variables (Hosmer and Lemeshow, 2000).   
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Appendix 3.24 (Univariate logistic regression results) shows the variables selected for 
inclusion in the logistic regression.   
 
All potential significant first degree interactions between the qualifying predictor 
variables were also tested for (Kleinbaum, Kupper, Nizam and Muller, 2008).   
During the interpretation of the final logistic regression model produced, significance 
levels were set at p<0.05.  
 
〉 Sample size for regression 
The sample size was calculated based on the hypothesised number of independent 
variables which would be included in the logistic regression model, i.e., 7 independent 
variables (section B, Aims and hypotheses).  Thus, based on a statistical significance 
level of 0.05, dropout rate of 40% and 7 independent variables, a sample size of n = 
150 patients was calculated (50 + [8 x 7] x 1.4 = 148.4) (Field, 2009).                                                     
 
〉 Assessing the regression model: goodness of fit and diagnostic 
statistics 
Various steps were taken to ascertain the goodness of fit and the generalisability of the 
final regression model.  After the regression model was generated, it was tested to see 
how well it represented the overall data and whether there were any outliers or cases 
exerting disproportionate influence and therefore biasing the model (Bagley et al., 
2001, Field, 2009, Ottenbacher, Ottenbacher, Tooth and Ostir, 2004).  Residual and 
influence statistics were examined to:  
 Isolate cases for which the model fits poorly (Standardized Residual and 
deviance statistics), and  
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 Isolate cases that exert an undue influence on the model (Cooks Distance, 
DFBeta, Leverage) 
Further, any outliers identified were not eliminated but examined to determine the 
reasons for their deviance.  The diagnostic statistics generated and their criteria for 
determining data cases that were outliers, or disproportionately influential, can be 
found in Appendix 3.25 (Diagnostic statistics conducted). 
 
〉 Assessing the regression model: generalisability and assumption 
testing 
After the model was assessed for goodness of fit, it was the assessed for 
generalisability.  This was to indicate whether the findings can be used to make 
inferences beyond the study sample, to a broader community of patients using inhaler 
devices (Field, 2009).  In order to generalise a regression model, various assumptions 
must be met (Bagley et al., 2001, Field, 2009, Ottenbacher et al., 2004).  The 
assumptions tested for and their criteria can be found in Appendix 3.26 (Assumption 
testing conducted). 
 
d. Statistical software used 
Statistical analyses in this study were performed using the software PASW version 18 
(IBM, Inc., Chicago, IL, USA). 
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D. Results 
i. Pharmacists 
1. Pharmacist recruitment  
A total of 31 pharmacists were recruited who actively participated in recruiting patients 
for this study.  Initially, 62 pharmacists were invited to participate in the study via email, 
telephone or in person.  The majority of pharmacists who consented to take part were 
those who were approached in person (67%), followed by those contacted via 
telephone (52%) and then via email (35%).  This is shown in Table 3.05. 
 
Table 3.05: Pharmacist recruitment 
Method of contact Numbers contacted Numbers consented 
Email 17 6 (35%) 
Telephone 21 11 (52%) 
In-person 24 16 (67%) 
Total 62 33 (53%) 
   
 
Pharmacists who consented to participate in the study received training through the 
CPE accredited QUIP workshop (explained in Methods, section C, ii, 2).  Table 3.06  
shows the number of pharmacists who participated in the workshop either in its small 
group format (at the Faculty of Pharmacy) or its individual one-on-one format (at their 
pharmacy).   
 
Table 3.06: Pharmacists completing the QUIP workshop in its small group and 
individual format. 
Format of workshop Numbers attending 
SMALL GROUP  
(Faculty of Pharmacy) 
i) Saturday 9-11am (27th February 2010) 
ii) Monday 7-9pm (1st March 2010) 
 
 
 
i) 9 
ii) 17 
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INDIVIDUAL  
(in pharmacy, 25th February - 8th April 2010) 
 
7 
Total pharmacists completing training workshop  
 
33  
Total study pharmacists (after drop-out post workshop) 31 
 
After receiving training, two pharmacists dropped out of the study (one going on 
annual leave, and another relocating away from Sydney), leaving a total of 31 
pharmacists to conduct the study.  Therefore the results presented henceforth pertain 
only to the 31 participating pharmacists.  
 
2. Pharmacist demographics and past inhaler technique education 
Table 3.07 shows the demographics of the pharmacists who participated in the study.  
Notably, a large majority of pharmacists reported having received some form of inhaler 
technique related education in the past. 
 
Table 3.07: Pharmacist demographics and past inhaler technique education   
 
 
 
 
 
 
 
 
 
Age (years) 21-30 N=19 (61%) 
31-40 N=5 (16%) 
41-50 N=5 (16%) 
51-60 N=1 (3%) 
61-70 N=1 (3%) 
Gender Male N=12 (39%) 
Job description Pharmacist in charge N=22 (71%) 
Sole proprietor N=4 (13%) 
Partner proprietor N=2 (6%) 
Pharmacist intern N=3 (10%) 
Past inhaler 
technique 
education received 
Yes N=23 (74%) 
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3. Pharmacy demographics 
The pharmacists who participated in this study worked in 23 different pharmacies 
located across twenty-one suburbs in the Sydney metropolitan region (Annandale, 
Artarmon, Auburn, Bonnyrigg, Blacktown, Brighton-le-sands, Broadway, Burwood, 
Coogee, Edensor Park, Glenmore Park, Green Valley, Kingsgrove, Kingswood, Manly 
Vale, Moorebank, Mt Pritchard, Parramatta, Picnic Point, Rozelle and St Ives).  It is 
from these pharmacies that patients were recruited for this study.  The locations of 
study pharmacies are marked (blue dots) on a map of metropolitan Sydney in Figure 
3.09. 
 
Figure 3.09: Geographic distribution of study pharmacies 
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Study pharmacy characteristics in regards to store location, prescription volume and 
provision of specialised services are shown in Table 3.08. 
 
Table 3.08: Characteristics of study pharmacies 
Location Shopping centre N=10 (43%) 
Isolated stand alone N=1 (4%) 
Neighbourhood stand alone N=10 (43%) 
Medical centre N=2 (9%) 
Estimated number of 
prescriptions     
dispensed per 7 days 
 
   
<300 N=4 (17%) 
301-800 N=8 (35%) 
801-1200 N=3 (13%) 
1201-2000 N=5 (22%) 
2001-3000 N=3 (13%) 
Provision of specialised 
services 
Yes N=22 (96%) 
Type/s of specialised 
service provided 
(note: each pharmacy 
usually provided multiple 
services) 
Home Medicines Review N=19  
Dosage Administration Aids N=21  
Patient Medication Profile N=14 
Diabetes Medication Assistance Service N=6 
 
 
4. Accuracy of inhaler technique assessment by pharmacists 
Pharmacists’ accuracy in assessing inhaler technique after watching pre-recorded 
video demonstrations of the pMDI, Turbuhaler™ and Accuhaler™ was measured, as 
explained in Table 3.02, next to workshop aim 3b (Methods, section C, ii, d).  For the 
pMDI, 52% (N=16) of pharmacists made a correct assessment of the video 
demonstration (i.e. allocated a score of 6 out 11) (Figure 3.10).   For the Turbuhaler™, 
58% (N=18) of pharmacists made a correct assessment of the video demonstration 
(i.e. allocated a score of 6 out 11) (Figure 3.11).  The greatest accuracy in assessment 
occurred with the Accuhaler™, where 74% (N=23) of pharmacists made a correct 
assessment of the video demonstration (i.e. allocated a score of 8 out of 11) (Figure 
3.12).   
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Figure 3.10: A. Pharmacists’ assessment of pMDI technique after viewing the pre-
recorded video demonstration.  B. Allocation of scores using the pMDI checklist to give 
a correct assessment of the video demonstration (i.e. score of 6 out of 11). 
  
 
A.                                            B.  
  
 
 
Figure 3.11: A. Pharmacist assessment of Turbuhaler™ (TH) technique after viewing 
the pre-reorded video demonstration. B. Allocation of scores using the Turbuhaler™ 
checklist to give a correct assessment of the video demonstration (i.e. score of 6 out of 
11). 
 
 
A.                    B. 
   
 
 
1.   Remove cap     
2.   Shake inhaler well   
3.   Exhale air out of lungs  
4.   Hold inhaler upright 
5.   Put mouthpiece between teeth 
and seal with lips 
6.   Inhale slowly and press canister 
firmly 
7.   Continue slow and deep 
inhalation 
8.   Hold breath, aim for 10 seconds 
9.   While still holding breath 
remove inhaler from mouth 
10.  Exhale away from mouthpiece 
11.  Replace cap 
 
Correct assessment score: 6/11 
 
1.   Unscrew and lift off cap 
2.   Hold inhaler upright 
3.   Rotate grip one way, then back 
until click is heard        
4.   Exhale air out of lungs 
5.   Exhale away from mouthpiece 
6.   Put mouthpiece between teeth 
and seal with lips 
7.   Inhale forcefully and deeply  
8.   Hold breath, aim for 10 seconds 
9.   While still holding breath 
remove inhaler from mouth 
10.  Exhale away from mouthpiece 
11. Replace cap 
 
Correct assessment score: 6/11 
N=16 pharmacists allocated 
the correct score of 6/11. 
N=18 pharmacists allocated 
the correct score of 6/11. 
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Figure 3.12: A. Pharmacist assessment of Accuhaler™ (ACC) technique after viewing 
the pre-recorded video demonstration. B. Allocation of scores using Accuhaler™ 
checklist to give a correct assessment of the video demonstration (i.e. score of 8 out of 
11). 
 
 
 
A.               B.   
 
  
 
 
 
5. Evaluation of the QUIP workshop  
On completion of the QUIP workshop, pharmacists evaluated the training they 
received by completing a brief questionnaire in response to three questions set by the 
CPE accrediting organisation, the PSA.  The results of the evaluation indicated that all 
pharmacists believed that the learning objectives were entirely met; most pharmacists 
believed that their personal learning needs were entirely met; and most pharmacists 
believed that the training was relevant to their day-to-day practice.  This is summarised 
in Table 3.09.        
 
 
 
 
 
1.   Open inhaler  
2.   Push lever back completely to 
load dose 
3.   Exhale air out of lungs 
4.   Exhale away from mouthpiece 
5.   Hold inhaler horizontally 
6.   Put mouthpiece between teeth 
and seal with lips 
7.   Inhale steadily and deeply 
8.   Hold breath, aiming for 10 
seconds 
9.   While still holding breath 
remove inhaler from mouth 
10.  Exhale away from mouthpiece 
11.  Close cover  
 
Correct assessment score: 8/11 
N=23 pharmacists allocated 
the correct score of 8/11. 
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Table 3.09: Pharmacists’ evaluation of the QUIP workshop – number of pharmacists 
rating “entirely met”, “partially met” or “not met” for each item, and any comments 
written.    
PSA 
evaluation 
question  
Pharmacists’ responses: ratings and comments 
ENTIRELY MET PARTIALLY MET 
NOT 
MET 
1. To what 
extent were 
the 
workshop 
aims met? 
 
N=31 (100%) 
“The demonstration coupled with the scoring, getting 
participants to demonstrate and be scored were great in 
reinforcing what was being taught.” 
“Quite thorough” 
“Well done” 
“Really good to have training on the devices again, each 
process broken down into steps and explained.” 
“Excellent workshop” 
“The activity comprehensively met the objectives outlined 
above” 
“Very well presented and made sure I understood 
techniques through demonstration.” 
“Very thorough” 
 
N=0 N=0 
2. To what 
degree were 
your own 
learning 
needs met 
through 
participating 
in this 
activity? 
 
N=30 (97%) 
“Greater insight on how to assess patient inhaler 
technique correctly.”  
“I found the workshop helped clarify my understanding 
and technique of the devices.”  
“Nice to review technique now and then.” 
“Able to get hands-on practise for using more than one 
device.” 
“Excellent to have hands-on practise to gain complete 
practical experience.”  
“Concise but good and relevant info” 
“Great, more confident with how to show inhaler 
technique and why it is important.” 
“Very valuable in reinforcing of correct technique.” 
 
N=1 (3%) 
“Need some 
further private 
time with the 
devices plus 
checklists” 
N=0 
3. To what 
degree was 
this activity 
relevant to 
your 
practice? 
 
N=29 (94%) 
“We have a high proportion of customers on asthma 
inhaler medications with varying levels of asthma control.  
Have a better understanding of the difficulty that may be 
experienced by patients using a pMDI.  Coordination was 
difficult along with creating a good seal around 
mouthpiece as experienced using placebo device.” 
“We dispense many inhaler devices daily therefore I think 
that this was really important.”  
“Nice to review technique now and then.” 
“Useful information for patients” 
“I believe most of our customers would not realise how 
much they can benefit from re-assessing their 
techniques.” 
“Anything concerned with health is relevant” 
“We have many elderly patients on inhalers who most 
likely do not use their inhalers properly.  Also very useful 
to hear pointers on how to approach patients about their 
inhaler technique.” 
“Many customers on asthma medication” 
“Asthma management is a crucial component in delivering 
the best possible care for patients at our practice.” 
“More confident to instruct patients with the proper 
techniques.” 
N=2 (6%) 
“Lack of time is 
always a 
barrier in 
community 
pharmacy” 
N=0 
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ii. Patients 
1. Patient recruitment  
One hundred and fifty patients were enrolled in the study of whom 139 (excluding the 6 
ineligible patients who were enrolled) completed the first visit and 127 (85%) returned 
to complete the second visit.  Figure 3.13 shows the flow of patients through the study 
from March to July 2010. 
 
Figure 3.13: Patient recruitment and retention throughout study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recruited 
(n=150) 
Visit 1 
(n=139) 
Visit 2 
(n=127) 
March-May 2010: 
 
– Written information provided 
– Consent form signed 
 
March-May 2010: 
 
– Inhaler technique assessed 
– Questionnaires completed 
– Inhaler technique education 
provided 
– All patients leave pharmacy 
with correct inhaler technique 
 
Approximately one month 
interval between visits 1 and 2 
 
April-July 2010: 
 
– Inhaler technique assessed 
– Questionnaires completed 
 
– Change of mind 
and declined to 
further participate 
(n=5) 
– Ineligible/did not 
meet inclusion 
criteria (n=6) 
 
– Discontinued 
because too busy, 
not contactable, 
hospitalised, or 
ceased preventer 
inhaler (n=13)  
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2. Patient demographics and asthma history 
Table 3.10 summarises the data relating to patient demographics and asthma history.  
Notably, there were no statistically significant differences between patients who 
maintained and those who did not maintain correct technique based on these 
demographic variables (p>.05, Mann Whitney U test or Chi-square test for 
independence).   
 
Table 3.10: Demographics and asthma history of study patients 
Age (years) Range 18 - 88 
Mean 53 (±19) 
Gender Male N=43 (31%) 
Highest level of education Primary N=1 (0.01%) 
Secondary N=61 (44%) 
TAFE N=34 (24%) 
Tertiary N=42 (30%) 
Asthma duration (years) Range 0.08 - 81 
Mean 26 (±18) 
Visit/s to a health care professional for 
asthma in past year 
0 N=25 (18%) 
1 N=31 (22%) 
2 N=33 (24%) 
3 N=20 (14%) 
>3 N=30 (22%) 
Other (non-asthma) medications taken No N=48 (35%) 
Yes, <5 N=63 (46%) 
Yes, ≥5 N=27 (19%) 
≥ 1 other medical condition experienced N= 83 (60%) 
≥ 1 other respiratory condition 
experienced 
N=33 (24%) 
≥ 1 visit/s to hospital/emergency room 
for asthma in past year 
N=27 (19%) 
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3. Inhaler devices used and previous technique education  
Table 3.11 summarises the data relating to patients’ inhaler device therapy and the 
nature of previous inhaler technique education received.  
 
Table 3.11: Inhaler devices used and previous technique education in study patients 
Type of preventer device used pMDI N=55 (40%) 
Turbuhaler™ N=41 (30%) 
Accuhaler™  N=43 (30%) 
Duration of preventer use [mean (±SD)] 7(±7) years 
Patients using > 1 type of inhaler 
device for asthma therapy 
N=81 (58%) 
Previous technique education received N=133 (96%) 
Previous technique education given by GP N=65 (49%) 
Pharmacist N=18 (14%) 
Respiratory 
physician 
N=10 (8%) 
Nurse N=6 (5%) 
Other N=2 (1%) 
> 1 Health care 
professional 
N=32 (23%) 
Time since last technique education 
[mean years (±SD)]  
7(±7) 
Physical technique demonstration 
included in previous education 
N=74 (53%) 
Reinforcement of technique  
education received on 1 occasion in 
past 
N=17 (12%) 
Reinforcement of technique education 
received ≥ 2 occasions in past 
N=14 (10%) 
Patient has shown another person 
inhaler technique 
N=35 (29%) 
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4. Inhaler technique at visits 1 and 2: technique maintenance   
At Visit 1, at baseline and prior to the delivery of education, 17% (n=24) of patients 
demonstrated correct technique (i.e. a score of 11).  Following the inhaler technique 
education delivered at visit 1, all participants (n=139) demonstrated correct inhaler 
technique.  Approximately one month later (visit 2) only 61% (n=77) of patients 
maintained correct inhaler technique.  The remaining 50 patients, although having 
demonstrated the ability to correctly use their inhaler device at visit 1, were not able to 
do so at visit 2.  Correct inhaler technique maintenance varied across the three 
devices used in the study.  That is amongst pMDI, Turbuhaler™ and Accuhaler™ 
users; 49% (n=25/51), 69% (n=27/39) and 68% (n=25/37) maintained correct inhaler 
technique respectively. The trend in patients’ inhaler technique for all devices over 
both visits is shown in Figure 3.14 below.       
 
Figure 3.14: Proportion of patients maintaining correct inhaler technique one month 
post education 
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5. Individual inhaler technique steps at visits 1 and 2 
At visit 1 (pre-education) the inhaler technique steps patients most frequently 
demonstrated incorrectly were: step 7 for the pMDI (continue slow and deep 
inhalation), step 2 for the Turbuhaler™ (hold inhaler upright) and step 3 for the 
Accuhaler™ (exhale air out of lungs).  At Visit 2 errors in some technique steps were 
still evident despite the fact that patients had demonstrated the ability to correctly 
perform all steps for their inhaler device after education at visit 1.  The steps that were 
most frequently performed in error at visit 2 were steps 3 and 6 for the pMDI (exhale 
air out of lungs and inhale slowly and press canister firmly), step 2 for the Turbuhaler™ 
(hold inhaler upright) and step 4 for the Accuhaler™ (exhale away from mouthpiece).  
Figures 3.15, 3.16 and 3.17 below show the proportion of patients correctly performing 
each step for the pMDI, Turbuhaler™  and Accuhaler™ at visits 1 (pre-education) and 
2.    
 
Figure 3.15: A. Proportion of patients correctly performing inhaler technique steps 1 to 
11 required for pMDI administration at visit 1 (pre-education) and visit 2.  B. Steps for 
pMDI administration. 
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B. 
 
 
 
 
 
 
 
 
 
Figure 3.16: A. Proportion of patients correctly performing inhaler technique steps 1 to 
11 required for Turbuhaler™ administration at visit 1 (pre-education) and visit 2. B. 
Steps for Turbuhaler™ administration. 
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1. Remove cap     
2. Shake inhaler well   
3. Exhale air out of lungs  
4. Hold inhaler upright 
5. Put mouthpiece between teeth and seal with lips 
6. Inhale slowly and press canister firmly 
7. Continue slow and deep inhalation 
8. Hold breath, aim for 10 seconds 
9. While still holding breath remove inhaler from mouth 
10. Exhale away from mouthpiece 
11. Replace cap 
1. Unscrew and lift off cap 
2. Hold inhaler upright 
3. Rotate grip one way, then back until click is heard        
4. Exhale air out of lungs 
5. Exhale away from mouthpiece 
6. Put mouthpiece between teeth and seal with lips 
7. Inhale forcefully and deeply  
8. Hold breath, aim for 10 seconds 
9. While still holding breath remove inhaler from mouth 
10. Exhale away from mouthpiece 
11. Replace cap 
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Figure 3.17: A. Proportion of patients correctly performing inhaler technique steps 1 to 
11 required for Accuhaler™ administration at visit 1 (pre-education) and visit 2. B. 
Steps for Accuhaler™ administration. 
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Visit 1 (pre-education)
V sit 2
1. Open inhaler  
2. Push lever back completely to load dose 
3. Exhale air out of lungs 
4. Exhale away from mouthpiece 
5. Hold inhaler horizontally 
6. Put mouthpiece between teeth and seal with lips 
7. Inhale steadily and deeply 
8. Hold breath, aiming for 10 seconds 
9. While still holding breath remove inhaler from mouth 
10. Exhale away from mouthpiece 
11. Close cover  
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6. Change in repeated measures variables 
Changes over time (i.e. during the approximate one month period between visits 1 and 
2) in asthma control (S-ACQ), adherence (MARS-5), preventer necessity and concerns 
beliefs (BMQ-S), inhaler technique beliefs (ITBQ) and motivation for correct technique 
were tested for.  Tests for normality (histograms, kurtosis and skewness, Kolmogorov-
Smirnov and Shapiro-Wilk tests) revealed non-normal distributions for all five data 
measures (Appendix 3.22: Normality statistics for repeat measures variables).    
 
Wilcoxon Signed Rank Test (for non-parametric analysis) was used and showed: 
 A statistically significant decrease in asthma control scores between visit 1 
(median score=1.2) and visit 2 (median score=1), T=1829, p<0.05, r= -0.22. 
 A statistically significant increase in adherence scores between visit 1 (median 
score=21) and visit 2 (median score=21.50), T=1691, p<0.05, r= -0.13. 
 No statistically significant differences in the remaining repeated measures 
variables collected (p>0.05). 
 
7. Determinants of inhaler technique maintenance: regression 
results 
Four independent variables qualified for inclusion in the backwards stepwise logistic 
regression after statistical screening (p<.25) as previously described (Methods, section 
iv, 4, c).  The screening results for each of the 28 unique study variables are shown in 
Appendix 3.24 (Univariate logistic regression results).  The four qualifying independent 
variables were: 
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 Inhaler technique at visit 1 
 Asthma control at visit 1 
 Motivation to practise correct inhaler technique at visit 1  
 Preventer device type (i.e. pMDI or DPI).   
 
After running the backwards stepwise logistic regression, with the four independent 
variables above, a statistically significant model was produced: X2 (N=125,3)=16.22, 
p=0.001.  The model generated could correctly classify 67.2% of patients (as either 
maintaining or not maintaining correct inhaler technique at visit 2), and explain 
between 12.2% and 16.5% of the variance in patients’ inhaler technique maintenance 
(Appendix 3.27: Logistic regression statistical output).   
 
The statistically significant model generated consisted of 3 out of the four independent 
variables tested.  They were:  
1) Preventer device type,  
2) Asthma control at visit 1, and  
3) Motivation to practice correct technique at visit 1.   
 
Each of these 3 variables were also individually statistically significant.  The strongest 
predictor of technique maintenance was the type of preventer used with an odds ratio 
of 2.6, indicating that patients who used DPIs were 2.6 times more likely to have 
maintained correct inhaler technique at one month compared to patients who used 
pMDIs, controlling for all other factors in the model.  Similarly, patients who had good 
asthma control at baseline were 2.3 times more likely to have maintained correct 
inhaler technique at one month.  Patients who were more motivated to practice correct 
technique at baseline were 1.2 times more likely to have maintained correct inhaler 
technique at one month.  Table 3.12 illustrates the logistic regression model described.   
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Table 3.12: The backward logistic regression model, and its 3 significant variables, 
predicting the likelihood of maintaining correct inhaler techniquea at one month. 
 
 
95% C.I. for odds ratioc 
Predictor Coding B SE Wald df p Odds 
Ratio 
Lower Upper 
Preventer 
Device 
Type 
0=pMDI 
(n=50) 
 
1=DPIb 
(n=75) 
 
.97 .40 5.91 1 .02 2.64 1.21 5.79 
Asthma 
Control 
0=scores≥1.5 
(n=52) 
 
1=scores<1.5 
(n=73) 
 
.82 .40 4.23 1 .04 2.23 1.04 4.99 
Motivation 
Score range 
1-10 
 
.22 .10 4.54 1 .03 1.24 1.02 1.52 
 
a Outcome variable coding: 0 = Visit 2 technique score < 11/11 (n=50), 1 = Visit 2 technique 
score is 11/11  (n=77) 
 
b Turbuhaler™ and Accuhaler™ groups were combined under “DPI” (Dry Powder Inhaler) to 
achieve sufficient group size for logistic regression analysis 
 
c
 C.I. = Confidence Interval 
 
 
 
8. Test for interaction terms 
All potential first degree interaction terms were tested for using the same fitting 
procedure (stepwise backwards logistic regression).  The ten variables entered into the 
regression were: 
 Inhaler technique 
 Device type 
 Asthma control  
 Motivation  
 Inhaler technique x Device type 
 Inhaler technique x Asthma control  
 Inhaler technique x Motivation  
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 Device type x Motivation  
 Device type x Asthma control  
 Asthma control x Motivation  
 
The regression model generated using these variables was significant [X2(n=125, 5) = 
23.1, p=.0005, R2=16.9-22.8%]. However, the significant predictor variables at the final 
step of the regression were the same as those in the original main effects model 
reported above (i.e. Device type, Asthma control and Motivation).  Although two extra 
variables (Inhaler Technique, and Asthma control x Motivation) appeared in the final 
step of the regression model, they were not significant and did not have reliable 
regression terms (i.e. confidence interval crossed 1; implausibly large odds ratio of 
202) (Appendix 3.28: Interaction terms statistical output). Thus, no interaction terms 
were found that would enhance the predictive power without compromising the 
reliability of the final regression model.    
 
9. Goodness of fit of regression model: diagnostic statistics 
The diagnostic statistics indicated that the logistic regression model fitted the data set 
well.  The standardised residuals, cooks distance and DFBeta did not identify any 
outliers.  The leverage statistics indicated two potentially influential cases; however 
these cases were highly unlikely to have a significant effect on the regression analyses 
because their cooks distance was < 1 (Field, 2009). The statistical results testing the 
goodness of fit of the regression model are summarised in Appendix 3.29 (Diagnostic 
statistics results). 
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10. Generalisability of regression model: assumption testing  
The tests for assumptions indicated that:  
 There was independence of error (all cases were independent). 
 The model was based on sufficient events per independent variable (4 
independent variables = 12.5 cases per variable, based on the sample of the 
smaller group). 
 There were no multicollinearity issues with any variables (all Tolerance values 
> 0.9 and mean Variance Inflation Factor=1.08). 
 Variables (motivation score) conformed with linear gradients (non-significant 
interaction term, p>.05). 
 There was a projected 5% loss of predictive power to the model if it were to be 
generalised to the sample population.   
The results of assumption testing for the regression model generated are summarised 
in Appendix 3.30 (Assumption testing results). 
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E. Discussion 
This is the first study to have explored inhaler technique maintenance in depth as the 
subject of focus.  As a starting point, a broad framework, conceptualising the 
phenomenon of inhaler technique maintenance, was set up in the Background (i.e. the 
“Inhaler Technique Maintenance Framework” illustrated in Figure 3.01).  This 
conceptual framework, importantly, allowed the potential determinants of inhaler 
technique maintenance to be explored from a theoretically grounded perspective.  
Established theories in the areas of skill learning (i.e. FSLT) and self-management (i.e. 
CSM), in particular, were used.  Subsequently, a wide range of patient factors – 
classified as demographic, clinical, inhaler device related, technique education related, 
and psychological – were explored in relation to inhaler technique maintenance.   
 
Three factors were identified through quantitative investigations as determinants of 
inhaler technique maintenance – inhaler device type, asthma control and motivation.   
That is, patients who were more likely to maintain correct inhaler technique one month 
after education were those who used a DPI as opposed to a pMDI, had better baseline 
asthma control, and had higher baseline motivation to practice correct inhaler 
technique.  Of note is the fact that patient motivation has been shown for the first time 
to play a role in the inhaler technique domain, specifically with regards to how patients 
maintain inhaler technique over time.   
 
Prior to commencing discussion of the determinants of inhaler technique maintenance, 
it bears mentioning that the levels of inhaler technique recorded throughout this study 
are comparable to what has been reported previously (Basheti et al., 2007, Bosnic-
Anticevich et al., 2010).  It was not surprising to find that the overwhelming majority of 
patients had poor inhaler technique at baseline (83%), nor to find that the educational 
intervention was successful in improving inhaler technique in those patients with poor 
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baseline technique, similar to what was achieved in other studies (Press et al., 2011).  
The fact that these improvements were not maintained (i.e. 39% of patients reverted to 
poor technique one month later), reflect the deterioration in technique over time also 
observed in past studies (Chapter 2, section C. iii, Table 2.02).  Notably, the reason/s 
patients revert to poor inhaler technique, despite having received technique education, 
and in the absence of other known barriers, is the gap in the literature that this study 
addresses.   
 
Device type was the first factor identified as a significant predictor of inhaler technique 
maintenance in the regression analysis.  Patients using a DPI (Turbuhaler™ or 
Accuhaler™) to administer their preventer medication were more likely to maintain 
correct inhaler technique at one month than patients using pMDIs.  Device type was 
not originally hypothesised to be a significant predictor of inhaler technique 
maintenance.   These results seem to suggest that DPIs are easier to use than pMDIs, 
however, this may be too simplistic an explanation in and of itself.  Despite some 
suggestion in the existing literature that DPIs are more “user friendly” than pMDIs 
(Rees, 2005) various past studies show that inhaler technique can be problematic 
across all devices, and further, that the rates of misuse with DPIs is commensurate 
with, or even greater than, that with pMDIs (Melani et al., 2011).  
 
Closer scrutiny of individual patient’s relative physical compatibility with, and 
preference for, various types of inhaler devices available for their treatment may have 
provided more insight regarding device type as a significant predictor of technique 
maintenance.  It is possible that due attention may not have been given in the past to 
selecting the most physically suitable device for patients in this study, since notably, 
past inhaler technique education for a large proportion of patients did not involve any 
form of physical demonstration.  Therefore in these patients, known barriers to 
technique maintenance (e.g. physical device use issues) may not have been 
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adequately addressed, and this in turn may have unduly influenced this study’s finding 
regarding device type as a predictor of technique maintenance.  Future studies may be 
improved by better controlling for issues relating to patient device compatibility, via, for 
example, recruiting inhaler device naïve patients and implementing a process of 
optimal device selection; or in patients already using an inhaler, implementing a 
process of re-assessing for device suitability and patient preferences, and changing 
the prescribed device if required.  This allows more scope to identify novel reasons 
behind poor inhaler technique maintenance, and further, to confirm if device type truly 
makes a difference to how patients maintain inhaler technique.    
 
Patients’ asthma control at baseline was the second predictor found to be significant in 
determining inhaler technique maintenance.  Specifically, patients with better baseline 
(visit 1) asthma control were more likely to maintain correct inhaler technique 
compared to patients with poorer baseline asthma control (i.e. there was a significant 
association between baseline/visit 1 asthma control and inhaler technique at visit 2).   
However, it was interesting to note that despite this association, no significant 
relationship was found between baseline/visit 1 asthma control and baseline/visit 1 
inhaler technique.  This could be related to statistical issues (i.e. the number of 
patients in the group with correct compared incorrect baseline technique, n=24 and 
n=115 respectively, was not sufficiently large enough to allow for meaningful 
correlations to be calculated) and/or to the possibility that other factors impacting on 
patients’ baseline asthma control (Haughney et al., 2008) outweighed any contribution 
inhaler technique may have had.   
 
This second explanation above, implying the negligible effect of inhaler technique on 
baseline asthma control, however, seems rather insufficient given that inhaler 
technique has been demonstrated in various past studies to be independently and 
significantly associated with asthma control (Basheti et al., 2007, Giraud and Roche, 
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2002, Giraud et al., 2011).  Thus it seems possible that the lack of association 
between baseline inhaler technique and baseline asthma control may be due to 
statistical anomalies.  However, having said this, alternative explanations are available 
for understanding the relationship between inhaler technique and asthma control 
shown in this study.                                                                                                                                                                                   
 
Alternative explanations for the changing relationship between asthma control and 
inhaler technique over the course of this study, implicate the role of patient motivation.  
Firstly, it was observed that an improvement in inhaler technique coincided with an 
improvement in asthma control (from visit 1 pre-education, to visit 2), and therefore 
there was a lag in time before asthma control and inhaler technique status were 
commensurate.  That is asthma control (baseline/visit 1) became associated with 
inhaler technique (visit 2) only after the passage of one month (note, visit 2 asthma 
control and visit 2 inhaler technique were correlated as expected).   
 
Secondly, when testing for interaction terms in the regression analysis (Results, 
section ii, 8) it appeared that the relationship between baseline/visit 1 asthma control 
and visit 2 inhaler technique (i.e. technique maintenance) was mediated by patient 
motivation (however the statistical results generated were not robust enough to 
confirm this relationship).  Based on these implications and the observed lag period 
discussed above, an explanation can be forwarded suggesting that patients with 
existing good asthma control are aware of this status, and that this awareness served 
as positive feedback and motivation for patients to persist with optimal asthma self-
management practices, including maintaining correct inhaler technique (provided 
patients are made aware of these practices, such as during the educational 
intervention at visit 1).   
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In contrast, amongst those patients with poor existing asthma control, recent positive 
personal experiences regarding asthma may not be available to reinforce the benefits 
of, and act as a source of motivation to persist with, optimal self-management 
practices such as correct technique maintenance.  This explanation thus reveals that 
patient-centred psychological factors such as perceptions and motivations may be 
playing a role in mediating the relationship between asthma control and inhaler 
technique maintenance.     
 
From a clinical perspective, relating to health care provision, these results regarding 
the relationship between asthma control and inhaler technique maintenance lends 
further support to past studies establishing the necessity of optimising inhaler device 
use (via improved technique education) as an important step towards achieving good 
asthma control (Basheti et al., 2007).  Although a large proportion of patients did not 
maintain correct inhaler technique, this study did show improved asthma control 
following improved inhaler technique from baseline, pre-education (17% of patients 
with correct technique), to visit 2 (60% of patients with correct inhaler technique).  
Further, in exploring the dynamics in the relationship between asthma control and 
inhaler technique, this study is able to contribute a unique patient-centred perspective 
to the matter.  Specifically, the potentially important role of patient psychological 
factors, i.e. perceptions and motivation, in the relationship between asthma control and 
inhaler technique maintenance is emphasised.   
 
An interesting implication arising from this study is that patients who experience 
improved asthma control may be more motivated to maintain the self-management 
strategy/ies they perceive to have led to the improvement, for example, maintaining 
correct inhaler technique.  Thus a reinforcing feedback loop between asthma control 
and inhaler technique, mediated by patient perceptions and motivations is postulated.  
An important further implication is that, in order to mitigate a negative feedback loop 
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from becoming entrenched, patients with poor asthma control are compelling 
candidates for inhaler technique education (and asthma reviews in general).  These 
interrelationships however are complex, and it is beyond the scope of this study to 
make definitive statements or to draw clear conclusions in relation to them.  The nature 
of this feedback loop, and implications for inhaler technique maintenance, may be 
better understood through further studies that delve more deeply into the relationship 
between patient clinical and psychological factors in technique maintenance.   
 
Patient motivation was identified as the final predictor of inhaler technique 
maintenance, with patients who indicated higher levels of motivation to practise correct 
inhaler technique during routine use being more likely to maintain correct inhaler 
technique.  From a theoretical perspective, given the important role of motivation in 
both skill and self-management behaviour maintenance (Bandura, 2005, Cornford, 
1996), it was perhaps not surprising to find motivation also having a role to play in 
inhaler technique maintenance.  The novel association uncovered in this study begins 
to establish some empirical evidence – more so than the above speculative 
interpretations regarding the mediating effect of motivation between asthma control 
and technique maintenance – for the role of patient motivation in inhaler technique 
maintenance.  This finding adds strength to the premise that inhaler technique 
maintenance involves more than maintaining a physical skill, and that promoting 
optimal inhaler technique maintenance lies beyond practical considerations. 
 
Precisely how patient motivation works to influence inhaler technique maintenance is 
yet to be determined.  However, in referring back to the unexplained observations of 
past studies, coupled with the new insights of this study, there is the possibility that 
social factors – specifically, regular contact with health care providers – may be 
facilitating patient motivation around inhaler technique.  Various studies have shown 
that patients tend to maintain correct inhaler technique so long as they are in regular 
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contact (monthly basis) with a health care professional (Basheti et al., 2007, Bosnic-
Anticevich et al., 2010).  In these studies, although the basis of the clinical visits were 
for the purpose of assessing patient inhaler technique, it must be noted that the 
proportion of patients maintaining correct inhaler technique as reported reflected the 
scenario before any re-education or corrections to technique occurred.  This seems to 
indicate that patients are more motivated to maintain correct inhaler technique simply 
by virtue of keeping in regular contact with their health care provider.   
 
Interestingly, similar conclusions have been drawn further afield regarding long term 
preventative health care behaviours (dental flossing) that also require a certain level of 
skill/technique.   McCaul, Glasgow and O'Neill (1992) showed in several prospective 
studies that participants’ adherence to dental flossing seemed contingent on the 
degree of continued contact with study program personnel.  Thus, the social 
determinants of patient motivation regarding inhaler technique maintenance forms 
another area identified for further study.   
 
Patient beliefs/perceptions around inhaler technique and device use may also be 
potentially facilitating the relationship identified between motivation and inhaler 
technique maintenance.  That is, there were study correlations that showed that 
patients who believed that practising correct inhaler technique would make a positive 
difference to their asthma experience, and in the benefits of regular inhaler use, were 
more motivated to maintain correct inhaler technique over time.  Notably, these 
correlations suggest that while patient beliefs (regarding inhaler technique and 
preventer therapy) did not have a direct influence on inhaler technique maintenance as 
hypothesised, they may be having an impact in an indirect manner, namely via 
modulating patient motivation.   However these speculations regarding the precise role 
of motivation in inhaler technique maintenance are not robust enough to draw clear 
conclusions in this complex area, thus warranting further studies of this novel finding. 
Chapter 3 – Quantitative Study  
133 
 
 
Having discussed the factors found to be significant determinants of inhaler technique 
maintenance, other factors hypothesised, but not found to be significant determinants 
of technique maintenance, will now be examined. Firstly, practise with inhaler 
technique seemed to have no significant bearing on its maintenance, with no 
associations found between the degree of practise (i.e. regularity of inhaler device use 
as indicated by MARS-5 adherence scores) or the nature of practise (i.e. whether or 
not patients showed others’ how to use their inhaler) and inhaler technique 
maintenance.  This may be related to the fact that whilst patients may have been 
engaged in technique practise, the accuracy of this practise could not be ascertained, 
since it was not within the scope of this study to measure how patients were using their 
inhaler device on a day-to-day basis.   
 
As discussed in the Background (section ii), even high levels of skill practise may 
prove to be fruitless if done so inaccurately and  unfortunately  may even be 
detrimental to optimal skill development due to the challenge involved in unlearning 
“bad habits” (Cornford, 2008, Shim and Williams Jr, 1980).  In terms of implications for 
health care provision, these observations suggest that although the brief nature of 
inhaler technique interventions may be advantageous in time poor clinical settings 
(such as the community pharmacy), extending the time for these interventions so that 
patients have more opportunity to engage in accurate practise, monitored by an 
expert, may ensure that the correct version of the skill is more successfully 
consolidated,  thus enhancing the chances of optimal inhaler technique maintenance.   
 
Further, contrary to what was hypothesised, patients’ baseline level of inhaler 
technique was not shown to be a significant predictor of inhaler technique 
maintenance in the regression analysis.   Baseline inhaler technique was proposed to 
be an indicator of how well patients have learned and consolidated the skill of inhaler 
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technique based on past technique education.  Thus those patients who demonstrated 
correct baseline inhaler technique (i.e. 17% of patients at visit 1) were considered to 
have more successfully consolidated the skill compared with those who demonstrated 
incorrect baseline technique.  Despite the regression results, preliminary analysis did 
in fact show a significant positive correlation between the two terms.  This relationship 
was perhaps lost in the regression analysis due to random variations in data that can 
occur with the backwards stepwise fitting procedure (Field, 2009), and also possibly 
because the significantly smaller numbers of patients belonging to the group with 
correct versus incorrect baseline technique (n=24 and n=115 respectively) affected the 
regression results.   
 
Nevertheless the positive correlation found between baseline technique and technique 
maintenance lends support to the importance of implementing processes and 
strategies from the outset of inhaler device therapy to help patients develop and 
consolidate correct inhaler technique skills.  As discussed earlier, it is not ideal for 
patients to have to unlearn and re-learn the correct version of technique; rather it is 
preferable for patients to master the correct technique from the beginning of their 
inhaler therapy.  Beyond these considerations however, it is interesting to note that the 
lack of firm evidence for the role of skill learning related-factors in inhaler technique 
maintenance  found in this study lends further support to the premise that inhaler 
technique maintenance involves more than physical/practical skill based issues.   
 
 
 
 
Various study methodological considerations and limitations will now be discussed so 
that the findings of this exploratory study may be interpreted with caution and also as a 
means to offer some insight into how future studies of a similar nature may be 
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improved.  Firstly, having multiple pharmacists (n=31) involved in assessing patients’ 
inhaler technique during this study potentially resulted in some inconsistencies 
regarding inhaler technique scores.  Data collected during the QUIP workshops did in 
fact reveal a level of inconsistency in pharmacists’ inhaler technique assessments 
(Results, section i, 4).  However every effort was made to reduce the likelihood of this 
occurring in the study setting, including dedicating learning activities not only to the 
skill of inhaler technique but also the skill of how to assess patient inhaler technique, 
and providing additional feedback and training to those pharmacists who required it 
(Methods, section ii, 2, d).   
 
One way of enhancing the level of assessment consistency in future would be to limit 
the number of pharmacists involved in technique assessment (e.g. having one or two 
pharmacists recruit and assess inhaler technique over all study visits for all patients), 
however, this alternative would have reduced the likelihood of reaching the target 
sample size (n=150 patients) within the set time frame of this study.  Thus a 
compromise was struck and, in choosing to involve multiple pharmacists, a method 
was used that was similar to that of past studies conducted in the same setting (i.e. 
Sydney metropolitan community pharmacies) (Basheti et al., 2007).  Further, through 
using this method, the target sample size was achieved. 
 
A second methodological consideration concerns the use of self-report methods to 
measure patient asthma control and adherence.  The self-report method has been 
criticised for being less objective in nature as patients have been found to 
overestimate their own asthma control (Laforest et al., 2007) and adherence (Foster et 
al., 2012).   However, the alternative more objective methods suggested  – such as 
spirometry and airways hyperresponsiveness tests for asthma control (Greening et al., 
2008), and blood assays and electronic device-docked monitors for adherence (Rand 
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and Wise, 1994) – are not without their limitations in terms of cost, invasiveness and 
practically of administration.   
 
Whilst acknowledging the limitations of the self-report method, it was nevertheless 
deemed to be the most suitable method of measurement (for asthma control and 
adherence) given both the constraints of this study, and the advantages of the self-
report method, i.e. its cost-effectiveness, minimum patient invasiveness and 
practicality to administer in the community pharmacy setting (Rand et al., 2012).  
Further, self-report instruments used to measure asthma control and adherence were 
both derived from validated (in asthma patients) sources, and have been shown to be 
comparable to the more objective measures (Cohen et al., 2009, Juniper, O'Byrne, 
Guyatt, Ferrie and King, 1999). 
 
A third methodological consideration lies in the way in which patient motivation was 
investigated.  The item used to measure patient motivation for optimal inhaler 
technique maintenance (i.e. “I am motivated to follow the correct steps when I use my 
inhaler”) was developed specifically for, and used for the first time in this study 
(although, given the option, a previously validated instrument would have been used).  
Due to study time constraints, the item devised was only tested for face-validity.  
However the development and use of a fully validated instrument would add strength 
to future studies.   
 
Further, in retrospect – now that patient motivation has emerged a significant predictor 
of inhaler technique maintenance – the item used to measure motivation seems 
inadequate for understanding the nuances and complexities in the relationship 
between the two phenomena.  More broadly, the quantitative methodology itself may 
not be enough to achieve this goal.  The reason for using a brief single item to 
measure motivation, instead of something more elaborate, was in-part, to minimise the 
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potential for respondent fatigue when filling out lengthy questionnaires, thereby 
managing the risk of patient drop-outs. In addition, since there was no bulwark of 
existing evidence attesting to role of motivation in technique maintenance, and the 
need to measure and test for the multiple other hypotheses in the questionnaires, it 
was deemed most appropriate not to overinvest in what was still a tentative area.  
However, given the results of this study, further investigations are warranted in which a 
more in-depth approach in examining the role of patient motivation in inhaler technique 
maintenance is adopted.   
 
As a final methodological consideration, it bears mentioning that while the regression 
model generated proved to fit the study data well, as indicated by goodness of fit 
diagnostic statistics, its capacity to be generalised to a broader population of patients 
using inhaler device therapy is limited without further studies.  Although most of the 
diagnostic tests for generalisability of the regression model were satisfied (i.e. 
independence of errors, low multicollinearity and conformity with linear gradients for 
continuous variables), cross validation calculations (using adjusted R2) indicated a 5% 
loss of predictive power (from 16.2% to 11.3%) if the model were to be generalised to 
the sample population (Results, section ii, 10).   
 
Further, the fact that a substantial degree of variance remains unexplained, before and 
after cross validation, cautions against generalising this model.  However, having said 
this, it should be noted that being designed as exploratory in nature, the thrust of this 
study was not to generalise its findings.   Rather, this study was designed as a first 
step in the in-depth examination of the phenomenon of inhaler technique maintenance 
and to generate evidence-based leads to guide further investigations.   
 
 
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In concluding this chapter it can be said that a better understanding of the 
phenomenon of inhaler technique maintenance has been gained, and that preliminary 
evidence now exists to address the gap in the literature which begs the question, why 
do patients not maintain correct inhaler technique despite “knowing how”?  Contrary to 
the current literature which approaches inhaler technique issues from a predominantly 
practical and physical device-use based perspective, this study emphasises the skill 
development and patient self-management contexts in which inhaler technique 
maintenance is embedded.  Through this approach, less tangible, patient-centred 
factors were revealed to have an impact on technique maintenance.  For the first time 
there is evidence to indicate that patient psychosocial factors, particularly motivation, 
may play a role in how they maintain inhaler technique.  This bolsters the premise that 
the reasons behind poor inhaler technique maintenance are more than simply practical 
and physical device-use related.   
 
This study strongly suggests that attempts to facilitate optimal technique maintenance 
must involve more than repeating inhaler technique instructions (as is the current 
practice recommendation), especially given the diminishing returns of this strategy (i.e. 
the benefits appear to wear off over time) (Basheti et al., 2007, Bosnic-Anticevich et 
al., 2010), and instead, take into greater consideration the patient-centred issues 
identified in this study.  Although it is not within the scope of this study to confirm 
precisely how these issues should be integrated into future interventions, further 
investigations from the perspective of patient motivation may provide greater 
understanding of the psychosocial reasons behind poor technique maintenance, and 
may ultimately lead to improved interventions for facilitating optimal inhaler technique 
maintenance over time.    
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F. Summary  
 This chapter aimed to explore the phenomenon of technique maintenance and 
to identify its determinants.   
 The ITMF, a conceptual framework, was set up to explore inhaler technique 
maintenance. Hypotheses regarding the predictors of technique maintenance 
were generated based on empirical and theoretical research from the skill 
learning and health behaviour literatures. 
  Backwards stepwise logistic regression identified three significant 
determinants of inhaler technique maintenance: device type, asthma control 
and patient motivation.   
 The association between motivation and inhaler technique maintenance is 
novel and tentative and may provide greater insight into the reasons behind 
poor inhaler technique maintenance given further investigation.  
Chapter 4 – Qualitative Study  
140 
 
 CHAPTER 4  
INHALER TECHNIQUE MAINTENANCE FROM THE 
PERSPECTIVE OF PATIENT MOTIVATION, A  
QUALITATIVE STUDY 
_____________________________________________________________________ 
THIS QUALITATIVE STUDY builds upon the findings of the previous study and further 
examines the novel association that was identified between patient motivation and 
inhaler technique maintenance (Chapter 3).  Specifically it aims to understand the 
influential factors determining why some patients had relatively higher, while others 
had relatively lower, motivation to maintain correct inhaler technique (and therefore 
tended to maintain or not maintain correct technique ).  Further, a qualitative approach 
was chosen as it allows for a more in-depth and finer grained exploration in this 
relatively new area of patient motivation in inhaler technique maintenance.  This study 
will add to addressing the overarching question of this thesis (i.e., Why patients do not 
maintain correct inhaler technique despite knowing how?) and may also have 
important practice implications in terms of how patient motivation can be enhanced or 
facilitated by health care providers to promote optimal inhaler technique maintenance 
in asthma self-management.     
 
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A. Background 
i. Defining motivation  
Motivation has been broadly defined as “the reason a person has for acting in a 
particular way”, and more specifically, as the conscious or unconscious incentive for 
action towards a desired goal, with the incentives giving purpose or direction to 
behaviour and typically arising from psychological or social factors (The Oxford English 
Dictonary, 2000).  Hence, in essence, the study of motivation is about understanding 
“why people do the things that they do” (Russell, 2008).  This construct of “motivation” 
can provide vital insight into identifying areas for improvement and facilitating change 
in people’s actions or behaviours (Russell, 2008).  This is of particular interest in the 
context of chronic conditions, where patient actions and behaviours, especially self-
management behaviours (e.g. inhaler technique maintenance), can be very influential 
on disease outcomes (Ryan, Patrick, Deci, and Williams, 2008). 
 
Motivation has been further defined as a “process whereby goal directed activities are 
energised, directed and sustained” (Schunk and Usher, 2012).  The last word of this 
definition has been highlighted here to emphasise that motivation is an important 
determinant not only for the initial stages of behaviour change, but also for the 
maintenance of behaviours over time (Rothman et al., 2004, Ryan and Deci, 2000b). 
Motivation is thus an especially important consideration in the context of a chronic 
condition such as asthma, whereby good patient health outcomes (e.g. in terms of 
asthma control, quality of life and health care costs) are heavily reliant on the 
maintenance of optimal self-management behaviours, including the maintenance of 
correct inhaler technique (Chapter 2, section B, ii).  A more in-depth investigation of 
patient motivation in the context of inhaler technique maintenance is not only 
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supported by the theoretical and empirical evidence (Chapter 3), but seems imperative 
based on the fundamental characteristics that define motivation.   
 
ii. Empirical evidence to guide an in-depth exploration of 
patient motivation in inhaler technique maintenance. 
Given the centrality of motivation in understanding the issues around behaviour 
maintenance, it is rather surprising that no known studies (barring the quantitative 
study reported in the previous chapter) have investigated this construct in relation to 
patients’ inhaler technique maintenance behaviour.  This may be related to the fact 
that the phenomenon of inhaler technique maintenance itself has only recently, in the 
body of work presented in this thesis, been a focal point of research.  Although there is 
a lack of further direct empirical evidence (i.e. on patient motivation in inhaler 
technique maintenance) to guide this current study, identifying past research that has 
examined patient motivation in the broader context of asthma may provide useful 
insights regarding influential factors on patient motivation in asthma self-management, 
which by extension may also have bearing on inhaler technique maintenance.       
 
To determine the nature and extent of existing research on patient motivation in 
asthma, a review of the literature was conducted using the search terms “asthma and 
motivation” (via the Medline and PsycINFO databases).  This process identified 213 
studies, of which 13 indicated in the abstract that motivation was the focus of the 
study, or was included as a research variable, and thus their full-text versions were 
retrieved for further examination.  The existence of numerous studies in this area 
seemed to suggest that researchers acknowledged or recognised the importance of 
patient motivation in asthma self-management.  Upon closer scrutiny, however, it 
became clear that the nature of these investigations, and therefore the subsequent 
insight that they could provide for the purposes of this study (aimed at an in-depth 
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examination of patient motivation in inhaler technique maintenance), were quite 
limited.  There were numerous reasons for this, including that studies: a) did not define 
motivation, and/or b) did not measure motivation, and/or c) used unvalidated 
instruments to measure motivation, and/or d) did not distinguish between the 
motivation to initiate versus the motivation to maintain self-management behaviours (a 
critical consideration for research on inhaler technique maintenance). The details of 
these studies, including how motivation was investigated, are summarised in Table 
4.01. 
 
Table 4.01: Existing studies on motivation and asthma, and their limitations for guiding 
this research. 
Studies on motivation and asthma Limitations of studies for informing this 
research 
Allen et. al., 2000. 
 
Assessing pediatric clinical 
asthma practices and 
perceptions: A new 
instrument 
 Did not investigate patient motivation 
(measured clinician’s perception of their 
patients’ motivation regarding various 
aspects of asthma management 
instead). 
Cochrane and 
Clark, 1990. 
 
Benefits and problems of a 
physical training programme 
for asthmatic patients 
Creer, 1991. 
 
The application of behavioral 
procedures to childhood 
asthma: Current and future 
perspectives 
 
 Not a research study, but a 
commentary article. 
 Motivation is not defined. 
Bennett, Rowe and 
Katz, 1998. 
Reported adherence with 
preventive asthma 
medication: A test of 
protection motivation theory 
 Motivation is implicit rather than well 
defined in Protection Motivation Theory 
(PMT). 
 PMT does not differentiate between 
initiation and maintenance of health 
behaviours (Orbell, 2007). 
 
Schaffer and Tian, 
2004. 
Promoting Adherence: 
Effects of Theory-Based 
Asthma Education 
Steven, Morrison 
and Drummond, 
2002. 
Lay versus professional 
motivation for asthma 
treatment: A cross-sectional, 
qualitative study in a single 
Glasgow general practice 
 Brief results reported on “influences on 
motivation… to undertake behaviour 
change”; 3 quotes were given, but were 
not related back to behaviour change. 
 Not investigation of behaviour 
maintenance. 
 
Wells et al., 2008. 
 
Race-ethnic differences in 
factors associated with 
inhaled steroid adherence 
among adults with asthma  Did not measure motivation (or did not 
specify how motivation was measured). 
Gustafson et al., 
2012. 
The effects of combining 
Web-based eHealth with 
telephone nurse case 
management for pediatric 
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asthma control: a 
randomized controlled trial 
Riekert, Borrelli, 
Bilderback and 
Rand, 2011. 
The development of a 
motivational interviewing 
intervention to promote 
medication adherence 
among inner-city, African-
American adolescents with 
asthma 
 Motivation was measured using single 
item questions, very similar to that used 
in the previous quantitative study 
(Chapter 3).  E.g. “On a scale of 1-10, 
where 1 is not motivated at all and 10 is 
very motivated, how motivated are you 
to take your [name of ICS] everyday?” 
(Foster et al., 2012). 
 Questions were devised by the authors 
and not validated. 
 Motivation for behaviour maintenance 
was not investigated. 
Halterman et al., 
2011. 
A pilot study to enhance 
preventive asthma care 
among urban adolescents 
with asthma 
Foster et al., 2012. 
 
Identifying patient-specific 
beliefs and behaviours for 
conversations about 
adherence in asthma 
Miles, Sawyer and 
Kennedy, 1995. 
 
A preliminary study of factors 
that influence children's 
sense of competence to 
manage their asthma 
 Used the “Health Self-Determinism 
Index for Children” to measure intrinsic 
versus extrinsic motivation to achieve 
healthy functioning. 
 There were no measures of behaviours 
or outcomes. 
 Motivation for behaviour maintenance 
was not investigated. 
 The adult version of the questionnaire 
the “Health Self-Determinism Index” is 
validated in the general adult 
population and used in health 
promotion but not in chronic illness 
contexts (Cox, 1985). 
 
Kyngas, 1999. 
 
Compliance of adolescents 
with asthma 
 The questionnaire used to measure 
motivation was designed for use in 
adolescents with diabetes; and not 
validated in asthma patients. 
 The questions used to measure 
motivation were not specified. 
 
 
 
At this juncture, after considering the empirical evidence in relation to motivation in 
asthma, it became clear that direction for an in-depth qualitative investigation into 
patient motivation in inhaler technique maintenance could not be gained in a 
substantive way from existing studies.  Therefore, as in the previous quantitative study, 
theoretical guidance was sought. 
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iii. Theoretical underpinning to guide an exploration of patient 
motivation in inhaler technique maintenance. 
Many theories and models exist in the health psychology field that aim to understand 
and explain the motivations behind patient health behaviours and the process of 
behaviour change (e.g. the Health Belief Model, Health Promotion Model, Theory of 
Reasoned Action, Self-efficacy theory, Protection-Motivation Theory, Common Sense 
Model, Self Determination Theory) (Bandura, 1997, Carter and Kulbok, 2002, Fishbein 
and Ajzen, 1980, Glanz, Rimer and Viswanath, 2008, Janz and Becker, 1984, 
Leventhal, 2003, Orbell, 2007,  Pender, 2010, Rogers, 1975, Williams, 2002).  All such 
theories, depending on the purpose of their application, invariantly have strengths and 
weakness.  However, the important strengths of a theory (or theories) chosen for the 
purposes of this study would include a theory/ies that: a) has been designed for and/or 
has been applied to study health behaviours in the chronic illness and asthma contexts 
(as opposed to a theory that focuses on preventative health care behaviours in healthy 
individuals, or health behaviours in individuals with acute illnesses);  b) can be used to 
study the maintenance of self-management behaviours, rather than only the initial 
stages of behaviour change (i.e. ideally the theory specifies the motivational factors 
involved in behaviour maintenance as opposed to only behaviour change or initiation); 
and c) clearly defines the concept of motivation in relation to health behaviour 
mainteance  Two theories were identified, that together, met these criteria and were 
selected to guide this study – Leventhal’s Common Sense Model of Illness Regulation 
(CSM) (Leventhal et al., 2003) and Ryan and Deci’s Self-Determination Theory (SDT) 
(Ryan and Deci, 2002).   
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1. The Common Sense Model of Illness Regulation (CSM) 
The Common Sense Model of Illness Regulation (CSM) was introduced and discussed 
in the previous chapter and hence will only be revised briefly here.  Figure 3.04 from 
the previous chapter is included below for reference; for an explanation of the 
individual components of the CSM in Figure 3.04, see Chapter 3, Background, section 
iii.   
 
Figure 3.04 (from Chapter 3).  The Common Sense Model of Illness Regulation 
adapted from the works of Leventhal, Horne and colleagues (Horne and Weinman, 
2002, Leventhal et al., 2003).  
 
 
 
 
 
 
 
 
 
 
 
a. Implications for patient motivation in inhaler technique 
maintenance 
The previous use of the CSM (Chapter 3) focused on identifying potential factors 
predicting inhaler technique maintenance behaviour in a direct fashion.  Here, the 
CSM is used to explore the potential factors influencing the motivation behind patients’ 
technique maintenance behaviour.  Although the CSM is not explicitly described as a 
1. Interpretation 
 
(Beliefs and 
feelings regarding 
illness/health 
threat) 
2. Coping/ self-
management 
 
(Adopted to 
reduce negative 
impact of illness) 
3. Appraisal 
 
(Perceived 
effectiveness of 
coping strategies) 
Cognitive Representation of Illness and Treatment 
(Identity, cause, consequences, timeline, cure/control) 
Emotional Representation of (or response to) Illness and Treatment 
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theory of motivation, it has been applied extensively in chronic illness settings, 
including in asthma, to understand why patients adopt the self-management or coping 
behaviours that they do.  The way in which the CSM functions to understand patients’ 
self-management behaviours closely reflects the elements that define motivation (i.e. 
to understand  “why people do the things that they do”) (Russell, 2008).  Further, the 
CSM is a model based on self-regulation (Chapter 3, section A, i), and notably, 
motivation is implicitly important in self-regulation (Bandura, 2005b).      
 
To briefly revise, the CSM seeks to understand why patients engage (or do not 
engage) in various self-management behaviours in chronic conditions by examining 
how patients consciously interpret the nature of a health threat   (Orbell, 2007).  In 
asthma, patient beliefs and feelings relating to their condition (shown in Figure 3.04 as 
cognitive and emotional representations of illness) (Leventhal et al., 2003), as well as 
its treatment (shown in Figure 3.04 as cognitive and emotional representations of 
treatment), can influence the self-management behaviours that they adopt (Horne, 
1999, Horne and Weinman, 2002).  Further, patient evaluations regarding the 
effectiveness of their self-management behaviours, on reducing the perceived 
negative impact of their illness, can also influence their long term self-management 
behaviours (shown in Figure 3.04 as appraisal) (Leventhal et al., 2003). 
 
The relevance of the CSM, in the context of patient motivation in inhaler technique 
maintenance, seems to be supported by correlations found in the previous quantitative 
study (Chapter 3).  Previously, via logistic regression, patient motivation to maintain 
correct inhaler technique was found to be one of the three significant predictors of 
inhaler technique maintenance (out of 28 variables tested).  Further, patient motivation 
to maintain correct inhaler technique, was found to be correlated to asthma treatment 
beliefs (specifically, the necessity of preventer medication and the benefits of 
practicing correct inhaler technique).   
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Based on both the theoretical principles of the CSM and the correlations found in 
Chapter 3, it is proposed that patient motivation in inhaler technique maintenance may 
be influenced by their perceptions of asthma, as well as perceptions of asthma 
treatment (this forms Hypotheses 1-3).    
 
b. Limitations of the CSM for this study 
Utilising the CSM was found to have several limitations in the context of this study.  
Firstly, the CSM does not lend itself to clearly articulating specific types of asthma and 
treatment beliefs and how they may be influencing patient motivation to self-manage, 
i.e. do certain asthma and treatment beliefs enhance or diminish patient motivation to 
self-manage?.  Although certain patient treatment beliefs (i.e. necessity and concerns 
regarding inhaled corticosteroids) have consistently predicted medication adherence 
(Clifford et al., 2008, Horne and Weinman, 2002, Mardby et al., 2007, Menckeberg et 
al., 2008, Ponieman et al., 2009), much less is known about how treatment beliefs may 
be influencing other self-management behaviours, including inhaler technique 
maintenance.   
 
Even less is  known about how specific patient beliefs and feelings around the 
condition of asthma itself may be influencing self-management.  For example, Horne 
and Weinman (2002) hypothesised that patients who more firmly believed that their 
asthma was a serious condition would be more likely to adopt better self-management 
in terms of adherence to inhaled corticosteroids.  The study findings, however, showed 
that these beliefs around asthma both inhibited as well as facilitated adherence, with 
unknown reasons for this seemingly contradictory finding.  The lack of specificity 
regarding the types of patient beliefs and feelings regarding asthma and asthma 
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treatment, and how that may be influencing patient motivation in self-management is 
thus one of the limitations of the CSM in the context of this study. 
 
Further limitations of the CSM include: not explicitly defining motivation and relating it 
to the constructs in the model (Figure 3.04), the absence of measures for motivation, 
and not distinguishing between the factors that may be relevant in predicting the 
maintenance as opposed to the initiation of self-management behaviours.  Highlighting 
the predictors of behaviour maintenance is clearly important for this study investigating 
inhaler technique maintenance.  This is especially pertinent given that previous 
research shows that the factors motivating a patient to initially adopt a specific 
behaviour can be different to those that motivate them to maintain the behaviour over 
the long term (Rothman, 2000, Rothman et al., 2004).  Thus an additional theory was 
selected to complement the CSM in guiding this current study – Ryan and Deci’s Self-
Determination Theory (SDT). 
 
2. Self-Determination Theory (SDT) 
Self-Determination Theory is a well-established theory of human motivation.  It is 
useful for this study because it defines and operationalises motivation, emphasises the 
motivational factors predictive of behaviour maintenance, and has been applied across 
various chronic illness contexts (Conner, 2008, Ryan and Deci, 2000b).   
 
Fundamentally, SDT is concerned with various “motivational states”, i.e. the type of 
motivation a person possesses, and how they may impact on a person’s behaviour 
(Deci and Ryan, 2012).  Notably, the type of motivation a person possesses is said to 
be a more important predictor of behavioural outcomes than the overall amount of 
motivation they possess (Deci and Ryan, 2012).  Interestingly, a bias for a quantitative 
approach to investigating patient motivation can be seen in many of the studies 
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summarised earlier in Table 4.01.  In light of SDT, it is perhaps clearer why these 
studies, being predominantly quantitative in nature, offered limited insight (over and 
above what was gained in Chapter 3), to guide a more in-depth exploration of patient 
motivation.      
 
According to SDT, exploring the nature of patient motivation in inhaler technique 
maintenance may provide additional and unique insight into the relationship between 
motivation and technique maintenance.  In particular, the factors predicting why some 
patients have higher whereas others have lower motivation to maintain optimal inhaler 
technique may be identified.   
 
Self-Determination Theory distinguishes between three broad types of motivation – 
amotivation, extrinsic motivation and intrinsic motivation.  A state of amotivation is 
when there is a lack of intention to act so that a person does not act, or acts passively.  
This occurs when a person does not value the activity, does not feel competent to 
perform it, or does not expect it to result in a desired outcome (Ryan and Deci, 2000b). 
When a person becomes motivated to act, either intrinsic motivation or extrinsic 
motivation (in its various forms) is said to be at play (Ryan and Deci, 2000b).  In a 
state of intrinsic motivation (also known as “autonomous motivation”) a person 
engages in performing an activity or behaviour predominantly due to the internal sense 
of satisfaction that they derive from this. This “internal satisfaction” is experienced as 
interest and enjoyment, and it is this quality which drives people to maintain the 
performance of intrinsically motivated activities over time (e.g. play) (Deci and Ryan, 
2012, Ryan and Deci, 2000a).  
 
Extrinsic motivation, in contrast, governs those activities that people engage in, by and 
large, not out of an inherent sense of satisfaction tied to performing the activity, but to 
obtain some sort of separate outcome that is distinct from the actual activity itself (Deci 
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and Ryan, 2012, Ryan and Deci, 2000a).  The scenario of inhaler technique 
maintenance, therefore, more readily lends itself to be interpreted according to the 
principles around extrinsic motivation than intrinsic motivation.  That is, for the patient, 
there is no inherent purpose to maintaining correct inhaler technique, in and of itself, 
without relating it to a separate result, e.g. to experience less asthma symptoms.  
Further, most health-related behaviours are not considered to be intrinsically motivated 
or inherently enjoyable (Ryan et al., 2008), and it is highly unlikely that patients will 
experience a sustaining sense of interest or enjoyment linked to the activity of 
performing inhaler technique in and of itself.  That is, patients may enjoy the outcomes 
of maintaining correct inhaler technique, but not maintaining correct inhaler technique 
itself.  Inhaler technique maintenance can thus be considered an activity 
predominantly driven by extrinsic motivation, and therefore the following sections will 
be framed around this construct.    
 
a. Extrinsic motivation: controlled versus autonomous – 
implications for inhaler technique maintenance 
Extrinsic motivation is not a unitary concept, rather it is regulated by various distinct 
contingencies resulting in either more “controlled”, or more “autonomous”, types of 
motivation (Deci and Ryan, 2012).  Any action or behaviour can be viewed in terms of 
the degree to which it is driven by controlled versus autonomous motivation (Williams, 
2002).  This is represented in Figure 4.01.  Notably, since the varying states of 
motivation lie on a continuum and are not dichotomous, they are represented by the 
black arrow with gradations.  Since the type of extrinsic motivation may influence 
behavioural outcomes, the nature of patients’ motivation during inhaler technique 
practice, whether predominantly controlled or autonomous, may have important 
implications for whether correct technique is maintained over time or not.   
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Figure 4.01: “Controlled” versus “Autonomous” motivation and the process of 
“Internalising” Extrinsic motivation in Self-Determination Theory (SDT).  
 
A. Explanation and characteristics of predominantly Controlled compared to 
predominantly Autonomous motivation in SDT.   
B. Implications for inhaler technique maintenance.   
C. The social environments that support the internalisation of extrinsic motivation so 
that it becomes more Autonomous in nature (Deci and Ryan, 2012, Ryan and Deci, 
2002, Ryan and Deci, 2000b, Ryan et al., 2008). 
 
 
   (See Table 4.02 for definitions)  
A. 
B. 
 C. 
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Controlled motivation has been described as motivation that is contingent on external 
“carrots and sticks” (Deci and Ryan, 2012), so that a person is acting primarily to gain 
a reward, avoid punishment or to comply with social pressures (Ryan et al., 2008).  
People who perform an activity primarily driven by controlled motivation are considered 
not to have fully understood, accepted or “internalised” (Ryan and Deci, 2000a) the 
personal importance of the activity.  Actions or behaviours arising from controlled 
motivation are not considered to be “self-determined” and tend not to be maintained 
when the external “carrots and sticks” are not in function (Deci and Ryan, 2012).   
 
Autonomous motivation, on the other end of the spectrum, drives those actions and 
behaviours that a person performs out of their own choice and full endorsement 
because the behaviour has been identified as personally important to them (Deci and 
Ryan, 2012, Williams, 2002).  The quality of a person’s motivation can shift from one 
that is predominantly controlled to one that is more autonomous via a process called 
“internalisation”, represented by the green arrow in Figure 4.01 (note this process is 
only relevant in extrinsic motivation; intrinsic motivation is always considered to be 
autonomous in nature and “fully internalised”) (Ryan et al., 2008).  The process of 
internalisation describes the extent to which a person comes to embrace the 
importance or value of, and regulation over, a certain action or behaviour (Ryan and 
Deci, 2000a).  The greater the extent to which the process of internalisation occurs, 
the more a person is said to have “inwardly grasped the meaning and worth” (Ryan 
and Deci, 2000a) of an activity, and the more autonomous in nature this person’s 
motivation will be for that activity (Ryan and Deci, 2000b).   
 
Importantly, behaviours arising predominantly from autonomous motivation are 
considered to be “self-determined” and are better maintained (Deci and Ryan, 2012).  
This has been shown across various health care contexts, where people with chronic 
conditions or health issues, who possessed greater degrees of autonomous motivation 
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to enact various health behaviours, were more successful at improving and 
maintaining these behaviours over time.  Examples of improved health behaviour 
maintenance (and improved health outcomes) associated with greater autonomous 
motivation include: better adherence to medication (Williams, Rodin, Ryan, Grolnick 
and Deci, 1998b), better glucose control in diabetes (Williams, Freedman, and Deci, 
1998a), better rates of smoking cessation (Williams, Gagne, Ryan, and Deci, 2002), 
greater attendance at addiction programs (Ryan, Plant and O'Malley, 1995), and 
maintained weight loss (Williams, Grow, Freedman, Ryan and Deci, 1996).  
 
Based on this evidence and the principles of SDT, it is proposed that patients with a 
greater degree of autonomous motivation to practice correct inhaler technique are 
more likely to maintain this practice over time (indicated in Figure 4.01, part B).  
Further, according to SDT, such a patient may be characterised as someone who has 
personally grasped the importance of practicing correct inhaler technique and one who 
takes ownership over this practice.  In contrast, correct inhaler technique maintenance 
is less likely to be demonstrated by those patients whose inhaler technique practice is 
driven largely by controlled motivation, that is, those patients who less resolutely 
identify practicing optimal inhaler technique as a personally important activity 
(Hypothesis 4).      
 
b. Health care professionals’ influence on patient motivation – 
implications for inhaler technique maintenance.   
The extent to which motivation for any activity is autonomous, is influenced by both 
innate personal factors (e.g. personality) and  the social environments that people 
interact within (e.g. relationships with health care providers) (Deci and Ryan, 2012).  
Investigating innate personal traits is beyond the scope of this thesis, and further, may 
do little to improve health care initiatives around optimising inhaler technique 
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maintenance since these personal factors may not be easily modifiable.  Social 
contexts, however, may be of greater relevance due to their implications for the 
patient-health care provider relationship and how they may be structured to help 
patients “internalise” motivation for inhaler technique maintenance and therefore be 
more likely to maintain correct inhaler technique.  
 
The social contexts that a person exists and interacts within, can either enhance or 
inhibit their development of autonomous motivation for various activities, depending on 
the degree to which it supports their sense of “autonomy”, “competence” and 
“relatedness” (Figure 4.01, part C).  Autonomy, competence and relatedness are 
constructs which form another key component of SDT.  They are what Deci and Ryan 
propose, based on empirical research, to be the “basic psychological needs” of a 
person (Deci and Ryan, 2012).  (Note, the concept of “autonomy” in SDT is complex 
and can refer to both a “motivational state”, as it has been discussed up until now, as 
well as a “basic psychological need”, as is discussed here).   
 
Table 4.02 explains each of these three basic psychological needs, in the patient self-
management context, and stipulates how health care professionals can structure their 
interactions with patients to support these needs in order to enhance patients’ 
autonomous motivation to self-manage (Ryan et al., 2008).  Numerous studies indicate 
that the more autonomy supportive patients perceive their health care providers to be, 
the better they maintain recommended health behaviours (Münster Halvari, Halvari, 
Bjørnebekk and Deci, 2010, Williams et al., 1996, Williams et al., 2006, Williams, 
McGregor, Zeldman, Freedman and Deci, 2004). 
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Table 4.02: “Autonomy”, “Competence” and “Relatedness” in the context of patient 
self-management, and how they can be facilitated by health care professionals. 
Basic 
psychological 
need: 
Explanation in the context of 
patient self-management 
behaviour: 
How health care professionals can 
support patients’ Autonomy, 
Competence and Relatedness to 
enhance autonomous motivation: 
AUTONOMY 
A patient experiences a sense of 
autonomy, when performing self-
management behaviours, to the 
degree that the self-management 
behaviour is perceived to arise from 
their own free will and choice.  A 
high degree of autonomy is 
indicated by a patient who 
personally values and takes 
responsibility/ownership over self-
management.  (Autonomy does not, 
however, refer to acting 
independently without support from 
others) (Williams, 2002, Ryan and 
Deci, 2002). 
 
 Provide relevant information and 
meaningful rationales for 
behaviour change. 
 Offer the patient opportunities to 
choose. 
 Minimise the use of pressure and 
control that detract from patients’ 
sense of choice (e.g. trying to 
motivate by leveraging position of 
authority, conveying conditional 
approval depending on patient’s 
actions). 
 Encourage patients to accept 
more responsibility for their self-
management behaviours. 
 Interact meaningfully with the 
patient (e.g. suspending 
judgement, listening, encouraging 
questions) and acknowledge their 
views so patients feel understood. 
 Support patients when they 
encounter resistances and 
barriers to change and help 
patients identify compatible self-
management options (Deci and 
Ryan, 2012, Ryan et al., 2008, 
Williams et al.,1998b, Williams, 
2002). 
 
(Note, through supporting a 
patient’s sense of autonomy, 
health care professionals can also 
enhance a patient’s sense of 
competence and relatedness) 
(Halvari and Halvari, 2006, Ryan 
et al., 2008, Williams et al., 2009).  
 
COMPETENCE 
Competence refers to the degree to 
which a patient feels that they have 
the technical skill and confidence to 
achieve desired outcomes or goals 
(Williams, 2002).  It is a patient’s 
“felt sense of confidence” (Ryan and 
Deci, 2002) and “efficaciousness” 
(Ryan and Deci, 2000b) to self-
manage.  It is closely related the 
construct of “perceived self-efficacy” 
– the belief in one’s ability to 
succeed at performing a certain 
activity, as defined by Bandura 
(Bandura, 1997).   
 
Note: Competence alone is not 
 Support patients’ sense of 
autonomy as described above. 
 Provide patients with the skills and 
tools required to enact self-
management (e.g. provision of 
gold-standard inhaler technique 
education via physical 
demonstration).   
 Provide informational feedback (or 
meaningful feedback in a genuine 
and positive manner) to help 
patients master self-management 
(Deci and Ryan, 2012).  
 Provide information in a measured 
way so that the patient is not 
overwhelmed and has the 
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enough for the maintenance of self-
management; it must be 
accompanied by a sense of 
autonomy (Ryan et al., 2008). 
opportunity to experience mastery 
relating to their self-management 
(Ryan et al., 2008). 
 
 
RELATEDNESS 
Relatedness refers to the extent to 
which a patient feels connected to 
others – notably their health care 
providers in the self-management 
context – in a warm, positive and 
interpersonal manner (Williams, 
2002).  Where there is a high level 
of relatedness in the patient-health 
care provider relationship, patients 
will feel respected, understood and 
cared for in the process of health 
care delivery (Ryan et al., 2008).   
 
 Support patients’ sense of 
autonomy as described above. 
 Spend time with the patient to 
understand their feelings and 
perspectives. 
 Express care (e.g. through 
empathy and good communication 
and interpersonal skills). 
 Establish trust and rapport with 
the patient (Deci and Ryan, 2012). 
 
Based on these principles of SDT, it is proposed that patients, who during the course 
of their asthma treatment, maintain relationships with health care professionals who 
enhance rather than diminish their sense of “autonomy”, “competence” and 
“relatedness”, are  more likely to maintain correct inhaler technique.  In these types of 
therapeutic relationships, patients are likely to experience a greater sense of 
satisfaction, trust and rapport with their health care providers (Hypotheses 5 and 6).     
 
iv. A qualitative, theoretically underpinned study. 
Despite the limited empirical evidence which could be drawn upon for the development 
of this study, a firm theoretical basis has now been established to inform and support 
this investigation of patient motivation in inhaler technique maintenance.  In examining 
and applying the principles of the CSM and SDT, it appears that patient motivation in 
inhaler technique maintenance may be more complex than shown in the previous 
quantitative study (Chapter 3).  The advantage of taking a qualitative approach in this 
study is its amenability to uncovering richer levels of data (Miles and Huberman, 
1994).  Thus the nuances of patient motivation in inhaler technique maintenance may 
be better examined in this study to build upon the findings of the previous quantitative 
study.  Ultimately, this study may contribute to a greater understanding of why some 
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patients are more, whereas others are less, likely to maintain optimal inhaler 
technique, as well as strategies for improving inhaler technique maintenance.     
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B. Aim and hypotheses 
The aim of this qualitative exploratory study is to gain a deeper understanding of the 
relationship between patient motivation and inhaler technique maintenance, identified 
in the previous quantitative study.  Specifically, this study aims to understand the 
factors influencing why some patients had relatively higher, while others had relatively 
lower, motivation to maintain correct inhaler technique 
 
Factors hypothesised to influence (i.e. enhance or diminish) patient motivation in 
inhaler technique maintenance are:  
1. Patient beliefs and feelings regarding asthma (to explore cognitive and 
emotional illness representations – CSM). 
2. Patient beliefs and feelings regarding asthma preventer therapy (to explore 
treatment representations – CSM).  
3. Patient beliefs about the benefits of correct inhaler technique maintenance (to 
explore appraisal – CSM). 
4. Patients’ perceived importance of, and ownership over, correct inhaler 
technique maintenance (to explore autonomy – SDT). 
5. Patients’ perceived confidence regarding correct inhaler technique 
maintenance (to explore competence – SDT). 
6. Patients’ perceived satisfaction, trust and rapport with their asthma health care 
providers (to explore relatedness – SDT). 
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C. Methods 
i. Overview 
The following study was qualitative and exploratory in nature involving semi-structured 
interviews with community based asthma patients.  Semi-structured interviews were 
conducted because they are conducive to in-depth examinations of topics (Minichiello, 
Aroni, Timewell and Alexander, 1995), and hence apt in this study aiming at a more 
detailed investigation of patient motivation in inhaler technique maintenance.  In a 
broader sense, the qualitative method itself has the capacity to “supplement, validate, 
explain, illuminate, or re-interpret quantitative data gathered from the same setting” 
(Miles and Huberman, 1994), thus again, fitting for the purposes of this study. 
Qualitative data is also richer, more holistic, and focuses on people’s “lived 
experiences” in natural social settings.  (Miles and Huberman, 1994, Pope and Mays, 
1995).  This makes it a useful method for understanding the personal “meanings” 
(Miles and Huberman, 1994) that people create about their experiences, which in this 
study, relate to patient experiences around asthma, self-management and inhaler 
device therapy. 
 
The Sydney University Human Research Ethics Committee approved this study prior 
to commencement (Appendix 4.03: Qualitative study ethics approval). 
 
ii. Recruitment and patient sample 
The patients who participated in this study were selected from amongst those who had 
previously completed the quantitative study (Chapter 3).  Recruitment occurred 
between March and November 2011 via written and telephone invitation.  Initially, a 
letter of invitation was mailed out to each patient who had completed the quantitative 
study (N = 127).  The letter explained the reason for this follow-up study, the 
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requirements (i.e. sharing personal views and experiences about one’s asthma), and 
informed patients that they may receive a telephone call in the near future inviting 
them to participate in this study (Appendix 4.01: Letter of invitation for interview).    
 
Subsequently, telephone recruitment occurred, during which patients were purposively 
selected (Mays and Pope, 1995) before being contacted.  The selection rationale was 
to achieve representation from those patients who, in the previous quantitative study, 
expressed higher as well as lower levels of motivation for practicing correct inhaler 
technique (i.e., both “Maintainers” and “Non-maintainers” were selected; these terms 
will be further explained in section iv, Data analysis).  Further, selection occurred so 
that there would be representation from both males and females, patients at various 
ages, patients with various levels of asthma control and patients using different types 
of inhaler devices.  Through maximising the variation in the patients recruited, the 
sampling aimed to increase the range in patient responses achieved (Kitto, Chesters 
and Grbich, 2008, Mays and Pope, 1995), and therefore allow for a more holistic 
understanding of the relationship between inhaler technique maintenance and patient 
motivation.     
 
iii. Patient Interviews 
1. The semi-structured interview guide 
A semi-structured interview guide was developed with questions that delved into the 
factors hypothesised (based on the CSM and SDT) to influence patient motivation in 
inhaler technique maintenance.  That is, questions centred on patient experiences, 
perceptions and feelings relating to inhaler technique and device use, as well as 
broader issues regarding asthma and self-management were asked.   
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The interview guide evolved throughout the study as questions were reviewed and 
refined after each interview to improve their clarity and effectiveness in eliciting rich 
and candid responses from patients (Appendix 4.02: Interview guide, version 8/final).  
The factors hypothesised to influence patient motivation in inhaler technique 
maintenance were explored during the interviews.   The typical questions asked 
around each factor are detailed in Table 4.03. 
 
Table 4.03: Factors, explored during interviews, hypothesised to influence patient 
motivation in inhaler technique maintenance, with the typical questions asked. 
 
Factors explored during interviews 
(theoretical basis) 
 
Typical interview questions 
Beliefs and feelings around the condition of 
asthma (Hypothesis 1: cognitive and emotional 
illness representations – CSM). (Leventhal et al., 
2003) 
“Could you tell me about your experience 
of asthma?” (probe into beliefs about 
identity, cause, cure, duration 
consequences); “How did that make you 
feel?” 
 
Beliefs and feelings around preventer therapy 
(Hypothesis 2: treatment representations – CSM) 
(Horne and Weinman, 2002)  
“Tell me about the medication you are 
taking for your asthma”; “How necessary 
is it for you to have the (preventer) in your 
life?”; “Is there anything that concerns you 
about using your (preventer)?” 
 
Beliefs about the benefits of correct inhaler 
technique maintenance (Hypothesis 3: appraisal – 
CSM) (Leventhal et al., 2003) 
“Do you think the way you use your 
inhaler makes a difference to your 
asthma? – How so?” 
 
Perceived importance of, and ownership over, 
maintaining correct inhaler technique. 
(Hypothesis 4: autonomy – SDT) (Deci and Ryan, 
2012) 
"What's the most important thing that you 
need to do when taking your (preventer) – 
why?"; “Who do you think is responsible 
for ensuring your inhaler technique is as 
good as it can be?” 
 
Perceived confidence regarding performing and 
maintaining correct inhaler technique. 
(Hypothesis 5: competence – SDT) 
 
*Note, all interviewed patients received gold-
standard inhaler technique education in the 
previous study (Chapter 3) to equip them with the 
skills that enable a sense of competence as 
stipulated by SDT (Deci and Ryan, 2012). 
“How confident or capable do you feel 
about sticking to all of the steps every 
time you use your (preventer)?” 
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Perceived satisfaction, trust and rapport with 
health care providers (Hypothesis 6: relatedness – 
SDT) (Deci and Ryan, 2012). 
“What is your (doctor, pharmacist etc.) like 
when it comes to your asthma?”; “How 
helpful or supportive do you find them?” 
 
 
2. Conducting interviews 
In-depth telephone interviews were conducted with patients who consented to 
participate in this study.  Interviews were conducted until saturation of themes, that is, 
until no further variation was found in how patients responded in terms of their 
experiences, perceptions and feelings relating to inhaler technique and device use, 
asthma and self-management.   
 
a. Telephone interviewing method 
Telephone, as opposed to face-to-face, interviewing was chosen due to its benefits in 
terms of being more flexible, being more time effective and reducing study costs. 
Further, this method has been used extensively in academic research (Gillham, 2000).  
However, the challenges in sustaining a conversation during a telephone interview due 
to the loss of non-verbal communication (e.g. eye contact and body language), and the 
potential resistance from interviewees receiving unsolicited or poorly timed calls were 
anticipated (Gillham, 2000).  Several measures were taken to mitigate these potential 
drawbacks of the telephone interviewing method: 
 To reduce the potential for resistance amongst patients, “cold-calling” was 
avoided.  That is, each patient was sent a letter of invitation (as explained 
earlier) at least a week prior to being contacted over the telephone by the 
researcher. 
 
 Patients were contacted for the interview at a time that was suitable for them.  
In a few cases, interruptions occurred in the patient’s setting during the 
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interview that may have affected engagement.  In these situations, permission 
was obtained to pause the interview, and for the researcher to re-contact the 
patient at a better time to re-commence the interview.   
 
 Special attention to verbal communication, including the use of appropriate 
tones of voice throughout the interview, using verbal signs to indicate listening 
(e.g. “uh-huh”), and being attentive to the appropriateness of interrupting or re-
directing the conversation.   
 
 To maintain focus, the telephone calls were made in a closed room free of 
interruptions and all relevant documents were at hand during the interview 
process (i.e. the interview guide and patient files from the quantitative study).      
 
b. Line of questioning 
Interviews commenced with a general line of inquiry, i.e., “Please tell me about your 
asthma…”, before more specific aspects relating to inhaler device use and technique 
were delved into.  This “funnelling approach” (Minichiello et al., 1995) encourages 
patients to think about issues in broader terms at first and is proposed to create a more 
relaxed atmosphere (Minichiello et al., 1995).  That is, patients may feel like they are 
being “tested” if the interview commenced with narrower questions which may appear 
to be evaluative and judgemental in nature (e.g. “How capable do you think you are at 
managing your asthma?”), potentially reducing the likelihood of patients being relaxed 
and forth-coming during the rest of the interview.  Once the interview commenced with 
patients reflecting broadly on their asthma, the order of the subsequent questions 
tended to be guided by the issues that patients brought up.  The rationale for this was 
to pay attention those areas that were personally important to the patient, and to 
encourage patients to be elaborative by facilitating a more free-flowing conversation.   
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iv. Data analysis 
All interviews were audio recorded and transcribed verbatim.  Immediately after each 
interview, notes were taken of first impressions, reflections, and salient points 
regarding the conversation, thereby commencing the preliminary stages of data 
analysis (notably, this qualitative data analysis was a much more iterative, and less 
demarcated and linear process, compared to the previous quantitative data analysis) 
(Creswell, 2003, Minichiello et al., 1995).  Subsequently content analysis was 
conducted.   
 
1. Content Analysis based on the Framework Approach 
The Framework approach (Ritchie and Spencer, 1994) is a method of content 
analysis.  Several distinct features allow it to be particularly suitable for application in 
the health care setting (Pope, Ziebland and Mays, 2000).  Developed by the National 
Centre for Social Research (Dixon-Woods, 2011), Framework analysis was designed 
to generate, based on the findings of qualitative data analysis, practice-orientated 
strategies to research questions (Green and Thorogood, 2004).  Themes can be 
generated via deductive (i.e. informed by theory) as well as inductive (i.e. informed by 
data) means (Ritchie and Spencer, 1994), compatible with the evolution and design of 
this study.   
 
The activities undertaken during data analysis are presented in Table 4.04 and are 
categorised into five main stages, based on those stipulated by the Framework 
approach (Ritchie and Spencer, 1994).  Notably, the themes of this study constituted 
of the range of patient responses regarding their experiences, perceptions and feelings 
relating to inhaler technique, device use, asthma, and self-management.  That is, 
factors that have the potential to provide insight into patient motivation in inhaler 
technique maintenance (as outlined in the Background).   
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Beyond descriptive theme identification, the Framework approach endorses a more 
sophisticated qualitative data analysis, requiring investigation into more complex 
theme connections (Creswell, 2003).  This is stipulated in the final stage of analysis, 
“Interpretation and mapping”, which is a key distinction of Framework analysis.  This 
stage, in addition to stage 4, “Charting”, was instrumental in addressing the aim of this 
study to understand the factors influencing why some patients had relatively higher, 
while others had relatively lower, motivation to maintain correct inhaler technique. 
 
Further, the terms “Maintainers” and “Non-maintainers” should be noted as they 
are used throughout this study for the purposes of addressing the aim stated above.  
These terms are based on the results of the previous quantitative study and are used 
here to indicate the relative level of patient motivation for inhaler technique 
maintenance.   
 
In the previous study (Chapter 3), patient motivation was found, via logistic regression, 
to be one of 3 significant predictors of inhaler technique maintenance (out of a total of 
28 variable tested).  Specifically, those patients who maintained correct inhaler 
technique (at visit 2, one month later) scored relatively higher on the motivation 
variable.  Whereas patients who did not maintain correct inhaler technique (at visit 2, 
one month later) scored relatively lower on the motivation variable.    
 
Therefore in this qualitative study, each patient interviewed was considered as either 
a:  
Maintainer: a patient who tended to possess a higher level of motivation to 
practice and maintain correct inhaler technique and who demonstrated correct 
inhaler technique maintenance (in the quantitative study, Chapter 3).   
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OR, 
 
Non-maintainer: a patient who tended to possess a lower level of motivation 
to practice and maintain correct inhaler technique and who did not demonstrate 
correct inhaler technique maintenance (in the quantitative study, Chapter 3).   
 
A key task during data analysis was to compare and contrast the interview responses 
of Maintainers and Non-maintainers.  This was in order to determine whether certain 
factors (i.e. patient experiences, perceptions or feelings) had the tendency to enhance 
and/or diminish motivation in inhaler technique maintenance.  The steps involved in 
this analysis are detailed in Stages 4 and 5 in Table 4.04. 
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Table 4.04: The data analysis conducted in this study as guided by the five stages of 
the Framework approach (Ritchie and Spencer, 1994).  
Stage of 
analysis Analysis activities 
1. Familiarisation 
 Familiarisation with the data was achieved through immersing in it. The 
researcher re-played and listened to audio recordings, read and re-
read transcripts, flagged emergent themes and noted preliminary 
reflections on the data. 
 
2. Identifying a 
thematic 
framework 
 
 A set of themes were identified, based on the 3 initial interviews 
conducted, and formed the initial thematic framework used for coding 
data.  
 The thematic framework was revised throughout the study, as 
necessary, as new themes emerged from subsequent interviews.   
 The thematic framework aimed to be comprehensive and account for 
all of the variation in patient responses on the core topics discussed 
(note, a comprehensive rather than parsimonious approach was taken 
given that there is little is known about patient motivation in inhaler 
technique maintenance; and further because motivation is a complex, 
multidimensional phenomenon that can be influenced by a combination 
of patient experiential, cognitive, and affective factors). 
 
3. Coding or 
indexing 
 
 All transcribed interview data were systematically coded using the 
thematic framework developed.   
 Nvivo 9 (QSR International Pty Ltd) software was used to aid data 
management and organisation. 
 
4. Charting 
 The themes identified in this study were summarised and displayed in 
a structured way to enable the responses from Maintainers and Non-
maintainers to be readily and visually comparable. 
 
5. Interpretation 
and mapping 
 The relationships between various themes were mapped out.  This 
allowed for a deeper interpretation of study findings via examining the 
inter-connectedness of themes in relation to patients’ inhaler technique 
maintenance status. 
 At this level of analysis it was possible to determine some of the 
characteristics of Maintainers and Non-maintainers based on the 
patterns of their responses.    
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2. Validation of Themes  
To enhance the interpretive vigour in the process of theme identification in this study, a 
sample of transcripts (n = 3) were independently read and coded for themes by three 
researchers (LO, SBA, LS) (Kitto et al., 2008).  Extensive discussion between the 
three researchers occurred before a consensus was reached on the final thematic 
framework. 
 
In addition, various other measures were taken to ensure that the study was 
conducted in a robust manner (Creswell, 2003, Kitto et al., 2008, Mays and Pope, 
1995). They included: 
 Documenting the data collection and analysis process through keeping a 
written log book and organising and storing data on computer software (NVivo).  
This readily retrievable documentation allows for other researchers to trace and 
scrutinise the data analysis conducted.  
 Summarising key statements back to patients at various points throughout the 
interview process to ensure accurate interpretation of patient responses.   
 Supporting the reported findings with an extensive range of patient quotes. 
 Triangulating the findings of this study with the results of the previous 
quantitative study and established theories (CSM and SDT). 
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D. Results  
The bulk of the study findings in this results section are conveyed in the form of a 
narrative passage (Creswell, 2003) featuring discussions of the core themes identified 
and their interconnectedness with each other, as well as with the other emergent 
themes.  This narrative passage is supported by verbatim quotes from patients, as well 
as various figures and models illustrating the relationships between themes.  Some 
preliminary results regarding the recruitment process and the patient sample, however, 
will be presented first.      
 
i. Recruitment and patient sample 
Twenty patients, from a pool of 127 who completed the previous quantitative study 
(Chapter 3), were interviewed between April and November 2011, with Figure 4.02 
showing the recruitment process.  As illustrated, one patient contacted the researcher 
to be interviewed in response to the letter of invitation mailed out.  Subsequently, the 
researcher telephoned 45 patients and invited them to participate in this study, of 
whom 22 answered the telephone and 20 agreed to be interviewed.  The reasons why 
the two patients declined to be interviewed were  time constraints and discontinuation 
of preventer therapy.    
 
Table 4.05 summarises the demographic and clinical backgrounds of the patients 
interviewed in this study (obtained from the baseline data collected in the quantitative 
study, Chapter 3), as well as the duration of the interviews.   
 
Table 4.05 shows that representation from both Maintainers (n=9 patients with higher 
motivation to maintain correct technique) and Non-maintainers (n=11 patients with 
lower motivation to maintain correct technique) was achieved.  
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 Figure 4.02: Patient recruitment into this study between March and November 2011. 
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Patient 
identifi-
cation 
Interview 
Duration 
Age 
(years) 
Gender: 
Female 
(F), Male 
(M). 
Asthma 
Duration 
(years) 
Preventer 
Inhaler 
Used for Asthma 
Reliever 
Inhaler 
Used for Asthma 
Other 
Inhalers Used 
Maintainer (M) or 
Non-maintainer 
(NM) 
1:PS 47min 77 F 20 
ACC 
(Seretide 250/50 
1bd) 
pMDI 
(Ventolin) 
No 
M 
2:JH 65min 62 M 2 
pMDI 
(Qvar 100 2bd) 
 
pMDI 
(Ventolin) 
No 
NM 
3:RL 48min 72 M 30 
TH 
(Seretide 500/50 
2bd) 
pMDI 
(Ventolin) 
DPI 
(Spiriva 
Handihaler) 
M 
4:DR 62min 76 M 70 
TH 
(Symbicort 200/6 
2bd) 
 
pMDI 
(Asmol) 
No 
M 
5:LJ 106min 54 M 33 
pMDI 
(Flixotide250 
4bd) 
pMDI 
(Ventolin, Oxis, Atrovent) 
No 
NM 
6:LN 47min 69 F 20 
ACC 
(Seretide 250/20 
1bd) 
pMDI 
(Ventolin) 
No 
M 
7:GW 62min 44 M 35 
pMDI 
(Seretide 250/25 
1bd) 
pMDI 
(Ventolin) 
No 
NM 
8:RH 49min 63 M 40 
ACC 
(Seretide250/50 
1bd) 
pMDI 
(Ventolin) 
No 
M 
9:BB 30min 74 M 74 
ACC 
(Seretide 250/50 
1bd) 
pMDI 
(Ventolin) 
DPI 
(Spiriva 
Handihaler) 
M 
Table 4.05: Patient demographic and clinical characteristics 
Note: 
− Patients are identified numerically (indicating the order the interviews occurred in) and by their initials. 
− Abbreviations: ACC (Accuhaler™), TH (Turbuhaler™), pMDI (pressurised Metered Dose Inhaler), DPI (Dry Powder Inhaler). 
− Rows for Non-maintainers (patients with lower motivation to maintain correct technique) are shaded. 
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10:DD 60min 62 F 20 
TH 
(Symbicort 400/12 
2bd –tds) 
pMDI 
(Asmol) 
No 
M 
11:SM 67min 62 F 15 
pMDI 
(Seretide 250/25 
1-2bd) 
pMDI 
(Ventolin) 
No 
M 
12:KK 53min 70 F 65 
pMDIs 
(Seretide250/25 
2bd and Tilade) 
pMDI 
(Ventolin) 
DPI 
(Spiriva 
Handihaler) 
M 
13:CH 72min 69 F 50 
pMDI 
(Seretide 250/50) 
 
pMDI 
(Ventolin) 
No 
NM 
14:MC 119min 63 F 10 
pMDI 
(Seretide 250/25 
1bd) 
pMDI 
(Ventolin) 
No 
NM 
15:LF 45min 65 F 45 
ACC 
(Flixotide 250 
1d) 
pMDI 
(Ventolin) 
No 
NM 
16:VT 25min 49 M 34 
pMDI 
(Seretide 250/25 
2bd) 
pMDI 
(Ventolin) 
No 
NM 
17:JC 53min 24 F 18 
ACC 
(Seretide 500/50 
2bd) 
pMDI 
(Ventolin) 
No 
NM 
18:FE 67min 67 F 20  
 
TH 
(Symbicort 200/6 
2bd) 
pMDI 
(Ventolin) 
No 
NM 
19:PF 47min 76 F 30 
pMDI 
(Seretide 250/25 
1bd) 
pMDI 
(Ventolin) 
DPI 
(Spiriva 
Handihaler) 
NM 
20:PL 72min 72 F 20 
TH 
(Symbicort 200/6 
1n) 
pMDI 
(Ventolin) 
No 
NM 
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ii. Patient interviews and emergent themes 
The interviews generated a substantial volume of data regarding patient psychosocial 
factors that were potentially influential on patient motivation to maintain correct inhaler 
technique.  That is, patient experiences, perceptions and feelings in relation to inhaler 
technique and device use, asthma, health and quality of life, asthma self-management, 
and social and therapeutic relationships.  The range of patient responses across these 
topic areas formed the individual themes identified in this study and is summarised in 
Appendix 4.04 (Qualitative study themes and how Maintainers and Non-maintainers 
responded).  It is not, however, within the scope of this thesis to report on all of the 
themes at length.  Therefore the most relevant themes in addressing the aim and 
hypotheses of this study were selected and reported here.      
 
The themes that will be focused upon in this results section can be grouped under 
three domains as listed below.   
 
1.  Inhaler technique and device use related themes (emerging from questions based 
on hypotheses 3-5): 
 a. Ease of device use 
 b. Confidence for correct inhaler technique 
 c. Ownership over correct inhaler technique 
 d. Importance of correct inhaler technique 
e. Inhaler use as an “unconscious habit” 
 
2. Asthma and self-management related themes (emerging from questions based on 
hypotheses 1 and 2): 
 a. Motivation to actively engage in asthma management 
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b. Motivation for a preventative-medication based asthma self-management 
approach 
c. Confidence in one’s ability to effectively self-manage 
 
3.  Themes on therapeutic relationships (emerging from questions based on 
hypotheses 6): 
 a. Satisfaction, trust and rapport with health care providers  
 b. Receptiveness to health care provider influence 
 
The themes that provided the most insight regarding the characteristics of Maintainers 
compared to Non-maintainers were found to be those in the second and third domains.  
These themes will be explained in detail in the subsequent sections.  The themes in 
the first domain, contrary to what was hypothesised, were much less insightful.  The 
themes in the first domain will also be briefly reported upon, for the purposes of 
illustrating why they were less powerful in characterising Maintainers and Non-
maintainers, compared to the themes in the second and third domains.   
 
The patient quotes reported are referenced with the patient’s interview order, initials 
and inhaler technique maintenance/motivation status (where M indicates Maintainer, 
and NM indicates Non-maintainer).  For example, (3:RL, M), means that the third 
interviewee was patient RL (initials), who was a Maintainer (patient with higher 
motivation to maintain correct technique).  
 
 
 
 
 
Chapter 4 – Qualitative Study  
176 
 
“It’s not bloody rocket science” 
 
1. Inhaler technique and device use related themes 
Patient responses in the inhaler technique and device use domain emerged from 
questions based on hypotheses 3-5.  It was observed that patients did not voluntarily 
speak about matters relating to inhaler technique or device use.  Patients were 
specifically questioned about inhaler device use in order to illicit responses in this area.  
On the whole, patient responses in this domain were very similar in nature, they also 
lacked emotion  Themes on inhaler technique and device use hence did not seem to 
offer clear insight into the distinguishing characteristics of Maintainers (patients with 
higher motivation to maintain correct technique) and Non-maintainers (patients with 
lower motivation to maintain correct technique), as will be explained further. 
 
a. Ease of device use (theme) 
Patients in this study used four distinct types of inhaler devices: the pressurised 
Metered Dose Inhaler (pMDI), Turbuhaler™, Accuhaler™ and the Handihaler™ (a Dry 
Powder Inhaler used by a handful of patients with co-morbid COPD).  Asthma 
preventer therapy was delivered via a pMDI, Turbuhaler™ or Accuhaler™, whereas 
asthma reliever therapy was always delivered via pMDIs for patients in this study (as 
shown in Table 4.05). Regardless of the device/s in question, the vast majority of 
patients perceived inhaler device use a “simple” (7:GW, NM) and “effortless” (1:PS, M) 
task.  This perception persisted whether patients were using only one type, or multiple 
different types of inhaler devices, and further, DPIs (i.e. the Turbuhaler™, Accuhaler™ 
Handihaler™)  and  pMDIs were both considered equally easy to use as illustrated in 
this excerpt: 
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“ … I don’t find any problem with it at all… I think they’re easy to use, simple 
enough, like you wouldn’t have to be a brain surgeon to use them would you?  
They’re pretty basic things to use, you know they’re not hard or anything, I 
don’t understand why they (other asthma patients) can’t (maintain correct 
technique) because like I said it’s not, it’s not bloody rocket science to use 
them… although they (the pMDI, Turbuhaler™ and Handihaler™) are three 
sort of various things to use I can’t see where there’s any hassle, in like using 
them the way they’re suppose…  the way they ought to be used”  (3:RL, M) 
 
Finding challenge or difficulty with performing inhaler technique was reported only by a 
few patients in relation to pMDI use, notably all of whom were Non-maintainers 
(patients with lower motivation for correct technique maintenance), for example: 
“I think a lot of us aren't really very good at doing it… it's a tricky thing to do, 
you know… I think it's tricky. It looks easy and sounds easy but when you 
actually do it, it's trickier than you think to try and not let that escape, that 
propellant” (14:MC, NM)  
 
b. Confidence for correct inhaler technique (theme) 
Relatively high levels of confidence in one’s ability to practice and maintain correct 
inhaler technique were found amongst the vast majority of patients (perhaps not 
surprisingly given their perceptions on ease of device use reported above).   Patient 
responses on self-confidence around inhaler technique were direct and unequivocal, 
as in these examples: 
“I’m very confident” (5:LJ, NM) 
“Oh very capable of that” (1:PS, M)  
“I was doing it properly anyway before the chemist came along” (11:SM, M) 
 
Further, no patient responses suggested a lack of confidence in device use and inhaler 
technique.     
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c. Ownership over correct inhaler technique (theme)  
The willingness to take ownership for practicing correct inhaler technique when using 
inhaler therapy was indicated by approximately half of the patients.  These patients 
indicated the responsibility for correct inhaler technique maintenance should be 
attributed to oneself, or oneself with the support of health care professionals.  The 
large majority of these patients were Maintainers (patients with higher motivation to 
maintain correct technique): 
“No, I think it’s up to me.  I mean they (health care professionals) can tell me 
what to do but if I’m not going to do it, then I’m not taking the responsibility for 
it, am I?” (12:KK, M) 
 
“Me.  People can tell you and give you all sorts of instructions, but unless you 
abide by them… you know it falls with you” (9:BB, M) 
 
“Me…they’ve (health care professionals) sort of like advised me what to use 
so, then I think it’s up to me to use those…” (3:RL, M) 
 
In cases where there seemed to be less ownership over practicing correct inhaler 
technique, the responsibility was to a large degree externalised and relegated mostly 
to health care professionals.  Incidentally, in all of these cases, the patients were Non-
maintainers (patients with lower motivation to maintain correct technique):   
Interviewer: Who do you think is responsible for making sure that you can use 
your inhalers properly, the right way, with the right technique? 
“Okay, well bodies like yourself, like I mean the people who are doing these 
studies… they’re (pharmacists) responsible too… I thought it was part of their 
job to make sure that you get it right” 
Interviewer: Yes, and what about your role as the patient with asthma? 
“Well they have to be made aware, because you can’t be aware unless you’re 
taught to a point… and then people forget and they become more aware if 
they’re contacted again the next year.” (5:LJ, NM)   
 
“Well, I’d say that’s probably going to be your pharmacist more than anything.  
Because they’re selling you the product.”(7:GW, NM) 
 
“Well I think that would be my pharmacist's role…” (17:JC, NM) 
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d. Importance of correct inhaler technique (theme) 
The vast majority of patients seemed to acknowledge the value of correct inhaler 
technique and the influence it can have on health outcomes.  When asked: “When you 
take your [inhaler name/s] what do you think is the most important thing you need to 
do?”, patients typically referred to inhaler technique, for example: 
 “…making sure you do it properly” (17:JC, NM),  
 
or the steps involved in inhaler technique, for example: 
“Well you got to breathe out as far as you can, and time it so that the breathing 
in is just a fraction after you push the plunger” (3:RL, M).   
 
Some patients also commented on the importance of each individual step involved in 
device use: 
“I think they’re all equally important because they all add up to the final result… 
it’s like saying it’s all right to… clean your front teeth but not your back teeth… 
But all those steps add up to the efficient way of using it and getting the best 
out of your medication” (10:DD, M) 
 
When questioned further about why correct inhaler technique was thought to be 
important, patients spoke about the wish to avoid undesirable therapeutic and health 
outcomes such as receiving an ineffective dose, worsening asthma symptoms, having 
to increase the dose of medication due to poor symptom control, asthma attacks.  An 
association was even made between poor inhaler technique, poor asthma control and 
death.  For example:  
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“…to get the full benefit of it you have to do it correctly… it’s extremely 
important to use it properly… So you don’t get any symptoms of asthma... if I 
use it correctly and it’s to my benefit then… I won’t have an asthma attack 
therefore I’m not putting any extra load on my lungs and if I use it incorrectly... 
well I just think that’ll be very foolish, because you could easily get an asthma 
attack.  And you can die.” (6:LN, M) 
 
“Yes I learned to inhale slowly and hold my head sort of upright more… And 
the other thing is too, that I know if I get the maximum use out of the 
medication, I might be able to use less and at the same time my medication will 
help me to be more stable.” (5:LJ, NM) 
 
The importance of practicing correct inhaler technique was challenged by only  one 
patient, who did not consider inhaler technique to be a priority in asthma therapy and 
doubted the benefits of being precise with technique and, perhaps not surprisingly, 
such beliefs were expressed by a Non-maintainer (a patient with lower motivation to 
maintain correct technique): 
“Well, I mean there’s directions there for that reason but sometimes the way I 
look at things, being mechanically minded and things like that, I sort of ask; 
‘well is there any scientific sign of evidence that it has any further benefit, or 
any further effect of doing it one way or doing it the other way?’  So you know 
that’s why I mean if it’s just about right that will still do the same job… I don’t 
think it’s so much the correct way, it’s more so the consistency of using it.” 
(7:GW, NM) 
 
e. Inhaler use as an “unconscious habit” (theme) 
Despite the fact that the majority of patients (barring the one example above) could 
articulate the reasons for the importance of paying attention to correct inhaler 
technique, and seemed to believe that inhaler technique would make a difference to 
their asthma experience, on a day-to-day basis this understanding did not appear to 
guide how patients actually performed inhaler technique.   
 
That is, patients did not seem to pay deliberate consideration to inhaler technique 
during routine use.  This is implied by the responses of over half of the patients 
interviewed, describing inhaler technique as, for example, an “automatic” (12:KK, M) 
action, or a matter of “habit” (4:DR, M), with matters concerning inhaler technique 
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seeming to meld inconspicuously with the details of daily life.  This familiar, and 
perhaps unthinking, attitude underpinning inhaler technique performance was a 
frequent theme amongst both Maintainers (patients with higher motivation to maintain 
correct technique) and Non-maintainers (patients with lower motivation to maintain 
correct technique): 
      “… it’s just automatic – like cleaning your teeth every morning.  It’s just an 
automatic thing I do… You just get into a rhythm of doing it and it just, you 
know – five, ten minutes of your morning and that’s it… you sit down and have 
a cup of coffee and read the paper or watch television…”(12:KK, M) 
 
“I mean I just do it. I guess it's programmed, I just do it but I don't know if I'm 
doing it correctly… I feel like I've been doing it for such a long time I probably 
just do it. I probably don't consciously think about steps to what I'm doing. I 
literally just click it back, take a breath in, hold it for a few seconds, click it back, 
leave it for a few seconds, breath and then I rinse my mouth out… I think as 
you go on you just - you get that you fall into bad patterns and bad habits… I 
probably do it so automatically I probably don't think ... or anything like that… I 
actually do do it wrong quite often really.” (17:JC, NM) 
 
“Maybe automatically I do, do it the way I do… Familiarity breeds contempt. I 
think you just forget.” (18:FE, NM) 
 
 
 
Overall, patient responses relating to inhaler technique and inhaler device use were 
rather homogenous, with the large majority of patients conveying similar attitudes and 
beliefs regarding inhaler technique and device use (i.e. correct inhaler technique and 
device use was believed to be both important and easy, and confidence in one’s 
abilities to practice with correct inhaler technique was unequivocally high).  A familiar, 
habitual, or non-deliberate attitude toward inhaler technique was also conveyed by 
many patients, equally by Maintainers (patients with higher motivation to maintain 
correct technique) and Non-maintainers (patients with lower motivation to maintain 
correct technique).   
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Despite some distinguishing features (i.e. only Non-maintainers reported  identifying 
challenges with device use, doubts with the importance of inhaler technique, and the 
lack of ownership over one’s inhaler technique status), in the majority of cases both 
patients who were Maintainers and Non-maintainers echoed similar sentiments in 
regard to inhaler technique and device use (Appendix 4.04: Qualitative study themes 
and how Maintainers and Non-maintainers responded).   
 
Without offering clear insight on the distinguishing characteristics of Maintainers 
compared to Non-maintainers, patient responses regarding inhaler technique were 
limited in illuminating the reasons why some patients were more, and others less 
motivated to maintain optimal inhaler technique.   
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“I changed my mind about two or three attacks ago” 
 
2. Asthma and self-management related themes – core factors 
influencing patient motivation in inhaler technique maintenance  
Patient responses in the asthma and self-management domain emerged from 
questions based on hypotheses 1 and 2.  Themes in this domain, compared to other 
study themes, appeared to be the most insightful in explaining patients’ relative 
difference in motivation concerning inhaler technique maintenance.  In particular, when 
these themes were mapped out (as per stage 5 of Framework analysis, Table 4.04) 
they could clearly distinguish the difference between Maintainers and Non-maintainers 
(this will be illustrated and explained in section 2d).  These themes were thus deemed 
the “core” study themes.  Each core theme (2a-c) reported on below is discussed with 
reference to various supporting or “corroborating” themes. The corroborating themes 
substantiate the core themes.  For clarity, the subheadings in this section (2a-c) flag 
only the core themes (note, both core and corroborating themes will be summarised in 
Figure 4.03, and a full account of study themes appears in Appendix 4.04).                 
 
a. Motivation to actively engage in asthma management (core 
theme) 
Personal wellbeing in the form of health and quality of life seemed highly valued by the 
patients in this study and was indicated by statements such as:  
“That's the first thing you think about is your health. How it impacts your whole 
life.” (15:LF, NM).   
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Further, the importance of maintaining good asthma control in order to support one’s 
desired levels of personal wellbeing was a connection many patients recognised, for 
example:   
“… it (poor asthma control) would affect your life in every way, I mean you’d be 
struggling to carry loads, you’d be struggling to do any physical exertion… I 
think asthma can affect almost every part of your life… (asthma control is) 
critical…I’m very very serious about my health and wellbeing” (2:JH, NM) 
 
“Well, it (good asthma control) makes life a lot easier.  And I mean, well it just 
lets you get on with life without being sick all the time, it’s everything.  It’s a 
quality of life.” (12:KK, M) 
 
The majority of patients considered that the threat that poorly controlled asthma may 
pose on one’s wellbeing could be significantly detrimental. When speaking about the 
consequences of poorly controlled asthma, many patients would recall and recount 
vivid past personal experiences of acute asthma exacerbations (such as patients 1:PS 
and 15:LF below), or in some instances, the patient, not having had personal 
experience, anticipated what poorly controlled asthma would be like (such a patient 
2:JH below), in both scenarios feelings of fear were clearly present:  
“Yes it is frightening.  It’s a nuisance… when I’ve got to go and play bowls or be 
out in it (the wind) or… I can get quite distressed you know… I was out 
shopping, I was in a shop we ordered our lunch, and it was quite frightening, 
it’s lucky I had Ventolin (reliever) with me” (1:PS, M) 
 
“Very hard to breathe, very hard to do anything and when you start to breathe 
you can breathe in but you cannot get that breath out to breathe back in again. 
It is really frightening.” (15:LF, NM) 
 
“ Um, it’s quite scary… fortunately I haven’t had a really major acute attack but, 
it’s sort of, each time you feel that way the immediate thing comes to mind that 
you feel like you’re going to drown, I’d hate to be in a situation where you were 
drowning cause that same sort of fear and not being able to breathe.”(2:JH, 
NM) 
      
Salient personal experiences of asthma exacerbations often served as turning-point 
events in patients’ lives.  That is, after such experiences, many patients were 
prompted to evaluate (or re-evaluate) their perceptions, attitudes and behaviours 
around asthma and asthma management.  Such experiences also heightened patients’ 
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perceptions of the threat of asthma on one’s wellbeing, and subsequently, their 
motivation to mitigate this threat was also enhanced.  Greater awareness of the threat 
of asthma based on experiencing significant asthma exacerbations was fundamental in 
motivating patients to “do something” about their asthma (2:JH, NM), and to actively 
engage (or re-engage) in asthma management in order to avoid further and future loss 
of wellbeing.  The following examples illustrate changes in patient beliefs and attitudes 
(acceptance of diagnosis and preventer therapy), and behaviours (use of preventer 
therapy), following turning-point events: 
Interviewer: So when did the doctor first tell you that it might be asthma or this 
is a diagnosis of asthma? 
“Well that would have been about 20 years ago” 
Interviewer: Did you believe them? 
“Not really” 
Interviewer: When did you change your mind? 
“I changed my mind about two or three attacks ago” (18:FE, NM)  
 
“… that was probably the lowest point in my life with feeling unwell and wheezy 
and just not being able to really do anything, I mean it’s quite amazing just, you 
know walk up stairs and you can feel it, and you know like one flight of stairs 
and you think ‘god, gosh it’s only one flight’… and it is a concern… I was 
concerned about my future, if that was to continue, which obviously made me 
do something about it.” (2:JH, NM) 
 
A further case illustrating the impact of perceived asthma threat on patient attitudes 
and behaviours around asthma and asthma management concerns a patient who had, 
interestingly, experienced severe asthma exacerbations for the first time in her life, just 
prior to being interviewed.  Shortly after these events, the threat of asthma to one’s 
health and quality of life was significantly heightened in this patient’s estimation, and 
her attitude towards asthma management, including those regarding inhaler use and 
technique, seemed to have transformed from “blasé” to “vigilant”, with an indication 
that behaviour change may also ensue: 
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“I’ve had an absolute shocker of a year …I’m just absolutely carked… I am 
really down at the moment for the simple reason I thought once the summer hit, 
I’d be okay… I’ve lost the plot this winter completely… It’s never been a 
problem in my life up until now… it started back in about April of this year and it 
hasn’t cleared up…I honestly thought last night I would have to call an 
ambulance.  That was the worst I have ever lived through last night…  
 
Well it [inhaler technique] is [important] now.  Before I was probably a little bit 
blasé in the past.  A bit blasé… Now I’m not because I know now that it’s a big 
problem in my life.  Remembering to do things, I know I’ve got to be more 
vigilant.  If it means I’ve got to use a preventer and if it means I’ve got to set it 
on a placemat in front of me at the table to remind me, I’m quite happy to do 
so” (13:CH, NM) 
  
There was a handful of patients who indicated markedly different sentiments to the 
majority (who believed that asthma – had been in the past, is in the present, or can be 
in the future – a significant threat to their personal wellbeing, and who were therefore 
more motivated to actively engage in asthma management).  The handful of patients 
who held a differing view, perceived asthma to be a relatively minor issue in their life, 
and a condition that was not likely to become worse in the future and of low threat to 
their personal wellbeing.  Further, these patients did not report experiencing episodes 
of asthma exacerbations that they considered to be a severe and warranting increased 
care.  For example: 
“…I know it's meant for preventatives, people use it all the time, but I think 
because I only get one attack of asthma a year I'm not a serious asthmatic.” 
(18:FE, NM) 
 
“Oh, probably just gives you a shortness of breath... not too much beyond 
that… other people have different grades I suppose or some are worse than 
others where mine is probably only, you know minor... generally speaking it’s 
not too bad…I don’t know what you call an asthma attack (chuckles)… I’ve 
never been to that extent… it’s just more of an inconvenience but it hasn’t 
caused any great drama… it’s (taking preventer) just something I don’t do 
consistently… unless it’s more serious I suppose (chuckles), but no way I need 
to worry, I might get around to it… ” (7:GW, NM) 
 
This particular combination of experiences and perceptions – lack of salient or 
memorable asthma exacerbations and lower perceived threat of asthma on one’s 
wellbeing – also coincided with lower patient motivation to actively engage in asthma 
management (e.g. patient 7:GW’s attitude and behaviour regarding adherence to 
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preventer treatment, above).  This is perhaps not surprising, since amongst patients 
where asthma is not perceived to be highly problematic, issues around asthma 
management would seem less personally relevant.  Hence motivation to engage in 
asthma management would be diminished.   
 
This logic was observed to extend to patient self-management regarding inhaler 
technique.  That is, all of the patients who perceived their asthma to be a minor/non-
threatening issue, were less motivated to engage in asthma management, and were 
also Non-maintainers (patients with lower motivation to maintain correct technique).  In 
contrast, those patients who did perceive asthma to be threatening to their wellbeing, 
were more motivated to engage in active asthma management, and were also in the 
majority of cases, Maintainers (patients with greater motivation to maintain correct 
technique).   
 
Patients’ broader sense of motivation to actively engage in asthma management, 
driven by perceptions of asthma threat, was thus observed to correspond, to a large 
degree, to the more specific motivation to maintain correct inhaler technique.        
 
This observation did not, however, consistently hold true.  For example, a handful of 
patients who had relatively greater motivation to actively engage in asthma 
management (i.e. patients 2:JH, 5:LJ, 13:CH and 15:PF, as shown in Appendix 4.05), 
were, contrary to what could be generalised from the observation above, Non-
maintainers (patients with lower motivation to maintain correct technique).   
 
Further analysis indicated that themes relating to patient attitudes and approaches to 
self-management could explain some of the inconsistency observed here.   
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b. Motivation for a preventative-medication based asthma self-
management approach (core theme)     
The core and corroborating themes reported  in this section focus on the responses 
from those patients who perceived asthma to potentially be a significant threat to their 
wellbeing, and who therefore indicated greater motivation to actively engage in asthma 
management, as described previously (Appendix 4.05, 1b). 
 
Amongst patients who were motivated to actively engage in asthma management, 
three distinct attitudes and approaches toward asthma self-management were 
identified, namely: reactive, preventative-lifestyle based, and preventative-medication 
based.   
 
Patients who adopted a reactive attitude and approach tended to engage in asthma 
self-management after they noticed the onset, or worsening of, asthma symptoms. 
When symptoms subsided, these patients tended to cease all medication therapy, and 
thus asthma self-management was very much symptom-driven or motivated.   This 
reactive attitude and approach were related to various factors, including: beliefs that 
non-medication/lifestyle self-management strategies were sufficient (e.g. quitting 
smoking and exercising), lack of knowledge or misinformation about preventer 
medication (e.g. resistance develops with regular use), lack of perceived benefits 
associated with preventer medication use, beliefs that medications in general should 
be avoided as much as possible, the belief that asthma is an episodic condition, and 
experiencing uncomfortable physical sensations immediately after using inhaled 
medication.    These patients did not recognise the benefits of regular preventer 
medication and seemed much more reliant on using their reliever medication.  For 
example: 
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“Symbicort (preventer) doesn't seem to make a difference to me. It doesn't 
honestly seem to make a difference. I feel as if it makes it harder to breathe - 
makes me worse… where the Ventolin (reliever) will clear the passage straight 
away, the Symbicort seems to put something… I feel as if there is a coating 
there that's making it harder - that's the only way I can describe it… this awful 
clagginess in my lungs… it seemed to be gluing me up rather than clearing me 
up.” (18:SM, NM) 
 
I do nothing as a prophylactic thing. I only use Ventolin through the nebuliser 
when I'm in the middle of a ghastly attack.. “(The preventer) probably would be 
no use at all… I am living without it. I don’t use it as a preventer and I'm quite 
well in between attacks, which are generally just once a year… I take so many 
drugs anyway but I don't want to be adding something that isn't necessary. If 
someone could tell me it was definitely necessary I would - preferably not with 
the Symbicort because I don't think that worked…” (18:FE, NM) 
 
“I could go 12 months and not need any puffers or anything ’cause I’ve given 
up smoking…at the moment I don’t feel I need it… I just take the Asmol 
(reliever) just to get me through the night… as I said, I’m just one that I can’t 
see the point in taking something all year round if I don’t need it. If I’m 
breathing OK, why need it?  Then if I do need it, it doesn’t have any effect… I 
don’t think you’d get the same… I would get the same relief… and the bottom 
line is you know your body you know your breathing and you know what you 
need without abusing it… if anything I underuse rather than overuse” (10:DD, 
M) 
 
In contrast to this, patients with a preventative attitude and approach, adopted self-
management strategies to stave off the onset of asthma symptoms and exacerbations, 
rather than reacting in response to symptoms.  Amongst these patients, the vast 
majority believed that using preventative asthma medication was essential for avoiding 
deterioration in one’s asthma and health and assumed this as a core self-management 
strategy: 
“I’ve been there and done that... I know what it’s like to have asthma...to 
struggle...I would not like to stop taking it (preventer) for fear that... that bloody 
horrible thing would come back again” (4:DR, M) 
 
“… I guess I wouldn’t really want the asthma to come back so that’s (preventer 
use) one way of trying to prevent it.” (9:BB, M) 
 
“Oh absolutely, you’ve just got to keep it (preventer) going.  You’ve gotta... you 
don’t want to get an attack.  You have to keep your preventatives going… 
that’d be very foolish because you could easily get an asthma attack and you 
can die – I mean if you don’t use medication, if you don’t get treated” (6:LN, M) 
 
“Well I think it’s (preventer use) important, don’t have more than one chance 
with your health” (8:RH, M) 
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Although some of these patients also expressed a strong desire not to be taking 
regular preventative medication (e.g. due to worry over the long term side effects of 
inhaled corticosteroids, or having experienced these side effects), over time their 
experience with poorly controlled asthma and its impact on their health and quality of 
life seemed to have convinced them that the benefits of medication self-management 
exceeds the risks and has influenced them to persist with taking preventer medication 
despite feeling worried.  For example: 
“… I do feel if I’m a little bit that way inclined, that I feel better if I take it 
(preventer).  If I don’t take it and I might be at bowls or somewhere and I’ll be 
coughing, say I’m out of it or something - I always try not to be – and I’ll realize 
I haven’t taken it…you know I think it is necessary, I do think it does work…But 
I would love not to have to (take preventer medication), but I do have to…I 
didn’t want to take medications, as it is now, I have osteopenia… and I put that 
down to the steroids, but I have to take it so there you are… once in a while, 
when those conditions are happening…he (G.P.) said take two in the morning, 
double it for two weeks, which I loathe to do (emphatic)…ohhh I loathe to do 
that, I think it’s killing me, but anyway…” (1:PS, M) 
 
“It’s like a man having food and water, without that you give it 2 days you’d be 
dead...either that (preventer use) or I can’t breathe, that’s it… I read on the 
computer that there’ll be like long term effects… people say by the time you 
take 4 (puffs of preventer) in the morning and 4 in the evening, you might as 
well be taking Prednisone anyway … they say it could have a bad effect on 
your lungs over time, but what do you do?” (5:LJ, NM) 
 
A preventative attitude and approach to asthma self-management, however, did not in 
every instance result in preventative medication therapy being prioritised.  In the case 
of one patient, despite indicating a firm commitment to proactively self-managing their 
asthma in order to mitigate its threat on their personal wellbeing, using inhaled 
preventer therapy was not firmly on the agenda.  Various disincentives against using 
preventer therapy were conveyed by the patient, including the belief that medication in 
general should be avoided and that lifestyle strategies were far more superior than 
preventer medication for managing asthma (such as maintaining fitness and reducing 
environmental allergen load).  Further, minimal benefit was perceived after using 
preventer medication by this patient.  Thus, although a preventative attitude toward 
asthma self-management was adopted, the approach this patient took differed to other 
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patients who also had a preventative mindset.  Specifically, non-medication, lifestyle 
strategies were prioritised, and the role of preventer therapy was relegated secondary 
to these preferred strategies (although it is possible that these views may be tempered 
if the patient should ever experience worsening asthma no longer responsive to non-
medication treatment).  The quote below draws together this particular patient’s 
reasons for adopting a preventative-lifestyle based self-management approach: 
“Look I am dead against medication of any sort, I get a headache, I hate taking 
a tablet so I try to use it as sparingly as I need… when I had my hernia done 
they gave me these really strong tablets for the pain.  And I said, hang on, I 
believe that pain means there’s something going on in your body you need to 
stop so masking it, that isn’t going to help… I want to know when I’m doing 
something that’s painful so that I’ll stop doing it… and I said ‘nah I’ll let my body 
repair itself…  
 
I do my best to avoid them (triggers) – I’ve changed my house and my office 
and things like that to get rid of carpet and blinds, soft furnishings basically… I 
also have an air purifier in my office and as well as in my bedroom... I change 
my bed clothes weekly I put eucalyptus oil in the wash when I wash my bed 
clothes… I use a clothes dryer which de-dusts and takes all the fluff out… the 
asthma is much much reduced… 
 
I’m very very serious about my health and wellbeing and food I eat and, my 
exercise regime, and I think to be honest that the biggest improvement for me 
has been… my fitness… and the puffers aid that fitness... Qvar (preventer), 
really doesn’t give you any, much, much of a better feeling, like a wellbeing 
feeling…” (2:JH, NM) 
 
This section has outlined the three distinct approaches to asthma management – 
reactive, preventative-lifestyle based, and preventative-medication based – adopted by 
patients who were motivated to actively engage in asthma management (Appendix 
4.05, 1b).   
 
Notably, it was found that patients with a reactive, or preventative-lifestyle based 
approach to asthma self-management, were all (bar one) Non-maintainers (patients 
with less motivation to maintain correct technique).  In contrast, those patients with a 
preventative-medication based approach were Maintainers (patients with higher 
motivation to maintain correct technique) in the vast majority of cases.   
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It is conceivable that patients who adopted a preventative-medication based approach 
to asthma self-management were more attentive to matters relating to the use of 
inhaled medication therapy, such as correct inhaler technique (compared to patients 
prioritising a reactive, or preventative-lifestyle based, approach).  This may explain 
why the majority of patients with a preventative-medication based approach were 
Maintainers (patients with higher motivation to maintain correct technique); and by the 
same logic, why all (bar one) of the patients with a reactive or preventative-lifestyle 
based approach were Non-maintainers (patients with lower motivation to maintain 
correct technique).       
 
Taking into account the first core theme (“motivation to actively engage in asthma 
management”) outlined earlier, in conjunction with this second core theme (“motivation 
for a preventative-medication based self-management approach”),  provided further 
insight into the distinguishing characteristics of Maintainers (patients with higher 
motivation to maintain correct technique) and Non-maintainers (patients with lower 
motivation to maintain correct technique) (Appendix 4.05). 
 
Some inconsistency still remained however.  That is, there were patients who indicated 
that they were highly motivated to engage in asthma management, AND who were 
motivated to do so via a preventative-medication based approach, yet counter to what 
was expected based on the observations so far, were Non-maintainers (patients with 
lower motivation to maintain correct technique) (i.e. patients 5:LJ and 19:PF, Appendix 
4.05, 2b).  Further analysis indicated that themes relating to patients’ confidence in 
their ability to effectively self-manage could explain this observation.   
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c. Confidence in one’s ability to effectively self-manage (core 
theme)   
The core and corroborating themes reported on in this section focus on the responses 
from those patients who were: 1) motivated to actively engage in asthma 
management, and 2) motivated to self-manage via a preventative-medication based 
approach (Appendix 4.05, 2b).     
 
Amongst these patients, those revealing a relatively high level of confidence in their 
ability to self-manage effectively, or a high level of “self-management self-efficacy”, 
were all Maintainers (patients with higher motivation to maintain correct technique).  
This confidence was clearly communicated during instances such as:    
 “Oh, I intend to stay like it [well controlled]… Very confident.” (12:KK, M) 
 
 “Well I’ve got it under control and I don’t think um I’m ever gonna have any bad 
asthma attacks anymore” (4:DR, M) 
 
“Oh I think I’m, I think I’m very capable.  I don’t think I need anybody else to say 
to me ‘Come on you better use this or use that’”(6:LN, M) 
 
On the contrary, a couple of patients expressed markedly lower levels of confidence in 
their ability to self-manage successfully.  This lower confidence was associated with 
negative emotions, perceived social barriers to self-management, and a perceived lack 
of control over asthma symptoms.  That is, symptom onset and exacerbations were 
believed to be highly unpredictable, not within personal control to avoid, and any 
precautionary efforts to improve one’s asthma experience were seen to be in vain.   
     
In the case below, although the patient firmly believes in the importance of actively 
engaging with preventative and medication based asthma self-management in order to 
avoid the detrimental consequences of asthma, he clearly lacks confidence in his own 
ability to do so.  Negative emotions seem to immobilise the patient, with emotional 
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weariness (stress and worry about asthma), physical weariness (from having severe 
asthma), and the perceived lack of social support, all acting to undermine the patient’s 
confidence in their own ability to successfully self-manage their asthma. 
“I don’t know if I’m managing, I’m just coping by the skin of me teeth… Do you 
know that my whole day is taken up with like medications, washouts, sprays, 
um coughing, walking around trying to feel better... so it goes on all day do you 
know what I mean?... one year meshes into the next because you’re seeing 
doctors, specialists... I’ve got a very good doctor, I... and the thing is that even 
they don’t know what to do with me...And I don’t know how short lived it would 
be, but it’s taken decades to get there, and then you know I get a little bit sort of 
unhappy or depressed... so hopefully I’m on the straight and narrow – but I 
know I’m not, I just go this way for a little while and there’ll be a little bit of a 
temperature change, and that’s shocking for asthmatics...so you can give the 
maximum effort and you just sink… I’ve gone through hell… it’s insane, and I’m 
more broke and I’ve had more days off than others...and not only that, it’s the 
torture of just being sick all the time… I mean if I go somewhere I can never 
stay out for the whole afternoon into the evening with friends to have dinner – 
when I get home I’d be crook… it’s like being a leper… I’ve never had a 
successful day since I got asthma… very very very tough and hard and anxious 
and exhausting and tiring and wearying and mentally and physically stressful.  
And when you don’t... I remember there was a period of time in my teens 
where I didn’t have asthma – it’s another world.” (5:LJ, NM) 
 
In another similar example, confidence to effectively self-manage seemed to be 
sapped by the patient’s recent experiences with poorly controlled asthma, and 
perceptions of asthma as an overwhelming condition.  Negative emotions feature 
again, with feelings of hopelessness, desperation, fear and stress dominating the 
interview: 
“… I’m not coping well.  As I mentioned previously, I need to cope at the 
moment… I’m struggling with every day to day things now which is not, I know 
is not good… I am getting very desperate… I am getting very desperate about 
it (asthma)…  I’m really losing the plot with it all now… I feel so stressed… I do 
feel my stress levels are now way out of control…I’m running out of puff.  I 
know it’s an effort now to go down the supermarket and not have to stop and 
use the puffer… I’m struggling with every day to day things now which is not, I 
know is not good… I’m just in no man’s land now.” (13:CH, NM) 
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Notably, both these patients, who responded with markedly lower levels of asthma 
self-management self-efficacy, were Non-maintainers (patients with lower motivation to 
maintain correct technique).   
 
Accounting for themes relating to patients’ perceived confidence with asthma self-
management enhanced understanding of the relationship between patient motivation 
and inhaler technique maintenance.  That is, after examining patient responses in 
relation to their: 1. motivation to actively engage in asthma management, 2. motivation 
to adopt a preventative and medication based self-management approach, and 3. 
confidence regarding asthma self-management, a more comprehensive understanding 
of the influential factors on patient motivation to maintain correct inhaler technique was 
achieved.  These results are summarised in the form of a model presented below.   
 
d. The “Inhaler Technique Maintenance and Motivation” (ITMAM) 
model: mapping out core and corroborating themes influencing 
patient motivation in inhaler technique maintenance 
The Inhaler Technique Maintenance and Motivation (ITMAM) model (Figure 4.03), 
underpinned by various types of motivation and self-efficacy, summarises the findings 
based on the core and corroborating themes presented in sections 2a-c.  This model 
arose from analysis that occurred predominantly during the “Interpretation and 
mapping” stage as per the Framework approach (Table 4.04, stage 5).  The ITMAM 
model was developed by mapping out how individual patients responded on each core 
theme (Appendix 4.05).  
 
The ITMAM model illustrates that patient motivation in inhaler technique maintenance 
may be contingent upon three core factors: 1. motivation to actively engage in asthma 
management, 2. motivation to adopt a preventative and medication based self-
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management approach, and 3. confidence, or belief, in one’s ability to effectively self-
manage (Figure 4.03).   
 
The ITMAM model also shows how these three core themes were interrelated to 
progressively explain the reasons behind the relatively higher and lower motivation for 
correct inhaler technique maintenance demonstrated by Maintainers and Non-
maintainers respectively.  The various other themes reported by patients underpinning 
the core themes (i.e. the corroborating themes) are also illustrated in the model (left 
hand side of Figure 4.03).  Corroborating themes were included in this model as a 
reference to explain the derivation of the core themes.     
 
Using the ITMAM model, it can be predicted that patients who maintain correct inhaler 
technique, and possess higher motivation to do so, can be characterised as those who 
have: 
1. Stronger motivation to actively engage in asthma management (in order to 
mitigate the threat of asthma on one’s wellbeing), AND 
2. Stronger motivation to adopt a preventative and medication based approach in 
self-management, AND 
3. Stronger confidence in their own ability to effectively self-manage. 
The model also predicts that patients who do not maintain correct inhaler technique, 
and possess lower motivation to do so, can be characterised as those who have: 
1. Weaker motivation to actively engage in asthma management (in order to 
mitigate the threat of asthma on one’s wellbeing), AND/OR 
2. Weaker motivation to adopt a preventative and medication based approach in 
self-management, AND/OR 
3. Weaker confidence in their own ability to effectively self-manage. 
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Figure 4.03: The Inhaler Technique Maintenance and Motivation (ITMAM) model 
characterising Maintainers and Non-maintainers. 
 
 
        
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
1. Motivation to actively 
engage in asthma 
management 
2. Motivation for a 
preventative and medication 
based self-management 
approach. 
3. Confidence, or belief, in 
one’s ability to self-manage 
effectively. 
a. Weaker motivation b. Stronger motivation 
a. Weaker motivation b. Stronger motivation 
a. Weaker self-efficacy  b. Stronger self-efficacy  
All Non-maintainers Majority Maintainers 
All, bar one, Non-
maintainers. 
Vast majority 
Maintainers. 
All Non-maintainers All Maintainers 
Amongst patients with stronger motivation 
to engage in asthma management: 
Amongst patients with stronger 
motivation for preventative and 
medication based self-management:  
– Perceived threat of 
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– Memorable 
experiences of past 
asthma symptom 
exacerbations. 
– Perceived threat of 
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on ideal self-
management 
strategies. 
– Attitudes and beliefs 
toward medication in 
general. 
– Attitudes, beliefs 
and knowledge on 
asthma medication. 
 
– Appraisal of past 
self-management 
strategies. 
– Perceived 
controllability of 
asthma. 
– Emotional 
responses to asthma. 
– Social support 
 
 
 
Core themes: Corroborating themes: 
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The core themes are ordered hierarchically (from 1a and b, to 3a and b) in the ITMAM 
model as shown in Figure 4.03.  This order is based on the observations and logic 
that, firstly, patients must be sufficiently motivated to engage in asthma self-
management activities (theme 1b), before the second theme, relating to the specific 
approaches taken in self-management becomes a relevant consideration.  Further, it 
was only after patients actually engaged in self-management activities, that their 
responses regarding confidence in self-management were deemed to be most 
authentic.  This is due to findings that showed that patients’ confidence in self-
management could be influenced by how successful they evaluated their past self-
management efforts to be.  Thus the themes appear in the order in which they do in 
the model presented in Figure 4.03. 
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“… it does make a difference” 
 
3. Themes on therapeutic relationships 
Patient responses in the therapeutic relationships domain emerged from questions 
based on hypothesis 6.  Although patients’ personal experiences were noted to be 
paramount in mobilising their motivations and actions in asthma self-management 
(Figure 4.03), health care professionals were still found to play a significant role in 
determining how patients coped with their asthma, especially amongst those patients 
most receptive to health care professional influence. 
 
a. Satisfaction, trust and rapport with health care providers (theme) 
Most patients in this study made substantive comments regarding the quality of the 
relationships with the health care providers they visited for their asthma, in terms of 
perceived satisfaction, trust and rapport.  Overall, the majority of patients evaluated 
their therapeutic relationships in a positive light.  Upon recalling past interactions, 
patients conveyed that knowledge, competence and good interpersonal and 
communication skills were attributes that some health care professionals possessed 
which instilled trust, satisfaction and rapport in the therapeutic relationship.  For 
example: 
“My two pharmacists have always been interested in our health... my children 
use to call my first pharmacist Uncle Dick... pharmacists were always been 
absolutely fabulous people… My doctor whom I trust implicitly says ‘you keep 
taking it’ so that’s exactly what I do...I’ve been going to two pharmacists for 
sixty years... he’s been looking after me for a long time, and I just trust him.” 
(4:DR, M) 
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“I’m on a few different things from my doctor and she’s excellent… she has 
been my doctor for a while and I would trust her judgment…  Yeah, very 
helpful.  She’ll sit back and answer questions if I’ve got any about anything... 
You need to know that you can go to a good GP who will listen to you and not 
fob you off or anything… and the pharmacist’s very good too… sometimes I go 
in and they might say you know ‘How are you going, are you OK?’… where we 
go they’re pretty proactive with that sort of thing.” (6:LN, M)  
 
“Oh I think they’re wonderful, yes, they’re very very helpful...getting 
medications they always explain everything to you…you can ask them 
anything, especially ____(pharmacist) and ____(pharmacist) and they will be 
very very helpful about everything, very knowledgeable I’d feel… they will also 
put you on to go to the doctor and even make an appointment for you if they 
think it’s necessary.” (1:PS, M) 
 
“My doctor … he’s also a motor racing licensing doctor so we’ve become quite 
good friends, as well as my doctor… he’s a pain in the bum because he takes 
so long with his patients (chuckles) but he’d be my first point of call… I’m quite 
happy to do whatever my doctor or pharmacist says. They’re only telling you for 
one reason and that’s because it’s going to be better for you... the important 
thing is that you follow the instructions correctly” (2:JH, NM) 
 
Importantly, the quality of the relationship with one’s health care providers, as 
evaluated by patients, did seem to “make a difference” (18:FE, NM) to patients and 
have an impact on their asthma self-management.  For instance, the following patient 
drew comparison between positive and negative interactions with health care 
professionals, and commented upon the potential for negative interactions to inhibit 
help seeking behaviour and as a result, limit access to appropriate treatment: 
“We’ve had excellent interaction with the majority of (health care providers) 
now… it does make a difference – sure it does, because if you don’t like the 
doctor you won’t go back. He might have something that will help you but you 
never know because you just don’t go back for more insults.” (18:FE, NM) 
 
b. Receptiveness to health care provider influence (theme) 
Notably, the quality of the relationship with one’s health care providers seemed to 
come under closer scrutiny by, and become a higher priority to, patients only after they 
became sufficiently motivated to actively engage in asthma self-management (i.e. as 
represented by theme 1b. in the ITMAM model, Figure 4.03).   
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These patients tended to hold much stronger views and opinions (compared to those 
less motivated to self-manage) regarding their trust in, and satisfaction and rapport 
with, the health care providers they interacted with.  Importantly, these patients 
seemed much more receptive to the influence of their health care providers, whether in 
a positive or negative manner.  The following example illustrates the supportive 
influence that a trusted health care provider had on a patient highly motivated to self-
manage effectively:    
“I was very very sick... by doing what I’m told to do is the way to get right and 
stay right… if you’re sick enough in the beginning you’re desperate enough to 
do as you’re told… whatever the doctors prescribe for me I take because I 
know they’re good doctors and they wouldn’t prescribe it if it wasn’t necessary 
to keep me fit... We only get one life. And if you want to live it and enjoy it, 
you’ve got to do as you’re told.” (12:KK, M) 
 
Interestingly, when patients were more receptive to the influence of supportive health 
care providers (i.e. those whom they had trust and rapport with), benefits were also 
gained in terms of enhanced patient motivation and confidence regarding self-
management:   
“I’ve been very very lucky that I’ve got good doctors... the doctors I’ve had have 
been very vigilant and supportive and my specialist is _______ at _______ and 
she is just wonderful... It’s very very good.  Very motivating you know, to get 
onto the right track and get better again... the pharmacists are very good...only 
too willing to put me aside and have a talk to me about it... I feel very confident 
because no matter where I go I have people that seem to care… And I think 
that in itself is a lot... I mean if you had doctors that didn’t care and showed no 
initiative about your well-being...you may have a different attitude... they’re only 
too willing to say “don’t feel that you’re a nuisance by coming up”...it means 
they care about you.” (12:KK, M) 
 
“… well I think when they show you things...have a word with you about certain 
things...you sort of realise you’re helping yourself... makes you feel a bit more 
sure of yourself... they’re certainly there to help you” (3:RL, M)  
 
The next example suggests that, even amongst those patients with strong beliefs 
against recommended asthma self-management strategies, the persistent messages 
of a trusted health care provider are likely to have influence over time: 
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“it took me a long time to accept - because I wouldn’t have any medications – 
that I had to be on a (preventer medication) program.  I used to go away on a 
holiday and not pack it (preventer medication), you know – ‘cause that’s 
ridiculous, I don’t have to take stuff everyday’ … after this trip overseas… I was 
really sick, I just coughed non-stop… I couldn’t talk to anybody, I was sick as 
anything... Yeah when I came back here he actually convinced me, the 
doctor… He just said ‘you-HAVE - got- asthma. You have got asthma and you 
have to stay on this forever.’ And I didn’t want to take medications… but I have 
to take it so there you are.” (1:PS, M) 
 
The next two examples illustrate how therapeutic relationship can also be perceived by 
patients (who were receptive to its influence) to have a negative influence on their 
lives.  In the case below, the patient’s evaluation of the relationship with their General 
Practitioner (G.P.) was very much negative.  Previously, this patient had perceived the 
same G.P. as “an extremely good doctor”, however, after experiencing recent and 
unprecedented asthma exacerbations, and becoming significantly more aware of the 
need for good quality health care support, this patient’s satisfaction, trust and rapport 
with this long-standing G.P. had markedly diminished.  Further, continued interactions 
with this health care provider in whom this patient now had little trust and satisfaction 
with, clearly had a negative influence on her emotional state, as indicated by her 
responses on this topic filled with feelings of dissatisfaction and desperation:        
“Last night would have to have been the worst night I think I’ve ever had… My 
current doctor at the moment…  I will not go back to.  I’ve been going to him for 
three years… It concerns me because I know I’m not getting proper help… he 
looked at the clock and reminded me that there’s other patients outside in the 
waiting room…  I honestly thought last night I would have to call an ambulance.  
That was the worst I have ever lived through last night… I’ve lost all confidence 
and faith in him… He is very short tempered.  I found him an extremely good 
doctor, but I’ve lost all confidence in him now.  He was very rude to me last 
week… I am at my wit’s end because I feel I am not getting proper help… I 
have to find a GP and I do not know where to go… That’s like finding a needle 
in a haystack in my opinion…” (13:CH, NM) 
 
In a detailed example of similar essence, it can be seen that patients’ lack of 
satisfaction, trust and rapport with their health care providers can stem from 
perceptions relating to health care providers’ lack of clinical as well interpersonal skills, 
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for example, lack of appropriate advice and guidance, inconsistent advice, inability to 
help make improvements in one’s asthma and lack of empathy: 
“Oh I think the doctor sort of had a go at it once or twice (technique 
education)… everyone had all sorts of funny opinions, but in the end half of it 
was hearsay.  Or they changed it and decided like holding the spray out of your 
mouth or away from your mouth... in the end they said it didn’t work, so it’s very 
difficult when you’re out there being a patient... ‘I was taught this way’ and 
someone would say ‘Oh no they don’t do that’ and then someone says ‘Yes 
they do’... I mean oh my god, you don’t know… It’s insane, and I’m more broke 
and I’ve had more days off than others... it’s the torture of just being sick all the 
time, and they (health care providers) don’t see it, they expect you think 
logically and sane, but they don’t really realise that you’re not in that position… 
they say you’re being a rebel and you’re not trying to work with the system but 
they also change medications on the market and you say to them ‘it doesn’t 
work’ and they just say ‘oh no,no; who are you? You’re an idiot.  Medical 
science shows this this, this, this, and that’… there’s a lot of those funny ones 
(G.P.s) now in some of those medical centres… they’re obviously not 
interested in people… a lot (of pharmacists) don’t care I can tell you.  It’s like 
you go there and they just say ‘Here you go’… lots of them can’t even be 
bothered looking, ‘Oh there’s the script, goodbye’... I went to this guy, Dr 
_______,… they’re supposed the be… the best of the best… They took me off 
everything and said I didn’t have asthma , and in the end I was in a car park 
and nearly collapsed and died, and finished back on everything…This is what 
I’m talking about, the journey to hell and back.” (5:LJ, NM) 
 
In contrast to the cases discussed so far, there were various instances in this study 
where patient opinions regarding therapeutic relationships were much less 
impassioned, and rather, more indifferent and detached.  These patients appeared to 
be less receptive to influence from health care providers (whether in a positive or 
negative manner).  Incidentally, these patients were also those who indicated less 
motivation to actively self-manage (as represented in the ITMAM model, Figure 4.03, 
theme 1a).    
 
The handful of patients who were less receptive to health care professionals’ influence,  
described their interactions with their health care providers as passive and 
transactional in nature, and did not indicate any strong feelings of satisfaction or 
dissatisfaction with the status quo: 
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“I just go to the doctor to get a prescription... and then go to the chemist and 
pay for it… that’s basically it… I don’t think they (G.P. and pharmacists) 
actually do anything in particular; just ask if anything’s going on, and it’s still 
alright type of thing, mainly you know, ‘Do you know how to use it?  Have you 
had this before?’  Or something like that, and obviously when you say you 
have, they don’t sort of go into any further detail unless you ask them I 
suppose.” (7:GW, NM)  
 
Even when there was a clear lack of support from one’s health care providers, these 
patients revealed what appeared to be only mild dissatisfaction: 
Interviewer: So tell me about your interaction with health care professionals 
when it comes to asthma. What’s that been like? 
“Look it’s sort of been a non-event honestly… there’s not been a lot of health 
care advising… there was no direction to - it was almost like, well this is what 
you’ve got, take this medication. As much as I think the medication’s helped 
me, I think there could have been a bit more direction.” (20:PL, NM) 
 
The findings thus far reveal that the quality of the therapeutic relationship, as 
evaluated by the patient, has important implications for asthma outcomes due to its 
potential to affect patient self-management (e.g. via influencing patient knowledge, 
confidence and motivation as illustrated in previous examples).  This is particularly the 
case amongst patients who are more receptive to health care professionals’ influence 
(i.e. those who were more motivated to actively engage in asthma self-management).   
 
c. Health care providers’ influence on patient motivation in inhaler 
technique maintenance  
By mapping out the relationship (as per stage 5 of Framework analysis, Table 4.04) 
between themes 3a-b, explained above, how health care providers influenced patients’ 
motivation regarding inhaler technique maintenance became clearer.    
 
It was identified that patients’ evaluation of their therapeutic relationships (in terms of 
the degree of satisfaction, trust and rapport they had with their health care providers; 
theme 3a), as well as their receptiveness to health care professional influences (theme 
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3b), was associated with how they maintained inhaler technique.  That is, it was 
observed that: 
1. Patients who were more receptive to health care professionals’ influence AND 
evaluated their therapeutic relationships positively, were in the vast majority, 
Maintainers (those with higher motivation to maintain correct technique),  
however, 
 
2. Patients who were less receptive to health care professionals’ influence; OR, 
more receptive BUT evaluated their therapeutic relationships negatively, were 
all Non-maintainers (those with lower motivation to maintain correct technique).   
 
These important interrelationships are mapped out in the cross-tabulation in Figure 
4.04. 
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Figure 4.04: The influence of therapeutic relationships on inhaler technique 
maintenance.   
 
Quadrant A: Patients more receptive to health care professional influence AND who 
had greater satisfaction, trust and rapport with their health care providers, 
predominantly were more motivated to maintain correct inhaler technique (i.e. 
Maintainers, denoted in brackets as “M”).  
Quadrants B, C and D: Patients less receptive to health care professional influence 
AND/OR had less satisfaction, trust and rapport with their health care providers, all 
were less motivated to maintain correct inhaler technique (i.e. Non-maintainers; 
denoted in brackets as “NM” and underlined). 
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The quality of therapeutic relationships from the patient’s perspective was found to be 
an important consideration for asthma management in general, and inhaler technique 
maintenance in particular.  The key findings in this domain are summarised in Figure 
4.05, which is an extension on the ITMAM model presented earlier (in Figure 4.03).   
 
In Figure 4.05, the point at which patients tended to become more receptive to health 
care professionals’ influence is indicated on the right hand side.  Figure 4.05 also 
indicates the points during which supportive health care professionals, administering 
effective interventions, seemed to have the greatest impact on patients’ skills, 
knowledge, motivation and confidence in asthma self-management, including in 
relation to inhaler technique maintenance (left hand side).        
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Figure 4.05: The ITMAM model, highlighting the points when patients become most 
receptive to health care professionals’ (HCP) influence, and may most benefit from 
health care intervention. 
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E. Discussion 
Through taking a finer-grained, qualitative approach, this study aimed to better 
understand the novel relationship between patient motivation and inhaler technique 
maintenance identified previously (Chapter 3).  As a result, new insights were revealed 
about the influential factors on patients’ motivation to maintain correct inhaler 
technique (and hence inhaler technique maintenance status).  In particular, patient 
psychosocial factors (including perceptions relating to asthma, asthma treatment, self-
management and therapeutic relationships) were found to explain in a substantive way 
why some patients possessed a relatively higher, whereas others possessed a lower, 
degree of motivation to maintain correct inhaler technique.  These influential 
psychosocial factors were identified as the “core” and “corroborating” themes of this 
study.   
 
The core and corroborating study themes highlighted the complex and 
multidimensional nature of patient motivation in inhaler technique maintenance and the 
important concept of personal relevance as a driving force behind patient motivation.  
These themes also formed the basis of the Inhaler Technique Maintenance and 
Motivation (ITMAM) model developed as part of the study findings (Results, section ii, 
2, d), which with further testing, may have clinical application for identifying those 
patients at risk of developing poor inhaler technique over time. The following 
discussion will examine these key insights and their implications for how patients 
maintain inhaler technique and how health care professionals may better facilitate 
improvements in inhaler technique maintenance.   
 
 
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In this section of the discussion, the influential (core and corroborating) themes 
identified in this study will be examined by taking into account various relevant 
theoretical perspectives.  Firstly, however, it must be acknowledged that a diverse 
range of themes was identified in this study consisting of patient responses relating to 
their experiences, perceptions and feelings around inhaler technique, device use, 
asthma, self-management and therapeutic relationships (Appendix 4.04).  All emergent 
study themes, theoretically (based on the CSM and SDT discussed in the 
Background), had the potential to influence patient motivation in inhaler technique 
maintenance, yet after deeper analysis (Methods, Table 4.04, step 5), it was clear that 
some themes were more influential than others.   
 
The study themes deemed “core” and “corroborating”, were those that were found 
(during stages 4 and 5 of Framework analysis, Table 4.04) to carry the most weight in 
explaining patients’ relatively higher or lower motivation to maintain correct inhaler 
technique.  Notably, the core and corroborating themes were closely interrelated, with 
corroborating themes substantiating the core themes by explaining their basis (as 
reported at length in the narrative passage section of the results).  For example, in the 
first tier of themes presented in the ITMAM model (Figure 4.03), the core theme – 
patient motivation to actively engage in asthma management, stronger or weaker – 
was firmly rooted in the corroborating themes – degree of threat patients perceived 
asthma to pose on their wellbeing, and past experiences of asthma exacerbations.   
 
Further, the relationships between the core and corroborating themes were frequently 
aligned with the theoretical principles underpinning this study.  For instance, the 
interrelatedness of the themes in the example given above, are closely aligned with 
the principles of the CSM (Leventhal et al., 2003).  That is, the relationship between 
the core and corroborating themes mirrors the relationship between the constructs of 
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“coping” (how patients self-manage) and “interpretation” (how patients make meaning 
of their asthma based on their perceptions and feelings) in the CSM.  Specifically, 
“coping”, is comparable to the core study theme: motivation to actively engage in 
asthma management.  Further, “interpretation” (especially relating to how patients 
interpret the “consequences” and “identity” of asthma) is comparable to the 
corroborating study themes: perceived threat of asthma, and experience of asthma 
exacerbations.  Thus the interrelatedness of the first tier of themes presented in the 
ITMAM model (Figure 4.03) is supported by principles of the CSM.       
 
Additional examples of how the interrelatedness of study themes align with theoretical 
principles can be found in both the second and third tier of themes presented in the 
ITMAM model.  For instance, in the second tier (Figure 4.03), similar to the previous 
example, the relationship between the core theme – motivation for a preventative-
medication based self-management approach; and corroborating themes – perceived 
threat of asthma, perceptions about the benefits/harms of medication in general, and 
preventer asthma therapy in particular; are underpinned by the CSM.  The relationship 
is also supported by Horne et al.’s work extending the CSM to account for the 
influence that patients’ medication related beliefs can have on self-management 
(Horne and Weinman, 2002, Horne and Weinman, 1999).   
 
Further, the interrelatedness of core and corroborating themes in the third tier (Figure 
4.03) are in line with tenets of the SDT, specifically in terms of how patients’ 
confidence to self-manage, i.e. “competence” in SDT, can be influenced by the quality 
of a patients’ social support, i.e. “relatedness” in SDT.  The broad framework of 
Bandura’s Social Cognitive Theory (SCT) (Bandura, 1997), depicting the 
interrelatedness between social, cognitive and behavioural factors also substantiates  
the relationships between this third tier of themes.  That is, Bandura’s SCT lends 
support to relationship between patients’ confidence in self-management (comparable 
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to the salient concept of “self-efficacy” in the cognitive arm of SCT) and the 
corroborating themes of social support (represented by the social arm of SCT) as well 
as appraisal of past self-management strategies (represented by the behavioural arm 
of SCT).  These examples thus demonstrate the foundations on which the core study 
themes were derived, as well as theoretical support for this derivation.  Both these 
mechanisms add depth and strength to the key study findings depicted in the ITMAM 
model (Figure 4.03).   
 
To briefly review, the key study findings showed that, patients with greater motivation 
to maintain correct inhaler technique (and therefore more likely to do so), were 
characterised as those who had:  
1) stronger motivation to actively engage in asthma management; AND,  
2) stronger motivation to adopt preventative-medication based self-management 
strategies; AND,  
3) stronger confidence in self-managing effectively.   
 
On the contrary, patients with less motivation to maintain correct inhaler technique, 
(and therefore less likely to do so), were characterised as those who had:  
1) weaker motivation to actively engage in asthma management; AND/OR,  
2) weaker motivation to adopt preventative-medication based self-management 
strategies; AND/OR,  
3) weaker confidence in self-managing effectively.   
 
 
 
The broader implications of this study’s findings will now be discussed.  Firstly, it bears 
mentioning that, as anticipated, the qualitative approach taken in this study did indeed 
allow for a more detailed understanding of the relationship between patient motivation 
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and inhaler technique maintenance, than could have been achieved via quantitative 
investigations alone.  In particular, this study highlighted the complex nature of patient 
motivation, even with respect to an activity as singular and defined as practicing 
inhaler technique.  One demonstration of this complexity lies in the finding that the 
influential factors on patient motivation were multifactorial and interrelated both 
horizontally, i.e. between core and corroborating themes, and vertically, i.e. the 
hierarchical relationship between core themes.  This hierarchical relationship is 
depicted in the ITMAM model in Figure 4.03.   
 
Another demonstration of complexity was in regards to the nature of the influential 
themes identified.  Surprisingly, and contrary to earlier hypotheses (hypotheses 3-5), 
amongst the factors found to be most influential on patient motivation in inhaler 
technique maintenance, none pertained to issues around inhaler technique or device 
use itself.  Patient responses regarding inhaler technique and device use were highly 
homogenous (Results, section ii, 1).  The large majority of patients conveyed similar 
sentiments regarding the ease of, and confidence in, using inhaler devices with correct 
technique; the importance of correct inhaler technique maintenance; and ownership 
over the activity.  Only in a very few instances did responses in this area seem to hint 
at why Maintainers and Non-maintainers possessed different levels of motivation.  
That is, the few patients reporting difficulty with correct device use, doubt over the 
value of correct inhaler technique, or lack of ownership over maintaining correct inhaler 
technique, were all Non-maintainers.  However, on the whole, the lack of variation in 
patient responses regarding inhaler technique and device use, rendered factors in this 
area very limited in their ability to explain differences in motivation regarding inhaler 
technique maintenance.   
 
Further, although this was clearly not the case, based on patient responses around 
inhaler technique and device use, it would seem that the majority of patients 
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interviewed would be considered quite motivated to maintain correct technique (i.e. 
were Maintainers).  Yet, in fact, over half of the patients interviewed were Non-
maintainers (lower motivation to maintain correct technique).  These findings are 
clearly inconsistent with study hypotheses around inhaler technique and device use, 
specifically those based on the principles of SDT, i.e. that patients’ sense of 
“autonomy” and “competence” pertaining to their inhaler technique/device use would 
influence their motivation in inhaler technique maintenance.  This perhaps 
demonstrates where the limitation of SDT lies in investigating the phenomenon of 
inhaler technique maintenance.  Through delving further into the study data, however, 
a compelling explanation for these unexpected findings emerged, relating to the 
concept of personal relevance.     
 
The lack of perceived personal relevance by patients, regarding issues around inhaler 
technique and device use, seemed to be the main reason why these issues were not 
found to have a compelling influence on patient motivation in inhaler technique 
maintenance.  Upon considering patient responses on inhaler technique/device use in 
the context of their entire interview, it appeared that they were rather superficially 
connected to patients’ actual or prevailing beliefs and feelings around their asthma 
experience.  Indicative of this, were patient responses featuring much less emotion 
when the topic shifted to inhaler technique and device use.  These cues were 
insightful, especially given that research within the field of emotion psychology 
postulates that a person’s primary motivational system is based on emotions, and that 
particularly, emotions work to mark certain events with significance and priority (Silvia, 
2012).  Therefore the lack of emotion found in patients’ inhaler technique/device use 
responses, suggests the relatively low priority, in terms of personal relevance, that 
these matters ranked.   
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Further evidence for the lower personal relevance of inhaler technique/device use 
matters stems from the observation that patients never voluntarily spoke about these 
matters in response to broad questioning (e.g. “tell me about your asthma” or “tell me 
about your asthma medication”), and had to be specifically prompted to do so during 
each interview.  In addition, reoccurring descriptions of inhaler technique and device 
use as a “habitual” or “automatic” activity (Results, section ii, 1, e), suggests that 
patients dedicated little conscious attention to this aspect of their asthma self-
management.  Again, this may be an indication of the lack of perceived personal 
relevance of inhaler technique/device use related issues.  
 
In contrast, factors found to have a more substantial influence on patients’ motivation 
in inhaler technique maintenance, i.e. core and corroborating themes related to 
asthma and self-management, appeared to be much more personally relevant to the 
patient.  This was evident in patient responses that tended to be more voluntary, 
lengthy, marked with emotions (e.g. fear of asthma attacks, optimism relating to 
effective self-management strategies), and connected to concrete experiences (e.g. 
symptom flare ups, medication side effects, impact of asthma on daily activities).  In 
this way, patients indicated that they had a good grasp of the personal implications, 
specifically on health and quality of life, of issues around asthma and self-management 
in general.  Interestingly, although patients demonstrated a fair level of knowledge or 
intellectual awareness of the issues around inhaler technique and device use, and its 
implications on asthma (perhaps as a result of their sensitisation to this knowledge 
through participation in the previous study), they did not seem to truly “internalise” 
(used in the same sense as described in SDT) this message as a matter of personal 
importance, for the reasons outlined above.      
 
Arguably, the themes around asthma and self-management, being more personally 
relevant to the patient, better represented their prevailing sentiments influencing self-
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management, including with regards to inhaler technique maintenance.  Hence, based 
on this reasoning, it became less surprising that the themes around asthma and self-
management were found to be much more insightful, than the themes around inhaler 
technique/device use, in explaining patients’ varying levels of motivation in inhaler 
technique maintenance.   
 
Interestingly, in looking back, some of the results of the quantitative study (Chapter 3, 
section E) may also substantiate the concept of personal relevance as an important 
consideration in examining patient motivation in inhaler technique maintenance.  
Specifically, patients’ level of motivation to maintain correct inhaler technique was, in 
the previous study, associated with the extent to which they believed inhaler technique 
would make a difference to their experience of asthma (i.e. there was a significant 
negative correlation between the two items: “I am motivated to follow the correct steps 
when I use my inhaler” and “The way I use my inhaler will not affect my asthma”).  
Notably, patients who were more motivated to maintain correct inhaler technique 
indicated stronger beliefs in the connection between the way that they used their 
inhaler device, in terms of following the correct technique, and their experience of 
asthma, a matter of personal relevance.     
 
Triangulating the results of the quantitative and qualitative studies suggests that future 
investigations aiming to further explore patients’ motivations and behaviours regarding 
inhaler technique maintenance, must account for patient perceptions on the broader, 
and arguably more personally meaningful, issues relating to their experiences around 
asthma and self-management in general.  Focusing solely on inhaler technique and 
device use issues will likely limit the insights generated.   
 
Through exploring the notion of personal relevance as discussed thus far, the 
theoretical principles examined in the Background (section iii) seemed to hold much 
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more pertinence.  Earlier, reference was made to the possible limitations of the 
theories utilised in this study for interpreting its findings.  This was ostensibly because 
the findings regarding inhaler technique/device use did not support the theoretically 
based hypotheses generated (i.e. hypotheses 3-5).  Upon deeper reflection, it is 
plausible that the theories chosen did not lend themselves well to interpreting the 
themes on inhaler technique/device use, because these themes were not greatly 
influential or revealing of patients’ underlying motivations for inhaler technique 
maintenance, as they lacked personal relevance.   Interestingly, after personal 
relevance emerged as an important concept, striking similarities were found between it 
and the key tenets of SDT, particularly relating to “autonomy” and “competence” (Ryan 
and Deci, 2000b).   
 
According to SDT, to review briefly, when a patient is motivated to act “autonomously”, 
the reason/s behind their actions are likely to be personally important or relevant.  
Importantly, activities driven by a more autonomous quality of motivation are shown to 
be maintained better over time (Deci and Ryan, 2012, Williams, 2002).  In this study, 
for example, patients were more likely to maintain correct inhaler technique in 
instances where relatively higher motivation to actively manage asthma (first tier of 
influential themes in the ITMAM model, Figure 4.03), via a preventative-medication 
based approach (second tier of influential themes in the ITMAM model, Figure 4.03) 
was observed.  Notably, and corroborated by the tenets of SDT, because these 
themes around asthma and self-management were of greater personal relevance than 
themes around inhaler technique/device use (as explained earlier), they were also 
more influential on the patients’ motivation in inhaler technique maintenance.  In 
particular, they were influential not only with respect to the relative magnitude of 
motivation, but also on the nature of patient motivation in terms of it being more or less 
autonomous.   
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Further, the third tier of themes in the ITMAM model (Figure 4.03), regarding 
confidence to self-manage successfully is comparable to the concept of “competence” 
described in SDT.  As outlined in the Background (section iii, 2), the constructs of 
competence and autonomy are interrelated in SDT.  Effectively this means that a 
greater sense of competence to self-manage may enhance patients’ sense of 
autonomous motivation for self-management activities, thereby increasing the 
likelihood that these activities are better maintained (Figure 4.01).  It is worth pointing 
out that the construct of competence seems most insightful when applied to the 
broader notion of asthma self-management, rather than the specific activity of 
practicing correct inhaler technique.  Again this may be related to the observation that 
patients could more readily identify the personally meaningful rationale behind “self-
management” as a general concept, rather than in the specific task of inhaler 
technique practice, especially since patients held different views about what 
constituted good or ideal asthma self-management, some of which did not even 
involve the use of inhaler devices.   
 
Interestingly, there is further tentative evidence to support future investigations into the 
relationship between self-efficacy and inhaler technique maintenance.  Specifically, a 
recent study demonstrated that patients with better inhaler technique also possessed 
greater self-efficacy (comparable to “competence”) for asthma self-management, 
rather than self-efficacy regarding inhaler technique (Sleath et al., 2012).   Self-
efficacy, although an important construct behind the regulation of patient motivation 
and behaviour (Bandura, 2004), could not, before this study, be as clearly applied the 
context of inhaler technique per se, due to the numerous accounts of patients’ 
overconfidence with, or gross overestimation of, their own inhaler technique (Erickson 
et al., 1998, Pinto Pereira et al., 2001, Souza et al., 2009).  The findings of this study 
however, suggest that self-efficacy may indeed be a worthwhile avenue of further 
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investigation in the context of inhaler technique maintenance, provided that the notion 
of personal relevance is also taken into account.           
 
As a final observation around the notion of personal relevance, it was interesting to 
note that what appeared to be of greater personal importance to patients, was avoiding 
or moving away from negative asthma outcomes (such as experiencing symptom flare 
ups, being hospitalised and being unable to participate fully in their lives), rather than 
moving toward and maintaining positive outcomes (e.g. maintaining good asthma 
control).  Although this may seem like different sides of the same coin, research 
indicates that such, albeit subtle, differences in perspective may have important 
implications regarding how patients maintain long term health behaviours.  Specifically, 
further investigating the construct of “avoidance-based” motivation (Rothman, 2000) in 
the context of inhaler technique maintenance may provide further useful insights.   
 
Avoidance-based motivation drives people to take action to move away from or 
prevent the occurrence of undesirable events (Rothman et al., 2004).  This is in 
contrast to “approach-based” motivation, which drives people to take action to move 
toward and reach more desirable states (Rothman et al., 2004).  Interestingly, 
Rothman et al. (2000, 2004) postulate that, while approach-based motivation provides 
useful insight regarding the initial stages of behaviour change, it is avoidance-based 
motivation that is more powerful for understanding how and why behaviours are 
maintained over time.  That is, in theorising the salient predictors of health behaviour 
maintenance, Rothman et al. (2000, 2004) identify avoidance-based motivation as a 
key factor.  Thus it is not surprising to observe the principles of avoidance-based 
motivation being reflected in the findings this study, and suggests that this may be 
another avenue worthy of further investigation. 
 
 
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The focus of discussion now shifts to the clinical and practical implications of this 
study, particularly, how health care professionals can facilitate better rates of inhaler 
technique maintenance amongst patients with asthma.  To start with, it was observed 
that patients in this study were either more or less receptive to the input, advice or 
influence of their health care providers.  In particular, patients who were more 
receptive to the influence of their health care providers were those who were also 
more motivated to take action to manage their asthma in order to avoid the potential 
negative consequences of the condition (with the reverse being the case for less 
receptive patients) (Figure 4.05).  Based on this, it would seem that a health care 
provider’s capacity to persuade patients to engage in appropriate asthma self-
management (including with respect to inhaler technique) is limited to how convinced 
patients are of the need to do so, based on their own experiences, rather than 
because of any direct input from the health care provider.   
 
Despite the salience of patients’ personal experiences, this study showed that health 
care professionals were far from powerless in prompting improvements in inhaler 
technique maintenance.  One of the first steps that health care professionals can take 
in this process, is to understand the underlying reasons for poor inhaler technique 
maintenance, and in particular, the reasons that lie beyond physical skill related 
factors.  To aid in this, and with further testing and validation, the ITMAM model 
(Figures 4.03 and 4.05) may be a useful clinical tool.  Specifically it may remind health 
care professionals of the influential factors around patients’ asthma self-management, 
including with regards to inhaler technique maintenance, as well as the points at which 
patients are likely to be more receptive to health care advice.   
 
The ITMAM model may also assist health care professionals in mapping out a process 
of clinical reasoning that can be used to identify patients at higher risk of developing 
poor inhaler technique over time.  In conjunction with this, evidence from this study 
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points to two other areas that health care professionals may focus upon to affect 
improvements in inhaler technique maintenance: 1) delivering inhaler technique 
education in a more personally relevant manner, and 2) cultivating interpersonal skills 
that create a greater sense of positive connection or “relatedness” (as per SDT) with 
the patient – both of which will be discussed at length now.          
 
Delivering inhaler technique education in a more personally relevant manner, suggests 
that health care professionals need to understand inhaler technique maintenance from 
the patient’s perspective.  As this study shows, patients’ views and sentiments, around 
inhaler technique itself, do not explain their motivations and behaviours regarding 
inhaler technique maintenance in a compelling way.  This is a strong indication that 
patients tend not to ascribe weight to inhaler technique issues in isolation of their 
broader experiences around asthma and self-management.  Therefore, health care 
professionals who intervene on inhaler technique issues, in isolation, may be less 
successful at helping patients achieve lasting improvements in inhaler technique.   
 
This offers further explanation as to why current clinical recommendations, particularly 
in the pharmacy setting, aimed at improving inhaler technique maintenance – focused 
on physical demonstrations of inhaler technique, repeated on a regular basis, 
independent from other aspects of asthma self-management – tend not to have lasting 
success (Chapter 2, Table 2.02).  This is not say that the current recommendations are 
not effective for enabling patients to initially grasp the physical manoeuvre required for 
correct inhaler technique.  As established earlier in this thesis, repeating inhaler 
technique instructions via iterative physical demonstration is far superior compared to 
various other methods for the purposes of teaching correct inhaler technique (van der 
Palen et al., 1997).  Further, by focusing solely on inhaler technique instruction, health 
care professionals can anticipate to spend no more than five minutes with each patient 
(Basheti et al., 2007), a time efficiency advantageous in busy practice environments.   
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However, in terms of supporting patients to maintain correct inhaler technique over 
time, and enhancing their motivation to do so, focusing solely on inhaler technique or 
device use issues at each interaction seems to fall short.  This study suggests that vital 
information about patients at risk of poor inhaler technique maintenance (i.e. the 
influential patient psychosocial factors) may be missed by engaging with patients only 
at the inhaler technique/device use level.  Further, repeatedly dispensing inhaler 
technique instructions, without addressing patient motivation or the issues most 
meaningful to them, may lead to patients feeling disengaged in their therapeutic 
relationships.  Feeling disengaged, in turn, may impair a patient’s sense of satisfaction, 
trust and rapport with their health care providers.  Hence, automatic repetition of 
inhaler technique instructions may not only have minimal benefit in terms of technique 
maintenance, but may also be potentially detrimental to the quality of the patient-health 
care provider relationship.  This study adds further evidence to the notion that health 
care professionals need to go beyond current recommendations to facilitate optimal 
inhaler technique maintenance in patients with asthma.   
 
In understanding and leveraging the power of personally relevant factors in mobilising 
patients to more actively self-manage (including with respect to practicing correct 
inhaler technique), health care professionals may be in a better position to facilitate 
optimal inhaler technique maintenance over time.  Practically, this suggests that health 
care professionals deliver inhaler technique education in a manner that clearly allows 
patients to see the link between inhaler technique maintenance and matters of 
personal importance.  One strategy for doing this involves positioning inhaler 
technique issues in the broader context of a patient’s asthma and self-management 
experience, for example, demonstrations of inhaler technique may be embedded in 
discussions emphasising optimal inhaler technique maintenance as an important 
strategy for reducing the chances of experiencing asthma exacerbations.  As 
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discussed earlier, and supported by the principles of SDT, patients who have a 
personally meaningful rationale for maintaining correct inhaler technique are more 
likely to do so.        
 
More contextualised and comprehensive inhaler technique education would of course 
be expected to be more complex and time consuming to deliver.  Notably, in a busy 
primary health care setting, there are likely to be more practical barriers to this type of 
intervention compared to shorter education sessions.  Nevertheless, it is a strategy 
worthy of further investigation, especially given the evidence demonstrating the 
diminishing benefits of current recommendations for inhaler technique education (as 
discussed in Chapter 2, section iii), and the potential long term clinical and cost-
savings benefits of a strategy that may result in more successful inhaler technique 
maintenance.   
 
Further support for investigation in this area can be found in studies that show better 
inhaler technique maintenance after more comprehensive self-management education.  
For example, in the study by Kritikos, Armour and Bosnic-Anticevich (2007), no 
deterioration in inhaler technique occurred in most patient groups (3 out of 4), twelve 
weeks after receiving inhaler technique education (via physical demonstration) that 
was part of a more comprehensive asthma self-management session (lasting 150 
minutes).  Although other studies testing similar interventions exist (Wilson et al., 
1993), and allude to good inhaler technique maintenance, they were less rigorous in 
repeating inhaler technique measures, therefore rendering it difficult to clearly observe 
inhaler technique maintenance trends over time.  However, to seek clarification of such 
studies provides additional grounds for further investigation.  At this point, it is also 
worth noting that in such studies, patient education is typically delivered in a small 
group format, which in some health care practice settings, may not be possible to 
orchestrate.  Therefore, from a clinical practice point of view, future investigations 
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would benefit from testing in the one-on-one, patient-health care provider context, 
since this is how the bulk of primary health care is delivered.    
 
Another way in which health care professionals can facilitate better inhaler technique 
maintenance is to cultivate interpersonal skills that create a sense of positive 
connection with the patient.  This suggestion arises from findings indicating that the 
quality of therapeutic relationships, as perceived by the patient, especially amongst 
those who are more receptive to health care professional influence, could influence 
inhaler technique maintenance (Figure 4.04).  In particular, patients who indicated a 
greater sense of positive connection – that is, greater satisfaction, trust and rapport – 
with their health care providers, tended to be more motivated to maintain correct 
inhaler technique.  Importantly, these patients described their health care providers not 
only as technically competent (i.e. being knowledgeable), but also as professionals 
who possessed good interpersonal skills.  Health care providers who communicated 
well, and with care, reassurance and empathy were valued by patients.   
 
The association between health care professionals’ interpersonal skills and patients’ 
inhaler technique maintenance is in line with earlier hypotheses, supported by 
theoretical principles.  To briefly review, it can be seen that the extent of positive 
connectedness patients felt with their health care providers, is synonymous with the 
concept of “relatedness” as described in SDT (Williams, 2002).  According to SDT, 
patients who have a greater sense relatedness with their health care providers tend to 
develop more autonomous motivation for self-management recommendations, and 
therefore more likely to maintain practices such as correct inhaler technique (Williams, 
2002).   
 
It is also worth further noting that these findings highlight that the health care 
professionals with whom patients felt positively connected, may have been facilitating 
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optimal inhaler technique maintenance, not necessarily because they were regularly 
intervening around the physical skill of inhaler technique, but because of their influence 
on various patient psychosocial factors.  Particularly on patients’ sense of social 
support and confidence to undertake self-management successfully, both factors 
which also contributed to patients’ sense of motivation around asthma self-
management (including with inhaler technique maintenance).  These findings 
incidentally add support to speculations along the same lines made in the previous 
quantitative chapter, i.e. that the influence health care professionals can have on 
patient motivation and confidence, may explain why some patients maintain correct 
inhaler technique simply by virtue of being in regular contact with their health care 
provider (Basheti et al., 2007).       
 
The quality of the patient-health care provider relationship can thus determine not only 
whether patients gain the requisite skills and knowledge for optimal self-management, 
but also the confidence and motivation to do so.  From a practical standpoint, these 
findings add further strength to the recommendation that health care professionals 
must look beyond the current recommendations of repeating inhaler technique 
instructions, in order to support optimal inhaler technique maintenance.  Instead, 
health care professionals who cultivate good interpersonal skills are likely to be better 
facilitators of optimal inhaler technique maintenance compared to those who 
demonstrate technical proficiency alone.   
 
Evidence from a recent observational study by Sleath et al. (2012) emerging shortly 
after this study, provides additional support for the association between health care 
professionals’ interpersonal skills and patients’ inhaler technique.  In their study, Sleath 
et al. (2012) examined the nature of health care professionals’ communication with 
their asthma patients (children aged 8 – 16 years), as well as patients’ inhaler 
technique (with various DPIs and pMDI) one month after visiting their health care 
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provider.  Interestingly, although this study did not appear to be designed with much 
theoretical guidance, its results seemed to closely resonate with the principles of SDT.  
Particularly with regards to the notion that health care professionals who facilitate the 
development of more autonomous motivation in their patients, via good 
interpersonal/communication skills, can better support correct inhaler technique over 
time.   
 
Some of the key results of Sleath et al.’s (2012) study will now be listed to illustrate the 
ways in which they resonated with SDT.  Further, a possible theoretical rationale 
explaining each result listed below, based on the principles of SDT, is included in 
brackets.  In Sleath et al.’s (2012) study it was shown that patients were more likely to 
demonstrate correct inhaler technique one month after visiting their health care 
provider, if during the visit, the health care provider: 1) included the patient’s input into 
the asthma treatment plan (this may enhance patients’ autonomous motivation through 
promoting a greater sense of ownership and choice in self-management); 2) discussed 
a written action plan with the patient (this may enhance patients’ autonomous 
motivation because it placed inhaler technique in a meaningful context, helping the 
patient to more clearly see its personal relevance); and 3) provided more education 
about preventer medication (again, patients’ autonomous motivation may be enhanced 
because a meaningful context is provided for the practice of inhaler technique).  In 
addition, patients who asked more medication questions during their visit also 
demonstrated better inhaler technique at one month (asking more questions may 
enhance patients’ autonomous motivation because it indicates that time was spent 
addressing issues of concern/importance to the patient, establishing a clearer link 
between inhaler technique and matters of personal relevance).  Thus, in this way, 
health care provider communication that appeared to foster greater levels of 
autonomous motivation in patients, tended to result in better inhaler technique over 
time.   
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It is important to point out that Sleath et al.’s (2012) study did not involve any active 
interventions on inhaler technique. Inhaler technique education was only observed 
during 2.4 - 14.4% of visits (depending on the type of device in question), and further, 
whether this education was gold-standard or not, was not commented upon.   
Nevertheless, significant associations were found between the quality of the patient-
health care provider interaction and patients’ inhaler technique.  This gives rise to the 
interesting implication that if health care providers could consistently be more holistic 
in engaging with patients, i.e. demonstrating good interpersonal skills, as well as gold-
standard technique instructions, an even better result may be achieved in terms of 
inhaler technique maintenance.  Therefore the relationship between health care 
professionals’ interpersonal skills and inhaler technique maintenance is an area worthy 
of further investigation.    
 
To summarise this section regarding health care provision, a set of practical 
recommendations for improving patients’ inhaler technique maintenance is suggested, 
using the ITMAM model (Figure 4.03) as a frame of reference.  The first point at the 
top of the ITMAM model indicates that when an asthma patient presents to their health 
care provider, they will either be more or less motivated to actively engage in asthma 
management (based on their personal views and experiences around asthma).  
Amongst those patients who are less motivated, and hence less likely to be receptive 
to their health care provider’s advice, health care providers may want to be mindful 
that any direct instructions or information they provide is not likely to be immediately or 
fully taken up by the patient.  Nevertheless, health care professionals may encourage 
patients to ask questions.  This may prompt patients to be more reflective of their 
situation, and also identify issues that are of personal importance to the patient.    
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On the contrary, amongst patients who are more motivated to engage in asthma 
management, and thus more receptive to health care professional input, health care 
providers may consider a more targeted counselling approach, such as identifying and 
addressing specific knowledge and skills gaps.  Amongst all patients, however, 
represented at all stages of the ITMAM model, health care professionals should aim to 
develop a therapeutic relationship that patients can feel a positive sense of connection 
in.  This may be achieved through cultivating interpersonal skills that build rapport and 
trust with patients, as well as facilitate patient motivation and confidence in self-
management.  Although such efforts may not produce immediate improvements, over 
time, patients are likely to benefit from the support of a health care provider they feel 
greater relatedness with (SDT).  Whether these recommendations translate into 
significant improvements in terms of patient outcomes, however, can only be 
confirmed with further investigations.      
 
 
 
This discussion will now examine the limitations and highlight some of the 
methodological considerations of this study so that its results may be interpreted with 
caution and future studies of a similar nature may be designed with improvements.  
Firstly, it needs to be acknowledged that the patients in this study were interviewed 
approximately one year after they had completed the previous quantitative study.  
However, the data regarding patients’ inhaler technique maintenance status and level 
of motivation utilised in this study, from which the classification of “Maintainer” or “Non-
maintainer” was based upon (Methods, section iv, 1), was derived from the previous 
quantitative study.  Clearly, the issue here is that, inhaler technique maintenance 
status and motivation, both being dynamic phenomena, may have changed between 
the times patients completed the quantitative study, and when they were interviewed 
for this present study. 
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In terms of inhaler technique maintenance status, it is expected, that one year after 
completing the quantitative study, there would have been a general deterioration in 
inhaler technique amongst study patients (this is based on the inhaler technique 
literature summarised in Chapter 2, Table 2.02; that technique tends to deteriorate 
over time regardless of the education received).  Potentially there may have been a 
greater number of Non-maintainers in this study than indicated by the quantitative 
data.  This may mean that the characteristics of Maintainers and Non-maintainers may 
be less clear cut or distinct than demonstrated in this study.  Ideally, patients’ inhaler 
technique could have been re-assessed at the time of their interviews to overcome this 
issue.  However, this was not feasible as the interviews were conducted over the 
telephone (for reasons outlined in the Methods, section iii, 2, a).  
 
In terms of patient motivation around inhaler technique maintenance, this study 
suggests that primarily, it tends to be shaped by major events such as patients’ past 
experience of asthma exacerbation/s (i.e. first tier of core and peripheral themes, 
Figure 4.03).  Notably, the vast majority of patients interviewed did not reveal 
experiencing any such major events over the past year since completing the 
quantitative study (the one exception being patient 13:CH, NM), suggesting that 
patient motivation for inhaler technique maintenance may have been relatively stable 
in this study.  Further indication for this lies in the findings of the quantitative study that 
showed no significant difference in patient motivation between study visits 1 and 2 
(Chapter 3, Results, section ii, 6).  However whether such stability in motivation is 
sustained over a longer period of time is unclear, and can only be ascertained through 
further studies.   
 
Overall, given the potential for patients’ inhaler technique maintenance status and 
motivation to fluctuate over time, further investigations are required to better 
Chapter 4 – Qualitative Study  
230 
 
understand the relationship between these two phenomena over a longer period of 
time.  Specifically, future studies may benefit from taking more frequent and/or 
commensurate measurements of patients’ inhaler technique maintenance status and 
motivation around inhaler technique maintenance, whilst also investigating the factors 
influencing motivation around inhaler technique maintenance.  However, despite these 
limitations, the fact that many of the findings of this study could be corroborated by the 
principles of long standing and well tested theories (such as SDT and CSM as 
discussed throughout this section), lends credence to the insights generated.   
 
Another area for consideration, regarding this study’s methodology, is related to the 
veracity of patient responses obtained in the interview process.  It must be 
acknowledged that, the interview process, not being anonymous, may increase the 
likelihood that patients are responding in a socially desirable manner (Green and 
Thorogood, 2004).  Further, not all patients may be as forthcoming or articulate in their 
responses.  To minimise these possibilities, the researcher worked to establish rapport 
with the patients before the commencement of each interview.  For example, patients 
were encouraged to speak freely and informed that there were no “right” or “wrong” 
answers and were allowed to complete the interview at their own pace and direction 
(described further in the Methods, section iii, 2).     
 
In addition, the telephone interview method was also acknowledged as a potential 
barrier against patients disclosing their views in a forthcoming or elaborate manner.  
Particularly, it has been expressed that, with the important dimension of non-verbal 
communication removed, telephone interviews may be more difficult to sustain 
compared to face-to-face interviews (Gillham, 2000).  Attributed to this reason, 20-30 
minutes have been reported as the maximum duration for telephone interviews 
(Gillham, 2000).  However these issues were not a noticeable problem in this study, 
where the vast majority of patients seemed quite eager in sharing their views, and with 
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the resultant interviews averaging 60 minutes in duration (Table 4.05).  The greatest 
issues associated with telephone interviewing in this study was the inability to 
physically re-assess patients’ inhaler technique as pointed out earlier.         
 
A final area of consideration is in regards to the qualitative study methodology in 
general.  Often, studies of a qualitative nature are claimed to be less “objective” due to 
their greater scope for personal interpretation (Creswell, 2003).  To add to this, studies 
focusing on people’s perceptions, motivations and behaviours tend to require higher 
levels of inference compared to studies investigating less dynamic subject matters 
(Gillham, 2000).  These considerations serve as an important reminder that steps 
should be taken to enhance the interpretative rigor of qualitative studies.   
 
In this study, various measures were taken to increase interpretative rigor.  For 
example, a clear theoretical grounding was established in the Background to inform 
the development of this study; the themes identified were validated (as described in 
the Methods, section iv, 2); and study findings were supported with a comprehensive 
selection of verbatim quotes to allow for readers’ own interpretations (Gillham, 2000).  
In addition, this study’s findings were also triangulated with, or interpreted in light of, 
the previous quantitative study, as well as with various well established theories, in 
particular the CSM and SDT.  This represents a more comprehensive approach that 
mitigates the potential for bias associated with using only one method to interpret the 
phenomena being investigated, and strengthens the conclusions drawn  (Kitto et al., 
2008).          
 
 
As a concluding comment to this chapter, it can be said that this qualitative follow-up 
study was instrumental in providing a deeper and more nuanced understanding of the 
relationship between patient motivation and inhaler technique maintenance.  In 
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particular, this study has demonstrated that various interrelated patient psychosocial 
factors, especially those that are considered of personal relevance by the patient, can 
influence patient motivation to maintain correct inhaler technique.  It also highlights 
innovative ways in which health care professionals can deliver more effective inhaler 
technique education and forge better therapeutic relationships to instigate 
improvements in patients’ inhaler technique maintenance.  Further investigations in the 
areas highlighted throughout this discussion are required to corroborate the findings of 
this study, as well as to test its practice recommendations.  However, as it stands, this 
study can be considered to have enriched the findings of the previous quantitative 
study, adding further insight to the overarching aim of this thesis to better understand 
the phenomenon of inhaler technique maintenance in patients with asthma.    
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F. Summary 
 This chapter aimed to explore the relationship between patient motivation and 
inhaler technique maintenance identified in the previous quantitative study. 
 Using a qualitative study design, influential themes explaining the relatively 
different levels of patient motivation in inhaler technique maintenance were 
identified.   
 The core set of influential study themes were: degree of patient motivation to 
actively engage in asthma self-management; degree of patient motivation to 
self-manage via a preventative-medication based approach; degree of patient 
confidence to self-manage effectively. 
 Influential themes did not relate to any inhaler technique/device use issues. 
Instead they seemed to stem from matters that patients could most readily 
identify the personal relevance in (e.g. experience of symptom exacerbations).     
 The Inhaler Technique Maintenance and Motivation (ITMAM) model was 
developed based on this study’s findings and may be a useful tool for health 
care professionals to identify patients at risk of poor inhaler technique 
maintenance.   
 Health care providers may improve inhaler technique maintenance by 
grounding inhaler technique education in a more personally relevant context.  
Cultivating interpersonal skills that enhance the sense of connectedness 
patients feel in their therapeutic relationships may also improve inhaler 
technique maintenance. 
 Further evidence is required to substantiate the findings and implications of this 
study, and various promising areas for future investigation have been identified 
in the discussion.
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 CHAPTER 5  
SUMMARY AND CONCLUSIONS 
_____________________________________________________________________ 
“KNOWING HOW” IS NOT ENOUGH, in a phrase, points to why patients with asthma 
often demonstrate poor inhaler technique maintenance despite the absence of known 
barriers.  This thesis presents the first body of work that examines the phenomenon of 
inhaler technique maintenance in-depth.  As a result of this research, various new 
explanations have been identified regarding the reasons why poor inhaler technique 
maintenance is consistently observed amongst patients with asthma.  These reasons 
underpin the notion that it is not enough to simply be able to use one’s device correctly 
in order to maintain optimal technique, and that less tangible considerations, such as a 
patient’s motivations around asthma management, are equally worthy of consideration.  
 
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A. Summary of work 
Asthma, and especially poorly managed asthma, is a source of significant burden for 
both the patient and the community at large (ACAM & WIMR, 2011, Barnes et al., 
1996).  This is especially the case in Australia where the prevalence of asthma is one 
of the highest by global standards (ACAM & WIMR, 2011, GINA 2012).  Effective 
treatment options for asthma do exist (AMH 2013), however, their success is 
contingent upon how patients engage in their use.  For example, the extent to which 
patients adhere to preventer therapy, or whether patients use their inhalers with the 
correct technique.  Importantly, how patients engage in using their asthma therapy has 
significant implications for their asthma outcomes (Chapter 2, section B, ii).   
 
How patients maintain inhaler technique, in particular, formed the focus of this 
research for several important reasons.  Correct inhaler technique maintenance is 
essential to good asthma self-management and constitutes an important strategy for 
improving asthma outcomes (Basheti et al., 2007, Melani et al., 2011).  Although there 
are multiple factors that contribute to patient asthma outcomes (Haughney et al., 
2008), inhaler technique has been shown to contribute both independently and 
significantly to patients’ asthma control status as well as quality of life (Basheti et al., 
2007, Giraud and Roche, 2002).   
 
The high prevalence of suboptimal inhaler technique demonstrated by patients 
(Lavorini et al., 2008, Melani et al., 2004, 2011), and the imperative to improve this 
status, has sparked much research in the area.  Gains have been made, for example, 
in identifying effective methods for patient technique education, through tactics such as 
repeated physical demonstration and “train the trainer” (Basheti et al., 2007, 2008, 
2009).  Nevertheless, patients’ inhaler technique has been shown, across various 
study settings, to deteriorate over time, despite having received gold-standard 
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technique education and initial successes in learning technique (Chapter 2, Table 
2.02).  These past studies, collectively, pointed to a gap in the literature concerning the 
reason/s why patients did not maintain correct inhaler technique, despite the absence 
of known barriers.  Investigating the phenomenon of inhaler technique maintenance 
amongst patients with asthma, and identifying the reasons why inhaler technique 
declines, despite the initial successes of current interventions, thus formed the thrust 
for the studies developed in this thesis (Chapters 3 and 4).   
 
The scope and approach taken in research conducted in this thesis can be broadly 
summarised as: exploratory, theoretically and empirically informed and patient-
centred.  Firstly, due to the lack of existing empirical evidence in the area of inhaler 
technique maintenance to inform the studies of this thesis in a more direct fashion, an 
exploratory approach was rendered as necessary initial steps.  Thus, the studies 
presented in this thesis were exploratory in nature, with a substantial basis in relevant 
theories to inform their development (FSLT, CSM and SDT in particular). 
 
Secondly, a patient-centred approach to investigating inhaler technique maintenance 
meant that patient behavioural and psychosocial factors were considered in this 
research to be potentially relevant in understanding inhaler technique maintenance.  
This is in contrast to the mainstay of studies published in the inhaler technique arena, 
that account for patient factors only so far as patient-demographic, patient-clinical, 
patient-device use related, or patient-technique education related.  A patient-centred 
approach, extending beyond such traditionally investigated factors, was deemed 
essential because inhaler technique maintenance constitutes a type of self-
management behaviour that patients adopt.  Further, and importantly, patient 
behaviours, including in the context of chronic condition self-management, are 
inextricably linked to psychosocial determinants such as beliefs, attitudes, motivations 
and interactions with health care professionals (Glanz, Rimer and Viswanath, 2008).                   
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The studies conducted in this thesis were also clinically oriented and based in the 
community pharmacy setting in the Sydney metropolitan area.  The community 
pharmacy setting, as discussed in Chapter 1, was chosen for this study because 
pharmacists are health care professionals highly suited to intervene and monitor on 
patients’ inhaler technique.  The prime reasons for this are pharmacists’ relative ease 
of accessibility to patients, their designation as medication experts in the community, 
and proven ability to improve asthma outcomes via service provision (Armour et al., 
2013).    
 
The research presented in this thesis unfolded in a sequential manner.  An initial 
quantitative study (Chapter 3) was conducted that identified research leads that were 
pursued in a follow-up qualitative study (Chapter 4).  Hence, this thesis evolved to be 
mixed-methods in approach (Creswell, 2003).  Hence, inhaler technique maintenance 
was investigated utilising two distinct research methods.  This allowed both breadth 
and depth in addressing the questions around inhaler technique maintenance 
(Creswell, 2003).  That is, while the quantitative study explored a much broader range 
of factors in relation to inhaler technique maintenance, the qualitative follow-up study 
honed in on particular novel findings of the quantitative study (i.e. relating to patient 
motivation), and explored these in much greater detail than could have been achieved 
via a quantitative approach alone.   
 
The key findings of this thesis are now highlighted with reference to the two studies .  
Firstly, the initial quantitative study (Chapter 3) explored various potential predictors of 
inhaler technique maintenance.  Potential predictors were identified through 
establishing a basic framework to conceptualise inhaler technique maintenance (i.e. 
the “Inhaler Technique Maintenance Framework”/“ITMF”, Chapter 3, Figure 3.01), and 
subsequently, by elaborating upon this framework (Chapter 3, Figure 3.05) via utilising 
well-established theories, including FSLT and the CSM (Fitts and Posner, 1967, 
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Leventhal et al., 2003).  From the pool of 28 unique variables that were tested in this 
study (Table 3.04), three were identified, via regression analyses, to be significant 
determinants of inhaler technique maintenance:  
1) Device type (DPI or pMDI) 
2) Asthma control (baseline) 
3) Motivation to practice correct inhaler technique (baseline) 
The results indicated that patients who were likely to maintain correct inhaler 
technique, one month after technique education (via physical demonstration), were 
those who were using a DPI as opposed to a pMDI, had better asthma control at 
baseline and possessed higher motivation to practice correct inhaler technique at 
baseline.    
 
Identifying Device type (DPI or pMDI) as a predictor of inhaler technique maintenance 
can be associated with various past studies indicating that DPIs can be easier to use 
than pMDIs for many patients (Rees, 2005).  Importantly, this finding implies that there 
is still much scope for health care professionals to actively address the known barriers 
(Chapter 2, section C, ii) to poor inhaler technique maintenance. For example, by 
ensuring inhaler devices are best suited to a patient’s physical abilities and 
preferences (Dolovich and Dand, 2011).   
 
Identifying Asthma control (baseline) and Motivation (baseline) as determinants of 
inhaler technique maintenance highlighted, for the first time, the potentially significant 
role that patient psychosocial factors may have in technique maintenance.  Although 
the mechanism by which asthma control was having an impact on inhaler technique 
maintenance could not be confirmed, there was some evidence to suggest that it 
involved having an influence on patient perceptions and motivations.  This, coupled 
with the fact that patient motivation was found to be an independently significant 
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predictor of inhaler technique maintenance, provided compelling evidence for further 
investigations in this area.      
 
The subsequent follow-up study conducted (Chapter 4), was qualitative in nature and 
designed to allow for a more in-depth exploration of patient psychosocial factors, in 
particular, patient motivation, in the context of inhaler technique maintenance.  The 
aim of this study was to better understand inhaler technique maintenance from the 
perspective of patient motivation, by investigating what rendered patients more or less 
motivated to maintain correct inhaler technique.  Again, as with the previous study, 
relevant theories (the CSM and SDT in particular) formed a very useful foundation in 
the development of this study (Deci and Ryan, 2012, Leventhal et al., 2003).     
 
Through the core themes identified in the qualitative study, the “Inhaler Technique 
Maintenance and Motivation” (ITMAM) model was developed (Figures 4.03 and 4.05).   
The ITMAM model indicates that differences in patient motivation to maintain inhaler 
technique can be attributed to their perceptions and feelings relating to asthma and 
self-management, as well as the influence of the health care providers whom patients 
interact with.  Further, “personal relevance”, as an important driver behind patient 
motivation to engage in asthma management activities, including in relation to inhaler 
technique maintenance, was an important concept identified in this study.          
 
Figure 5.01 summarises the key findings identified in this thesis.  Further, it illustrates 
the triangulation of theories with data, and quantitative and qualitative study methods 
that is a feature of this research.  This triangulation, notably, adds strength to the 
conclusions that are drawn in this thesis (Kitto et al., 2008).   
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1. Motivation to actively 
engage in asthma 
management 
2. Motivation for a 
preventative and medication 
based self-management 
approach. 
3. Confidence, or belief, in 
one’s ability to self-manage 
effectively. 
a. Weaker motivation b. Stronger motivation 
a. Weaker motivation b. Stronger motivation 
a. Weaker self-efficacy  b. Stronger self-efficacy  
All Non-maintainers Majority Maintainers 
All, bar one, Non-
maintainers. 
Vast majority 
Maintainers. 
All Non-maintainers All Maintainers 
Amongst patients with stronger motivation 
to engage in asthma management: 
Amongst patients with stronger 
motivation for preventative and 
medication based self-management:  
A. Quantitative Study (Chapter 3) B. Qualitative Study (Chapter 4) 
Inhaler Technique Maintenance Framework 
(ITMF), conceptualising inhaler technique 
maintenance: 
Determinants of inhaler technique 
maintenance (logistic regression): 
 DEVICE TYPE 
 ASTHMA CONTROL 
 MOTIVATION 
Patients more 
motivated to self-
manage were also 
more receptive to 
HCP influence 
(whether positive 
or negative). 
Effective HCP 
intervention 
may enhance 
patients’…   
 
Effective HCP 
intervention 
may enhance 
patients’…   
 
The Inhaler Technique Maintenance and Motivation (ITMAM) model, 
showing core themes characterising Maintainers (patients with higher 
motivation to maintain correct technique) and Non-maintainers (patients 
with lower motivation to maintain correct technique), and practice 
implications: 
Newly identified association between patient 
psychosocial factors and inhaler technique 
maintenance. Follow up qualitative study. 
Theoretical underpinning: Fitts’ Skill Learning Theory, Common Sense Model, Self-Determination Theory. 
Figure 5.01: Summary of the work presented in this thesis  
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B. Recommendations for facilitating optimal inhaler 
technique maintenance  
In drawing together  the quantitative and qualitative studies, which were informed by 
both the empirical and theoretical literature, it can concluded  that facilitating  optimal 
inhaler technique maintenance, extends beyond practical or skill-related inhaler device 
use considerations.  In fact, both studies indicated that patients’ existing skills, 
knowledge or perceptions relating to inhaler technique or device use had little bearing 
on whether they maintained correct inhaler technique, or whether they were motivated 
to do so. 
 
Although the provision of inhaler technique instructions, via repeat physical 
demonstration (Chapter 3, section C, iii, 1), is an essential part of optimal inhaler 
technique maintenance (Basheti et al., 2007), implemented in isolation, this strategy 
does not seem to offer patients a meaningful and compelling rationale to maintain 
correct technique over time.  In order to enhance the likelihood of correct inhaler 
technique maintenance, it seems necessary that health care professionals interact with 
patients in a more holistic manner and recognise the relevance of good interpersonal 
or communication skills in supporting optimal patient self-management.           
 
Based on the work undertaken in this thesis, several practical recommendations are 
made on how health care professionals in the primary care setting, in particular, 
community pharmacy, can support patients to maintain correct inhaler technique over 
time:          
1. Address known barriers to poor technique maintenance.  For example, when 
teaching inhaler technique, use gold-standard methods (Basheti et al., 2007, 
2008, 2009), rather than less effective methods (such as giving out written 
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instructions alone); periodically re-assessing patients’ physical compatibility 
with their prescribed inhaler device/s; asking about patient preferences 
regarding inhaler devices.      
2. Allow patients more time and opportunity to engage in accurate inhaler 
technique practise guided by health care professional feedback.  This 
contributes to  the correct version of the skill being consolidated, thus 
enhancing the chances of optimal inhaler technique maintenance (Cornford, 
2008, Shim and Williams Jr, 1980). 
 
3. Use the ITMAM model developed as part of the qualitative study as a clinical 
tool to identify patients at risk of developing poor inhaler technique over time 
(Figure 4.03, 4.05 and 5.01).  For example, health care professionals, referring 
to the ITMAM model, may probe into certain beliefs and attitudes that patients 
possess (left hand side, Figure 4.03) to gauge their relative level of motivation 
to participate in self-management via a preventative-medication based 
approach, and relative level of self-efficacy to self-manage effectively.  Beliefs 
and attitudes indicating relatively lower patient motivation to engage in 
preventative-medication based self-management, and lower patient self-
management self-efficacy, may flag to the health care provider those patients 
who are at risk of poor inhaler technique and asthma control over time.  These 
patients may be identified as those who may benefit the most from an 
intervention centred on, or including, inhaler technique education.      
 
4. Adopt a more consultative and holistic approach when providing inhaler 
technique education, rather than a didactic approach.  For example, provide 
inhaler technique instructions in conjunction with discussions regarding 
patients’ asthma management in general, or engage in a discussion regarding 
patients’ recent experience of asthma.  This is based on the notion that 
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enhancing patients’ ability to identify with the personal importance of practicing 
correct inhaler technique can lead to better technique maintenance  (qualitative 
study).  
 
5. Identify opportune times to reinforce self-management advice, including inhaler 
technique education, such as when a patient has experienced a recent flare up 
in asthma symptoms.  Notably, patients with poor asthma control may be more 
prone to developing poor inhaler technique over time (quantitative study).  
Further, patients who have experienced recent symptom exacerbations are 
likely to be more receptive to health care professionals’ advice (qualitative 
study). 
     
6. Cultivate satisfaction, trust and rapport in therapeutic relationships with patients 
via good interpersonal skills (as per examples in Table 4.02).  This is based on 
the findings of the qualitative study showing that patients who were receptive to 
health care professionals’ influence, and who perceived themselves to be 
positively connected in their therapeutic relationships, were more likely to have 
maintained correct inhaler technique.    
 
These recommendations may require health care professionals to invest more time in 
their interactions with their patients, and therefore may be challenging to implement in 
light of the practical constraints common in many primary care practices such as 
community pharmacies.  However, the costly burden of asthma on patients and the 
community, and the potential for such health care services to alleviate this burden (via 
improved treatment outcomes, costs and quality of life) are compelling reasons for 
individual practitioners as well as governments to invest in strategies that result in 
sustained improvements in asthma management. 
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C. Future research directions 
As the first known body of work that has taken an in-depth investigation into the 
phenomenon of inhaler technique maintenance, this research would benefit from 
further studies corroborating its findings and recommendations.  In broad terms, it 
would be useful to investigate the determinants of inhaler technique maintenance 
amongst larger and more diverse patient populations to determine the degree of 
generalisability of the findings identified in this thesis. 
 
Various other specific issues have also been identified throughout the discussions in 
this thesis (i.e. Chapters 3 and 4, section E) as potential areas for future research.  
These studies, if undertaken, would provide a means to better understand the newly 
identified role of patient psychosocial factors in inhaler technique maintenance, and 
perhaps asthma self-management in general.  These potential areas for future 
research include: 
1) Developing a validated questionnaire to measure patient motivation in inhaler 
technique maintenance. 
 
2) Conducting longer term studies to measure the relationship between patient 
motivation, inhaler technique maintenance and psychosocial factors identified 
in the ITMAM model (Figure 4.05); and whether/how it changes over time.  
 
3) Measuring patient self-efficacy in self-management (confidence to self-manage 
effectively) and its influence on inhaler technique maintenance status.   
 
4) Investigating the role of “avoidance-based motivation” (Chapter 4, section E) in 
inhaler technique maintenance. 
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It is also important to conduct further studies on the recommendations for practice 
made earlier.  This is in order to determine how well these recommendations may be 
adapted to the clinical practice setting, how feasible they are to implement and sustain 
and whether they result in clinically significant improvements.  Studies in this area may 
involve:    
1) Testing and validating the ITMAM model developed (Figure 4.05) and its 
potential to be used as a clinical tool in asthma for identifying patients at risk of 
poor inhaler technique.  Notably, there is also scope to investigate the ITMAM 
model in the context of other asthma self-management behaviours (e.g. 
adherence), or in relation to other chronic conditions. 
 
2) A randomised controlled trail conducted in the community pharmacy setting 
comparing the impact, on patients’ technique maintenance, of brief technique 
education (i.e. providing inhaler technique instructions alone) versus holistic 
asthma education (i.e. providing inhaler technique instructions as part of a 
more comprehensive asthma self-management intervention).  
 
3) Investigating the influence of health care professionals’ interpersonal or 
communication skills on patients’ inhaler technique maintenance.   
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D. Concluding remarks 
The phenomenon of inhaler technique maintenance has been investigated in-depth for 
the first time.  Specifically, this research represents the first coordinated endeavour to 
identify the determinants of inhaler technique maintenance in patients with asthma.  
Being patient-centred, in terms of examining behavioural and psychosocial factors, 
and the extensive use of theory, are not common approaches in the existing inhaler 
technique research.  In this thesis, however, these strategies have proven to be 
instrumental in generating new insights.   
 
The novel work in this thesis has contributed to the field of inhaler technique research 
in several important ways.  In particular, the exploration of patient behavioural and 
psychosocial factors in the context of inhaler technique maintenance has resulted in 
empirical evidence pointing to a significant association between these factors for the 
first time.  The findings of this thesis have further enabled the identification of new 
directions for future research. 
 
Ensuring patients maintain correct inhaler technique, although only one element of 
asthma management, is nevertheless highly important for its success.  The way in 
which patients maintain inhaler technique, has a significant impact on asthma 
outcomes, both on a personal and community scale.  Fundamentally, optimal inhaler 
technique maintenance contributes to better asthma control, and having well controlled 
asthma as put by one patient: “… it just lets you get on with life without being sick all 
the time… Well it’s everything.  It’s a quality of life” – KK. 
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Ref:  PB/PE 
10 November 2009 
Dr Sinthia Bosnic-Anticevich 
Faculty of Pharmacy 
Pharmacy Building – A15 
The University of Sydney 
Email: sinthia@pharm.usyd.edu.au 
 
Dear Dr Bosnic-Anticevich, 
Thank you for your correspondence dated 29 October 2009 addressing comments made 
to you by the Human Research Ethics Committee (HREC).  After considering the 
additional information, the Executive Committee at its meeting held on 3 November 2009 
approved your protocol entitled “Improving inhaler technique maintenance – 
developing novel ways to optimise inhaler instruction for asthma patients”. 
 
Details of the approval are as follows: 
 
Ref No.: 11-2009/12226 
Approval Period: November 2009 – November 2010 
Authorised Personnel: Dr Sinthia Bosnic-Anticevich 
               Dr Lorraine Smith 
               Ms Ludmila Ovchinikova 
                                
   
The HREC is a fully constituted Ethics Committee in accordance with the National 
Statement on Ethical Conduct in Research Involving Humans-March 2007 under Section 
5.1.29 
 
The approval of this project is conditional upon your continuing compliance with the 
National Statement on Ethical Conduct in Research Involving Humans.  We draw to your 
attention the requirement that a report on this research must be submitted every 12 
months from the date of the approval or on completion of the project, whichever occurs 
first.  Failure to submit reports will result in withdrawal of consent for the project to 
proceed. 
 
Chief Investigator / Supervisor’s responsibilities to ensure that: 
 
 
 
 
 
 
ABN 15 211 513 464 
 
 Marietta Coutinho 
Deputy Manager 
Human Research Ethics Administration 
Telephone: +61 2 8627 8176 
Facsimile: +61 2 8627 8177 
Email: mcoutinho@usyd.edu.au 
 
 
Mailing Address: 
Level 6 
Jane Foss Russell Building – G02 
The University of Sydney  
NSW 2006 AUSTRALIA 
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(1) All serious and unexpected adverse events should be reported to the HREC as soon 
as possible. 
(2) All unforeseen events that might affect continued ethical acceptability of the project 
should be reported to the HREC as soon as possible. 
(3) The HREC must be notified as soon as possible of any changes to the protocol.  All 
changes must be approved by the HREC before continuation of the research project.  
These include:- 
• If any of the investigators change or leave the University. 
• Any changes to the Participant Information Statement and/or Consent Form. 
(4) All research participants are to be provided with a Participant Information Statement 
and Consent Form, unless otherwise agreed by the Committee.  The Participant 
Information Statement and Consent Form are to be on University of Sydney letterhead 
and include the full title of the research project and telephone contacts for the 
researchers, unless otherwise agreed by the Committee and the following statement must 
appear on the bottom of the Participant Information Statement. Any person with concerns 
or complaints about the conduct of a research study can contact the Deputy Manager, 
Human Ethics Administration, University of Sydney, on (02) 8627 8176 (Telephone); (02) 
8627 8177 (Facsimile) or human.ethics@usyd.edu.au (Email). 
(5) Copies of all signed Consent Forms must be retained and made available to the 
HREC on request. 
(6) It is your responsibility to provide a copy of this letter to any internal/external granting 
agencies if requested. 
(7) The HREC approval is valid for four (4) years from the Approval Period stated in this 
letter.  Investigators are requested to submit a progress report annually.  
(8) A report and a copy of any published material should be provided at the completion of 
the Project. 
 
Yours sincerely 
 
  
 
 
 
 
 
Associate Professor Philip Beale 
Chairman 
Human Research Ethics Committee 
 
Copy:  Ms Ludmila Ovchinikova  lovc6632@uni.sydney.edu.au 
 
Encl.  Approved Participant Information Statement (Pharmacist) 
  Approved Participant Information Statement 
  Approved Consent Form (Pharmacist) 
  Approved Participant Consent Form 
  Approved Letter of invitation to pharmacist 
  Approved Pharmacist baseline survey 
  Approved Patient questionnaires 
  Approved inhaler technique scoring sheet for pharmacists 
  Approved inhaler technique scoring sheet for patients  
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Letter of Invitation 
Dear Pharmacist,  
 
You are invited to participate in a study which will examine inhaler device use in community 
based asthma patients.  
 
As a community pharmacist you are in an excellent position to recognise patients who may 
have poor asthma control due to sub-optimal medication use with their inhalers. We know 
that large numbers of patients do not use their asthma inhaler devices with the proper 
technique and so do not gain the full treatment benefit.  You may have noticed that 
pharmacists are becoming increasingly active in patient care services - these have been 
shown to have a positive impact on medication therapy outcomes for people with asthma. 
 
The aim of this study is to better understand patterns of inhaler medication use in the 
asthma patients who visit your pharmacy.  The results of the study will be used to develop 
tools that pharmacists can use to improve inhaler device use leading to better asthma 
management. 
 
Choosing to participate in this study will mean that you will attend a 2 hour workshop 
on asthma management with inhaler medication at the Faculty of Pharmacy, meet your 
asthma patients on 2 visits over a 1 month period, complete short questionnaires, teach 
your patients how to use their inhaler devices and give your patients telephone reminders 
before their follow up visit. 
 
The benefits of participation include: 
o Customer satisfaction due to the specialised service received 
o Customers spending their gift voucher in your pharmacy   
o Awarding of CPE points for workshop participation 
o A good opportunity to refresh your asthma management knowledge  
 
 
Yours faithfully, 
 
   Ludmila Ovchinikova
  
                                                                   
Faculty of Pharmacy 
 
 
 
 
  
 Ludmila Ovchinikova BPharm (Hons) 
Room S114 
Building A15 
University of Sydney NSW 2006  
AUSTRALIA 
Telephone:   +61 2 9351 4501 
Facsimile:  +61 2 9351 4451 
            Email:lovc6632@uni.sydney.edu.au 
Web:   www.usyd.edu.au/  
 
 
Appendix 3.03: PSA CPE accreditation 
275 
 
 
 
 
 
 
Dear Ludmila, 
Accreditation Application NX090016-APN 
The following activity has been accredited by the Pharmaceutical Society of Australia. 
Activity name Provider/sponsor Date and location Accreditation 
number 
Number and type of 
points allocated 
Quality Use of 
Inhalers in Pharmacy 
workshop 
Faculty of 
Pharmacy 
Faculty of Pharmacy, 
University of Sydney 
February 2010 weekday 
evening TBC 
NX090016 Group 2 = Points 3.5 
 
 
The CPD&PI logo may be used on promotional material associated with this activity provided the 
following wording accompanies it:  
   
A participation list must be returned in electronic format (preferably Excel) to this office within 
two weeks of the completion of the activity.  The participant list must include activity name, 
accreditation number, number and type of points allocated, date of participation/completion, 
provider and sponsor company, participant names and PSA member numbers.  A template can be 
downloaded from www.psa.org.au/cpdpi 
Please be aware that it is the provider’s responsibility to ensure the activity is delivered according 
to the Criteria for the accreditation of activities for Continuing Professional Development and 
Practice Improvement and the information submitted in the application.  Please notify us of any 
changes to the activity should they arise, as this may affect the final point allocation. 
Special consideration has been granted to waive the Application fee for this event.                                    
An invoice for the administration fee of $110 (including GST) will be forwarded to you shortly. 
Yours sincerely 
 
DOMENICA BASKIN                                                                                                                                               
NSW State Manage
This activity has been accredited by the Pharmaceutical Society of Australia                                
as a Group 2 activity for 3.5 points.  Accreditation number: NX090016. 
PSA is authorised by the Australian Pharmacy Council to accredit providers of CPD 
activities that may be used as supporting evidence of continuing competence  
10 December 2009 
 
Ludmila Ovchinikova 
 
Faculty of Pharmacy 
Building A15, Science rd, Camperdown 
University of Sydney 
NSW 2006 
 
Reference: DB/GO 
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 Faculty of Pharmacy 
 
 
 
PHARMACIST PARTICIPANT INFORMATION STATEMENT 
Research Project 
 
 Title: The Inhaler Technique Maintenance Study 
 
(1) What is the study about? 
You are invited to take part in a research study into the use of inhaler 
devices by people with asthma. The aim of this study is to investigate 
patterns of inhaler device use in people with asthma and the factors that can 
impact on this.  It has been shown many people using inhaler devices have 
difficulty getting the exact technique correct and this may compromise their 
levels of asthma control.  Further, it known that community pharmacists can 
effectively educate patients to improve inhaler technique and asthma control.  
 
(2) Who is carrying out the study? 
The study is being conducted by Ms Ludmila Ovchinikova and will form the 
basis for the degree of Doctor of Philosophy at the University of Sydney 
under the supervision of Dr Sinthia Bosnic-Anticevich and Dr Lorraine Smith, 
all from the Faculty of Pharmacy. 
 
(3) What does the study involve? 
The study involves participation in an inhaler device evening workshop held 
at the Faculty of Pharmacy, University of Sydney.  During this workshop you 
will be taught on how to train patients on the correct technique for using the 
pressurised Metered Dose Inhaler, Turbuhaler or Accuhaler.  You will fill out 
a brief survey regarding past inhaler device education.  You will also receive 
a thorough explanation of the recruitment process and conducting the study 
in your pharmacy. 
 
You will be asked to aim to recruit 5 to 10 eligible patients for the study from 
your pharmacy by obtaining written informed consent.  You will then assess 
patient inhaler technique, educate on inhaler technique and assist patients in 
filling out questionnaires.  
  
Patients will come back for a follow up visit at your pharmacy in one month.  
At this point you will be asked to re-assess their inhaler technique and direct 
them to fill out further questionnaires. 
 
  ABN 15 211 513 464 
 
  
 Sinthia Bosnic-Anticevich BPharm(Hons), PhD 
Room N405 
Building A15 
University of Sydney NSW 2006  
AUSTRALIA 
Telephone:   +61 2 9351 5818 
Facsimile:  +61 2 9351 4391 
Email: sinthia@pharm.usyd.edu.au 
Web:   www.usyd.edu.au/  
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(4) How much time will the study take? 
• The evening workshop will take 2 hours 
• The recruitment process will be given a 4 week period  
• Both the initial and follow up patient visits should take approximately 15 
minutes 
 
 
(5) Can I withdraw from the study? 
Being in this study is completely voluntary - you are not under any 
obligation to consent, and if you do consent you can withdraw at any time 
without affecting your relationship with the University of Sydney.  However if 
you choose to withdraw after having already recruited patients into the 
study, you will be asked to give permission for the researcher to continue to 
conduct the study inside your pharmacy.    
 
 
(6) Will anyone else know the results? 
All aspects of the study, including results, will be strictly confidential and 
only the researchers will have access to information on participants. A 
report of the study may be submitted for publication, but individual 
participants will not be identifiable in such a report. 
 
(7) Will the study benefit me? 
You will be given opportunity to receive training that will update your 
knowledge and skills in asthma management.  You will be able to extend 
these skills into everyday practise and enhance service delivery to your 
patients.  Further, each patient you recruit into the study will receive a $20 
gift voucher that they can spend in your pharmacy. 
 
(8) Can I tell other people about the study? 
You are free to discuss the study with others if you so wish. 
 
 
(9) What if I require further information? 
When you have read this information, Ludmila Ovchinikova will discuss it 
with you further and answer any questions you may have.  If you would like 
to know more at any stage, please feel free to contact Dr Sinthia Bosnic-
Anticevich on (02) 9351 5818 or Ludmila Ovchinikova on (02) 9351 4501.    
 
(10) What if I have a complaint or concerns? 
 
Any person with concerns or complaints about the conduct of a 
research study can contact the Deputy Manager, Human Ethics 
Administration, University of Sydney on (02) 8627 8176 (Telephone); 
(02) 8627 7177 (Facsimile) or human.ethics@usyd.edu.au (Email). 
This information sheet is for you to keep 
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 Faculty of Pharmacy 
 
 
 
 
PHARMACIST PARTICIPANT CONSENT FORM 
 
I, .............................................................................[PRINT NAME], give consent to my 
participation in the research project 
 
TITLE:  “The Inhaler Technique Maintenance Study”  
 
In giving my consent I acknowledge that: 
 
1. The procedures required for the project and the time involved have been 
explained to me, and any questions I have about the project have been 
answered to my satisfaction. 
 
2. I have read the Participant Information Statement and have been given the 
opportunity to discuss the information and my involvement in the project with 
the researcher/s Dr Sinthia Bosnic-Anticevich, Dr Lorraine Smith and Ms 
Ludmila Ovchinikova of the Faculty of Pharmacy, The University of Sydney.  
 
3. I understand that I can withdraw from the study at any time, without affecting 
my relationship with the researcher(s) or the University of Sydney now or in 
the future. 
 
4. I understand that my involvement is strictly confidential and no information 
about me will be used in any way that reveals my identity. 
 
5. I understand that being in this study is completely voluntary – I am not under 
any obligation to consent. 
 
6.  I consent to: –  
i)        Attending an inhaler technique evening  
          workshop conducted by  the researcher       YES            
 
  ii) Conducting the study in my pharmacy        YES            
 
iii)  Recruiting patients for the study and assessing   
 
  ABN 15 211 513 464 
 
  
 Sinthia Bosnic-Anticevich BPharm(Hons), PhD 
Room N405 
Building A15 
University of Sydney NSW 2006  
AUSTRALIA 
Telephone:   +61 2 9351 5818 
Facsimile:  +61 2 9351 4391 
Email: sinthia@pharm.usyd.edu.au 
Web:   www.usyd.edu.au/  
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   and training them on inhaler technique       YES                                                      
  iv)      Assisting patients with filling out           YES         
          questionnaires        
   
  v) Collecting and storing patient data in a  
   confidential manner         YES         
 
vi)     Participating in the follow-up        YES         
     
  vii) Receiving Feedback                         YES         
 
If you answered YES to the “Receiving Feedback Question (vii)”, please        
provide your details i.e. mailing address, email address. 
 
Feedback Option 
 
Address:  ____________________________________________________ 
 
____________________________________________________ 
 
Email: _____________________________________________________ 
 
 
 
Signed:  ..............................................................................................................................   
 
Name:   ..............................................................................................................................  
 
Date:   ..............................................................................................................................  
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Learning area Activities Time 
Welcome and 
setting up group 
dynamics 
LO: Group welcome. Housekeeping re OH&S, amenities and 
refreshments.  Introduce presenters (LO, SBA, LS). A round of 
self-introductions. Ice-breaker video.  Interaction protocol. 
Group learning goals and objectives (with slide).  
5 min 
Refreshment break Monday evening workshop (15min) 
Contextualising 
Inhaler technique                                                                                                            
SBA: Presentation on inhaler technique (problems and 
consequences) in the context of asthma self-management.
10 min 
Expert inhaler 
technique 
modelling 
SBA: Demonstrate technique with placebo pMDI, TH and ACC. 
LO: Step-by-step commentary on demonstration – rationale 
behind each step (with aid of checklist slides) 
5 min 
Hands-on 
interactive inhaler 
technique 
learning 
Attendees: Practise inhaler technique with personal placebo 
devices and printed checklists until confident.  Then work in 
pairs to assess each other’s techniques with provision of 
feedback until competence and confidence achieved. 
15 min 
Interactive 
learning on 
inhaler technique 
assessment and 
instruction 
LO: Explain iterative assessment and technique demonstration 
process for instructing patients and pointers for helping patients 
remember steps (with slides). 
LS and volunteer attendee: Role play a community pharmacy 
scenario on technique counselling – assessment and 
instruction; between pseudo-asthma patient (LS) and 
pharmacist (attendee).  
Remaining attendees: Practice assessing technique with 
checklist as they watch role play. 
Group: Feedback and questions on role play.  Discussion on 
how to overcome communication barriers and patient 
resistance to inhaler technique counselling. 
Attendees: Watch video demonstrations (LO) of suboptimal 
inhaler technique with the pMDI, TH and ACC.  Score 
technique using printed checklist for the 3 devices. 
Group: Feedback on assessment outcomes. Clarifications and 
discussion regarding the assessment procedure. 
20 min 
Refreshment break Saturday morning workshop (15min) 
Study recruitment  LO: Explain workshop transition onto discussing the study 
protocol.  Explain participant recruitment, recruitment time 
frame; pre-empt the possible challenges with recruitment and 
aids to enhance participation (flyers and posters).  
Group: Brainstorm on recruitment tips and strategies (on 
worksheets) 
10 min 
Study protocol LO: Disseminate the ITeM Study Manual.  Go through the 
manual layout; protocol step-by-step; data collection procedure; 
administration regarding vouchers and reimbursement process; 
who to contact for support. 
15 min 
Inhaler technique 
competency 
assessment and 
workshop 
surveys 
Assess attendee inhaler technique one-on-one (LO, SBA or 
LS). Give feedback using printed checklist, verbal guidance and 
physical demonstration.  Continue process until attendee 
demonstrates correct techniques. 
Remaining attendees to fill in study workshop survey, PSA 
evaluation form, attendance records whilst waiting. 
20 min 
Conclusion LO: Recap on workshop, taking final questions. Hand out 
certificates of attendance. Thank attendees.  
5 min 
 Total time 120min 
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Quality Use of Inhalers in Pharmacy 
Workshop
Dr Sinthia Bosnic-Anticevich, Dr Lorraine Smith, LudmilaOvchinikova
ASTHMA
›Asthma is an inflammatory airways condition
›Prevalence of asthma in Australia is relatively high
- 14-16% in children, 10-12% in adults1
›Optimum management important to improve patient 
outcomes and reduce costs
- Lifestyle: Avoiding triggers
- Drug: Appropriate and correct use of medication 
MEDICATIONS
Faculty of Pharmacy
Respiratory 
Infections
Stress
Triggers
Allergen 
Exposure
Using device 
incorrectly
Adherence
Non intentional / intentional
THE INHALER ROUTE
› All patients with asthma use inhaler devices
› The inhaled route is effective…
IT IS ALL ABOUT GOOD CONTROL !
› The right medications
› The right regimen
› At the right time
› In the right way (inhaler technique)
› A continual and dynamic process  ……….
THE INHALED ROUTE
› “Aerosol deposition and the resulting therapeutic response 
are critically dependent on the patient’s inhalation technique”
› Up to 94% of patients use their inhaler devices incorrectly 
› Patients are not aware of this
› Health care professionals often focus on other things
SOME PROBLEMS…
 Appendix 3.07: QUIP lecture slides 
 
282 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONSEQUENCES OF POOR TECHNIQUE
Patients' poor knowledge of 
correct inhaler technique
Incorrect use of the 
inhalers
Loss of optimal   
effect of preventative  
& reliever medication
Under management 
of patients' asthma
Decrease in patients' 
adherence to inhaler 
therapy 
Increased side-effects
of un-needed therapy
Physicians prescribing 
higher doses of 
preventative 
medication/ add on oral 
therapy
Increase in cost (More 
doctor and hospital 
visits to manage 
asthma and side effects 
of therapy.  
More days off work/ 
school)
MEDICATIONS – IN THE RIGHT WAY
› Assume it is poor (approx 80-90%)
› Recognise the possible consequence to medication 
management 
› Know you can improve
› Appreciate you will need to review and re-educate
THE STATISTICS ON INHALER USE
› Efficient devices, however, incorrectly used
› Turbuhaler (TH) - Incorrect technique is common (54% of 
patients)
› Accuhaler/Diskus (ACC) - Incorrect technique is common 
(50% of patients)
› Pressurised metered dose inhalers (pMDIs) – Incorrect 
technique is common (56% of patients)
WHO IS CHECKING INHALER TECHNIQUE ?
Source of advice on inhaler use:
› Regular medical practitioner 75%
› Pharmacist                           8%
Mode of education 
› Both verbal information and physical demonstration 47%
When was instruction received
› First time device use  96%
Subsequent checking of technique?
› By the pharmacist 3%
› By another Health care professional 11%
WHY ARE PATIENTS NOT BEING EDUCATED
› Incorrect inhaler technique: Health care providers (various 
devices): 31- 85% 
› Pharmacists TH: 43 - 71% , ACC: 55%
› Lack of confidence
› Perception that advice may not be welcome
THE PRODUCTS
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OUR FOCUS
› Pressurised Metered Dose Inhalers (pMDI) 
› Dry Powder Inhalers (DPI)
Easi-Breathe Autohaler
Metered Dose Inhaler
Press-activated devices Breath-activated devices
Multi-dose devices
Accuhaler/Diskus
Aeroliser
TurbuhalerDiskhaler
Handihaler
Single-dose devices
Inhaler technique intervention
Assess 
technique
Educate
Especially highlighting
initial problems
HOW DO WE CHECK TECHNIQUE ?
› Physical demonstration and verbal explanation
WHAT WE KNOW IS ESSENTIAL !
WHAT CAN WE ACHIEVE?
› Through a simple intervention (<5 mins)…..
› Effective in improving inhaler technique
› Improved asthma outcomes
› BETTER CONTROL
› Better PEF variability, mean PEF, AQOL, perceived control
› Similar magnitude to that achieved with additional medication
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Quality Use of Inhalers 
In Pharmacy
Workshop
Saturday 27th February 2010
Faculty of Pharmacy 
University of Sydney
Workshop Outcomes
You will:
1. Understand inhaler misuse and 
pharmacist’s role
2. Be experts in AC, TH, pMDI use
3. Be confident patient educators
4. Be confident ITeM study investigators
Pressurised Metered Dose Inhaler
1. Remove cap  
2. Shake inhaler well 
3. Exhale air out of lungs
4. Hold inhaler upright
5. Put mouthpiece between teeth and seal with lips
6. Start to Inhale slowly and press canister firmly
7. Continue slow and deep inhalation
8. Hold breath for as long as is comfortable (aim for 10
seconds)
9. While still holding breath remove inhaler from mouth
10. Exhale away from mouthpiece
11. Replace cap
Accuhaler 
1.  Open inhaler 
2. Push lever back completely to load dose
3.  Exhale air out of lungs
4.  Exhale away from mouthpiece
5.  Hold inhaler horizontally
6.  Put mouthpiece between teeth and seal with lips
7.  Inhale steadily and deeply
8.  Hold breath for as long as is comfortable (aim for 10 
seconds)
9. While still holding breath remove inhaler from mouth
10.  Exhale away from mouthpiece
11.  Close cover
Turbuhaler
1.  Unscrew and lift off cap
2.  Hold inhaler upright
3. Rotate grip one way, then back until click is heard to 
load dose        
4.  Exhale air out of lungs
5.  Exhale away from mouthpiece
6.  Put mouthpiece between teeth and seal with lips
7.  Inhale forcefully and deeply 
8. Hold breath for as long as is comfortable (aim for 10 
seconds)
9. While still holding breath remove inhaler from mouth
10. Exhale away from mouthpiece
11. Replace cap
Teaching Technique
ASSESS
PATIENT 
DEMONSTRATES
TEACH
YOU 
DEMONSTRATE
PHYSICAL DEMONSTRATION
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3Ps of Inhaler Technique
pMDI Turbuhaler Accuhaler
P
rep
a
re
1 Cap
2 Shake
3 Exhale
4 Upright
5 Seal
1 Cap
2 Upright
3 Rotate
4 Exhale
5 Away
6 Seal
1 Open
2 Lever
3 Exhale
4 Away
5 Horizontal
6 Seal
P
e
rfo
rm
6 Press & inhale
7 Continue
8 Hold breath
7 Deep & forceful
8 Hold breath
7 Deep & steady
8 Hold breath
P
e
rfect
9 Remove inhaler 
10 Exhale away
11 Cap
9 Remove inhaler 
10 Exhale away
11 Cap
9 Remove inhaler 
10 Exhale away
11 Cover
 
Recruitment Tips
• Display Poster 
• Approach all possible participants
• Make a list from database
• Existing good working relationships
• Flags for next visit
• Emphasise study benefits…
 
ITeM Study Protocol
Recruit
Patient
1. Invite patient to participate and explain the 
purpose of the study
2. Complete the Eligibility for Study 
checklist (F1)
3. Give out Participant Information 
Statement (F2)
4. Ask participant to sign the Consent Form
(F3). Place in plastic sleeve.
5. Allow 2 weeks for recruiting
ITeM Study Protocol
Between Visit 
1 and 2 Reminder phone call to participant for
follow up visit         
Congratulations!
You now:
1. Understand inhaler misuse and 
pharmacist’s role
2. Are experts in AC, TH, pMDI use
3. Are confident patient educators
4. Are confident ITeM study investigators
ITeM Study Protocol
Visit 1
1. Ask participant to complete the Pharmacy 
Asthma Inhaler Device Use Survey Visit 1 
(F4)
2. Complete the Medication Profile (F5) with 
the participant
3. Using the Inhaler Technique Scoring Sheet 
Visit 1 (F6) assess participant inhaler 
technique.  Give a score out of 11.
4. Correct technique if necessary as per 
workshop 
5. Make appointment for the 4 week follow-up 
visit with participant
Pointers
• All paperwork back in folder for collection 
except…
• Only trained pharmacists to counsel
• Confidential storage of data
• Group email
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Do you have asthma? 
 
Are you 18 years or over? 
 
Are you using one of these inhalers? 
          
                          
       
 
 
                                                                                                                                                                                  
 
 
 
 
 
 
 
 
 
 
 
Ask Your Pharmacist How You Can  
Manage Your Asthma,
Help Asthma Research 
& 
Receive a Gift Voucher for Your Time 
 
The Inhaler Technique 
Maintenance Study 
 
 
 
 
A research project being conducted through the Faculty of Pharmacy, University of Sydney. 
Images from http://www.patient.co.uk/health/Inhalers-for-Asthma.htm accessed 13/1/10 
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This certificate is in recognition that 
 
____________________________________ 
 
has successfully completed the workshop: 
“Quality Use of Inhalers in Pharmacy” 
Which was run at the  
Faculty of Pharmacy, University of Sydney 
on the 27/2/2010 and 1/3/2010 
 
 
 
 
                                                                                                                             
                                                                              
 
 
 
Dr Sinthia Bosnic-Anticevich 
Senior Lecturer in Pharmacy Practice
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                                                                                           Faculty of 
Pharmacy 
 
PARTICIPANT INFORMATION STATEMENT 
Research Project 
 
Title: The Inhaler Technique Maintenance Study 
 
(1) What is the study about? 
You are invited to take part in a research study into the use of inhaler 
devices by people with asthma. The aim of this study is to investigate 
patterns of inhaler device use in people with asthma and the factors 
that can impact on this.  It has been shown many people using inhaler 
devices have difficulty getting the exact technique correct and this may 
compromise their levels of asthma control.    
 
(2) Who is carrying out the study? 
The study is being conducted by Ms Ludmila Ovchinikova and will form 
the basis for the degree of Doctor of Philosophy at the University of 
Sydney under the supervision of Dr Sinthia Bosnic-Anticevich and Dr 
Lorraine Smith, all from the Faculty of Pharmacy. 
 
(3) What does the study involve? 
This study involves visiting your community pharmacy on two 
occasions.  The second visit will be one month after your first visit.  On 
both visits your pharmacist will be checking the way you use your 
inhaler device and providing training on optimal inhaler medication use.  
You will also be asked to provide some information about yourself; 
your asthma and medication use and fill out questionnaires.  
    
 (4) How much time will the study take? 
Both the first and second visit should take approximately 15 - 20 
minutes.  
 
  ABN 15 211 513 464 
 
  
 Sinthia Bosnic-Anticevich BPharm(Hons), PhD 
Room N405 
Building A15 
University of Sydney NSW 2006  
AUSTRALIA 
Telephone:   +61 2 9351 5818 
Facsimile:  +61 2 9351 4391 
Email: sinthia@pharm.usyd.edu.au 
Web:   www.usyd.edu.au/  
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 (5) Can I withdraw from the study? 
Being in this study is completely voluntary - you are not under any 
obligation to consent and - if you do consent - you can withdraw at any 
time without affecting your relationship with the University of Sydney or 
your community pharmacy. 
 
(6) Will anyone else know the results? 
All aspects of the study, including results, will be strictly confidential 
and only the researchers will have access to information on 
participants. A report of the study may be submitted for publication, but 
individual participants will not be identifiable in such a report. 
 
(7) Will the study benefit me? 
Firstly, you may find improvements in the way you use your asthma 
inhaler device and this may lead to better levels of asthma control.  
Secondly, you will also receive a $20 gift voucher to spend in the 
pharmacy at the completion of the study in recognition of the costs 
incurred as a result of attending the 2 pharmacy visits. 
 
(8) Can I tell other people about the study? 
You are free to discuss the study with others if you so wish. 
 
(9) What if I require further information? 
When you have read this information, your pharmacist will discuss it 
with you further and answer any questions you may have.  If you would 
like to know more at any stage, please feel free to contact Dr Sinthia 
Bosnic-Anticevich on (02) 9351 5818 or Ludmila Ovchinikova on (02) 
9351 4501.    
 
(10) What if I have a complaint or concerns? 
 
Any person with concerns or complaints about the conduct of a 
research study can contact the Deputy Manager, Human Ethics 
Administration, University of Sydney on (02) 8627 8176 
(Telephone); (02) 8627 7177 (Facsimile) or 
human.ethics@usyd.edu.au (Email). 
This information sheet is for you to keep 
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          Faculty of 
Pharmacy 
 
 
PARTICIPANT CONSENT FORM 
 
I, .............................................................................[PRINT NAME], give 
consent to my participation in the research project 
 
TITLE:  “The Inhaler Technique Maintenance Study”  
 
In giving my consent I acknowledge that: 
 
1. The procedures required for the project and the time involved 
have been explained to me, and any questions I have about the 
project have been answered to my satisfaction. 
 
2. I have read the Participant Information Statement and have been 
given the opportunity to discuss the information and my 
involvement in the project with the researcher/s Dr Sinthia Bosnic-
Anticevich, Dr Lorraine Smith and Ms Ludmila Ovchinikova of the 
Faculty of Pharmacy, The University of Sydney.  
 
3. I understand that I can withdraw from the study at any time, 
without affecting my relationship with the researchers, the 
University of Sydney or my community pharmacy now or in the 
future. 
 
4. I understand that my involvement is strictly confidential and no 
information about me will be used in any way that reveals my 
identity. 
 
 
  ABN 15 211 513 464 
 
  
 Sinthia Bosnic-Anticevich BPharm(Hons), PhD 
Room N405 
Building A15 
University of Sydney NSW 2006  
AUSTRALIA 
Telephone:   +61 2 9351 5818 
Facsimile:  +61 2 9351 4391 
Email: sinthia@pharm.usyd.edu.au 
Web:   www.usyd.edu.au/  
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5. I understand that being in this study is completely voluntary – I am 
not under any obligation to consent. 
 
6.  I consent to:  
  
  i) Being checked on my inhaler technique           YES     NO                        
      by my pharmacist or the researcher 
 
 
ii) Receiving inhaler device education from 
    my pharmacist or the researcher        YES NO        
                                                
 
iii) Completing questionnaires relating to my       YES     NO         
     asthma and medication use  
        
 
iv) Participating in the 1 month follow-up        YES    NO         
     
 
    v) Receiving Feedback                       YES     NO        
 
If you answered YES to the “Receiving Feedback Question 
(v)”, please provide your details i.e. mailing address, email 
address. 
 
Feedback Option 
 
Address:  ___________________________________________ 
 
___________________________________________ 
 
 
Email: ___________________________________________ 
 
 
 
Signed:  .............................................................................................................   
 
Name:  .............................................................................................................   
 
Date:   .............................................................................................................  
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Medication Profile 
Pharmacists please complete the following patient medication profile during Visit 1. 
 
 Patient name ____________________________      Date________________ 
 
 
1.     Which type of preventer inhaler is the patient currently prescribed? 
         Pressurised Metered Dose Inhaler  
         Turbuhaler 
         Accuhaler 
 
2.     In relation to the patient’s preventer medication, please specify the: 
 
a. Name__________________________ 
 
b. Strength_______________________      c. Dose:         ____ puffs              ____times per day 
 
  
3.     How many years and/or months has the patient used this particular 
         inhaler device? 
        _________________________________________________________________ 
 
 
4.     Please list any other types of inhaler devices the patient is  
         currently using:  
        _________________________________________________________________ 
 
        _________________________________________________________________ 
        
        _________________________________________________________________ 
 
 
5.     Is the patient currently taking any oral medication (e.g. Montelukast or  
         Zafirlukast) for their asthma? 
           No 
           Yes, please specify___________________________________________             
 
 
6.     Is the patient currently taking any other regular medication (OTC or prescription)               
          NOT for their asthma? 
           No 
           Yes, Please specify___________________________________________ 
    
                                                    ___________________________________________ 
 
                                                    ___________________________________________ 
Please turn 
over for score 
sheet (F6) 
 
F5 
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Appendix 3.18: Stickers affixed on patients’ inhaler device   
Pre-printed stickers for the Accuhaler™     Pre-printed stickers for the pMDI  
 
       
304 
 
Appendix 3.18: Stickers affixed on patients’ inhaler device   
Pre-printed stickers for the Turbuhaler™  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
305 
 
Appendix 3.18: Stickers affixed on patients’ inhaler device   
 
 
Inhaler technique stickers, as would appear, affixed on patients’ inhaler device. 
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Appendix 3.19: Patient visit 2 questionnaire_F7 
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Email newsletter sent 25 March 2010 
 
Hello Pharmacists,  
 
Thank you for your feedback on your recruitment over the past week. 
 
I do appreciate all your efforts and am heartened by the positive feedback you report 
that you are receiving from your patients.  Like those who have been using their device 
for 10 years but you are the first person to actually show them how! 
 
At this point in time we have not yet reached our target number of 150 patients - we are 
just over half way there.  It is important that we meet this target for research purposes. 
As you know I am here to help in any way I can and I know as a group we can get there! 
 
You’ll find below tips for successful recruiting that other pharmacists have reported back 
to me.  
 
At this stage please continue to recruit patients without stressing about the timeframe.  
Let’s assess the situation every few days to see how much further we have to go. 
 
You will also be expecting some of your patients to start returning for Visit 2 in the 
coming week.  Could you please give them reminder phone calls? 
 
As always – happy investigating! 
 
Ludmila  
 
 
           Recruitment progress at 25 March 
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Recruitment tips from our fellow pharmacists: 
 
# Ask those who are purchasing Ventolin/Asmol if they are also on a preventer. 
If you have spare placebos, the patient can demonstrate on these straight away.  
Alternatively you could write an appointment for them to come back with their own 
preventer. 
 
# Empahsise how quick and simple the study really is – many pharmacists tell me that the 
survey takes less than 10min. 
In fact the patient should really know that you are providing a free service that you have 
undertaken specialised training for and there is everything for them to gain! 
 
# Discuss the study with your support staff/dispensary assistants and ask them to flag 
eligible patients. 
 
# Photocopy the study information and give it to potential patients to take home; on the 
sheet write down your availabilities at the pharmacy.  This may take the pressure off of 
putting patients on the spot if that’s what they feel. 
 
# Allow patients to fill out the survey at home if they wish as long as they bring it back. 
 
# Work as a team – for those pharmacists who have a buddy in the same pharmacy that is 
also enrolled in the study, take advantage of this arrangement.  E.g. you could refer 
patients to one another to get around timing/roster constraints. 
 
# Ask every patient who could be potentially eligible to take part  
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Email newsletter sent 7 April 2010 
 
Hello Pharmacists,  
As you can see we are making progress with recruitment, only a third of the way to go! 
 
 
Thank you for all your very useful feedback about your own experiences with the study. 
 
Thank you also to those pharmacists who are continuing to help to recruit beyond their 
own five patients - your contribution to our group goal is much appreciated. 
 
Below is the feedback some of these pharmacists have given me on how they approached 
recruiting. 
 
We welcome any further comments and tips you may want to share with everyone else. 
 
I will be in touch about further progress - we are getting there! 
 
For now I wish everyone a safe and happy Easter ☺ 
 
Ludmila 
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Ngaire Thewlis  Calman’s Pharmacy Picnic Point 
 
• Emphasise the interaction will be quick 
• Get patients to fill out the survey while waiting for their prescription - no extra time 
off the patient. 
• Explain the study to your support staff and colleagues so they can help out in the 
process 
• For patients who may be nervous about demonstrating technique, tell them the 
exercise is about improving the pharmacist’s ability to teach inhaler use; it is not a 
test for them. 
 
Alice and Badria  MediAdvice Pharmacy Glenmore Park 
 
• Talk positively about the study 
• Tell patients the interaction is quick and simple 
• If you are working with another study pharmacist, work together on your cases 
 
 
Anderson Leong  Fullife Pharmacy Moorebank 
 
• Ask your regular customers to ‘help you out’ with conducting a study about their 
asthma 
• Approach all patients who are getting a prescription dispensed for a preventer 
inhaler   
 
 
Jenny Nguyen  Harrisons Pharmacy Broadway 
 
• State that your invitation is exclusive with the study limited to only 5 people  
• Saying that it is research being conducted by the University of Sydney has helped 
• State the research showing up to 90% of patients have incorrect technique  
there are 11 steps to correct technique and it is often more difficult than assumed 
 incorrect use = wasting their money on medication. 
• Actively look out for patients and approach all possible candidates 
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Email newsletter sent 12 April 2010 
 
Hello Pharmacists, 
Good news - based on your feedback over the past week we are getting closer to our 
target… 
 
We do have a little bit more to go with the numbers and I anticipate that this won’t take 
much longer – thanks for your continued efforts! 
 
If anyone has more up to date numbers please let me know. 
 
Most of you will also be expecting/having return visits from your patients.   
Please give your patients a reminder phone call if you haven’t already so it all runs 
smoothly for you. 
 
It will be very interesting to see your findings at Visit 2 - it will help us answer our burning 
research question about inhaler technique maintenance!  
 
Happy investigating ☺ 
 
Ludmila 
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Email newsletter sent 19 April 2010 
 
Hello Pharmacists,  
 
As you can see form our recruitment chart below, you have continued to make progress, 
well done and keep up the good work! 
 
Right now most of you will be in the midst of conducting Visit 2 with your patients.   
 
 Give your patients a quick reminder call to help them remember their appointment 
with you.  
 
If like other pharmacists, you find that you have extra patients that would like to 
participate in the study you are most welcome to enroll them at this stage.  Just let me 
know and I’ll supply the necessary documents. 
 
In the meantime feel free to contact me with any feedback or issues you’d like to discuss. 
 
Happy investigating ☺ 
 
Ludmila 
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Email newsletter sent 18 June 2010 
 
Hello Pharmacists, 
You will be happy to know that we are near completion with the data collection for the 
ITeM Study. 
 
In wrapping up the study: 
There are just a handful of patients left who need to come back for Visit 2.  If you still 
have such patients please do contact them again to complete the study.  As you would 
appreciate, this is important for us to reach our target numbers for data analyses.  
 
I will be contacting and visiting you in the next two weeks for the final data audit and 
collection.  Please have your folders ready for this. 
 
If you need to fill out a tax invoice for reimbursement of vouchers, you can find the 
template for this in my email dated the 31/5.  Simply fill out and email back. 
 
In Thanks: 
Thank you all for your participation in the ITeM Study and support with my research!  It 
wouldn’t have been possible without your contributions.  I hope your experience has 
been rewarding and that your patients benefit from taking part.  
 
In the meantime I will be setting out to analyse all the data you have collected… I’m sure 
there will be interesting findings!  We’ll be in touch to keep you informed. 
 
Please feel free to contact me if there are any queries. 
 
See you soon ☺ 
 
Ludmila  
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Testing for normality of sampling distributions: 
 
(With the dependent t-test we analyse the difference between scores because we are interested in the sampling 
distribution of these differences and not the raw data. To test for normality before a dependent t-test create a 
new variable by computing the difference between scores.  Check if this new variable is normally distributed pg. 
329) 
 
Three new variables were created in SPSS: 
1. BMQ V1 – V2 scores (difference in medication belief scores between visit 1 and 2) 
2. MARS V1 – V2 scores (difference in adherence scores between visit 1 and 2) 
3. AC V1 –V2 scores (difference in asthma control scores between visit 1 and 2) 
 
Data were represented graphically and tested using the Kolmogorov-Smirnov and Shapiro-Wilk 
tests.  All three data sets were found to be non-normally distributed. 
 
1. BMQ V1 – V2 scores: 
 
 
 
 
 
 
 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
V1 - V2 score  .110 125 .001 .955 125 .000 
a. Test values are significant   
The distribution for the BMQ V1-V2 scores, D(125) = 0.11, p< 0.05 is significantly not normal    
 
 
Skewness = -0.614 (-ve indicating pile up on right side, tail pointing to lower 
scores)   Kurtosis = 2.202 (+ve indicating pointy and heavy tailed).  These 
should be 0 in normal distribution. 
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2. MARS V1 – V2 scores 
 
 
 
 
 
 
 
 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
MARS V1 - V2 score .168 122 .000 .876 122 .000 
a. Lilliefors Significance Correction 
 
The distribution for the MARS V1 – V2 scores, D(122) = 0.168, p<0.05, is significantly not normal 
Skewness = - 0.138 (-ve indicating pile up on right side, tail pointing to lower 
scores)   Kurtosis = 5.783 (+ve indicating pointy and heavy tailed).  These 
should be 0 in normal distribution. 
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3. AC V1 –V2 scores 
 
 
 
 
 
 
 
 
 
 
 
 
 
The distribution for the AC V1 – V2 scores, D(127) = 0.125, p<0.05, is significantly not normal 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
AC V1 - V2 score .125 127 .000 .911 127 .000 
a. Lilliefors Significance Correction 
Skewness = 0.904 (+ve indicating pile up on left side, tail pointing to higher 
scores)   Kurtosis = 4.030 (+ve indicating pointy and heavy tailed).  These 
should be 0 in normal distribution. 
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Appendix 3.23: Rationale for statistical selection of independent variables 
Logistic Regression Analyses Pathway:
Study aim:  To identify predictors of inhaler technique maintenance one month post  
assessment  and instruction in a cohort of asthma patients.
-The study was designed to be exploratory with no a priori assumptions
-At 1 month n=127
-Data were collected for 28 unique study variables
Ideally  - All 28 unique
variables entered into 
a backwards stepwise 
logistic regression (Sun 
et al 1996)
Gives richer model and better prediction within this 
specific data set.
Detects more potential confounders within data set
The conditions of 
our data:
Sun et al. 1996 recommends 
method 1 over 2, as 
bivariate selection 'cannot 
possibly control for possible 
confounding'
Variable selection 
necessary for reliable 
anaylses 
1) Based on prior knowledge/
data/theory 
N = 127 
with Group 1=50 Group 2=77
Ideally ten cases per 
variable.
(50/10 = 5 variables) 
To do this N must be ≥ 560 cases (28x10x2).  
Method of
selection
2) Based on statistical
bivariate and univariate 
selection
'When data are inadeqate 
[including all study variables] 
can produce a numerically 
unstable multivariate model...we 
should select a subset of 
variables based on results of 
univariate analyses'  - Hosmer 
and Lemshow (2000, pg 96).
BUT study is exploratory due to lack of existing 
data; decided that no a prior assumptions  to be 
made;  no directly relevant theories exist 
Phase 1: Correlations - Pearsons, 
Point Biserial and Spearmans 
(p<.25)
Phase 2: Between groups 
differences - Mann Whitney 
U and Chi square test of 
independence (p<.25)
Phase 3: Univariate Logistic 
Regression (p<.25, 
Confidence interval does not 
cross 1)
Hosmer and Lemshow (2000) 
recognises the limitation of the 
univariate approach in  
accounting for confounders and 
to compensate recommends  'we 
should choose a significance level 
large enough to allow the 
suspected varibles [i.e. collection 
of counfounders] to become 
candidates for inclusion in the 
multivariable model' pg. 95
This level is a p-value<0.25 
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  Univariate Logistic Regression  
Variable                                    Description p value 95% Confidence Interval  
1a 
† ‡
Critical technique errors at V1 (≥1 vs 0) 0.02 1.15-5.09  
1b 
†
 Technique score at V1 (3-11) 0.0005 1.15-1.73  
1c 
†
 Number of critical errors at V1 0.01 0.38-0.89  
2a Preventer type (pMDI vs TH vs ACC) 0.09 0.90-5.23 (pMDI vs TH), 0.98-5.61 
(pMDI vs ACC). 
 
2b 
†
Preventer type (pMDI vs DPI) 0.03 1.08-4.68  
3 Preventer duration (0-45 years) 0.13 0.92-1.01  
4 Other devices (none vs same vs different) 0.06 0.17-1.62 (none vs same), 0.52-4.01 
(none vs different). 
 
5 Oral Asthma Medication (no vs yes) 0.85 0.18-4.01  
6a Other medication (None vs <5 vs ≥5) 0.31 0.61-3.02 (none vs <5), 0.78-6.45 
(none vs ≥5). 
 
6b Other medication (no vs yes) 0.24 0.74-3.30  
7a Age (18 -88 years) 0.83 0.98-1.02  
7b Age (<60 vs ≥60) 0.65 0.41-1.74  
8 Gender (male vs female) 0.59 0.37-1.77  
9 Education (primary&secondary vs tafe&tertiary) 0.12 0.86-3.65  
10 Asthma duration (0.08 - 81 years) 0.12 1.00-1.04  
11 Other medical conditions (no vs yes) 0.39 0.35-1.52  
12 Other lung conditions (no vs yes) 0.30 0.66-3.87  
13 Hospitalisations (0 vs ≥1) 0.95 0.37-2.57  
14a HCP visits (0 - 52 times) 0.01 0.75-1.00  
14b HCP visits (0 vs 1 vs 2 vs 3 vs >3) 0.34 0.23-2.76 (0 vs 1), 0.21-2.29 (0 vs 2), 
0.15-2.05 (0 vs 3)                                      
0.95-1.08 (0 vs >3). 
 
14c HCP visits (0 vs ≥1) 0.26 0.20-1.57  
15 When was preventer technique taught                                                         
(Never vs 1st prx OR after vs 1st prx & after) 
0.28 0.67-7.67 (never vs 1st prx Or after), 
0.71-15.85 (never vs 1st prx & after). 
 
16a Last preventer instruction (0.003 - 43 years) 0.56 0.94-1.03  
16b Last preventer instruction (≤3 m vs >3m) 0.32 0.27-1.53  
16c Last preventer instruction (≤1 m vs >1m) 0.12 0.19-1.22  
17 When was reliever technique taught                                                                                           
(Never vs 1st prx OR after vs 1st prx & after) 
0.42 0.67-6.95 (never vs 1st prx Or after), 
0.39 - 7.15(never vs 1st prx & after). 
 
18a Last reliever instruction (0.001 - 60 years) 0.08 0.99-1.05  
18b Last reliever instruction (≤1 m vs >1m) 0.19 0.18-1.42  
18c Last reliever instruction (≤3 m vs >3m) 0.10 0.17-1.18  
19 Mode of past technique instruction (No physical 
demo vs physical demo) 
0.5 0.62-2.63  
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20a Previous technique recheck (0-15 times) 0.28 0.85-1.59  
20b Previous technique recheck (no vs yes) 0.61 0.54-2.88  
21a Shown technique to others (0-100 times) 0.02 0.94-1.36  
21b Shown technique to others (0 vs once vs >once) 0.24 0.11-2.54 (0 vs once), 0.75-4.70 (0 vs 
> once). 
 
21c Shown technique to others (0 vs ≥once) 0.46 0.46-1.37  
22 Last shown technique (0.003 -  30 years) 0.09 0.85-1.02  
23a V1 Asthma Control score (0-4.7) 0.09 0.50-1.06  
23b 
†
V1 Asthma Control (≥1.5 vs <1.5) 0.02 1.13-4.90  
24a V1 Adherence score (6-25) 0.16 0.98-1.14  
24b V1 Adherence (≤21 vs >21) 0.60 0.59-2.51  
25a V1 Necessity score (7-25) 0.39 0.95-1.13  
25b V1 Necessity (<20 vs ≥20) 0.21 0.77-3.33  
26a V1 Concern score (5-24) 0.15 0.87-1.02  
26b V1 Concern (<20 vs ≥20) 0.09 0.79-13.94  
26c V1 Necessity Concerns Differential score (-10 to +20) 0.09 0.99-1.13  
27 V1 Inhaler Technique Beliefs score (9-30) 0.72 0.95-1.08  
28 
†
V1 Motivation SCORE (1-10) 0.01 1.05-1.54  
 
† Variables where p<.25 and the confidence interval does not cross 1. 
 
‡
 The dichotomised variable 'Visit 1 critical technique errors 'was chosen (over technique score or 
the number of critical errors at Visit 1) because: 
1. Dichotomising Visit 1 technique scores (into <11 and 11) results in uneven groups increasing 
chances of overfitting (i.e. two groups of n=24 vs n=115). 
2. Using raw visit 1 technique score is not ideal as the measurements do not fall on a continous 
scale i.e. the relative signifcance of of each step is not accounted for.  This is similar for the 
'number of critical errors'.  
Further using Visit 2 critical errors as the outcome measure was considered, but this 
measurement results in uneven groups increasing the chance of overfitting data (i.e. two groups 
of n=103 vs n=24)  
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Diagnostic statistics conducted for outliers and influential cases (Field, 2009). 
Diagnostic 
statistic  
Description/and model goodness of fit criteria  
Standardised 
Residuals 
• The residual is the difference between the value predicted by the 
regression model and value observed in the data set.  The smaller the 
residual the better he model fits the data.  A residual for each 
observation in the data set is calculated, collectively referred to as 
residuals.     
• Residuals are standardised in order to define general cut-off values.   
• The purpose of the Standardised residual is to identify points that the 
model fits poorly 
• Values of standardised residuals indicating model is poor fit for data: 
o If > 1% cases have values > 2.58, and 
o If  > 5% cases have values >1.96, and 
o If any case has a value > 3.29  
Cooks 
Distance  
• An influence statistic used to identify points that exert a 
disproportionate influence on the model.  
• Any value > 1 may indicate an  influential case  
DFBeta  • An influence statistic used to identify points that exert a 
disproportionate influence on the model.  
• Any value > 1 may indicate an influential case. 
Leverage  • An influence statistic used to identify points that exert a 
disproportionate influence on the model.  
• Average leverage is = (k+1)/N, where k is the number of predictors in 
model and N is the sample number.  
• Any value > 2 to 3 times the average leverage may indicate an 
influential case. 
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Assumptions tested for in the final logistic regression model generated to 
determine generalisability of model (Field, 2009, Bagley et al., 2001). 
 
Assumption tested Description and criteria for meeting assumption 
Independence or 
errors 
The cases of data are not related, i.e. each value of the outcome 
variable comes from a separate case.   
Sufficient cases per 
independent variable  
 
In logistic regression it is suggested that the number of the less 
common of the two possible outcomes (i.e. the smaller group of 
either the number of patients who did, or did not, maintain 
technique) divided by the number of predictor variables entered 
into the regression is ≥ 10.  
Multicollinearity • Multicollinearity describes a strong correlation between two 
or more predictor variables in a regression model. 
• Multicollinearity is undesirable and problematic for regression 
(it indicates unreliable regression coefficients, limits the 
amount of variance accounted for, makes it difficult to 
distinguish the important predictors). 
• The correlation matrix for predictor variables were scanned 
for high degree correlations (above 0.8) 
• Variance Inflation Factor (VIF) and Tolerance (1/VIF) statistics 
were examined to determine the degree of multicollinearity in 
the model generated. 
• VIF values > 10 is a cause for concern; an average VIF 
substantially > 1 indicates regression may be biased. 
• Tolerance values < 0.1 indicates a serious problem; tolerance 
< 0.2 indicates a potential problem. 
 
Conformity with 
linear gradient for 
continuous variables 
 
• Continuous variables in a logistic regression should conform 
with linearity of the logit. 
• To test for this assumption a logistic regression (forced entry 
method, all variables entered in as a single block) was 
performed with all of the qualifying variables as well as the 
interaction terms of any continuous predictor variables and 
their logs i.e. predictor variable x Ln(predictor variable). 
• A violation of the assumption of linearity of the logit is 
indicated by any interaction terms found to be significant 
after performing the regression.  
   
Cross-validation • Cross validation is when the accuracy of the regression model 
is assessed over different samples (Field, 2009). 
• A severe drop of the predictive power of the model when 
applied across a different sample means the model is not 
generalizable. 
• The adjusted R2 value was examined. It indicates the loss in 
predictive value/ shrinkage if the model is applied to the 
sample population.    
• The adjusted R2 was calculated using Stein’s formula: 
adjusted R2 = 1 – [(n-1/n-k-1)(n-2/n-k-2)(n+1/n)] (1 – R2), 
where R2 is the unadjusted value, n is number of participants 
and k is number of predictors. 
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Results for diagnostic statistics conducted to examine goodness of fit of 
model/for outliers and influential cases. 
Diagnostic statistic  Goodness of fit criteria  Results  
Standardised 
Residuals 
Values of standardised 
residuals indicating model 
is poor fit for data: 
• If > 1% cases have 
values > 2.58, and 
• If  > 5% cases have 
values >1.96, and 
• If any case has a 
value > 3.29 (Field, 
2009) 
No values were > 1.96 therefore this 
statistic did not identify any points 
which the model fits poorly. 
Cooks Distance  Any value > 1 may indicate 
an  influential case. 
No values were > 1; therefore this 
statistic did not identify any points 
that exerted a disproportionate 
influence on the model. 
DFBeta  Any value > 1 may indicate 
an influential case (Field, 
2009) (Field pg. 218) 
No values were > 1; therefore this 
statistic did not identify any points 
that exerted a disproportionate 
influence on the model. 
Leverage  Any value > 2 to 3 times the 
average leverage may 
indicate an influential case. 
• Expected leverage = K+1/N = 
4+1/125 = 0.04. 
• Two influential cases with values > 
2x0.04 = 0.08 were identified. 
• Leverage = 0.17 for case 16.  
Suspected reason: patient did not 
complete visit 2, therefore missing 
values. 
• Leverage = 0.18 for case 135.  
Suspected reason: outlier case i.e. 
patient maintained correct 
technique, had good asthma 
control, used a DPI, but scored low 
for motivation.  
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Results for assumptions tested to determine the generalisability of the logistic 
regression model. 
 
Assumption 
tested 
Criteria  Results  
Independence or 
errors 
Each value of the outcome 
variable comes from a 
separate case.   
All 125 cases used in the logistic 
regression were unique. 
Sufficient cases 
per independent 
variable  
 
N (the number of the smaller 
group of either patients who 
did, or did not, maintain 
technique)/ (number of 
predictor variables entered 
into the regression) ≥ 10.  
- N = 50 (number of patients not 
maintaining correct technique); 4 
predictor variables were entered in to 
the regression. 
- 50/4 = 12.5, indicating sufficient 
cases per independent variable.  
Multicollinearity - Correlations between 
predictor variables should not 
be > 0.8. 
- VIF values > 10 is a cause for 
concern; an average VIF 
substantially > 1 indicates 
regression may be biased. 
- Tolerance values < 0.1 
indicate a serious problem; 
tolerance < 0.2 indicates a 
potential problem. 
 
- No correlations between were > 0.8 
- No VIF value > 10 
- Average VIF = 1.08, which is not 
substantially greater than 1. 
- No tolerance values were < 0.2 (all 
tolerance values > 0.90). 
- These tests indicate that the 
assumption for no multicollinearity 
was met.  
Conformity with 
linear gradient for 
continuous 
variables 
 
If interaction terms for 
continuous variables are 
significant after performing 
the regression, the 
assumption of linerarity of the 
logit is violated. 
   
- One continuous predictor variable 
was entered into the regression, 
motivation. 
- A forced entry logistic regression 
was conducted with the following 
independent variables: inhaler 
technique, device type, asthma 
control, motivation, and 
Ln(motivation) x motivation. 
-   The interaction term was not 
significant in the regression model 
produced (p=0.93). 
- The assumption for linearity of the 
logit was met.  
Cross-validation - The adjusted R2 value 
indicates the loss in predictive 
value/ shrinkage if the model 
is applied to the sample 
population.    
- The adjusted R2 is calculated:  
adjusted R2 = 1 – [(n-1/n-k-
1)(n-2/n-k-2)(n+1/n)] (1 – R2), 
where R2 is the unadjusted 
value, n is number of 
participants and k is number 
of predictors. 
 
- Adjusted R2=0.1127 (given n=125, 
k=3, R2=0.1622) 
- Thus the predictive power of the 
model is calculated to shrink to 
11.27%, from 16.22%, if applied to the 
sample population.  
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This table shows the baseline factors significantly correlated with baseline motivation 
(Pearson’s R, p<0.05).   
  
 Motivation 
Motivation 1 
Inhaler Technique Beliefs 0.28 
Preventer necessity beliefs 0.20 
Preventer concerns beliefs -0.02 
Preventer Adherence 0.31 
Inhaler Technique 0.26 
Age 0.31 
Multiple medications 0.25 
Asthma duration 0.17 
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Letter of Invitation 
Dear_________________________ 
 
Mid last year you participated in the Inhaler Technique Maintenance Study at your local 
pharmacy.  You would have demonstrated the use of your inhaler device and also filled out some 
questionnaires.   
 
We would like to thank you for your contribution to our research and also invite you to take 
part in a telephone interview with the researcher (Ludmila Ovchinikova) on your views about 
your asthma and asthma medication.  Your personal opinions on the subject are very important 
to us. 
 
If you wish to take part, the researcher will conduct a telephone interview with you, at a time 
convenient for you.  You may freely voice any opinions you have about your asthma and asthma 
medications.  The interview will be audio-taped and will take between 15-30 minutes, depending 
on how much you wish to say.   
 
Your participation is voluntary and anything you disclose will be kept strictly confidential.  Further 
study information will be provided upon request or if you decide to take part.    
 
The researcher will be contacting you via telephone in one week’s time regarding your decision.   
 
If you are keen to take part please feel free to contact us so we can schedule an interview time.  
Also please do not hesitate to contact us if you have any further questions. 
 
Yours faithfully, 
 
 
Ludmila Ovchinikova and  
Dr Sinthia Bosnic-Anticevich 
11 March 2011 
   
 Sinthia Bosnic-Anticevich 
 BPharm(Hons), PhD 
Room N405 
Building A15 
University of Sydney NSW 2006  
AUSTRALIA 
Telephone:   +61 2 9351 5818 
Facsimile:  +61 2 9351 439 
Email:sinthia.bosnic-anticevich 
@sydney.edu.au 
Web:   www.usyd.edu.au/  
 
ABN 15 211 513 464 
Faculty of Pharmacy 
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Contact Information: 
 
LUDMILA OVCHINIKOVA 
BPharm(Hons), PhD Candidate 
Telephone: 9351 4501 
Mobile: 0404 437 770 
Email: ludmila.ovchinikova@sydney.edu.au 
 
 
OR  
 
SINTHIA BOSNIC-ANTICEVICH 
BPharm(Hons), PhD 
Telephone: 9351 5818 
Email: sinthia.bosnic-anticevich@sydney.edu.au 
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Patient: 
       Date: 
       Time: 
 
 
Interview Guide  
 
- Thank you  
 
- Interview about: experience with asthma and inhaler medication      
 
- Feel free to express your opinions  
  
- Some questions may seem repetitive – make sure I get exact meaning of what you’re saying and not misinterpreting 
anything. 
 
- Interview will be tape recorded 
 
- Everything you say to me will be kept confidential 
 
- Feel free to ask questions at any time during the interview 
 
- Before we start – are you comfortable?  We can pause at any time during the interview if you need, just let me know. 
 
Asthma  
 
1. Could you tell me about your experience with asthma? 
 
Identity: how has your asthma developed or changed over time? Has your asthma always been like this? 
 
Cause: What’s caused your asthma? 
 
Consequences: What is life like with asthma? 
 
Duration: Have you always had asthma? 
 
Cure: How can you get cured of asthma? 
 
* How severe would you rate your asthma? Always like this? 
* Any particularly bad/scary experiences with asthma?  
 
Asthma Control 
 
1. What does it mean to have well controlled asthma? (belief) 
 
2. How would you describe your level of asthma control? / 
    How well under control is your asthma? Always? 
  Why? signs? 
 
 
3. How confident do you feel that your asthma will always be well controlled? 
Why? (self-efficacy) 
 
 
4. How important is it to you for your asthma to be maintained at a well-controlled 
Appendix 4.02: Interview guide, version 8/final. 
 
347 
 
level? (value) 
   - Why? 
(Asthma control is about what your asthma is like on a day to day basis; in terms of, for instance - how bad your 
symptoms were when you woke in the morning, how short of breath you felt recently, how much you’ve wheezed recently, 
how much Ventolin you’ve used recently, if you’ve been woken up by asthma at night time and if you’ve found it more 
difficult to do your usual activities e.g. you may have missed work. 
So basically it’s how smoothly or not smoothly your day to day life is running because of your asthma. 
So does this make sense to you?) 
 
 
Self-management/ treatment strategies 
 
1. What sort of things do you do to get your asthma better? 
Why do you do these things? (motivation & autonomy for s/management) 
 
2. How do you know that what you’re doing is working? (Feedback) 
 
3. How capable do you feel about always being able to do the things you need to to 
manage your asthma? (self efficacy) 
 
4. Are there things that make it hard to manage your asthma they way you would 
like to? 
 
 
Medications 
 
- Clarify asthma medicines 
 
1.  Could you tell me about the medications that you are taking for your asthma… 
 
- what does it do for your asthma?  
 
- How is it different to Reliever 
 
- How do you know it’s working? (Feedback) 
 
 
 
2. Is there anything at all that concerns you about using your _______(prv)? 
 
 -  What about in the past? 
 
 -  Experienced anything (else) that concerns you?  e.g. SEs 
 
 
3. How necessary is it for you to have the ___________(prv) in your life?  Is this true 
for all of the time? 
 
 
 
4. Many people find a way to take their _________ (prv) that suits them, different to 
what was prescribed… 
 – How are you taking you’re taking your____(prv)?  Why? 
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5. How do you feel about your asthma treatment? Keeping on top of it? 
 
** When it comes to your asthma medication, in your opinion, what are the most 
important things that you need to be doing when you are taking them?** 
  
- What about the way that you use your inhaler? (autonomy – values technique, 
sees the purpose?) 
 
‘The way you use your inhaler’ 
 
1. How do you find it to physically use your inhaler devices? 
 
2. Do you know why your (preventer inhaler) come with those nitty gritty 
instructions for using them? 
 
3. Do you think the way that you use your inhaler (e.g. if you miss a step here and 
there) makes a difference your overall asthma? 
 How? (Importance or lack of) 
 
4. Do you think it’s worth the effort to remember all the steps? (Importance or lack 
of) 
 
5. So how willingly are you to follow the exact steps every single time you use your 
inhaler? Why? (direct motivation for technique) 
 
 
 6. How confident or capable do you feel about sticking to all of the steps every 
time you use your (prv)? 
  What makes you say that? 
 
 
Maintaining correct technique 
 
Relate to patient’s own scores: 
 
1. I noticed on our records that a lot of people came back at visit 2, after being 
shown by the pharmacist the correct technique, still with a few errors.   
 
 
 - Why do you think this is the case?  
 
 - What can we do to eliminate recurrent errors? 
 
 - What sort of things would help you stick to correct inhaler technique? 
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2. I noticed that like the a lot of people you missed out on a couple of steps with 
your inhaler technique when you came back the 2nd time, can you remember why 
this happened? 
 
HCPs 
 
1. Tell me, which health care professionals have you seen in the past or do you still 
see for your asthma? 
  
- How often would you see them? Who do you see most regularly? 
 
 
2. How helpful or supportive do you actually find them? 
- What about with inhaler use; how have they helped you here? 
- Was this as a result of being in the study or did it happen at other times? 
 
 
3.  (Besides what you have already mentioned) What (other) benefits do you think 
you get when you visit your (health care professional)? 
 - patient confidence, motivation   
 
Responsibility: 
 
1. Who do you think is responsible for making sure your asthma is well managed?/ 
Technique stays correct   
 
______________________________________________________________________ 
 
 
* Written information for you to keep 
* Consent form to sign and return in reply paid envelope included 
       Confirm address  
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Qualitative study themes; how Maintainers and Non-maintainers responded. 
− Themes identified in the qualitative study (relating to patient attitudes/beliefs, 
feelings and experiences regarding inhaler technique and device use; asthma, 
health and quality of life; asthma self-management; and social and therapeutic 
relationships) that may influence patient motivation to maintain correct inhaler 
technique.   
− Listed under each theme are those patients (identified by their interview number 
and initials) who reported that particular theme.   
− Patients who were Non-maintainers (those with less motivation to maintain correct 
technique) are underlined. Maintainers (patients with more motivation to maintain 
correct technique) are not underlined.  
 
Themes related to inhaler technique and device use 
Perceived 
importance of 
correct technique:  
〉 High importance: 
10:DD, 1:PS, 11:SM, 12:KK, 4:DR, 3:RL, 6:LN, 9:BB, 8:RH,  
2:JH, 5:LJ, 18:FE, 19:PF, 20:PL, 14:MC, 15:LF  
〉 Importance dependent on symptom presence –  greater importance when 
symptoms present: 
13:CH, 17:JC 
〉 Low importance: 
7:GW 
〉 Technique maintenance perceived as a matter of habit: 
12:KK, 3:RL, 9:BB, 8:RH, 4:DR,  
17:JC, 18:FE, 15:LF, 14:MC, 20:PL, 13:CH 
〉 Perceived improved technique associated with improved asthma symptoms: 
4:DD, 1:PS, 11:SM, 12:KK, 3:RL, 4:DR,  
13:CH, 17:JC, 19:PF 
 
Perceived 
ease/difficulty 
with inhaler 
device use: 
〉 Device/s perceived to be easy to use: 
10:DD, 1:PS, 11:SM, 3:RL, 4:DR, 6:LN, 8:RH, 9:BB,  
2:JH,7:GW, 13:CH, 15:LF, 20:PL 
〉 Use of multiple types of devices; not perceived to increase difficulty to practise 
correct technique; DPIs and pMDIs perceived equally easy to use: 
10:DD, 1:PS, 12:KK, 3:RL, 4:DR, 8:RH, 9:BB, 6:LN  
〉 pMDI perceived to be more difficult to use than DPI (and using both devices): 
17:JC  
〉 pMDI perceived to be difficult to use (using only pMDIs): 
14:MC, 19:PF 
 
Perceived 
confidence with 
maintaining 
correct technique: 
〉 High confidence: 
1:PS, 3:RL, 4:DR, 6:LN, 8:RH, 9:BB, 10:DD, 11:SM, 12:KK,  
2:JH, 7:GW, 5:LJ, 13:CH, 15:LF, 18:FE, 20:PL, 17:JC 
 
Perceived 
responsibility for 
correct technique  
maintenance:  
〉 Predominantly personal or shared (with HCP) responsibility: 
11:SM, 3:RL, 12:KK, 6:LN, 9:BB, 8:RH,  
2:JH, 15:LF 
〉 Minimal personal responsibility; responsibility attributed to external agents 
(e.g. HCPs): 
7:GW, 5:LJ, 17:JC, 20:PL  
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Themes related to asthma, health and quality of life 
Concept of 
asthma and 
acceptance of 
diagnosis 
〉 Asthma related to symptom experience: 
10:DD, 1:PS, 11:SM, 12:KK, 3:RL, 4:DR, 6:LN, 8:RH, 9:BB,  
2:JH, 5:LJ, 7:GW, 13:CH, 14:MC, 15:LF, 16:VT, 19:PF, 20:PL 
〉 Diagnosis of asthma was denied in the past or currently: 
11:SM, 1:PS,  
18:FE, 19:PF 
 
Duration of 
asthma 
〉 Chronic:  
12:KK, 
 5:LJ, 14:MC 
〉 Episodic: 
10:DD, 11:SM, 9:BB, 4:DR,  
2:JH, 7:GW, 16:VT, 18:FE, 20:PL 
 
Cause of asthma 〉 Genetic:  
4:DR,  
5:LJ 
〉 Cigarette smoking:  
10:DD, 1:PS 
〉 Stress and trauma:  
10:DD 
〉 Allergens:  
2:JH 
〉 Medication (B-blocker) side effect:  
11:SM 
〉 Unknown:  
9:BB, 3:RL, 6:LN 
 
Importance of 
asthma control, 
health and quality 
of life.  
 
〉 Good asthma control believed important for health and quality of life: 
10:DD, 1:PS, 11:SM, 12:KK,3:RL, 4:DR, 8:RH, 6:LN, 9:BB,  
2:JH, 7:GW, 5:LJ, 18:FE, 20:PL, 13:CH, 14:MC, 15:LF, 16:VT, 17:JC, 19:PF 
〉 Health highly valued: 
1:PS, 12:KK, 10:DD, 11:SM, 6:LN, 8:RH,  
2:JH 
 
Perceived threat 
of asthma and  
〉 High threat to quality of life and/or mortality; turning point experiences: 
10:DD, 9:BB, 3:RL, 8:RH, 12:KK, 4:DR, 6:LN, 1:PS, 2:JH, 19:PF, 20:PL, 5:LJ, 
13:CH 
〉 Minimal threat to quality of life and health: 
7:GW, 15:LF, 16:VT, 14:MC, 20:PL 
 
Memorable 
experiences of 
past asthma 
exacerbations 
〉 Severe asthma exacerbations experienced in past:  
4:DR, 1:PS,8:RH, 9:BB, 3:RL, 10:DD, 6:LN, 11:SM, 12:KK, 5:LJ, 2:JH, 14:MC, 
15:LF, 17:JC, 18:FE, 19:PF, 20:PL 
〉 Severe asthma exacerbations never experienced: 
7:GW, 16:VT 
〉 Severe asthma exacerbations experienced for the first time at time of interview: 
13:CH 
 
Witnessing 〉 Witnessing severe asthma symptoms in others reinforces high perceived threat: 
 Appendix: 4.04: Qualitative study themes and how Maintainers and Non-
maintainers responded. 
 
353 
 
asthma in others 6:LN,  
5:LJ 
〉 Witnessing severe asthma symptoms in others reinforces low perceived threat: 
10:DD, 11:SM, 
7:GW, 16:VT 
 
Themes related to asthma self-management 
Attitude and 
approach to self-
management    
〉 Preventative attitude/approaches (via medication or lifestyle strategies): 
4:DR, 3:RL, 9:BB, 1:PS, 12:KK, 6:LN, 8:RH,  
2:JH, 5:LJ, 14;MC, 15:LF, 17:JC, 19:PF 
〉 Reactive, symptom based use of preventer: 
11:SM, 10:DD,  
7:GW, 20:PL, 13:CH, 16:VT, 18:FE 
 
Attitude toward 
medication in 
general 
〉 Beneficial to take whatever medication is necessary to stay well: 
12:KK, 11:SM, 
 5:LJ 
〉 Medication should be avoided: 
1:PS, 11:SM, 10:DD,  
2:JH, 19:PF, 20:PL, 18:FE 
 
Attitude toward 
preventer 
medication   
〉 High necessity – asthma control achieved via medication: 
11:SM, 12:KK, 3:RL, 4:DR, 6:LN, 8:RH, 1:PS, 9:BB,  
5:LJ, 14:MC, 15:LF, 17:JC, 19:PF, 20:PL 
〉 Low necessity – asthma control primarily achieved via lifestyle means  (fitness, 
allergy avoidance, quitting smoking):  
10:DD,  
2:JH, 13:CH, 18:FE 
〉 Benefits perceived (asthma symptoms improved): 
11:SM, 12:KK, 3:RL, 4:DR, 6:LN, 8:RH, 9:BB, 1:PS,  
17:JC, 15:LF, 19:PF, 20:PL 
〉 No or inconsistent benefits perceived: 
2:JH, 7:GW, 5:LJ, 13:CH, 18:FE 
〉 Immediate uncomfortable physical sensation felt after DPI use: 
2:JH, 15:LF  
〉 Side effects experienced with ICS (e.g. oral thrush, sore throat): 
10:DD, 1:PS,  
5:LJ, 15:LF, 18:FE 
〉 No side effects with ICS: 
11:SM, 12:KK, 3:RL, 4:DR, 6:LN, 8:RH, 9:BB,  
2:JH, 7:GW, 13:CH, 14:MC, 19:PF, 20:PL 
〉 No concerns: 
11:SM, 12:KK, 3:RL, 4:DR, 8:RH,  
7:GW, 13:CH 
〉 Current and/or past concerns: 
6:LN, 10:DD, 1:PS,  
2:JH, 5:LJ, 17:JC, 18:FE, 14:MC 
 
Influence of 
comorbidities on 
asthma self-
management 
〉 Co-morbid respiratory conditions boosted motivation to maintain lung health:  
1:PS, 4:DR, 6:LN, 11:SM, 3:RL, 8:RH, 9:BB, 12:KK,  
14:MC, 19:PF 
〉 Co-morbidities (e.g. hypertension and diabetes) were prioritised over asthma: 
4:DR, 10:DD, 11:SM,  
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7:GW, 16:VT, 18:FE, 20:PL 
〉 Co-morbidities (e.g. HF, ABPA, depression) increased difficulty to self-manage 
asthma: 
13:CH, 5:LJ 
 
Social and 
personal barriers 
to good  self-
management  
〉 Medication costs perceived to be too high (due to non-pbs listing, poly-
pharmacy): 
1:PS,  
5:LJ 
〉 Trauma (loss of job, divorce, death of loved ones): 
10:DD,  
5:LJ, 13:CH, 16:VT, 20:PL 
 
Perceived 
confidence with 
self-management  
〉 High (based on effectiveness of past self-management, availability of effective 
medication treatment and health care professional support): 
10:DD, 1:PS, 6:LN, 11:SM, 4:DR, 9:BB, 12:KK, 3:RL,  
2:JH, 20:PL, 14:MC, 15:LF, 18:FE 
〉 Low or ambivalent : 
7:GW, 5:LJ, 13:CH, 19:PF 
 
Perceived 
responsibility for 
self-management  
〉 Predominantly personal or shared (with HCP) responsibility: 
1:PS, 12:KK, 3:RL, 4:DR, 6:LN, 9:BB, 8:RH,  
2:JH, 14:MC, 15:LF, 16:VT, 17:JC, 18:FE, 19:PF, 20:PL 
〉 Minimal personal responsibility; responsibility attributed to external agents 
(e.g. HCPs): 
5:LJ, 13:CH 
 
Themes related to social and therapeutic relationships 
Perceived 
satisfaction, trust 
and rapport  with 
HCPs 
〉 High (with all HCPs): 
10:DD, 1:PS, 11:SM, 12:KK, 3:RL, 4:DR, 6:LN, 8:RH, 
 2:JH, 14:MC, 16:VT, 18:FE, 19:PF 
〉 Low (with one or more HCP): 
13:CH, 20:PL, 5:LJ 
〉 Mixed (varied between HCPs): 
15:LF, 17:JC 
〉 Indifferent: 
7:GW 
 
Perceived support 
from significant 
others 
〉 Family identified as a source of support in asthma management: 
12:KK, 4:DR, 6:LN  
14:MC, 17:JC, 18:FE 
〉 Desire to reduce burden of ill health on family identified as a source of 
motivation to maintain well controlled asthma: 
12:KK, 4:DR, 6:LN,  
13:CH 
〉 Friends and colleagues identified as a source of support in asthma management: 
10:DD, 12:KK,  
14:MC 
〉 Lack of perceived support from family and friends in asthma management: 
5:LJ, 13:CH, 19:PF 
 
 Appendix 4.05: Individual patient responses on core study themes and the 
interrelatedness of core study themes.   
 
355 
 
 
 
The interconnected themes characterising patients with higher (initials) and lower (initials, underlined) motivation for 
inhaler technique maintenance. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
1. Motivation to actively 
engage in asthma 
management 
2. Motivation for a 
preventative and medication 
based self-management 
approach. 
3. Confidence, or belief, in 
one’s ability to self-manage 
effectively. 
a. Weaker motivation b. Stronger motivation 
a. Weaker motivation b. Stronger motivation 
a. Weaker self-efficacy  b. Stronger self-efficacy  
7:GW, 14:MC, 15:LF, 
16:VT, 20:PL. 
1:PS, 2:JH, 3:RL, 4:DR, 5:LJ 
6:LN, 8:RH, 9:BB, 10:DD, 
12:KK, 13:CH, 15:PF.  
2:JH, 10:DD, 13:CH, 
18:FE. 
1:PS, 3:RL, 4:DR, 5:LJ 6:LN, 
8:RH, 9:BB, 11:SM, 12:KK, 
19:PF. 
5:LJ, 15:PF. 
 
1:PS, 3:RL, 4:DR, 6:LN, 
9:BB, 11:SM, 12:KK. 
Amongst patients with stronger motivation 
to engage in asthma management: 
Amongst patients with stronger 
motivation for preventative and 
medication based self-management:  
– Perceived threat of 
asthma on wellbeing. 
– Memorable 
experiences of past 
asthma symptom 
exacerbations. 
– Perceived threat of 
asthma on wellbeing. 
– Attitudes and beliefs 
on ideal self-
management 
strategies. 
– Attitudes and beliefs 
toward medication in 
general. 
– Attitudes, beliefs 
and knowledge on 
asthma medication. 
 
– Appraisal of past 
self-management 
strategies. 
– Perceived 
controllability of 
asthma. 
– Emotional 
responses to asthma. 
– Social support 
 
 
 
Core themes: Corroborating themes: 
